{
  "experiment_metadata": {
    "model": "qwen3-32b",
    "experiment": "e1_kg_minimal",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000
  },
  "results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "Between 2023 and 2024, the gross benefit obligation for LMT's nonqualified defined benefit pension plans decreased from $1.0 billion to $905 million. Additionally, the actuarial losses recorded in accumulated other comprehensive loss, pretax, declined from $347 million in 2023 to $303 million in 2024, indicating a reduction in the net actuarial losses related to these plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Announces]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Nonqualified Defined Benefit Pension Plans (FIN_INST)",
        "Nonqualified Defined Benefit Pension Plans (FIN_INST) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3700,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 94,
        "total_tokens": 1669
      }
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "General Motors' long-term rate of return assumption on U.S. pension plan assets increased from 5.4% at December 31, 2021 (as reported in the 2022 10-K) to 6.5% at December 31, 2024 (as stated in the 2024 10-K), reflecting a significant upward revision of 1.1 percentage points over the period. This increase indicates a strategic adjustment in the company's asset mix, with a likely shift toward higher-yielding or alternative asset classes aimed at improving funded positions and mitigating volatility. The company's rebalancing of the pension asset portfolio aligns with its broader objective of aligning the strategic asset mix with long-term liabilities and risk tolerance, as guided by periodic studies and fiduciary considerations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Rebalances]- ORG",
      "triplets_used": [
        "GM (ORG) -> Asset Portfolio Mix (ACCOUNTING_POLICY)",
        "Asset Portfolio Mix (ACCOUNTING_POLICY) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7231,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2466,
        "completion_tokens": 184,
        "total_tokens": 2650
      }
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "Chevron's relationship with PDC Energy evolved significantly between 2023 and 2024, as PDC was acquired by Chevron in a business combination during 2023, as noted in the 2023 10-K. By 2024, the integration of PDC's legacy assets contributed to a $2.2 billion increase in U.S. upstream sales volumes and a 19% rise in net oil-equivalent production, driven by the full-year inclusion of PDC's operations. However, these gains were partially offset by lower realizations reducing earnings by $790 million, as detailed in the 2024 10-K. The acquisition thus had a material operational and financial impact, enhancing production and sales but also introducing realization challenges.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> PDC Energy (COMP)",
        "PDC Energy (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3439,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 169,
        "total_tokens": 1664
      }
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "Between 2022 and 2024, Southern Company's treatment and valuation of energy-related derivatives shifted in terms of financial statement presentation. In 2022, the company disclosed the pre-tax effects of unrealized gains (losses) from energy-related derivatives designated as regulatory hedging instruments, which were deferred. By 2024, the company reflected the fair value of energy-related derivatives in its balance sheets, categorizing them as either assets or liabilities under \"Other\" or separately as \"Risk Management Activities,\" indicating a change in how these instruments were valued and presented. This shift suggests a move from deferring unrealized gains and losses to recognizing their fair value directly on the balance sheet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Energy-Related Derivatives (FIN_INST)",
        "Energy-Related Derivatives (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_324",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_283",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 731,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 840,
        "completion_tokens": 185,
        "total_tokens": 1025
      }
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "Between 2022 and 2024, Chevron's financial relationship with Tengizchevroil (TCO) showed a decline in both investment carrying value and equity earnings. At the end of 2024, the carrying value of Chevron's investment in TCO was $27,368 million, up slightly from $26,954 million in 2023 but still lower than the $27,368 million in 2022. Meanwhile, Chevron's equity earnings from TCO dropped from $4,386 million in 2022 to $3,375 million in 2023 and further to $3,033 million in 2024, reflecting a consistent decline in returns from this joint venture. This trend suggests a weakening financial performance or operational challenges at TCO during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Tengizchevroil (COMP)",
        "Tengizchevroil (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8204,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2689,
        "completion_tokens": 164,
        "total_tokens": 2854
      }
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "Walmart's ownership stake in Alert Innovation evolved significantly between fiscal 2023 and fiscal 2024. In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, making Walmart a 100% owner. However, by fiscal 2024, this relationship changed as the entity was subsequently sold and deconsolidated in fiscal 2025, effectively ending Walmart's ownership stake in Alert Innovation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Sells]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Alert Innovation (COMP)",
        "Alert Innovation (COMP) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6013,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2144,
        "completion_tokens": 117,
        "total_tokens": 2261
      }
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "Starbucks' foreign currency - other derivative asset position increased significantly from $32.0 million in fiscal 2023 to $1.9 million in current assets and $1.7 million in long-term assets in fiscal 2024, while its derivative liability position rose from $2.0 million to $4.7 million in current liabilities and $4.1 million in long-term liabilities. This shift suggests a more active use of derivative instruments to hedge against foreign currency exposure, indicating that Starbucks is proactively managing its currency risk through a diversified strategy that includes both asset and liability positions to mitigate potential volatility in earnings from foreign operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Foreign currency - other (FIN_INST)",
        "Foreign currency - other (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7017,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2409,
        "completion_tokens": 169,
        "total_tokens": 2579
      }
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "Between fiscal years 2022 and 2024, Medtronic's treatment of A Preferred Shares evolved from having 1,872 shares outstanding in 2022 to having none outstanding by 2024. Specifically, in the third quarter of fiscal year 2022, Medtronic redeemed the 1,872 previously outstanding A Preferred Shares for $0.075 million, after which no A Preferred Shares were outstanding as of April 29, 2022. This status was maintained through fiscal year 2024, as no A Preferred Shares were outstanding as of April 26, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> A Preferred Shares (FIN_INST)",
        "A Preferred Shares (FIN_INST) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4257,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1705,
        "completion_tokens": 126,
        "total_tokens": 1832
      }
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "Between 2022 and 2023, Comcast's financial relationship with Atairos, in terms of equity income (losses) driven by fair value adjustments on underlying investments, shifted from a loss of $434 million in 2022 to income of $1.1 billion in 2023. This significant improvement reflects a turnaround in the fair value adjustments of Atairos’s portfolio, indicating stronger performance of its underlying investments in 2023 compared to the prior year. These changes directly impacted Comcast’s equity in net income (losses) of investees, highlighting the volatility and strategic importance of this investment in Comcast’s consolidated financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Atairos (COMP)",
        "Atairos (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4425,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1748,
        "completion_tokens": 162,
        "total_tokens": 1911
      }
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "From 2023 to 2024, COP's natural gas reserves in the Asia Pacific/Middle East region decreased slightly from 312 billion cubic feet at the end of 2023 to 296 billion cubic feet at the end of 2024. This decline was primarily driven by production and sales, which reduced reserves by 25 billion and 385 billion cubic feet, respectively, partially offset by minor revisions and extensions. Despite the reserve decline, COP continues to operate in the Asia Pacific/Middle East region, as disclosed in its 10-K filings, indicating a strategic presence in the area, albeit with a focus on managing existing reserves rather than significant new developments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Asia Pacific/Middle East (GPE)",
        "Asia Pacific/Middle East (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_150",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 18440,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5259,
        "completion_tokens": 162,
        "total_tokens": 5422
      }
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "ENBREL's revenue in Canada declined from $113 million in 2021 to $73 million in 2022 (-35%), further dropped to $47 million in 2023 (-36%), and fell to $28 million in 2024 (-40%), indicating a consistent and accelerating decline in its market performance. This downward trajectory suggests weakening demand or market share in Canada, likely reflecting broader challenges for ENBREL as a product, as disclosed by AMGN. The continued revenue erosion underscores a negative market trend for ENBREL in the Canadian market over the 2022–2024 period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> ENBREL - Canada (PRODUCT)",
        "ENBREL - Canada (PRODUCT) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1494,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1007,
        "completion_tokens": 136,
        "total_tokens": 1143
      }
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "From fiscal 2023 to fiscal 2024, Qualcomm has maintained a consistent focus on linking human capital advancements with executive compensation, with the HR and Compensation Committee considering progress in this area when determining executives' bonuses. In fiscal 2024, this linkage was formalized as a non-financial performance modifier, which could adjust executives' bonus payouts by a multiple ranging from 0.9 to 1.1, based on the company’s progress toward human capital advancements. This approach reflects Qualcomm’s ongoing commitment to aligning leadership incentives with broader workforce development and inclusion goals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Focuses_On]-> CONCEPT <-[Guides_On]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> Human Capital Advancements (CONCEPT)",
        "Human Capital Advancements (CONCEPT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11875,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3625,
        "completion_tokens": 158,
        "total_tokens": 3783
      }
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "Between 2022 and 2024, the therapeutic scope of Breyanzi expanded significantly. In 2022, Breyanzi was in development for 3L+ Chronic Lymphocytic Leukemia (CLL) and 3L+ Follicular Lymphoma (FL), with trials TRANSCEND-CLL-004 and TRANSCEND-FL expected to conclude in 2023/24. By 2024, Breyanzi received FDA accelerated approval in March for relapsed or refractory CLL or Small Lymphocytic Lymphoma (SLL) in patients with at least two prior therapies, and in May for relapsed or refractory FL after two or more lines of treatment, reflecting a broader and more defined indication for B-cell malignancies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Breyanzi (PRODUCT)",
        "Breyanzi (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3783,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1578,
        "completion_tokens": 150,
        "total_tokens": 1728
      }
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "Disney's Resorts and Vacations segment reported revenue of $7,949 million in 2023 and $8,375 million in 2024, reflecting a 5% growth. This growth is slightly lower than the overall revenue growth of the Parks & Experiences segment, which increased by 5% as well, from $32,549 million in 2023 to $34,151 million in 2024. While both the segment and the broader Parks & Experiences division grew at the same rate, the Resorts and Vacations segment's performance was a key contributor to the overall segment growth, driven by continued demand for Disney's hotel stays, cruise vacations, and vacation club properties.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Resorts and Vacations (PRODUCT)",
        "Resorts and Vacations (PRODUCT) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6124,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2181,
        "completion_tokens": 153,
        "total_tokens": 2334
      }
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "Between 2023 and 2024, the structure and value of CVS's forward contracts associated with ASR transactions evolved in terms of notional amounts and timing. In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion, with the remaining 20% of shares received in February 2023. In 2024, the Company entered into a larger $3.0 billion ASR with Morgan Stanley, which was structured as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion, with the remaining 15% of shares received in March 2024. This shift reflects a larger notional amount and a slightly reduced percentage (15% vs. 20%) for the final share delivery, while maintaining a consistent $0.4 billion forward contract value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Reclassifies]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Forward Contract (FIN_INST)",
        "Forward Contract (FIN_INST) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_175",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5342,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1974,
        "completion_tokens": 211,
        "total_tokens": 2186
      }
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology showed increased transparency from 2023 to 2024 in terms of fair value categorization. In both 2023 and 2024, the company noted that certain investments measured using the net asset value per share practical expedient were not categorized in the fair value hierarchy. However, in the 2024 10-K filing, Duke Energy added a reconciliation table for Level 3 assets, providing a detailed breakdown of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets measured at fair value with significant unobservable inputs. This enhancement in 2024 reflects a step toward greater transparency in how the trust's assets are valued and categorized under the fair value hierarchy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Master Retirement Trust (FIN_INST)",
        "Master Retirement Trust (FIN_INST) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_219",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_228",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1626,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1062,
        "completion_tokens": 206,
        "total_tokens": 1268
      }
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "Between 2023 and 2024, Pfizer's financial obligations and revenue recognition related to Paxlovid shifted significantly due to the U.S. government's return of EUA-labeled inventory and the creation of the U.S. Strategic National Stockpile (SNS). In 2023, Pfizer recorded a $3.5 billion non-cash revenue reversal, partially related to 2022 sales, due to the expected return of 6.5 million treatment courses. By 2024, this was adjusted to a $771 million favorable adjustment after 5.1 million courses were actually returned by February 29, 2024. Additionally, in 2024, Pfizer recognized $442 million in revenue tied to the creation of the U.S. SNS, which includes 1.0 million treatment courses to be supplied at no cost through 2028. These changes reflect a transition from government procurement to commercialization and long-term pandemic preparedness.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Paxlovid (PRODUCT)",
        "Paxlovid (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7438,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2513,
        "completion_tokens": 213,
        "total_tokens": 2726
      }
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "ERLEADA's financial performance increased significantly from 2022 to 2023, with sales rising from $1,881 million to $2,387 million, representing a 26.9% total growth, driven by a 27.5% operational increase, partially offset by a 0.6% negative currency impact. This strong growth highlights ERLEADA's growing importance within J&J's oncology portfolio, especially as ZYTIGA's sales declined by 49.9% during the same period. The performance underscores ERLEADA's role as a key contributor to J&J's oncology segment, which saw an overall 10.5% increase in revenue in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> ERLEADA (PRODUCT)",
        "ERLEADA (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10486,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3253,
        "completion_tokens": 142,
        "total_tokens": 3395
      }
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "ERLEADA's global sales increased from $1,291 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This significant rise indicates a strong market trajectory, reflecting successful market penetration and acceptance of the product, which is produced and disclosed by JNJ. The growth outperformed many other oncology products and highlights ERLEADA's increasing role in JNJ's oncology portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> ERLEADA (PRODUCT)",
        "ERLEADA (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9265,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2943,
        "completion_tokens": 102,
        "total_tokens": 3046
      }
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "NVDA's debt management strategy regarding the 0.584% Notes Due 2024 evolved from fiscal year 2023 to 2024, as the company repaid the notes in fiscal year 2025, as disclosed in the 2024 10-K. In both fiscal years 2023 and 2024, the notes had a consistent carrying value of $1,250 million, with an effective interest rate of 0.66% and a remaining term of 0.4 years as of January 28, 2024. The repayment of the notes in fiscal year 2025 reflects a proactive approach to managing short-term debt obligations, aligning with the company's broader financial strategy to maintain compliance with covenants and optimize capital structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> 0.584% Notes Due 2024 (FIN_INST)",
        "0.584% Notes Due 2024 (FIN_INST) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4454,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1747,
        "completion_tokens": 157,
        "total_tokens": 1904
      }
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "Honeywell's investment in Mortgage/Asset-backed securities significantly decreased between 2022 and 2023. In 2022, the investment was reported at $982 million under U.S. Plans, while in 2023, it dropped to $10 million under Non-U.S. Plans, representing a reduction of $972 million. This decline highlights a substantial shift in Honeywell's investment strategy or asset allocation in this category during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "HON (ORG) -> Mortgage/Asset-backed securities (FIN_INST)",
        "Mortgage/Asset-backed securities (FIN_INST) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7528,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2525,
        "completion_tokens": 104,
        "total_tokens": 2629
      }
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "Between 2022 and 2023, Capital One (COF) continued to utilize securitized debt obligations as part of its diversified funding mix, alongside deposits, senior and subordinated notes, and other wholesale funding sources. In 2023, securitized debt obligations had a carrying value of $18,043 million and a fair value of $18,067 million, classified entirely under Level 2 of the fair value hierarchy, indicating they were valued using observable market inputs. This reflects their role as a stable and accessible component of COF’s funding strategy, consistent with the company’s objective of maintaining a diverse funding portfolio to support liquidity and capital needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Raises]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "COF (ORG) -> Securitized Debt Obligations (FIN_INST)",
        "Securitized Debt Obligations (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_210",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5947,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2139,
        "completion_tokens": 167,
        "total_tokens": 2306
      }
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "From 2023 to 2024, JPMorgan’s treatment of CECL capital transition provisions under U.S. capital rules reflected a phase-in process, as the CECL-related capital benefit decreased from $1.4 billion as of December 31, 2023, to $720 million as of December 31, 2024, with the benefit fully phased in by January 1, 2025. This quantitative change represents a reduction of $680 million in the CECL-related capital benefit during the period, consistent with the transition provisions in the U.S. capital rules, which also permitted the application of the Standardized approach to certain assets, including those from First Republic.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "JPM (ORG) -> U.S. Capital Rules (REGULATORY_REQUIREMENT)",
        "U.S. Capital Rules (REGULATORY_REQUIREMENT) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2938,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 156,
        "total_tokens": 1556
      }
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolved significantly. In December 2020, Salesforce established a $3.0 billion unsecured revolving credit facility under the Prior Credit Agreement, which was set to mature in December 2025. In October 2024, Salesforce replaced this with a new Revolving Loan Credit Agreement, increasing the facility's capacity to $5.0 billion and extending its maturity to October 2029. Notably, there were no outstanding borrowings under either facility as of the respective reporting dates (January 31, 2024, and January 31, 2025). The amendments reflect a strategic enhancement of Salesforce's financial flexibility for general corporate purposes, including potential acquisitions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CRM (ORG) -> Revolving Loan Credit Agreement (FIN_INST)",
        "Revolving Loan Credit Agreement (FIN_INST) -> CRM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7228,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2446,
        "completion_tokens": 194,
        "total_tokens": 2640
      }
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "Between 2022 and 2024, UPS operated its Coyote truckload brokerage services as part of its Supply Chain Solutions business, offering customized capacity solutions through a combination of its fleet and third-party carriers. However, in the third quarter of 2024, UPS completed the divestiture of Coyote, resulting in a pre-tax gain of $156 million ($152 million after tax) recorded in Other expenses in the 2024 consolidated income statement. This strategic move marked a shift from maintaining Coyote as a part of its logistics portfolio to divesting it, thereby impacting UPS’s 2024 financials positively through the gain on the sale.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Divests]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Coyote (COMP)",
        "Coyote (COMP) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9280,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2945,
        "completion_tokens": 159,
        "total_tokens": 3104
      }
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "Between 2023 and 2024, Union Pacific's relationship with chassis significantly shifted, with a notable decrease in both total units and ownership. In 2023, Union Pacific owned 30,635 chassis and leased 17,705, totaling 48,340 units with an average age of 13.2 years. By 2024, the total chassis count dropped to 5,553 units, with only 4,356 owned and 1,197 leased, reflecting a substantial reduction in both ownership and reliance on chassis. This shift indicates a strategic move away from chassis dependency, as highlighted by the ORG-PRODUCT relationship in the knowledge graph.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Chassis (PRODUCT)",
        "Chassis (PRODUCT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_8",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 991,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 879,
        "completion_tokens": 145,
        "total_tokens": 1024
      }
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "Between 2022 and 2024, Boeing has consistently classified its aluminum agreements as derivative instruments for accounting purposes, but not designated for hedge accounting treatment. In 2022, these agreements were described as being used to address long-term strategic sourcing objectives and non-U.S. business requirements, with changes in fair value recorded directly in earnings. By 2024, the agreements remained similarly structured, with the added detail that the quantities of aluminum are offset and priced at prevailing market prices. Additionally, in 2024, Boeing expanded its use of derivative instruments to include foreign currency forward contracts and commodity swaps, extending its risk management approach. The time horizon for these aluminum agreements was not explicitly stated in 2022, but in 2024, Boeing indicated that its broader commodity contracts hedge forecasted transactions through 2028, suggesting a potential extension or alignment of the aluminum agreements' timeframes with this longer horizon.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "BA (ORG) -> Aluminum Agreements (FIN_INST)",
        "Aluminum Agreements (FIN_INST) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4847,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1863,
        "completion_tokens": 256,
        "total_tokens": 2120
      }
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "Procter & Gamble's exposure to currency rate risk has remained materially unchanged between the fiscal years ended June 30, 2023, and June 30, 2024. The company continues to leverage its diversified global operations as a natural hedge and employs forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk associated with financing operations. PG maintains confidence in its ability to mitigate near-term exchange rate fluctuations, as it believes—at a 95% confidence level based on historical currency rate movements—that a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "PG (ORG) -> Currency Rate Exposure (RISK_FACTOR)",
        "Currency Rate Exposure (RISK_FACTOR) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11256,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3479,
        "completion_tokens": 171,
        "total_tokens": 3651
      }
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "Between 2022 and 2024, Adobe has significantly expanded Frame.io's functional scope and integration with its ecosystem. In 2022, Frame.io was listed as a trademark under Adobe, indicating its ownership and inclusion in Adobe's portfolio. By 2024, Frame.io had evolved into a cloud-native creative collaboration platform with enhanced capabilities, including support for video workflows beyond post-production (e.g., casting, location scouting, and marketing campaign management), as well as integration with still images, design files, and PDFs. It is directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, enabling seamless frame-specific feedback. Additionally, Frame.io is part of Adobe GenStudio, a suite that includes Adobe Express and Firefly Services, allowing for scalable content production. This evolution reflects Adobe's strategy to position Frame.io as a central hub for collaborative creative workflows, deeply embedded within its broader product ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Frame.io (COMP)",
        "Frame.io (COMP) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5921,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2117,
        "completion_tokens": 253,
        "total_tokens": 2371
      }
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "Between the 2022 and 2023 fiscal years, AMD's financial relationship with the ATMP JV remained consistent in terms of its 15% equity interest and the use of the equity method of accounting due to significant influence. The carrying value of AMD's investment in the ATMP JV increased from approximately $69 million as of December 25, 2022, to $69 million as of December 25, 2023, indicating no material change in valuation during the period. Financial disclosures in both years included details on purchases from and resales to the ATMP JV, with 2023 continuing to report these transactions as non-impactful to the consolidated statement of operations. Additionally, AMD maintained its position of no obligation to fund the ATMP JV, and no goodwill impairment was recorded in either year, as confirmed by annual impairment tests.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "AMD (ORG) -> ATMP JV (COMP)",
        "ATMP JV (COMP) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5282,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1966,
        "completion_tokens": 207,
        "total_tokens": 2173
      }
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024, indicating a decline of $174 million. Despite this reduction, the segment remains a key component of Honeywell's Aerospace Technologies division, which saw overall growth in net sales. This suggests that while Honeywell's position in the original equipment market may be facing headwinds, its broader aerospace business is benefiting from increased demand in areas like the aftermarket and defense, reinforcing its diversified presence in the aerospace sector.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "HON (ORG) -> Commercial Aviation Original Equipment (PRODUCT)",
        "Commercial Aviation Original Equipment (PRODUCT) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6716,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2332,
        "completion_tokens": 147,
        "total_tokens": 2479
      }
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "The global revenue contribution from Heart Failure Devices increased from $1,161 million in 2023 to $1,279 million in 2024, representing a 10.2% total change in revenue. This growth was slightly adjusted for exchange rate impacts, resulting in a 10.3% increase excluding exchange effects, highlighting the segment's strong performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Increases]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Heart Failure Devices (PRODUCT)",
        "Heart Failure Devices (PRODUCT) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2024.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7231,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2450,
        "completion_tokens": 83,
        "total_tokens": 2534
      }
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "Between 2022 and 2023, IBM's treatment of the 0.300% Notes due 2028 evolved from being referenced in the 2022 filing as part of the instruments incorporated by reference from a prior Form 8-K (filed February 10, 2020) to being explicitly listed in the 2023 filing with a specific trading symbol (IBM 28B) and noted as registered on the New York Stock Exchange. This indicates a shift from a general reference to a direct disclosure of the notes' trading details, reflecting increased transparency and possibly a change in reporting practices or regulatory requirements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 0.300% Notes due 2028 (FIN_INST)",
        "0.300% Notes due 2028 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8968,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2869,
        "completion_tokens": 142,
        "total_tokens": 3011
      }
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "Apple's financial performance in the Rest of Asia Pacific region from 2022 to 2023 showed modest growth in both net sales and operating income. Net sales increased from $29,375 million in 2022 to $29,615 million in 2023, representing a slight rise of $240 million. Similarly, operating income improved from $11,569 million in 2022 to $12,066 million in 2023, an increase of $497 million. These figures indicate a positive but measured evolution in the region's financial performance during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> Rest of Asia Pacific (GPE)",
        "Rest of Asia Pacific (GPE) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3664,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 125,
        "total_tokens": 1679
      }
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "The vesting period for stock options issued under the 2007 Omnibus Incentive Plan changed from a five-year pro rata vesting period for grants made prior to 2022 to a four-year pro rata vesting period for grants made after December 31, 2021, as disclosed in both the 2022 and 2024 10-K filings. This change reflects an amendment to the plan, though the Compensation Committee retains discretion to set different vesting terms for executive officers and certain other employees. Outside directors continue to receive fully vested options at the grant date.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> 2007 Omnibus Incentive Plan (ACCOUNTING_POLICY)",
        "2007 Omnibus Incentive Plan (ACCOUNTING_POLICY) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7170,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2462,
        "completion_tokens": 138,
        "total_tokens": 2601
      }
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "From 2022 to 2023, CVS maintained a consistent approach to validating the fair value estimates for its Level 2 debt securities, with no adjustments made to the prices obtained in either year. The Company continued to compare a quarterly sample of Level 2 debt security prices to secondary sources, reviewing variances exceeding a specified threshold to ensure the primary source prices were appropriate. Additionally, the internal investment team consistently compared obtained prices to their own independent fair value estimates. In both 2022 and 2023, the Company obtained one price per Level 2 debt security and did not adjust any of those prices, indicating a stable and reliable validation process over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Obtains]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Level 2 Debt Securities Prices (FIN_INST)",
        "Level 2 Debt Securities Prices (FIN_INST) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_148",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_153",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5606,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2057,
        "completion_tokens": 180,
        "total_tokens": 2237
      }
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "Between 2022 and 2023, CVS maintained a consistent classification and valuation methodology for privately-placed equity securities, categorizing them under Level 3 due to the absence of an active market. The fair value determination for these securities continued to rely on internal analysis of each investment's financial statements and cash flow projections. The unobservable inputs remained unchanged, including earnings and revenue multiples, discounts for lack of marketability, and comparability adjustments. Notably, there was no material evolution in the methodology between the two periods, as both 2022 and 2023 disclosures reflect the same approach and assumptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Classifies]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Privately-Placed Equity Securities (FIN_INST)",
        "Privately-Placed Equity Securities (FIN_INST) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_148",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_153",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5606,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2060,
        "completion_tokens": 169,
        "total_tokens": 2229
      }
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, representing an 8.8% decline at actual currency rates. Internationally, revenue increased slightly from $151 million in 2023 to $153 million in 2024, a 1.5% growth at actual currency rates, indicating a modest improvement in international performance despite the overall decline in U.S. revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Alphagan/Combigan (PRODUCT)",
        "Alphagan/Combigan (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14548,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4276,
        "completion_tokens": 100,
        "total_tokens": 4376
      }
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "Chevron's relationship with PDC Energy evolved significantly from 2023 to 2024, as PDC was acquired by Chevron in a business combination during 2023 and excluded from Chevron's internal control assessment at year-end 2023. By 2024, PDC's production became fully integrated into Chevron's operations, contributing to a seven percent increase in worldwide oil-equivalent production to 3.3 million barrels per day. This operational integration, particularly in the Permian Basin, directly enhanced Chevron's overall production performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> PDC Energy (COMP)",
        "PDC Energy (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3485,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 134,
        "total_tokens": 1644
      }
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "From 2023 to 2024, UPS significantly enhanced its cold-chain logistics capabilities by expanding its healthcare and life sciences logistics services, both domestically and internationally. In 2023, UPS acquired Bomi Group and MNX Global Logistics to broaden its reach and service offerings in complex cold-chain logistics. Building on this momentum, in early 2025 (as detailed in the 2024 10-K), UPS acquired Frigo-Trans and Biotech & Pharma Logistics for approximately $440 million, further increasing its international cold-chain logistics capabilities. These acquisitions collectively reflect UPS's strategic investment in strengthening its position in the specialized healthcare logistics market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enhances]-> PRODUCT <-[Increases]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Cold-Chain Logistics Capabilities (PRODUCT)",
        "Cold-Chain Logistics Capabilities (PRODUCT) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3584,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 175,
        "total_tokens": 1715
      }
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "Linde plc's non-employee director restricted stock unit (RSU) award program has evolved significantly between 2022 and 2024, reflecting a stronger emphasis on governance structure and long-term shareholder alignment. In 2022, the program was part of the 2021 Linde plc Long Term Incentive Plan, which included various forms of equity awards, including non-employee director RSUs, as disclosed in the 10-K filing. By 2024, the program had transitioned under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan, with specific forms for non-employee director RSUs introduced for grants made in 2019 and thereafter. Additionally, in 2024, Linde plc introduced the Non-employee Director Deferral Program, adopted on July 30, 2024, further reinforcing long-term alignment by allowing deferral of compensation. These developments underscore Linde's commitment to aligning director incentives with long-term shareholder value through structured equity and deferral mechanisms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Non-Employee Director Restricted Stock Unit Award (ACCOUNTING_POLICY)",
        "Non-Employee Director Restricted Stock Unit Award (ACCOUNTING_POLICY) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15105,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4450,
        "completion_tokens": 246,
        "total_tokens": 4696
      }
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "Between 2022 and 2024, General Motors (GM) maintained both financial and legal relationships with Stellantis, primarily stemming from GM's 2017 sale of the Opel/Vauxhall business to PSA Group (now Stellantis). Financially, GM had previously recognized gains related to Stellantis warrants in 2021, as noted in the 2022 10-K filing. Legally, GM continued to face potential indemnification obligations under the 2017 Master Agreement, including for emissions claims, product liabilities, and recalls related to the Opel/Vauxhall business. By 2024, GM had indemnified Stellantis for an immaterial amount related to certain recalls, including Takata inflator issues in legacy Opel vehicles, and remained subject to potential future claims, though such further indemnification was deemed remote. Additionally, GM faced regulatory inquiries from the European Commission and UK CMA concerning Opel's past conduct, though no material accrual was recorded as of December 31, 2024. Thus, while GM's investment in Stellantis had previously yielded gains, its ongoing obligations were largely contingent and immaterial in the most recent reporting period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Guarantees]- ORG",
      "triplets_used": [
        "GM (ORG) -> Stellantis (COMP)",
        "Stellantis (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6494,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2261,
        "completion_tokens": 285,
        "total_tokens": 2547
      }
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "From 2022 to 2024, Southern Company's treatment and disclosure of energy-related derivatives evolved from primarily reporting their pre-tax income effects to emphasizing their fair value presentation on the balance sheet. In 2022, the focus was on the impact of these derivatives on the statements of income, particularly for Southern Company and Southern Company Gas. By 2024, the company shifted to disclosing the fair value of energy-related derivatives, along with interest rate and foreign currency derivatives, as either assets or liabilities in the balance sheets, categorized under \"Other\" or separately as \"Risk Management Activities.\" This shift reflects a more comprehensive and transparent financial presentation of derivative instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Energy-Related Derivatives (FIN_INST)",
        "Energy-Related Derivatives (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_327",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_283",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 630,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 808,
        "completion_tokens": 187,
        "total_tokens": 995
      }
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "Between 2023 and 2024, GILD's strategic relationship with Arcus evolved significantly in terms of equity ownership and governance influence. In 2023, GILD owned approximately 19.9% of Arcus' voting stock and had two designees on Arcus' board of directors. By January 2024, GILD increased its ownership to 33% through a $320 million equity investment and amended the Collaboration Agreement, which also expanded its board representation to three designees. These actions reflect a strengthening of GILD's influence over Arcus, aligning with the investment and dependency relationship indicated by the knowledge graph triplets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Arcus (COMP)",
        "Arcus (COMP) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11277,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3448,
        "completion_tokens": 156,
        "total_tokens": 3604
      }
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "The maturity date of the 2021 Multicurrency Credit Facility was extended from June 28, 2024 (as of 2022) to July 1, 2026 in 2023, while its borrowing capacity remained unchanged at $6.0 billion. In 2022, the facility's commitments were increased to $6.0 billion following the December 8, 2021 amendment, and in 2023, the June 2023 amendment further extended the maturity but maintained the same borrowing capacity. Additionally, the facility continued to include a $3.5 billion sublimit for multicurrency borrowings, with usage in 2023 primarily for repaying outstanding indebtedness and general corporate purposes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Modifies]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> 2021 Multicurrency Credit Facility (FIN_INST)",
        "2021 Multicurrency Credit Facility (FIN_INST) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7740,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2574,
        "completion_tokens": 153,
        "total_tokens": 2728
      }
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "Chevron's utilization of imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, refinery capacity utilization at U.S. refineries declined from 90.8% in 2023 to 86.6% in 2024, while overall average crude unit distillation capacity utilization also decreased slightly from 89.8% in 2023 to 87.9% in 2024. These changes reflect a reduction in operational efficiency during 2024, despite ongoing projects to enhance refinery flexibility, including the completion of the Pasadena Refinery upgrade in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Processes]-> RAW_MATERIAL <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Imported Crude Oil (RAW_MATERIAL)",
        "Imported Crude Oil (RAW_MATERIAL) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6572,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2293,
        "completion_tokens": 146,
        "total_tokens": 2439
      }
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "UPS's hedging position in British Pound Sterling decreased from 663 million GBP in 2023 to 536 million GBP in 2024, reflecting a reduction in exposure. This decline aligns with a broader trend of decreasing currency hedges for the Euro and increasing hedges for the Hong Kong Dollar and newly introduced Chinese Renminbi in 2024. The shift suggests a strategic reallocation of UPS's currency risk management efforts, likely in response to changing market dynamics and exposure priorities, emphasizing a more diversified and adaptive approach to managing foreign exchange risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "UPS (ORG) -> British Pound Sterling Hedges (FIN_INST)",
        "British Pound Sterling Hedges (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_137",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1096,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 924,
        "completion_tokens": 144,
        "total_tokens": 1068
      }
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "The fair value of Bank of America’s money market investments increased from $868 million at December 31, 2022, to $1.2 billion at December 31, 2023, and further to $1.3 billion at December 31, 2024. This upward trend suggests a growing allocation to short-term, highly liquid investments, likely reflecting a strategy to preserve capital and manage liquidity in a potentially volatile market environment. The increase aligns with the broader shift in collateral composition, with a higher proportion of prime collateral in 2024, indicating a more conservative approach to short-term investment risk management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Money Market Investments (FIN_INST)",
        "Money Market Investments (FIN_INST) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BAC_10k_2024.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5496,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2026,
        "completion_tokens": 152,
        "total_tokens": 2178
      }
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "The maximum expected volume of natural gas subject to physical supply contracts with sell-back options decreased from 2022 to 2024 across Southern Company's subsidiaries. In 2022, the total was 26 million mmBtu, with allocations of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had reduced to 15 million mmBtu, with allocations of 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This reflects a decline in the contractual flexibility for sell-backs across all subsidiaries.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Physical Natural Gas Supply Contracts (FIN_INST)",
        "Physical Natural Gas Supply Contracts (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_319",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_281",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4520,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1785,
        "completion_tokens": 174,
        "total_tokens": 1960
      }
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "The integration and application of the Firefly Vector Model across Adobe's product suite evolved significantly between 2023 and 2024. In 2023, Firefly was introduced into Adobe Express, enabling users to generate custom vector graphics from text prompts in over 100 languages, with a focus on commercial safety and ease of use. By 2024, the Firefly Vector Model had expanded further, with enhanced integration into Adobe Illustrator through features like Firefly-powered Generative Recolor and broader support for vector generation. Additionally, Firefly was embedded into Adobe InDesign, expanding its reach into design and layout workflows. These developments reflect Adobe’s strategic move to embed generative AI capabilities across its creative ecosystem, enhancing productivity and creative expression for users across multiple platforms and use cases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Firefly Vector Model (PRODUCT)",
        "Firefly Vector Model (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10426,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3240,
        "completion_tokens": 214,
        "total_tokens": 3455
      }
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "From 2023 to 2024, the commercial significance of Biktarvy for Gilead (GILD) has grown, as it remained the top-selling HIV product in both years, with total revenue increasing from $18,175 million in 2023 to $19,377 million in 2024. This growth reflects its continued dominance in the HIV treatment market, driven by strong U.S. and international sales. However, the 2024 10-K highlights potential risks to sustaining this growth, including competition and the possibility of shifts in treatment paradigms, particularly if nucleoside-based therapies like TAF lose favor. These factors underscore the importance of innovation and strategic development in maintaining GILD's HIV business leadership.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Biktarvy (PRODUCT)",
        "Biktarvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 32241,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 8696,
        "completion_tokens": 174,
        "total_tokens": 8870
      }
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "Between 2022 and 2023, the Series 2018-1A Securities, issued by American Tower Corporation (AMT) as part of the 2018 securitization, had an outstanding principal amount of $496.1 million in 2022, which remained largely unchanged at $496.8 million in 2023. The securities carry a fixed interest rate of 3.652%, as disclosed in both the 2022 and 2023 filings. Notably, the securities are structured with no principal repayments required until March 2028, indicating a stable financial structure over the observed period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Series 2018-1A Securities (FIN_INST)",
        "Series 2018-1A Securities (FIN_INST) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_118",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8440,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2756,
        "completion_tokens": 129,
        "total_tokens": 2886
      }
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "UPS's relationship with Coyote evolved significantly from 2023 to 2024, both financially and strategically. In 2023, UPS recorded a $111 million impairment charge for the Coyote trade name due to declining revenues and challenging market conditions, and began evaluating strategic alternatives for the truckload brokerage business. By 2024, UPS completed the divestiture of Coyote, which contributed to a $976 million revenue decline in the Forwarding businesses within Supply Chain Solutions. This reflects a strategic shift to divest underperforming assets and refocus on higher-growth areas, as evidenced by revenue growth in Logistics and digital businesses post-divestiture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Announces]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Coyote (COMP)",
        "Coyote (COMP) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7376,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2466,
        "completion_tokens": 169,
        "total_tokens": 2636
      }
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "Linde plc's Performance Share Unit Awards (PSUs) for grants beginning in 2019 incorporated two distinct performance metrics: Return on Capital (as detailed in Exhibit 10.11N in the 2018 10-K, referenced in Chunk 1) and Total Shareholder Return (as outlined in Exhibit 10.11O in the 2018 10-K, also in Chunk 1). By 2024, these same PSU structures were retained, with the Return on Capital and Total Shareholder Return metrics continuing to be disclosed in the 2024 10-K (Chunk 2, Exhibits 10.10l and 10.10m), indicating no material change in the performance metrics used for these awards between 2019 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Performance Share Unit Award (FIN_INST)",
        "Performance Share Unit Award (FIN_INST) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2022.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15302,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4476,
        "completion_tokens": 152,
        "total_tokens": 4628
      }
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "Between 2023 and 2024, the regulatory status of Trodelvy evolved from being an FDA-approved oncology product with an indication under accelerated approval to receiving a second Breakthrough Therapy designation in 2024 for the treatment of extensive-stage small cell lung cancer. In 2023, Trodelvy was already approved for multiple indications, including triple-negative breast cancer and urothelial cancer, with one indication approved under accelerated approval contingent on confirmatory trials. By 2024, the Breakthrough Therapy designation reflects the FDA's recognition of Trodelvy's potential to significantly improve outcomes in a new, serious indication, signaling continued progress in its development trajectory and expanding its therapeutic utility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Trodelvy (PRODUCT)",
        "Trodelvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9246,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2941,
        "completion_tokens": 190,
        "total_tokens": 3131
      }
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "From 2023 to 2024, the Vertex AI platform within Google Cloud has evolved significantly in terms of capabilities and integration with generative AI models. In 2023, Vertex AI enabled developers to train, tune, augment, and deploy applications using generative AI models and services like Enterprise Search and Conversations, positioning it as a key tool for innovation on Google Cloud. By 2024, the platform had advanced further, now providing developers with the ability to train, test, and deploy applications using Gemini and other leading generative AI models, alongside services such as vector search and distillation. This evolution reflects Google's broader investment in AI infrastructure and its commitment to making advanced AI capabilities more accessible and scalable for developers and enterprises.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Vertex AI Platform (PRODUCT)",
        "Vertex AI Platform (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10709,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3322,
        "completion_tokens": 202,
        "total_tokens": 3525
      }
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "From 2022 to 2024, SO has consistently excluded the immaterial premium and intrinsic value associated with weather derivatives from its derivative valuations, as noted in both the 2022 and 2024 disclosures. In 2022, the exclusion also applied to cash collateral held in broker margin accounts ($3 million, $28 million, and $99 million for 2021, 2020, and 2019, respectively), while in 2024, the gross amounts offset included cash collateral of $17 million and $62 million for 2024 and 2023, respectively. This indicates a continued treatment of weather derivatives as immaterial to derivative valuations, though the specific collateral amounts have changed over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Weather Derivatives (FIN_INST)",
        "Weather Derivatives (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_122",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_285",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 969,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 897,
        "completion_tokens": 166,
        "total_tokens": 1064
      }
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "Between 2023 and 2024, Biktarvy's regulatory and market positioning evolved through expanded FDA approvals, enhancing its role in HIV treatment. In 2023, Biktarvy was listed with a U.S. patent expiration in 2033, indicating its long-term market exclusivity. By 2024, Gilead disclosed that the FDA approved an expanded indication for Biktarvy to treat HIV patients with suppressed viral loads and known or suspected M184V/I resistance, as well as updated its label to include safety and efficacy data for pregnant individuals with HIV-1. These updates reinforced Biktarvy’s therapeutic versatility and broadened its patient applicability, strengthening its market position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Biktarvy (PRODUCT)",
        "Biktarvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4580,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1770,
        "completion_tokens": 168,
        "total_tokens": 1938
      }
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "AMT's utilization of the 2021 Multicurrency Credit Facility changed significantly between 2022 and 2023. In 2022, AMT borrowed $850.0 million under the facility, using the funds to repay existing indebtedness and for general corporate purposes. By 2023, AMT had borrowed an aggregate of $3.0 billion under the facility but repaid $6.1 billion, including €842.6 million ($919.1 million) in revolving indebtedness, primarily to repay the 2021 USD Two Year Delayed Draw Term Loan and for general corporate purposes. Additionally, in June 2023, AMT amended the facility, extending its maturity date to July 1, 2026, maintaining a $6.0 billion borrowing capacity, and switching from LIBOR to SOFR-based pricing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> 2021 Multicurrency Credit Facility (FIN_INST)",
        "2021 Multicurrency Credit Facility (FIN_INST) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3354,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 176,
        "total_tokens": 1665
      }
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "Between 2023 and 2024, Google Ad Manager has remained a central platform for Alphabet's advertising revenue recognition, particularly for Google Network properties. In both years, it is highlighted as one of the primary tools through which customers purchase advertising inventory, alongside Google Ads and Google Display & Video 360. The 2023 and 2024 filings confirm that Alphabet generally reports advertising revenues from Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue, with payments to partners classified as cost of revenues. This reflects Google Ad Manager’s role in facilitating control over advertising inventory before it is transferred to customers, reinforcing Alphabet’s position as the principal in these transactions. The integration with revenue reporting models has remained consistent, emphasizing Alphabet’s discretion in pricing and responsibility to customers, which supports the gross revenue recognition model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Ad Manager (PRODUCT)",
        "Google Ad Manager (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8532,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2782,
        "completion_tokens": 249,
        "total_tokens": 3032
      }
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "Between 2023 and 2024, UPS's financial exposure and strategic positioning regarding Roadie evolved significantly in terms of goodwill impairment and risk assessment. In 2023, UPS recorded a $56 million goodwill impairment charge for Roadie, indicating a decline in its fair value relative to its carrying value. By 2024, while no goodwill impairments were recorded, Roadie was identified as one of three reporting units with limited excess of fair value over carrying value, exposing it to a greater risk of future impairment. This risk is heightened by sensitivity to changes in cost of capital or projected cash flows, with a 100 basis point increase or 10% reduction in cash flows potentially leading to impairment. Thus, while UPS maintained Roadie's goodwill in 2024, its strategic positioning reflects increased financial exposure and a cautious outlook due to uncertain business conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Roadie (COMP)",
        "Roadie (COMP) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5395,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1984,
        "completion_tokens": 224,
        "total_tokens": 2209
      }
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "From 2022 to 2024, Linde's relationship with helium evolved from being a supplier of helium (RAW_MATERIAL) to experiencing a negative impact from higher helium costs, as reflected in the 2024 10-K. In 2024, global helium wholesale sales decreased by 2%, contributing to a $32 million sales decline in the \"Other\" segment. However, operating profit in the \"Other\" segment increased by $19 million (44%) due to insurance recovery for LAMT, despite higher helium-related costs. This highlights a shift from helium as a core business driver to a cost burden, affecting both sales and profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> RAW_MATERIAL <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Helium (RAW_MATERIAL)",
        "Helium (RAW_MATERIAL) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1321,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 971,
        "completion_tokens": 148,
        "total_tokens": 1119
      }
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "The total value of loans covered under long-term credit protection agreements with FNMA and FHLMC decreased from $18.2 billion ($8.7 billion in 2023 and $9.5 billion in 2022) at December 31, 2023, to $16.7 billion ($8.0 billion in 2024 and $8.7 billion in 2023) at December 31, 2024. This decline indicates a reduction in the Corporation’s credit risk exposure on residential mortgage loans, as these loans are fully protected by credit guarantees from FNMA and FHLMC, and the Corporation does not record an allowance for credit losses on them. The decrease suggests a strategic shift or reduction in the volume of such insured residential mortgage loans, potentially reflecting improved credit quality or changes in the Corporation’s risk management approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Credit Protection Agreements (ACCOUNTING_POLICY)",
        "Credit Protection Agreements (ACCOUNTING_POLICY) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BAC_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6407,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2273,
        "completion_tokens": 190,
        "total_tokens": 2463
      }
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "Adobe's strategic positioning of Adobe Firefly has evolved from 2023 to 2024 by emphasizing its integration into Adobe's broader product ecosystem and enhancing its generative AI capabilities for commercial use. In 2023, Adobe Firefly was positioned as a competitive differentiator by offering natively integrated generative AI tools designed to be safe and effective within Creative Cloud and Document Cloud. By 2024, Adobe continued to focus on AI innovation, incorporating Firefly into a broader AI strategy across its offerings while addressing the growing regulatory landscape. However, Adobe now faces increased regulatory risks, particularly with the implementation of the EU AI Act and evolving global AI regulations, which could impose compliance costs, limit monetization strategies, and expose the company to legal and reputational risks. These developments underscore Adobe's ongoing efforts to balance innovation with responsible AI governance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Adobe Firefly (PRODUCT)",
        "Adobe Firefly (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9173,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2934,
        "completion_tokens": 239,
        "total_tokens": 3173
      }
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "Between 2023 and 2024, Trodelvy demonstrated strong financial performance and advanced its regulatory trajectory. In 2023, Trodelvy generated $1,063 million in total product sales, reflecting a 56% increase from $680 million in 2022, indicating robust market adoption. In 2024, Trodelvy received its second Breakthrough Therapy designation from the FDA for the treatment of adult patients with extensive-stage small cell lung cancer, highlighting its potential to significantly improve clinical outcomes and accelerate regulatory review. This regulatory progress, combined with the substantial revenue growth, underscores Trodelvy's evolving role as a key oncology product for Gilead.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Trodelvy (PRODUCT)",
        "Trodelvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8693,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2794,
        "completion_tokens": 171,
        "total_tokens": 2965
      }
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, as evidenced by its 36.4 percent equity interest in Angola LNG Limited, which processes and liquefies natural gas in Angola for international markets. In 2022, Angola LNG contributed to improved income from equity affiliates, as noted in the income statement where upstream-related earnings from Angola LNG were a key factor in the $5,657 million income from equity affiliates. By 2024, Chevron's investment in Angola LNG remained a significant strategic asset, with the company maintaining a strong presence in global LNG markets. Additionally, Chevron's broader financial engagement with equity affiliates, including Angola LNG, was supported by increasing net loans to affiliates, which rose from $4,278 million in 2022 to $4,731 million in 2024, reflecting ongoing capital support for affiliate operations and development projects.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Angola LNG (COMP)",
        "Angola LNG (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3547,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 233,
        "total_tokens": 1764
      }
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "From 2023 to 2024, the value of META's Fixed-Rate Senior Unsecured Notes increased significantly, rising from $18.50 billion as of December 31, 2023, to $29.0 billion as of December 31, 2024. This increase was driven by an issuance of $10.50 billion in Notes during August 2024, in addition to the $8.46 billion in net proceeds from the issuance of Notes in May 2023, which also contributed to the 2023 year-end balance. The evolution of the Notes reflects META's ongoing capital-raising activities as part of its liquidity and capital resource strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "META (ORG) -> Fixed-Rate Senior Unsecured Notes (FIN_INST)",
        "Fixed-Rate Senior Unsecured Notes (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1777,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1081,
        "completion_tokens": 138,
        "total_tokens": 1219
      }
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "LIN's financial exposure to helium transitioned from being a supply in 2023 to a dependency in 2024, as reflected in its 10-K filings. In 2023, LIN disclosed helium as a raw material it supplies, indicating a role in the helium value chain without significant sourcing risk. By 2024, LIN shifted its characterization of helium to a dependency, citing increased sourcing costs and volatility in helium prices, which began to impact its production expenses and operational planning. This change highlights a growing financial vulnerability tied to helium as a critical input rather than a commodity it controls or merely distributes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> RAW_MATERIAL <-[Depends_On]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Helium (RAW_MATERIAL)",
        "Helium (RAW_MATERIAL) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 94,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 672,
        "completion_tokens": 157,
        "total_tokens": 829
      }
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "PayPal increased its utilization of European customer balances for credit activities between 2022 and 2023, with the CSSF approval rising from $3.8 billion in 2022 to $3.0 billion in 2023. This represents a **-21.05% change** (calculated as (3.0 - 3.8)/3.8 * 100) in the amount approved for such activities. Additionally, the percentage of European customer balances designated for credit activities increased from 37% in 2022 to 39% in 2023, reflecting a slight improvement in the proportion of balances allocated to credit activities despite the absolute dollar amount decreasing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Credit Activities (FIN_INST)",
        "Credit Activities (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9746,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3085,
        "completion_tokens": 145,
        "total_tokens": 3230
      }
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "Starbucks' exposure to \"Foreign currency - other instruments\" decreased in fair value from $1,164 million as of October 1, 2023, to $920 million as of September 29, 2024. Additionally, the net gains included in Accumulated Other Comprehensive Income (AOCI) for these instruments dropped from $39.6 million in 2023 to $11.5 million in 2024. The expected reclassification impact on earnings within 12 months also declined from $39.6 million to $9.5 million, indicating a reduction in the anticipated earnings impact from these hedging instruments over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Foreign currency - other (FIN_INST)",
        "Foreign currency - other (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4054,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1666,
        "completion_tokens": 140,
        "total_tokens": 1807
      }
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "From 2022 to 2023, the fair value of energy-related derivatives held by Alabama Power decreased from $55 million to $15 million, indicating a significant reduction in asset position. For Georgia Power, the fair value of energy-related derivatives also declined, from $75 million in 2022 to $13 million in 2023. Concurrently, the liability positions for both companies increased: Alabama Power's liabilities rose from $11 million to $110 million, and Georgia Power's liabilities increased from $8 million to $124 million. This shift reflects a directional change from a more asset-heavy position in 2022 to a more liability-heavy position in 2023 for both entities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Energy-related derivatives (FIN_INST)",
        "Energy-related derivatives (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_311",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_281",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 23085,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6426,
        "completion_tokens": 166,
        "total_tokens": 6592
      }
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "From 2022 to 2023, the asset allocation strategy for the U.S. Retiree Health Care Plan shifted significantly, with the percentage of fixed income securities increasing from 65% to 80%, while the percentage of equity securities decreased from 35% to 20%. This change reflects a more conservative allocation in 2023, as evidenced by the higher weight given to fixed income and cash equivalents. The data from 2022, as detailed in the prior year's 10-K, shows that total assets were $385, with $248 in fixed income and $137 in equity securities, aligning with the disclosed percentages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "TXN (ORG) -> U.S. Retiree Health Care Plan (FIN_INST)",
        "U.S. Retiree Health Care Plan (FIN_INST) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3222,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 145,
        "total_tokens": 1611
      }
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "Between 2022 and 2023, the regulatory approval status of Trodelvy (sacituzumab govitecan-hziy), produced by Gilead (GILD), expanded significantly. In 2022, Trodelvy was approved for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who had received two or more prior systemic therapies, and for adult patients with locally advanced or metastatic urothelial cancer who had previously received a platinum-containing chemotherapy and a PD-1/PD-L1 inhibitor (with accelerated approval contingent on confirmatory trials). In 2023, Gilead received both FDA and EC approvals for a new indication: Trodelvy for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer who had received endocrine-based therapy and at least two additional systemic therapies in the advanced setting. This expansion highlights the growing regulatory recognition of Trodelvy’s therapeutic utility across different breast cancer subtypes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Trodelvy (PRODUCT)",
        "Trodelvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9054,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2891,
        "completion_tokens": 271,
        "total_tokens": 3163
      }
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "Between 2023 and 2024, Meta’s disclosure on user perception as a risk factor shifted in focus and emphasis. In 2023, the company highlighted the potential negative impact of user sentiment changes stemming from concerns around product quality, data practices, privacy, content moderation, and regulatory compliance, which could lead to decreased engagement and user trust. The 2024 filing, while not explicitly listing user perception as a standalone risk factor, embedded related risks within broader strategic and operational challenges, such as the potential negative user reaction to acquisitions, changes in product policies, and the integration of new technologies. This suggests a more integrated approach, where user perception is now contextualized within the broader implications of business decisions, including strategic investments and regulatory actions, reflecting a shift from standalone user sentiment risks to a more systemic view of how business operations and external factors collectively influence user trust and engagement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "META (ORG) -> User Perception (RISK_FACTOR)",
        "User Perception (RISK_FACTOR) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9314,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2984,
        "completion_tokens": 261,
        "total_tokens": 3246
      }
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "The notional amount of Lockheed Martin's variable interest rate swaps increased from $500 million at December 31, 2021, to $1.3 billion at both December 31, 2023, and 2024. This growth indicates a more active interest rate risk management strategy, as the company is using these swaps—designated as fair value hedges—to hedge against changes in the fair value of its fixed-rate borrowings by effectively converting them to variable-rate borrowings. The increase suggests a deliberate effort to manage exposure to interest rate fluctuations, particularly as the company’s total debt increased from $12.8 billion in 2021 to $21.6 billion in 2024, reflecting a more proactive approach to mitigating interest rate risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Uses]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Variable Interest Rate Swaps (FIN_INST)",
        "Variable Interest Rate Swaps (FIN_INST) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12505,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3779,
        "completion_tokens": 178,
        "total_tokens": 3958
      }
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "Between 2022 and 2023, PayPal's approach to its Seller Protection Programs remained consistent in terms of the financial provisions for transaction losses, as evidenced by the allowance for transaction losses remaining relatively stable. In 2022, the allowance for transaction losses was $66 million, and by 2023, it slightly decreased to $64 million. This suggests that PayPal maintained a measured and conservative approach to provisioning for potential losses under its Seller Protection Programs, with no significant changes in the estimated risk exposure during this period. Additionally, the programs continued to be classified as assurance-type warranties, with associated costs recorded in transaction and credit losses at the time of payment transactions, as outlined in both years’ disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Risk]-> ACCOUNTING_POLICY <-[Provides]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Seller Protection Programs (ACCOUNTING_POLICY)",
        "Seller Protection Programs (ACCOUNTING_POLICY) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7727,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2583,
        "completion_tokens": 201,
        "total_tokens": 2784
      }
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "Starbucks' derivative positions for \"Foreign currency - other\" changed significantly from fiscal year 2023 to 2024. In 2023, the balance sheet reported $32.0 million in derivative assets and $2.0 million in derivative liabilities, while in 2024, these amounts dropped to $1.9 million in derivative assets and $4.7 million in derivative liabilities. This represents a net decrease in derivative assets of $30.1 million and an increase in derivative liabilities of $2.7 million, resulting in a total reduction in the net position of $32.8 million on the balance sheet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Foreign currency - other (FIN_INST)",
        "Foreign currency - other (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4387,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1752,
        "completion_tokens": 141,
        "total_tokens": 1894
      }
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "From 2022 to 2023, the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions shifted significantly. In 2022, energy-related derivatives resulted in a loss of $11 million on natural gas revenues and a loss of $65 million on the cost of natural gas, leading to a total loss of $76 million in non-designated hedging relationships. In 2023, the impact improved, with a gain of $59 million on the cost of natural gas and no reported gain or loss on natural gas revenues, resulting in a net gain of $59 million. This reflects a reversal from losses in 2022 to a gain in 2023, indicating a positive evolution in the financial impact of these hedging positions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Energy-related derivatives (FIN_INST)",
        "Energy-related derivatives (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_327",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_295",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2346,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 174,
        "total_tokens": 1401
      }
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "Between 2023 and 2024, Walmart's Deferred Compensation Matching Plan was amended and restated effective November 8, 2023, as disclosed in both the 2023 and 2024 10-K filings. In the 2023 filing, the plan was listed as a new exhibit (10.1) with the effective date noted, while in the 2024 filing, it was incorporated by reference to the 2024 10-K, indicating that the revised plan was formally documented and included in the 2024 filing. This evolution shows the plan was finalized and officially disclosed in the 2024 filing after being introduced in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Deferred Compensation Matching Plan (ACCOUNTING_POLICY)",
        "Deferred Compensation Matching Plan (ACCOUNTING_POLICY) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 19403,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5514,
        "completion_tokens": 139,
        "total_tokens": 5653
      }
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "Between 2023 and 2024, SPG continued to disclose LTIP Units as potentially dilutive securities, with no material dilutive effect in both years. In 2023, SPG noted that it did not adjust net income or weighted average shares outstanding for income allocable to limited partners or units, as there was no dilutive impact. By 2024, the disclosure remained consistent regarding the lack of material dilutive effect, but SPG shifted its language to explicitly state that it accrues \"distributions\" rather than \"dividends\" when declared, reflecting a subtle evolution in the treatment and terminology used for these accruals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> LTIP Units (FIN_INST)",
        "LTIP Units (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1235,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 942,
        "completion_tokens": 154,
        "total_tokens": 1097
      }
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved significantly between 2023 and 2024 in response to regulatory actions and decisions. In 2023, Meta faced an Irish Data Protection Commission (IDPC) decision that invalidated its reliance on Standard Contractual Clauses (SCCs) for transferring EEA user data to the U.S., resulting in a €1.2 billion fine and corrective orders. Meta appealed and began implementing steps to comply with the newly established EU-U.S. DPF, which replaced the invalidated Privacy Shield and received an adequacy decision from the European Commission in July 2023. By 2024, Meta had fully implemented compliance measures under the EU-U.S. DPF following engagement with the IDPC, but continued to face regulatory scrutiny, including a European Commission investigation into its \"subscription for no ads\" model under the Digital Markets Act (DMA), which raised concerns about consumer protection and compliance. These developments underscore Meta’s ongoing efforts to adapt its data transfer and compliance strategies in response to evolving EU regulatory frameworks and enforcement actions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "META (ORG) -> EU-U.S. DPF (REGULATORY_REQUIREMENT)",
        "EU-U.S. DPF (REGULATORY_REQUIREMENT) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13553,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4043,
        "completion_tokens": 288,
        "total_tokens": 4331
      }
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "Between 2023 and 2024, Linde has evolved its approach to green hydrogen production by shifting terminology from \"colors\" (e.g., gray, blue, green) to a focus on \"carbon intensity\" to describe hydrogen production methods. In 2023, Linde described green hydrogen as being produced via electrolysis using renewable energy or from steam methane reforming of biomethane. By 2024, the company emphasized that green (renewable) hydrogen is produced through electrolysis using renewable energy and water as feedstock, with a stronger focus on non-fossil feedstocks. Additionally, Linde has expanded its low-carbon hydrogen offerings, including blue hydrogen, which involves carbon capture and sequestration. This evolution reflects an increased emphasis on renewable energy sources and cleaner production methods, aligning with broader sustainability goals and market demands for low-carbon energy solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Green Hydrogen (PRODUCT)",
        "Green Hydrogen (PRODUCT) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10329,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3223,
        "completion_tokens": 225,
        "total_tokens": 3448
      }
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "Between 2022 and 2023, Southern Company's relationship with Sequent transitioned from ownership to a post-sale financial and regulatory impact. In 2021, Southern Company Gas sold Sequent to Williams Field Services Group for $159 million, generating a pre-tax gain of $121 million ($92 million after tax), as noted in the 2022 filing. However, the sale had financial implications, including an $85 million increase in tax expense due to changes in state apportionment rates. In the 2023 filing, the financial impact of the Sequent sale continued to be reflected, with the pre-tax gain and additional tax expense still reported under relevant categories, indicating that the transaction had lasting financial effects on Southern Company's tax and earnings structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> COMP <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "SO (ORG) -> Sequent (COMP)",
        "Sequent (COMP) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_302",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5551,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2016,
        "completion_tokens": 191,
        "total_tokens": 2207
      }
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "Between 2023 and 2024, Walmart's relationship with the Allswell brand evolved from being a listed private brand in its merchandise portfolio to being explicitly highlighted among a broader and more detailed list of private brands in its 2024 10-K filing. In 2023, Allswell was mentioned as one of several private brands, while in 2024, it was included in a more comprehensive list that also introduced new private brands like \"bettergoods,\" indicating a potential expansion or reorganization of Walmart’s private brand strategy. This evolution suggests that Allswell continues to hold a strategic position within Walmart’s private brand portfolio, particularly in the health and wellness or home categories, and reflects the company’s ongoing emphasis on strengthening its private label offerings to compete with national brands and meet consumer demand for curated, in-house products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Allswell (PRODUCT)",
        "Allswell (PRODUCT) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5366,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1984,
        "completion_tokens": 221,
        "total_tokens": 2206
      }
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "From 2022 to 2023, the strategic importance of TXN's Embedded Processing products increased, as evidenced by their performance and emphasis in the company's operations. In 2023, Embedded Processing revenue grew despite an overall 12.5% decline in total revenue, highlighting its resilience and strategic value. Additionally, TXN explicitly emphasized its focus on embedded processing as a core part of its business model, generating strong cash flow and supporting long-term growth, particularly in high-potential markets like industrial and automotive. This strategic emphasis aligns with the company’s ongoing investments in R&D and capital expenditures, reinforcing the evolving significance of Embedded Processing in TXN’s portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Focuses_On]- ORG",
      "triplets_used": [
        "TXN (ORG) -> Embedded Processing Products (PRODUCT)",
        "Embedded Processing Products (PRODUCT) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2022.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2023.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7049,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2405,
        "completion_tokens": 184,
        "total_tokens": 2589
      }
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "Chevron's involvement in Angola LNG has remained significant from 2022 to 2024, with the company maintaining a 36.4 percent interest in Angola LNG Limited, which processes and liquefies natural gas for international markets. In 2022, Angola LNG was included in Chevron's share of production by affiliates, indicating its operational contribution to Chevron's upstream portfolio. By 2024, Chevron's stake in Angola LNG is explicitly highlighted in its equity affiliate disclosures, underscoring its continued strategic investment in key LNG projects. This sustained involvement reflects Chevron's long-term positioning in the global LNG market, emphasizing its commitment to natural gas production and access to international energy demand.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Angola LNG (COMP)",
        "Angola LNG (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3759,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1572,
        "completion_tokens": 184,
        "total_tokens": 1757
      }
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "The CH-53K program contributed to increased production volume and financial performance within Lockheed Martin's RMS division, evolving from a $540 million sales contributor in 2021 to a partial driver of a $1.1 billion increase in RMS product sales by 2024. In 2021, the program supported higher net sales and operating profit due to increased production and risk retirements, while by 2024, it continued to positively impact RMS sales with higher production volume, despite being partially offset by lower volume on the VH-92A program. This progression indicates the CH-53K's growing and sustained importance within RMS's portfolio, reflecting its role as a key production program contributing to the division's financial growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "LMT (ORG) -> CH-53K (PRODUCT)",
        "CH-53K (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3423,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 182,
        "total_tokens": 1680
      }
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "Between 2022 and 2023, PayPal refined its use of macroeconomic factors in its loss curves for revolving consumer credit products. In 2022, the reasonable and supportable forecast period for revolving products was 2 years, and macroeconomic factors such as unemployment and credit card charge-off rates were applied using a single external scenario. By 2023, the forecast period for revolving products was extended to approximately 5 years, and the macroeconomic factors incorporated included forecasted trends in household disposable income and retail e-commerce sales, with unemployment rates used only through the first quarter of 2023. Additionally, in the second quarter of 2023, PayPal updated its expected credit loss models for revolving consumer receivables, although these changes did not have a material impact on the provision for the year ended December 31, 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Loss Curves (ACCOUNTING_POLICY)",
        "Loss Curves (ACCOUNTING_POLICY) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12137,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3672,
        "completion_tokens": 218,
        "total_tokens": 3891
      }
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "Starbucks' foreign currency debt-related gains or losses included in AOCI changed from a loss of $6.3 million in 2023 to a gain of $135.2 million in 2024. This significant shift from a loss to a gain indicates that the company experienced favorable foreign currency movements in 2024, likely due to a stronger U.S. dollar relative to the currencies in which it holds debt. The change highlights Starbucks' exposure to foreign currency fluctuations, particularly through its debt obligations, and suggests that the company may have either hedged effectively or benefited from favorable exchange rate movements in the reporting period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Foreign currency debt (FIN_INST)",
        "Foreign currency debt (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9712,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3081,
        "completion_tokens": 158,
        "total_tokens": 3239
      }
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "Between 2022 and 2023, the fair value of energy-related derivatives for Alabama Power increased from $15 million to $110 million, while for Georgia Power, it rose from $13 million to $124 million. This indicates a significant upward trend in the fair value of these derivatives for both subsidiaries. The overall trend in their combined liabilities related to energy-related derivatives also shows an increase, from $28 million in 2022 ($15 million + $13 million) to $234 million in 2023 ($110 million + $124 million), reflecting a substantial rise in liabilities tied to these financial instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Energy-related derivatives (FIN_INST)",
        "Energy-related derivatives (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_327",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_281",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13881,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4129,
        "completion_tokens": 150,
        "total_tokens": 4279
      }
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Walmart's financial relationship with Alert Innovation evolved from an acquisition to a subsequent disposition. In fiscal 2023, Walmart acquired the remaining noncontrolling interest in Alert Innovation for $0.4 billion, increasing its ownership to approximately 100%. By fiscal 2024, Alert Innovation remained a consolidated subsidiary, but in fiscal 2025, it was sold and deconsolidated. This progression reflects Walmart's strategy of acquiring and later divesting certain technology-related assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Acquires]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Alert Innovation (COMP)",
        "Alert Innovation (COMP) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3893,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1616,
        "completion_tokens": 134,
        "total_tokens": 1750
      }
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "Between 2022 and 2023, the regulatory approval status of Trodelvy advanced significantly, with Gilead receiving FDA approval in 2023 for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. Additionally, in 2023, Gilead also received EC approval for Trodelvy as monotherapy for a similar patient population in Europe. This regulatory progress, combined with the earlier mention in 2022 of Trodelvy's growth within Gilead’s oncology franchise, indicates a strategic focus on expanding Trodelvy’s market access and reinforcing Gilead’s commitment to oncology innovation and commercialization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Trodelvy (PRODUCT)",
        "Trodelvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8160,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2671,
        "completion_tokens": 189,
        "total_tokens": 2860
      }
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group's (SPG) financial relationship with Authentic Brands Group (ABG) evolved through capital transactions and strategic positioning. In 2023, SPG recognized non-cash pre-tax gains of $36.4 million and $145.8 million from deemed disposals due to ownership dilutions in ABG, reflecting a shift in equity interest. In 2024, SPG continued its strategic engagement with ABG through its partnership with SPARC Group, which had previously acquired Reebok assets and entered a long-term strategic partnership with ABG to manage Reebok in the U.S. This partnership, established in 2022, underscores SPG's ongoing strategic positioning to leverage ABG's brand management capabilities. Overall, the relationship has transitioned from capital gains through equity adjustments to a more integrated operational and brand management collaboration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> ABG (COMP)",
        "ABG (COMP) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6534,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2266,
        "completion_tokens": 218,
        "total_tokens": 2484
      }
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "Between 2022 and 2024, Chevron's relationship with Chevron Phillips Chemical Company LLC, as reflected in its financial reporting, showed a steady increase in the value of its investment. In 2022, the investment was valued at $7,765 million, rising to $8,571 million by 2024, indicating a growth of $806 million over the two-year period. Additionally, Chevron's equity in earnings from Chevron Phillips Chemical Company LLC increased from $867 million in 2022 to $903 million in 2024, reflecting improved financial performance and a strengthening investment relationship.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Chevron Phillips Chemical Company LLC (COMP)",
        "Chevron Phillips Chemical Company LLC (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8317,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2729,
        "completion_tokens": 142,
        "total_tokens": 2872
      }
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "Between the end of 2023 and the end of 2024, Meta's Facilities Consolidation Strategy transitioned from being \"substantially completed\" to \"fully completed,\" as disclosed in its 10-K filings. As of December 31, 2023, the company had substantially completed the facilities consolidation initiatives, while by December 31, 2024, it reported that all 2022 restructuring initiatives, including the facilities consolidation, were fully completed. This evolution reflects the successful execution of Meta's strategy to optimize its real estate footprint, contributing to its broader efficiency and realignment goals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "META (ORG) -> Facilities Consolidation Strategy (ACCOUNTING_POLICY)",
        "Facilities Consolidation Strategy (ACCOUNTING_POLICY) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1634,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1058,
        "completion_tokens": 152,
        "total_tokens": 1211
      }
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "Lockheed Martin's involvement in hypersonics programs from 2022 to 2024 has evolved with a stronger strategic focus on advancing and expanding these capabilities, particularly in response to U.S. government priorities. In 2022, the company highlighted that its growth in hypersonics would be influenced by the overall budget environment, program transitions to production, and government funding decisions. By 2024, hypersonics programs were explicitly listed as a major initiative under the Missiles and Fire Control segment, with active development and production efforts for the U.S. Air Force and Army, reflecting a shift from planning and risk mitigation to active program execution and expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Hypersonics Programs (PRODUCT)",
        "Hypersonics Programs (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11386,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3485,
        "completion_tokens": 175,
        "total_tokens": 3661
      }
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "From 2022 to 2023, Southern Company shifted its treatment and disclosure of energy-related derivatives by changing their designation from regulatory hedging instruments to non-hedging instruments. In 2022, the company disclosed the pre-tax effects of unrealized gains and losses from derivatives designated as regulatory hedging instruments, which were deferred. By 2023, the focus shifted to derivatives not designated as hedging instruments, with the pre-tax effects directly impacting the statements of income for both Southern Company and Southern Company Gas. This change reflects a shift in how these instruments are accounted for and their direct impact on reported earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Energy-Related Derivatives (FIN_INST)",
        "Energy-Related Derivatives (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_324",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_295",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 661,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 813,
        "completion_tokens": 170,
        "total_tokens": 983
      }
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "Between 2022 and 2023, Gilead's intellectual property strategy regarding Truvada evolved as the company moved beyond the October 2020 loss of exclusivity in the U.S., which was disclosed in the 2022 10-K as having transitory impacts on the HIV franchise. By 2023, Gilead focused on managing the patent landscape for its key products, including Truvada, by providing detailed patent expiration disclosures in its 10-K, reflecting a strategic emphasis on transparency around intellectual property timelines. This shift highlights Gilead's transition from addressing the post-exclusivity market dynamics to proactively outlining future IP protections and competitive positioning.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Truvada (PRODUCT)",
        "Truvada (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4842,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1840,
        "completion_tokens": 169,
        "total_tokens": 2009
      }
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "Between 2022 and 2024, SPG's use of the Supplemental Facility evolved from a significant drawdown in 2021 to full repayment by 2023. In January 2022, SPG repaid $1.05 billion outstanding under the Supplemental Facility, which had been drawn in December 2021 to fund the early extinguishment of $1.16 billion in mortgages. By November 2023, SPG repaid €750 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility using proceeds from the issuance of €750 million in senior unsecured bonds. As of December 31, 2024, there was no outstanding balance under the Supplemental Facility, indicating that SPG had fully repaid its borrowings and maintained compliance with all covenants during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Supplemental Facility (FIN_INST)",
        "Supplemental Facility (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9600,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3037,
        "completion_tokens": 179,
        "total_tokens": 3216
      }
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "From 2022 to 2024, MetLife's cash buffer needs have remained a central consideration in its capital management strategy, influencing liquidity levels and capital allocation decisions. In 2022, MetLife emphasized its strong liquidity position, with $12.4 billion in short-term liquidity and $223.0 billion in liquid assets, and highlighted the role of cash buffers in ensuring resilience under stress scenarios and regulatory requirements. By 2024, the company continued to maintain a buffer of cash and liquid assets, acknowledging that these buffers may limit capital available for innovation, acquisitions, or shareholder returns. The evolving emphasis on cash buffers reflects ongoing regulatory and market pressures, as well as the need to balance liquidity with capital efficiency in a dynamic economic environment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "MET (ORG) -> Cash Buffer Needs (RISK_FACTOR)",
        "Cash Buffer Needs (RISK_FACTOR) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_122",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10797,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3352,
        "completion_tokens": 205,
        "total_tokens": 3557
      }
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "Between 2022 and 2023, Starbucks' exposure to 'Foreign currency - other' derivatives shifted significantly in terms of asset and liability classifications. In 2022, 'Foreign currency - other' was classified as a Derivative Liability under Accrued liabilities with a value of $0.3 million, down from $7.4 million in the prior year. By 2023, this exposure transitioned to being primarily an asset, with $1.9 million listed under Prepaid expenses and other current assets and $1.7 million under Other long-term assets, while the liability classification under Accrued liabilities decreased to $4.7 million. This indicates a shift from a net liability position to a more balanced or net asset position in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Foreign currency - other (FIN_INST)",
        "Foreign currency - other (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5598,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2045,
        "completion_tokens": 176,
        "total_tokens": 2222
      }
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "From 2023 to 2024, The Coca-Cola Company's relationship with Coca-Cola FEMSA remained strategically significant as one of its largest independent bottling partners, responsible for operations across multiple Latin American countries. In 2023, Coca-Cola FEMSA was identified as the top bottling partner by unit case volume, reflecting its key role in the Coca-Cola system. By 2024, The Coca-Cola Company also maintained a 28% equity stake in Coca-Cola FEMSA, as disclosed in its equity method investments, indicating a continued financial commitment and strategic alignment with the bottler. This dual relationship—both as a franchisor and a shareholder—highlights the importance of Coca-Cola FEMSA to The Coca-Cola Company's global operations and growth in key emerging markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Coca-Cola FEMSA (COMP)",
        "Coca-Cola FEMSA (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8009,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2641,
        "completion_tokens": 194,
        "total_tokens": 2835
      }
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "Between 2022 and 2024, Intel has increasingly positioned FPGAs as a critical component within its broader product ecosystem, particularly in adjacent products across the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG). In 2022, FPGAs were highlighted as part of Intel’s comprehensive platform solutions, integrated with products like modems, Ethernet, and silicon photonics, as well as Mobileye and PSG offerings. By 2024, FPGAs were further emphasized in the context of transformative technologies such as AI and 5G, aligning with Intel’s strategic focus on high-performance computing and next-generation infrastructure. This evolution reflects a shift toward leveraging FPGAs not just as standalone products but as enablers of Intel’s broader production focus on advanced, interconnected solutions for data centers, autonomous systems, and edge computing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "INTC (ORG) -> FPGA (PRODUCT)",
        "FPGA (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 32719,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 8817,
        "completion_tokens": 225,
        "total_tokens": 9042
      }
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "From 2022 to 2023, ConocoPhillips' financial activity in the Lower 48 region showed significant growth in depreciation, depletion, and amortization (DD&A) expenses, increasing from $4,854 million in 2022 to $5,729 million in 2023. This rise aligns with asset acquisition activity in the Lower 48, particularly driven by the Concho acquisition in 2022, which contributed to upward revisions of 162 MMBOE from infill drilling. These developments reflect both increased operational scale and higher depletion costs associated with expanded asset bases in the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Lower 48 (GPE)",
        "Lower 48 (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_164",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2210,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 140,
        "total_tokens": 1335
      }
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "Between 2022 and 2024, Emerson's financial and strategic relationship with AspenTech evolved significantly. In 2022, Emerson contributed approximately $6.0 billion in cash to Heritage AspenTech stockholders to form \"New AspenTech,\" resulting in Emerson owning 55% of the outstanding shares on a fully diluted basis. This acquisition positively impacted Emerson's 2023 gross margin by 0.6 percentage points due to favorable price and mix. By 2024, while the Test & Measurement acquisition contributed to a 1.8 percentage point increase in gross margin to 50.8%, acquisition-related inventory step-up amortization negatively impacted margins by approximately 1.3 percentage points. Overall, the strategic integration of AspenTech into Emerson's portfolio contributed to both ownership structure changes and mixed financial impacts on gross margins over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5530,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2022,
        "completion_tokens": 215,
        "total_tokens": 2238
      }
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "Between 2022 and 2024, the treatment and availability of shares under the 2015 Director Stock Plan evolved in terms of share recovery and issuance mechanics as outlined in MetLife, Inc.'s disclosures. In 2022, the plan specified that shares recovered due to unissued awards, cash settlements, or share tendering for tax or exercise price purposes are reauthorized for issuance, with the recovery calculations considering a 1:1 ratio for shares issued under the 2015 Director Stock Plan. By 2024, cumulative share recoveries from 2015 to 2023 totaled 35,770,685 shares, contributing to a total of 37,608,213 shares recovered since the plan’s inception. However, these recoveries were partially offset by shares used for new awards and reinvested dividends, resulting in 30,660,961 shares remaining available for future issuance under the 2015 Stock Plan and 2015 Director Stock Plan as of 2024. The mechanics ensure that share availability is adjusted for corporate events and that only net shares issued are counted, preserving the integrity of the plan’s share reserve.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "MET (ORG) -> 2015 Director Stock Plan (ACCOUNTING_POLICY)",
        "2015 Director Stock Plan (ACCOUNTING_POLICY) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_335",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_311",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8115,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2684,
        "completion_tokens": 267,
        "total_tokens": 2952
      }
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 with increased strategic emphasis on leveraging the partnership for product innovation and global distribution, as highlighted in the 2023 10-K. In fiscal 2022, the Channel Development segment reported a 16% revenue increase, driven by higher product sales to and royalty revenue from the Global Coffee Alliance. By fiscal 2023, the Alliance was explicitly mentioned as a key licensing and distribution channel, integral to Starbucks' strategy for expanding its coffee and tea products across diverse markets. This reflects a stronger focus on the Alliance as a growth driver, contributing to both revenue and brand extension in fiscal 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Positively_Impacts]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Global Coffee Alliance (COMP)",
        "Global Coffee Alliance (COMP) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10394,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3244,
        "completion_tokens": 186,
        "total_tokens": 3431
      }
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "Between 2022 and 2023, NEE's financial stake in the Mountain Valley Pipeline remained a key component of its equity method investments, with NEE's interest ranging from 32% to 55% in 2022 and narrowing to a range of 32.8% to 52.6% in 2023. Notably, the Mountain Valley Pipeline was explicitly included in NEE's equity method investees in 2023, as highlighted in Note 4 and Note 15 of the 2023 10-K, whereas in 2022 it was referenced only in Note 15. This increased emphasis in 2023 suggests a strategic focus on maintaining and possibly expanding its involvement in natural gas infrastructure projects, aligning with NEE's broader investment strategy in energy assets that support its operational and generation needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Mountain Valley Pipeline (COMP)",
        "Mountain Valley Pipeline (COMP) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2293,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 179,
        "total_tokens": 1396
      }
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Medtronic's InterStim Therapy product line has evolved by expanding its neurostimulator offerings and therapeutic indications. In 2022, the product line included the InterStim II, InterStim Micro, and InterStim X neurostimulators, targeting overactive bladder, urinary retention, and bowel incontinence. By 2024, the line continued to feature the InterStim X and InterStim II recharge-free neurostimulators, along with the InterStim Micro rechargeable neurostimulator, maintaining its focus on pelvic health therapies while emphasizing growth in these indications. This evolution reflects Medtronic's ongoing commitment to advancing its neurostimulation portfolio for chronic pelvic health conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MDT (ORG) -> InterStim Therapy (PRODUCT)",
        "InterStim Therapy (PRODUCT) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8060,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2651,
        "completion_tokens": 181,
        "total_tokens": 2832
      }
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "From 2022 to 2024, Simon Property Group's (SPG) financial stake and strategic relationship with Authentic Brands Group (ABG) evolved significantly. In 2021, SPG increased its interest in SPARC Group (which includes ABG) by acquiring additional interests of 5.05% and 1.37%. In the first quarter of 2022, SPARC Group acquired Reebok's assets and operations and entered into a long-term strategic partnership with ABG to serve as the core licensee and operating partner for Reebok in the U.S., deepening their collaboration. By December 2021, SPG had sold a portion of its interest in ABG, recording a pre-tax gain of $18.8 million, but then reinvested $100.0 million to acquire additional interests, signaling a continued strategic and financial commitment to ABG.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> ABG (COMP)",
        "ABG (COMP) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6522,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2255,
        "completion_tokens": 190,
        "total_tokens": 2446
      }
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "ConocoPhillips' investment activity in the Lower 48 region, as reflected in depreciation, depletion, and amortization (DD&A) expenses, increased significantly from 2021 to 2023. DD&A expenses for the Lower 48 rose from $4,067 million in 2021 to $5,729 million in 2023, indicating a growing capital investment and production activity in the region. This aligns with the substantial additions to proved reserves in the Lower 48, as shown in the reserve changes from 2018 to 2021, including significant increases from purchases and extensions in 2021. The upward trend in DD&A expenses reflects the company's strategic focus on the Lower 48 as a key operational area.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Lower 48 (GPE)",
        "Lower 48 (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_158",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10872,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3353,
        "completion_tokens": 166,
        "total_tokens": 3519
      }
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "From 2023 to 2024, Verizon's (VZ) treatment and valuation approach for international bonds remained consistent in methodology but showed a reduction in holdings. In 2023, international bonds were valued using matrix pricing with inputs from independent third-party valuation sources, reflecting a transparent and market-based approach. In 2024, VZ reported $12 million in international bonds, categorized under Level 1 ($10 million) and Level 2 ($2 million) in the fair value hierarchy, indicating continued reliance on observable market data for valuation. This evolution suggests a stable and market-driven valuation strategy, with a slight decrease in the size of international bond holdings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "VZ (ORG) -> International Bonds (FIN_INST)",
        "International Bonds (FIN_INST) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4354,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1725,
        "completion_tokens": 173,
        "total_tokens": 1898
      }
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "Between 2022 and 2024, Emerson's relationship with AspenTech evolved significantly in terms of both financial stake and operational integration. In 2022, Emerson acquired Heritage AspenTech, significantly increasing its stake in the company, and by the end of fiscal 2022, Emerson held a controlling interest in AspenTech. By 2024, Emerson owned 55 percent of the outstanding shares of AspenTech on a fully diluted basis, and AspenTech and its subsidiaries operated under the name 'Aspen Technology, Inc.' with its stock traded under the ticker symbol 'AZPN.' This acquisition led to operational integration, as reflected in Emerson’s financials through increased cost of sales and SG&A expenses in 2023 and 2024, attributed to the inclusion of AspenTech’s operations and the Test & Measurement acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6658,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2295,
        "completion_tokens": 201,
        "total_tokens": 2497
      }
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "Between 2022 and 2023, Starbucks' position in interest rate swaps shifted significantly in terms of classification and associated liabilities. In 2022, Starbucks reported a derivative liability of $34.0 million for interest rate swaps under \"Other long-term liabilities\" as of October 2, 2022. By 2023, the interest rate swaps were still classified as designated derivative instruments but were reported as liabilities of $41.4 million under \"Other long-term liabilities\" as of October 1, 2023, indicating an increase in associated liabilities. This evolution reflects Starbucks' ongoing use of interest rate swaps for risk management, with the swaps remaining a material component of its long-term liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Interest rate swap (FIN_INST)",
        "Interest rate swap (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5598,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2040,
        "completion_tokens": 177,
        "total_tokens": 2218
      }
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "From 2022 to 2023, NextEra Energy Resources' (NEER) financial commitment and involvement in the Mountain Valley Pipeline (MVP) evolved significantly. In 2022, due to legal and regulatory challenges, including the U.S. Court of Appeals for the Fourth Circuit vacating key permits, NEER concluded that the probability of MVP completion was very low. As a result, NEER recorded a $0.8 billion pre-tax impairment charge in the first quarter of 2022, fully writing off its $0.6 billion equity method investment and recognizing a $0.2 billion liability for its share of future abandonment and removal (ARO) costs. By 2023, NEER maintained its 32.8% equity stake in MVP and entered into a 20-year natural gas transportation agreement with MVP, committing approximately $70 million per year, contingent on the pipeline's completion. This reflects a shift from a significant impairment in 2022 to ongoing financial obligations tied to MVP's uncertain construction progress in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Mountain Valley Pipeline (COMP)",
        "Mountain Valley Pipeline (COMP) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8175,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2678,
        "completion_tokens": 243,
        "total_tokens": 2921
      }
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "The Coca-Cola Company's investment in equity and debt securities by its captive insurance company, which reinsures group annuity insurance contracts covering obligations of certain European and Canadian pension plans, increased from $1,643 million as of December 31, 2023, to $1,883 million as of December 31, 2024. This reflects a $240 million increase in the solvency capital funds allocated to marketable equity and debt securities over the one-year period. These investments are classified as other noncurrent assets in the consolidated balance sheets, as they are not available to satisfy current obligations. The evolution of these investments aligns with the Company's strategy to meet regulatory solvency requirements while managing market risks through its captive insurance structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Group Annuity Insurance Contracts (FIN_INST)",
        "Group Annuity Insurance Contracts (FIN_INST) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12383,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3751,
        "completion_tokens": 198,
        "total_tokens": 3949
      }
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "Intel's approach to the Intel 4 process node evolved significantly from 2022 to 2024, transitioning from a development and ramp-up phase to high-volume manufacturing and strategic integration into its product roadmap. In 2022, Intel 4 was still in the ramp-up phase, as reflected in period charges associated with its development. By 2024, Intel 4 had moved to high-volume manufacturing in Ireland and was used in the first high-volume client product, the Intel Core Ultra processor, which began shipping in 2023. Intel 4 is expected to represent an increasing share of processor production in 2025, solidifying its role as a foundational node in Intel's transition to EUV lithography and its broader strategy to regain process leadership.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Intel 4 (PRODUCT)",
        "Intel 4 (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10236,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3199,
        "completion_tokens": 184,
        "total_tokens": 3384
      }
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "Between 2022 and 2024, Emerson's strategic relationship with AspenTech evolved significantly in terms of ownership and financial integration. In 2022, AspenTech was acquired by Emerson, with the Heritage AspenTech business operating as part of Emerson's portfolio. By 2024, Emerson completed a spin-off and merger transaction, creating \"New AspenTech,\" in which Emerson retained a 55% ownership stake in the newly formed entity. Financially, the Heritage AspenTech acquisition in 2022 positively impacted Emerson’s gross margins in 2023, while the subsequent spin-off in 2024 led to increased SG&A expenses and other deductions, including acquisition-related amortization and restructuring costs. This transition marked a shift from full integration to a majority-owned, separately traded entity, reflecting a strategic repositioning of Emerson’s industrial software business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9337,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2968,
        "completion_tokens": 219,
        "total_tokens": 3187
      }
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "From 2022 to 2024, Intel's approach to the Intel 4 process node evolved significantly in terms of manufacturing readiness and performance. Initially introduced in 2022 as part of Intel's updated naming structure, Intel 4 marked the company's first use of EUV lithography and was positioned as a major step forward in density scaling and performance-per-watt, offering approximately 20% improvement over Intel 7. By 2024, Intel 4 had moved to high-volume manufacturing in Ireland, with the Intel Core Ultra processor as its first high-volume client product, which began shipping in 2023. This transition to high-volume production in Ireland underscores Intel's progress in manufacturing readiness and its strategic shift in production locations to optimize efficiency and scale. The successful ramp of Intel 4 also laid the groundwork for subsequent nodes like Intel 3 and the upcoming Intel 18A, reflecting Intel's ongoing commitment to advancing its process technology roadmap.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Intel 4 (PRODUCT)",
        "Intel 4 (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6531,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2268,
        "completion_tokens": 244,
        "total_tokens": 2513
      }
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "Between 2022 and 2024, the InterStim Micro neurostimulator has maintained a key role within MDT's Pelvic Health therapies, specifically in treating overactive bladder, non-obstructive urinary retention, and chronic fecal incontinence. In 2022, it was listed among the principal pelvic health products alongside the InterStim X and InterStim II. By 2024, the InterStim Micro was highlighted as a rechargeable option within the continued growth of Pelvic Health therapies, emphasizing its importance alongside the recharge-free InterStim X and InterStim II. This evolution reflects MDT's strategy to offer a comprehensive range of neurostimulation solutions tailored to patient needs and market demands.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MDT (ORG) -> InterStim Micro (PRODUCT)",
        "InterStim Micro (PRODUCT) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7269,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2446,
        "completion_tokens": 175,
        "total_tokens": 2621
      }
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "The disclosure around the dilutive effect of LTIP Units shows consistency from 2022 to 2024, with SPG indicating that no securities, including LTIP Units, had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, as well as for 2021, 2020, and 2019. While the 2022 filing notes the inclusion of LTIP Units among potentially dilutive securities, the 2024 filing similarly lists them but reaffirms no material impact across the reporting periods. This suggests that, despite the ongoing presence of LTIP Units as a potential dilutive instrument, they have not significantly affected diluted earnings per share during these years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> LTIP Units (FIN_INST)",
        "LTIP Units (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 993,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 885,
        "completion_tokens": 163,
        "total_tokens": 1048
      }
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "From 2022 to 2024, MetLife's approach to managing cash buffer needs in relation to stock repurchases has reflected a balance between maintaining liquidity and returning capital to shareholders. In 2022, MetLife had $1.5 billion of remaining repurchase authorization under a $3.0 billion program authorized in August 2021, with cash buffer needs explicitly cited as a potential constraint on repurchases in its disclosures. By 2024, while no specific remaining repurchase authorization amount is provided, MetLife continued to emphasize the importance of maintaining a cash buffer to meet regulatory and liquidity requirements, noting that such needs could limit its ability to pay dividends or repurchase stock. This evolution underscores MetLife's ongoing prioritization of liquidity and regulatory compliance alongside its commitment to capital return, with cash buffer considerations increasingly shaping its financial strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "MET (ORG) -> Cash Buffer Needs (RISK_FACTOR)",
        "Cash Buffer Needs (RISK_FACTOR) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7908,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2632,
        "completion_tokens": 232,
        "total_tokens": 2865
      }
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "From fiscal year 2022 to 2023, Starbucks' foreign currency - other derivative positions showed significant changes in both asset and liability classifications on the balance sheet. In 2022, foreign currency - other derivative assets were reported at $32.0 million under \"Prepaid expenses and other current assets\" and $22.9 million under \"Other long-term assets,\" while liabilities were $2.0 million in \"Accrued liabilities\" and none in long-term liabilities. By 2023, derivative assets increased to $1.9 million in current assets and $1.7 million in long-term assets, while liabilities rose to $4.7 million in accrued liabilities and $4.1 million in long-term liabilities, indicating a shift toward a net liability position and a reclassification toward longer-term obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Foreign currency - other (FIN_INST)",
        "Foreign currency - other (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9670,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3072,
        "completion_tokens": 194,
        "total_tokens": 3267
      }
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024, Procter & Gamble's global cash management strategy has evolved in response to its restructuring activities and corporate-level financial performance. In fiscal 2022, restructuring costs were within the historical range of $250 to $500 million, with $147 million in restructuring accruals, and the Company reported improved corporate net earnings of $485 million, driven by lower restructuring charges and tax benefits. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses from the liquidation of operations in certain Enterprise Markets. Despite the higher restructuring charges and a $1.4 billion impairment charge on the Gillette intangible asset, the Company maintained its global cash management strategy, emphasizing liquidity, tax efficiency, and the use of operating cash flow to fund dividends and strategic investments, reflecting its continued strong financial position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "PG (ORG) -> Global Cash Management Strategy (ACCOUNTING_POLICY)",
        "Global Cash Management Strategy (ACCOUNTING_POLICY) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7376,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2505,
        "completion_tokens": 255,
        "total_tokens": 2761
      }
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "Between 2022 and 2023, NVIDIA's positioning and application of Omniverse evolved significantly, particularly in its integration with enterprise solutions and simulation technologies. In 2022, Omniverse was described as a virtual world simulation and collaboration platform for 3D workflows, used in enterprise applications such as virtual car showrooms, surgical training, and architectural walkthroughs. It was highlighted as a key component of NVIDIA's AI-driven automotive solutions, including DRIVE Chauffeur and DRIVE Concierge, which leverage Omniverse Avatar for real-time conversational AI. By 2023, Omniverse had expanded into a development platform and operating system for building virtual world simulation applications, adopted by industrial enterprises to digitalize physical assets and processes—such as creating digital twins of factories and testing autonomous systems—powered by NVIDIA’s accelerated computing infrastructure both on-premises and in the cloud. This evolution reflects a broader integration of Omniverse into enterprise-scale simulation and digital transformation initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Omniverse (PRODUCT)",
        "Omniverse (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11394,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3490,
        "completion_tokens": 277,
        "total_tokens": 3767
      }
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "AMT's financial commitments related to communications sites evolved from 2023 to 2024, with 2023 anticipating approximately $450 million in spending for the construction of 2,500 to 3,500 communications sites globally. By 2024, the focus shifted to future obligations, including payments under non-cancellable initial terms and renewal periods for these sites, with potential consequences of losing sites and related tenant revenues if not renewed. Additionally, AMT faced $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024, underscoring the long-term financial commitments tied to its communications infrastructure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Communications Sites (PRODUCT)",
        "Communications Sites (PRODUCT) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3496,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 170,
        "total_tokens": 1686
      }
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "ExxonMobil's characterization of asset divestitures in relation to strategic objectives remained consistent between 2023 and 2024, with both years emphasizing that assets are divested when they no longer meet strategic objectives or are worth considerably more to others. However, the 2024 filing omitted the phrase \"proceeds associated with sales of subsidiaries, property, plant and equipment, and sales and returns of investments,\" replacing it with the more general \"proceeds from asset sales and returns of investments,\" subtly streamlining the language while retaining the core rationale for divestitures and their integration into cash flow analysis for investors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Assets Contributing to Strategic Objectives (ACCOUNTING_POLICY)",
        "Assets Contributing to Strategic Objectives (ACCOUNTING_POLICY) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2616,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 167,
        "total_tokens": 1498
      }
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "Comcast's financial exposure to Universal Beijing Resort, as reflected in consolidated assets and liabilities, decreased from 2022 to 2023. As of December 31, 2021 (Chunk 1), the consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By December 31, 2023 (Chunk 2), these amounts had declined to $7.8 billion in assets and $7.2 billion in liabilities. This reduction suggests a decrease in the scale of the resort's operations or asset base, or potentially the repayment of some liabilities, indicating a slight reduction in Comcast's consolidated financial exposure to the entity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Consolidates]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Universal Beijing Resort (COMP)",
        "Universal Beijing Resort (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5527,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2024,
        "completion_tokens": 163,
        "total_tokens": 2188
      }
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "Between 2023 and 2024, Caterpillar's exposure to Customer Demand Volatility as a risk factor has evolved to reflect heightened economic and supply chain uncertainties. In 2023, the risk was primarily linked to macroeconomic conditions, such as commodity price fluctuations, infrastructure spending, and the cyclical nature of industries like energy, mining, and transportation, which could reduce capital expenditures and impact Caterpillar’s financial performance. The 2024 filing expands on this by emphasizing the compounding effects of catastrophic events—such as pandemics, supply chain disruptions, and labor shortages—which have increased demand uncertainty and inflationary pressures. These events have further strained Caterpillar’s ability to meet customer demand, exacerbating the risk’s impact on both financial performance and supply chain stability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Customer Demand Volatility (RISK_FACTOR)",
        "Customer Demand Volatility (RISK_FACTOR) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11056,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3425,
        "completion_tokens": 215,
        "total_tokens": 3641
      }
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "From 2022 to 2024, the fair value of Net derivative assets (liabilities) increased from $19 million (as of December 31, 2021, with a Level 3 balance of $31 million and changes in net income of $(43) million in 2022) to $58 million by December 31, 2023. The valuation methodology in 2024 primarily relied on discounted cash flows using swap rates as a significant unobservable input, with a weighted average of 4%. In 2022, the valuation also used Level 3 inputs, with changes in net income impacting the balance through gains and losses. Thus, the fair value increased significantly, and the valuation technique remained consistent with the use of unobservable inputs, though the specific inputs shifted to swap rates by 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Included_in_Net_Income]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "COF (ORG) -> Net derivative assets (liabilities) (FIN_INST)",
        "Net derivative assets (liabilities) (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_220",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_217",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13042,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3901,
        "completion_tokens": 181,
        "total_tokens": 4083
      }
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "From 2022 to 2023, NVIDIA's GeForce NOW cloud gaming offering has evolved from being a key component of the company's broader GPU and cloud platform ecosystem to a more strategically integrated and expanded service within NVIDIA's accelerated computing vision. In 2022, GeForce NOW was positioned as a cloud platform that enabled interactive graphics applications, such as games, to be accessed from any device, leveraging NVIDIA's GPU-based infrastructure and software stacks. By 2023, GeForce NOW was highlighted as part of NVIDIA's broader gaming portfolio, which includes RTX GPUs and cloud-based solutions, emphasizing its role in enabling high-quality, AI-enhanced gaming experiences on underpowered devices. This evolution reflects NVIDIA's continued focus on unifying hardware and software across its platforms, with GeForce NOW playing a central role in extending the reach and accessibility of its GPU-powered innovations in gaming and cloud computing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> GeForce NOW (PRODUCT)",
        "GeForce NOW (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11421,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3493,
        "completion_tokens": 240,
        "total_tokens": 3734
      }
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "Inlyta's revenue increased slightly from $1.003 billion in 2022 to $1.036 billion in 2023, representing a 3% operational growth and a 5% increase in the U.S. market. This growth was driven by the adoption of combination therapies involving Inlyta and immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., as well as continued growth in emerging markets globally. However, these gains were partially offset by lower volumes and reduced net pricing in certain European markets. Additionally, Inlyta's product patents are scheduled to expire in 2025 across major markets, which could pose future challenges to its revenue performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Inlyta (PRODUCT)",
        "Inlyta (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 22484,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6243,
        "completion_tokens": 171,
        "total_tokens": 6415
      }
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "From 2023 to 2024, the treatment and valuation of network location intangibles evolved in both amortization assumptions and impairment review processes. In 2023, AMT amortized these intangibles over the shorter of the ground lease term or up to 20 years, using a straight-line method with a weighted average remaining amortization period of 15 years. By 2024, the Company maintained amortization over useful lives generally ranging from two to thirty years but emphasized a more granular impairment review process, assessing network location intangibles on an individual tower basis and tenant-related intangibles on a tenant-by-tenant basis. Impairment assessments now explicitly consider factors such as lease non-renewals, tenant financial viability, and projected undiscounted future cash flows, with impairment losses measured using discounted cash flows or fair value. Additionally, AMT revised its asset retirement obligation settlement dates in 2024, impacting related intangible asset valuations and amortization indirectly by extending estimated settlement dates and adjusting liabilities and expenses accordingly.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Amortizes]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Network Location Intangibles (FIN_INST)",
        "Network Location Intangibles (FIN_INST) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8046,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2662,
        "completion_tokens": 281,
        "total_tokens": 2943
      }
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "ExxonMobil has significantly intensified its strategic focus on Guyana between 2023 and 2024, as evidenced by its upstream growth portfolio and production capacity. In 2023, Guyana's Stabroek Block saw exploration success with four new discoveries, and the Prosperity FPSO reached full capacity in early 2024, with combined gross production from three vessels exceeding 390 thousand barrels of oil per day (kbd) in 2023 and nearly 440 kbd in Q4 2023. By 2024, Guyana was explicitly categorized as an \"Advantaged Asset\" within ExxonMobil's earnings drivers, underscoring its strategic importance. The company anticipates six FPSO vessels operating on the Stabroek Block by late 2027, with the Whiptail project progressing through regulatory approvals, further solidifying Guyana's role in ExxonMobil's long-term upstream growth strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Guyana (GPE)",
        "Guyana (GPE) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8791,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2829,
        "completion_tokens": 209,
        "total_tokens": 3038
      }
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "Between 2022 and 2023, the X1 platform's integration with third-party streaming services evolved from providing access to services like Disney+ and Netflix to also incorporating the Xumo Stream Box and Xumo Play, as well as the ad-supported tier of Peacock. Additionally, in 2023, Comcast launched the NOW TV service, which offers internet-based video content without a set-top box and includes integrated access to free streaming channels. These developments indicate that Comcast is enhancing the X1 platform's flexibility and content breadth to better compete with standalone streaming services, thereby reducing cord-cutting. By integrating more third-party and in-house streaming options, Comcast is likely aiming to increase customer retention and elevate ARPU through bundled offerings and expanded service tiers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> X1 Platform (PRODUCT)",
        "X1 Platform (PRODUCT) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11023,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3413,
        "completion_tokens": 205,
        "total_tokens": 3618
      }
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "Between 2023 and 2024, Caterpillar's relationship with FG Wilson, in terms of distribution network coverage for electric power generation systems, has expanded significantly. In 2023, FG Wilson systems were distributed through a worldwide network of 110 distributors covering 109 countries. By 2024, this network had grown to 108 distributors covering 158 countries, indicating an enhanced global reach and more efficient distribution infrastructure for Caterpillar’s electric power generation systems under the FG Wilson brand.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "CAT (ORG) -> FG Wilson (PRODUCT)",
        "FG Wilson (PRODUCT) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9052,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2899,
        "completion_tokens": 132,
        "total_tokens": 3031
      }
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "Capital One's exposure to securitized debt obligations increased slightly between 2022 and 2024 in terms of both carrying value and fair value. In 2022, the carrying value of these obligations was not explicitly stated in the provided text, but the context from the 10-K filing indicates that securitized debt obligations are reported under liabilities on the consolidated balance sheets. By 2024, the carrying value of securitized debt obligations was $18,043 million, with a corresponding fair value of $18,067 million, as disclosed in the 2024 10-K. This reflects a minimal increase in both metrics compared to 2022, suggesting relatively stable exposure to these obligations over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Reports]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "COF (ORG) -> Securitized Debt Obligations (FIN_INST)",
        "Securitized Debt Obligations (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_179",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_220",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6373,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2242,
        "completion_tokens": 173,
        "total_tokens": 2416
      }
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "Between 2023 and 2024, McDonald's continued to utilize line of credit agreements as part of its cash flow management and financing activities, as disclosed in both years’ 10-K filings. In 2023, the Company reported strong cash flow from operations of $9.6 billion and used line of credit agreements to support short-term funding needs, particularly as financing activities saw a decrease of $2.2 billion due to increased bond issuances. By 2024, cash flow from operations slightly declined to $9.4 billion, and free cash flow dropped to $6.7 billion, while financing activities increased to $7.5 billion, driven by decreased bond issuances. Despite the lower cash balance at year-end 2024 ($1.1 billion vs. $4.6 billion in 2023), McDonald's maintained access to line of credit agreements and commercial paper borrowings to meet short-term liquidity needs, underscoring their ongoing role in the Company’s financial flexibility and strategic execution of its Restaurant Development initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Line of Credit Agreements (FIN_INST)",
        "Line of Credit Agreements (FIN_INST) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5345,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1978,
        "completion_tokens": 248,
        "total_tokens": 2226
      }
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "Between 2022 and 2024, the Worldwide Business Conduct Manual has remained a central component of Procter & Gamble’s internal control framework, consistently reinforcing the company’s commitment to ethical business practices and compliance with legal and regulatory standards. In both years, the Manual is highlighted as a foundational tool that supports internal controls by promoting integrity and aligning employee behavior with the company’s Purpose, Values, and Principles. The continued emphasis on the Manual in 2024, alongside the ongoing effectiveness of internal controls as affirmed by Deloitte & Touche LLP, indicates that Procter & Gamble maintains a robust and stable approach to governance, with a focus on long-term compliance and ethical business conduct.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "PG (ORG) -> Worldwide Business Conduct Manual (ACCOUNTING_POLICY)",
        "Worldwide Business Conduct Manual (ACCOUNTING_POLICY) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7193,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2463,
        "completion_tokens": 192,
        "total_tokens": 2656
      }
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "Exxon's strategic positioning in Guyana has significantly evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions. In 2023, Guyana's long-lived assets were reported at $9,689 million, up from $6,766 million in 2022 and $4,892 million in 2021, indicating a growing capital commitment to the region. By 2024, Guyana is explicitly categorized as an \"Advantaged Asset\" in the updated earnings driver definitions, highlighting its strategic importance as a high-value, growth-driving project. This inclusion underscores Exxon’s focus on leveraging Guyana’s resource potential to enhance earnings through volume and mix improvements, aligning with broader strategic objectives of advantaged volume growth and integration across segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Guyana (GPE)",
        "Guyana (GPE) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4108,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1659,
        "completion_tokens": 196,
        "total_tokens": 1855
      }
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "Capital One's reliance on securitized debt obligations as a funding source, as disclosed in its 2024 10-K, shows that securitized debt obligations amounted to $14,264 million in carrying value (with an estimated fair value of $14,335 million) as of December 31, 2024. While the 2022 10-K does not provide a specific dollar amount for securitized debt obligations, it does confirm that securitized debt obligations were part of Capital One's funding strategy, alongside deposits, senior and subordinated notes, and other wholesale funding sources. The 2024 figures indicate that securitized debt obligations remain a material component of the company’s funding mix, though the exact evolution from 2022 to 2024 in terms of percentage or proportion relative to other funding sources cannot be quantified without additional data from 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Raises]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "COF (ORG) -> Securitized Debt Obligations (FIN_INST)",
        "Securitized Debt Obligations (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_219",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5947,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2131,
        "completion_tokens": 209,
        "total_tokens": 2340
      }
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "Between fiscal years 2022 and 2023, NVIDIA's Omniverse platform evolved from being positioned as real-time 3D design collaboration and virtual world simulation software to a development platform and operating system for building virtual world simulation applications. In 2022, Omniverse was highlighted as a tool empowering artists and designers to collaborate in leading design applications, while in 2023, it was described as a subscription-based enterprise solution enabling industrial enterprises to digitalize physical assets and processes, such as building digital twins of factories and testing autonomous systems. This shift reflects a stronger focus on enterprise adoption, with Omniverse being integrated into NVIDIA’s broader accelerated computing infrastructure, both on-premises and in the cloud, to support complex simulation and digital transformation initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Omniverse (PRODUCT)",
        "Omniverse (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11421,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3483,
        "completion_tokens": 219,
        "total_tokens": 3703
      }
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "Between 2022 and 2023, the net amounts due under Pfizer's agreements with Viatris shifted from $94 million as of December 31, 2022, to $33 million as of December 31, 2023, indicating a significant reduction in the amount Pfizer owed to Viatris. This change reflects the ongoing transition and completion of services under the interim agreements, including the TSAs, which were largely completed by the end of 2023. The financial relationship remains structured through MSAs and agency arrangements, with the cash flows primarily classified under operating activities, except for a $277 million payment to Viatris in 2021, which was recorded under financing activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Viatris (COMP)",
        "Viatris (COMP) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6991,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2380,
        "completion_tokens": 167,
        "total_tokens": 2547
      }
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "ExxonMobil's strategic emphasis on Guyana has intensified between 2023 and 2024, as reflected in both project activity and classification. In 2023, Guyana accounted for 4.6 million offshore acres, with 12.6 net exploratory and development wells completed, and the Payara development commenced with the Prosperity FPSO, while the Yellowtail and Uaru projects advanced. By 2024, Guyana was explicitly classified as an \"Advantaged Asset\" within the updated earnings drivers, placing it in the same category as the Permian Basin and LNG, which underscores its strategic and financial significance. This classification change highlights ExxonMobil's recognition of Guyana's role in driving volume growth and high returns, aligning with the company's broader focus on high-impact, integrated projects.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Guyana (GPE)",
        "Guyana (GPE) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5180,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1929,
        "completion_tokens": 198,
        "total_tokens": 2127
      }
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "From 2022 to 2023, the weighted-average interest rate for CMCSA's senior notes with maturities greater than 10 years remained stable at 3.67% in 2022 and increased slightly to 3.8% in 2023. The face value of these senior notes decreased from $52.8 billion in 2022 to $53.4 billion in 2023, indicating a modest increase in the total amount outstanding despite the stable to slightly higher interest rate.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Senior Notes Greater than 10 Years (FIN_INST)",
        "Senior Notes Greater than 10 Years (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6215,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2198,
        "completion_tokens": 100,
        "total_tokens": 2299
      }
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "Between 2023 and 2024, the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shifted their domestic equity investment allocations and valuation methodologies as follows:\n\nFor **Alabama Power**, the domestic equity allocation increased from **$396 million (Level 2)** in 2023 to **$443 million (Level 2)** in 2024, indicating a slight increase in the amount invested and a continued reliance on Level 2 inputs for valuation. There were no Level 1 inputs in 2024, similar to 2023.\n\nFor **Georgia Power**, the domestic equity allocation increased significantly from **$255 million (Level 2)** in 2023 to **$321 million (Level 2)** in 2024. Like Alabama Power, Georgia Power also used only Level 2 inputs for valuation in both years, with no Level 1 inputs reported. \n\nThus, both companies maintained their use of Level 2 inputs for domestic equity valuation, with increases in the amounts invested in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Nuclear decommissioning trusts (FIN_INST)",
        "Nuclear decommissioning trusts (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_284",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_277",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 21769,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6113,
        "completion_tokens": 231,
        "total_tokens": 6345
      }
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "NVIDIA's strategic positioning of CUDA from 2022 to 2023 has evolved to become a foundational element of its full-stack computing platform, enabling cross-market integration and scalability. In 2022, CUDA was highlighted as a core building block for NVIDIA’s accelerated computing architecture, supporting diverse end markets such as Automotive, where it underpinned the DRIVE platform for autonomous driving and AI-powered cockpit solutions. By 2023, CUDA's role expanded to serve as the programming model across a broader ecosystem, supporting not only AI and deep learning but also enterprise applications, generative AI, and data-center-scale solutions. This evolution reflects NVIDIA’s platform strategy, leveraging CUDA’s programmable architecture to unify hardware, software, and domain-specific libraries across industries, including healthcare, automotive, and cloud services, thereby enhancing its value proposition and ecosystem strength.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> CUDA (PRODUCT)",
        "CUDA (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11778,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3587,
        "completion_tokens": 237,
        "total_tokens": 3824
      }
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "From 2022 to 2023, Pfizer's financial obligations and contractual relationships with Viatris, stemming from the 2020 spin-off of the Upjohn Business, evolved as transitional service agreements (TSAs) and manufacturing and supply agreements (MSAs) were largely completed by December 31, 2023. As of December 31, 2023, the net amount due to Viatris under these agreements was $33 million, a significant decrease from $94 million as of December 31, 2022. These amounts, along with related cash flows, were primarily classified under operating activities, except for a $277 million payment to Viatris in 2021, which was reported under financing activities. The reduction in net amounts owed reflects the winding down of transitional obligations between the two entities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Viatris (COMP)",
        "Viatris (COMP) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8124,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2671,
        "completion_tokens": 191,
        "total_tokens": 2862
      }
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "From 2022 to 2023, the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs has remained interconnected, with both factors contributing to operational and financial uncertainty. In 2022, Duke Energy noted that retail deregulation could lead to increased competition, asset impairment, and unrecovered costs, which could impact its ability to recover environmental compliance expenses through rate structures. By 2023, the company reiterated these concerns, emphasizing that environmental regulations continue to drive significant capital and operating expenditures, and that deregulation could further complicate cost recovery. Additionally, in 2023, Duke Energy highlighted the potential for more stringent climate-related regulations, which could increase compliance costs and necessitate early retirement of generation assets, compounding the financial pressures from both deregulation and environmental mandates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Retail Deregulation (REGULATORY_REQUIREMENT)",
        "Retail Deregulation (REGULATORY_REQUIREMENT) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15162,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4442,
        "completion_tokens": 243,
        "total_tokens": 4686
      }
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market share. This contrasts with the pricing strategy applied to Skoal during 2023, where multiple price increases were implemented, including hikes of $0.09 to $0.10 per can in January and April 2023, and a $0.09 per can increase in February 2022. These price increases suggest an attempt to maintain profitability amid a shrinking retail share.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Skoal (PRODUCT)",
        "Skoal (PRODUCT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5712,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2063,
        "completion_tokens": 116,
        "total_tokens": 2179
      }
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million between 2023 and 2024, as shown in both the 2023 and 2024 10-K filings. This consistency, alongside the larger allocation to money market mutual funds, suggests a stable and conservative short-term investment strategy focused on liquidity and low-risk instruments. The lack of changes in these holdings indicates Amgen's prioritization of capital preservation and ready access to cash in its investment approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> Other short-term interest-bearing securities (FIN_INST)",
        "Other short-term interest-bearing securities (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1776,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1106,
        "completion_tokens": 129,
        "total_tokens": 1235
      }
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "General Dynamics' involvement in Abrams Main Battle Tank Upgrades has evolved from 2022 to 2024 in both contract scope and value. In 2022, General Dynamics received a $360 million contract from the U.S. Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the contract scope had expanded to include engineering and logistics support services, as well as system and sustainment technical support, with the contract value increasing to $350 million. This reflects a shift toward a more comprehensive support model, emphasizing not only upgrades but also long-term sustainment and technical services, indicating a broader and more sustained engagement with the U.S. Army.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Receives]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GD (ORG) -> Abrams Main Battle Tank Upgrades (PRODUCT)",
        "Abrams Main Battle Tank Upgrades (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2962,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 180,
        "total_tokens": 1568
      }
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "From 2023 to 2024, AIG's financial relationship with Corebridge evolved in two key ways. In 2023, AIG disclosed that Corebridge had the ability to continue borrowing under its arrangement through February 25, 2025, indicating an ongoing borrowing relationship. By 2024, AIG began recognizing income from Corebridge through its equity method, which included both dividends received and changes in Corebridge's stock price following its spin-off on June 10, 2024. This shift reflects a transition from a borrowing-focused relationship to one involving income recognition as a result of AIG's continued stake in Corebridge.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Impacts]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Corebridge (COMP)",
        "Corebridge (COMP) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1022,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 887,
        "completion_tokens": 155,
        "total_tokens": 1042
      }
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Solar Roof has evolved from a focus on product design and installation improvements to addressing production challenges and strategic dependencies. In 2022, Tesla emphasized enhancing the Solar Roof's aesthetic and functional integration with Powerwall and its own solar inverter, while expanding installation capabilities through partnerships with real estate developers. By 2024, the company acknowledged ongoing production bottlenecks and supply chain complexities affecting Solar Roof ramps, similar to those seen in vehicle and energy storage production. Strategic dependencies on global suppliers and the need for localized procurement at new manufacturing sites further highlight the challenges in scaling Solar Roof production efficiently and cost-effectively.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Solar Roof (PRODUCT)",
        "Solar Roof (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10512,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3263,
        "completion_tokens": 203,
        "total_tokens": 3467
      }
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "The retail share of Skoal in the U.S. oral tobacco market decreased from 9.3% in 2023 to 7.6% in 2024, as shown in the retail share data. This decline suggests a weakening competitive positioning for Skoal, as it lost market share to other brands like on! (which gained share) and other competitors. Given that Altria (MO) owns Skoal and is focusing on growing its smoke-free product portfolio, this reduction in retail share highlights potential challenges in maintaining consumer preference within the oral tobacco segment amid shifting market dynamics and regulatory pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Skoal (PRODUCT)",
        "Skoal (PRODUCT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6604,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2284,
        "completion_tokens": 145,
        "total_tokens": 2429
      }
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "Between 2023 and 2024, the risk associated with the concentration of device share among premium tier companies has remained a persistent concern for Qualcomm, as highlighted in both the 2023 and 2024 10-K filings. The continued consolidation of device share among a few key OEMs, particularly at the premium tier, has reinforced Qualcomm’s dependence on a small number of customers and licensees for a significant portion of its revenue. This concentration heightens the potential for pricing pressures and revenue instability, as the purchasing power of these dominant OEMs could lead to lower product prices and reduced margins. Additionally, the risk of customers vertically integrating or shifting to competitors’ products, along with geopolitical tensions affecting business with Chinese OEMs, further threatens Qualcomm’s pricing power and revenue stability in both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> Concentration_of_Device_Share (RISK_FACTOR)",
        "Concentration_of_Device_Share (RISK_FACTOR) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12852,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3879,
        "completion_tokens": 219,
        "total_tokens": 4098
      }
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million between 2023 and 2024, as both the 2023 and 2024 10-K filings report identical amounts under amortized cost and fair value. This consistency suggests a stable approach to short-term liquidity management, with Amgen maintaining its investment in money market mutual funds as part of its available-for-sale portfolio during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> Money market mutual funds (FIN_INST)",
        "Money market mutual funds (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1776,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1084,
        "completion_tokens": 105,
        "total_tokens": 1189
      }
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "General Dynamics' participation in the Capital Construction Fund (CCF) has seen a gradual increase in the amount of U.S. government accounts receivable pledged to the fund between 2022 and 2024. In 2021 and 2020, the pledged amount was $295 million, as reported in the 2022 10-K. By 2023, this amount had risen to $315 million, and by 2024, it further increased to $333 million, according to the 2024 10-K. This reflects a steady growth in General Dynamics' engagement with the CCF, which allows the company to defer taxes on eligible earnings as long as the proceeds are used for qualified maritime activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Participates_In]- ORG",
      "triplets_used": [
        "GD (ORG) -> Capital Construction Fund (FIN_INST)",
        "Capital Construction Fund (FIN_INST) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6703,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2331,
        "completion_tokens": 152,
        "total_tokens": 2484
      }
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly following the 2022 IPO and subsequent tax deconsolidation, impacting both tax implications and investment income. In 2023, Corebridge was deconsolidated from AIG’s U.S. federal income tax group due to AIG’s ownership dropping below 80%, resulting in Corebridge no longer being included in AIG’s consolidated tax return and a five-year restriction on future consolidated filing between AIG and Corebridge entities. This deconsolidation also meant that Corebridge’s unused net operating losses and tax credits remained with Corebridge and were no longer available to AIG. By 2024, AIG’s investment income from Corebridge was recognized through the equity method, reflecting dividends received and changes in Corebridge’s stock price, as outlined in the 2024 10-K. These changes illustrate a shift from direct tax integration to a more indirect, investment-based relationship with tax and financial reporting implications for both entities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Impacts]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Corebridge (COMP)",
        "Corebridge (COMP) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_255",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4123,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1675,
        "completion_tokens": 256,
        "total_tokens": 1932
      }
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "From 2022 to 2024, Tesla’s approach to Solar Roof production has evolved from a focus on improving installation capabilities and reducing costs through training and collaboration with developers to addressing broader operational and supply chain challenges as production scales. In 2022, Tesla emphasized onboarding installers, streamlining installation time, and leveraging real estate partnerships to boost Solar Roof deployment. By 2024, the company acknowledged increased complexity in managing supply chains, including risks from component shortages, supplier reliability, and the need for localized procurement at new facilities. Additionally, Tesla highlighted the potential for production delays and bottlenecks, particularly as it ramps new products and expands globally, underscoring the growing interdependence between Solar Roof and Tesla’s broader manufacturing and supply chain strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Solar Roof (PRODUCT)",
        "Solar Roof (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12245,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3701,
        "completion_tokens": 225,
        "total_tokens": 3927
      }
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina decreased from $8 billion to $9 billion in 2022 to $7 billion to $8 billion by 2023. This reduction, along with $4 billion spent through 2023 (up from $3.1 billion by 2021), indicates progress under the Coal Ash Act, as the company has completed excavations at additional sites, including Asheville, and continues to comply with regulatory requirements through settlement agreements and ongoing closure activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Coal Ash Act (REGULATORY_REQUIREMENT)",
        "Coal Ash Act (REGULATORY_REQUIREMENT) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12682,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3837,
        "completion_tokens": 131,
        "total_tokens": 3969
      }
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024, indicating a slight improvement in its market position within the overall oral tobacco product segment, which saw a decline in total retail share from 42.5% in 2023 to 37.5% in 2024. This suggests that 'on!' gained relative market share despite a shrinking overall segment, reflecting its competitive positioning compared to other oral tobacco products like Copenhagen and Skoal during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> on! (PRODUCT)",
        "on! (PRODUCT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6604,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2297,
        "completion_tokens": 123,
        "total_tokens": 2420
      }
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "Qualcomm's reliance on Chinese OEMs for revenue remained significant from 2023 to 2024, as both annual reports highlight that a substantial portion of its revenues is derived from a small number of customers, including certain Chinese OEMs, particularly in the premium tier handset market. The 2023 and 2024 filings both emphasize the ongoing concentration of device share among a few companies, with Chinese OEMs increasing their market presence in China and beyond. This continued dependence raises business stability concerns due to potential political tensions between the U.S. and China, the risk of customers vertically integrating or switching to competitors, and the possibility of fluctuating purchase volumes or delayed orders, all of which could negatively impact Qualcomm's revenues and cash flow.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Derives_Revenues_From]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> Chinese OEMs (COMP)",
        "Chinese OEMs (COMP) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12852,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3848,
        "completion_tokens": 202,
        "total_tokens": 4051
      }
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "Between 2022 and 2023, Amgen's total available-for-sale investments increased significantly from $4,335 million to $10,404 million. In 2022, these investments included marketable securities worth $1,676 million, while in 2023, the composition shifted entirely to short-term interest-bearing securities, primarily consisting of money market mutual funds ($10,266 million) and other short-term interest-bearing securities ($138 million), with no holdings in U.S. Treasury bills. This reflects a strategic reallocation toward highly liquid, short-term instruments in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> Total available-for-sale investments (FIN_INST)",
        "Total available-for-sale investments (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1261,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 964,
        "completion_tokens": 142,
        "total_tokens": 1106
      }
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "Shake Shack's presence as a tenant across SPG's premium outlet properties evolved between 2022 and 2023, with the brand appearing in the tenant list of Woodbury Common Premium Outlets in 2022 and continuing to be listed there in 2023. Additionally, in 2023, Shake Shack expanded its presence by entering Las Vegas North Premium Outlets, indicating a slight expansion in its footprint within SPG's premium outlet portfolio during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Shake Shack (COMP)",
        "Shake Shack (COMP) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 18229,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5181,
        "completion_tokens": 110,
        "total_tokens": 5291
      }
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "Between 2022 and 2024, retirement annuity contracts remained classified as Level 3 assets within the fair value hierarchy, indicating that GD continued to value these assets using unobservable inputs and internal valuation models. In 2022, Level 3 assets explicitly included retirement annuity contracts alongside insurance deposit contracts and real estate funds. By 2024, the classification remained unchanged, with retirement annuity contracts still grouped under Level 3, suggesting that GD’s valuation methodology for these contracts has not shifted toward more observable market inputs. This consistency implies that GD continues to rely on internal assumptions and modeling for these assets, reflecting the lack of active market data for retirement annuity contracts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Consists_Of]- ORG",
      "triplets_used": [
        "GD (ORG) -> Retirement Annuity Contracts (FIN_INST)",
        "Retirement Annuity Contracts (FIN_INST) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3250,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 193,
        "total_tokens": 1662
      }
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved in two key ways. In 2023, potential equity dilution was a factor due to Blackstone's exchange right, which allowed it to convert its ownership in Corebridge into AIG common shares, though this right was terminated following Corebridge's IPO in September 2022. By 2024, AIG's treatment of Corebridge shifted to recognizing income under the equity method, as reflected in the pre-tax income attributable to Corebridge for the period June 10, 2024, to December 31, 2024, which included both dividends and changes in Corebridge's stock price. This transition from potential dilution to income recognition illustrates a shift in AIG's financial exposure from equity dilution risk to income generation through its stake in Corebridge.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Impacts]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Corebridge (COMP)",
        "Corebridge (COMP) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_242",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1198,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 933,
        "completion_tokens": 201,
        "total_tokens": 1134
      }
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "Comcast's financial exposure to Universal Beijing Resort increased slightly from 2022 to 2024, as evidenced by the debt disclosures and consolidation treatment. In 2022, Universal Beijing Resort had $3.6 billion in debt not guaranteed by Comcast, while in 2024, the debt outstanding was $3.4 billion. Despite this slight decrease in debt, the consolidated assets and liabilities of Universal Beijing Resort rose from $7.8 billion and $7.2 billion in 2023 to $7.3 billion and $7.0 billion in 2024, reflecting continued investment and operational activity. Comcast's 30% ownership stake remains its maximum risk of financial loss, with no additional guarantees or liquidity arrangements in place.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Universal Beijing Resort (COMP)",
        "Universal Beijing Resort (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8064,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2656,
        "completion_tokens": 173,
        "total_tokens": 2830
      }
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "Between 2022 and 2023, the structure of aircraft trade-in commitments remained largely consistent in terms of timing and valuation methodology, with the fair market value of trade-in aircraft typically established 45 or fewer days before the delivery of the new aircraft. However, there was a shift in customer eligibility, as the 2023 disclosure specifically references \"some Gulfstream customers\" holding trade-in options, indicating a more defined or narrowed customer base compared to the broader \"some customers\" mentioned in 2022. Risk exposure also remained similar, with commitments structured to either establish fair market value or guarantee a predetermined trade-in value, both of which carry potential risk in adverse market conditions. Notably, the estimated change in fair market values from the date of the commitments was not material in both years, suggesting that the company continues to manage these exposures without significant financial impact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Offers]- ORG",
      "triplets_used": [
        "GD (ORG) -> Aircraft Trade-ins (ACCOUNTING_POLICY)",
        "Aircraft Trade-ins (ACCOUNTING_POLICY) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8178,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2688,
        "completion_tokens": 242,
        "total_tokens": 2930
      }
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Tesla Semi evolved from being a future commercial vehicle in the planning phase to entering **pilot production**, as noted in the 2024 10-K. In 2022, the Semi was described as one of Tesla's planned electric vehicles, with no specific production status mentioned, indicating it was still in the development and announcement stage. By 2024, the Semi was listed under **Nevada** with a production status of **\"Pilot production\"**, signaling a shift toward active development and preparation for commercialization. This evolution reflects Tesla's strategic positioning of the Semi as a key component in its broader product lineup, aiming to expand beyond consumer vehicles into the commercial and industrial electric vehicle market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Tesla Semi (PRODUCT)",
        "Tesla Semi (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4713,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1819,
        "completion_tokens": 194,
        "total_tokens": 2013
      }
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "The valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $397 million in 2023, and further to $402 million in 2024. This gradual increase indicates that Altria maintained a cautious outlook on the realizability of the associated deferred tax assets over this period, suggesting continued uncertainty about the ability to utilize the tax benefits from its investment in Cronos. The persistence of the valuation allowance through 2024 reflects ongoing concerns about the future profitability or strategic value of the investment necessary to realize these deferred tax assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Cronos Warrant (FIN_INST)",
        "Cronos Warrant (FIN_INST) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5510,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2033,
        "completion_tokens": 155,
        "total_tokens": 2188
      }
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "Amgen's financial treatment of its investment in BeiGene shifted in Q1 2023 from the equity method to fair value accounting, resulting in gains recognized in earnings during 2023. By 2024, this investment contributed to net unrealized losses on strategic equity investments, contrasting with the prior year's gains. This evolution reflects a change in valuation methodology and market performance, impacting Amgen's Other income (expense), net. Additionally, while the BeiGene investment is central to this financial narrative, broader tax developments, including the implementation of the OECD global minimum tax in certain jurisdictions starting in 2024, influenced Amgen's overall tax expense and regulatory environment during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Recognizes_Losses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> BeiGene Investment (FIN_INST)",
        "BeiGene Investment (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6605,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2283,
        "completion_tokens": 185,
        "total_tokens": 2469
      }
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "Between 2023 and 2024, Disney+ Hotstar's positioning and market strategy evolved significantly, particularly in terms of regional branding and service structure. In 2023, Disney+ Hotstar was described as a DTC service primarily in India, offering general entertainment, family, and sports programming, reflecting its distinct regional focus compared to the global Disney+ brand. By 2024, the strategy shifted in Latin America, where Disney+ and Star+ were merged into a single Disney+ product offering by the end of June 2024, streamlining the service structure and enhancing brand consistency. Additionally, in India and other Southeast Asian countries, the service retained its distinct \"Disney+ Hotstar\" branding, emphasizing localized content and market-specific positioning. This evolution reflects a broader effort to unify and optimize the Disney+ brand while maintaining tailored regional strategies where necessary.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Disney+ Hotstar (PRODUCT)",
        "Disney+ Hotstar (PRODUCT) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7810,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2593,
        "completion_tokens": 231,
        "total_tokens": 2824
      }
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "Between 2023 and 2024, PayPal's approach to its Protection Programs evolved to address increasing risk exposure and enhance loss recovery mechanisms. In 2023, PayPal disclosed that its protection programs are integrated into its primary service offering and are designed to protect both merchants and consumers from fraud and counterparty performance, with associated costs estimated and recorded in transaction and credit losses at the time of the transaction. By 2024, PayPal emphasized the growing complexity and evolving nature of fraud, highlighting that its protection programs now face heightened risks due to new fraud schemes and regulatory changes. The company noted that while it actively seeks to recover losses from merchants, such recoveries may be insufficient, particularly when merchants are unwilling or unable to pay. This evolution reflects PayPal's heightened focus on risk management and the challenges in ensuring effective loss recovery amid a more dynamic fraud landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Protection Programs (ACCOUNTING_POLICY)",
        "Protection Programs (ACCOUNTING_POLICY) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11022,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3402,
        "completion_tokens": 249,
        "total_tokens": 3651
      }
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "From 2022 to 2024, NextEra Energy's (NEE) relationship with solar generation facilities evolved from direct ownership and operational control to a more structured ownership and financial exposure model through consolidated and nonconsolidated entities. In 2022, NEE's subsidiary, NextEra Energy Resources (NEER), sold a 90% noncontrolling interest in a portfolio of solar generation facilities (totaling 900 MW) and a 100% interest in a 100 MW solar-plus-storage facility to a NEP subsidiary, reducing NEE's direct ownership but retaining operational control through an affiliate. By 2024, NEE consolidated multiple variable interest entities (VIEs) that own and operate solar generation facilities with a total capacity of approximately 3,485 MW, with ownership interests ranging from 50% to 67%. These VIEs are financed through third-party debt with no recourse to NEE’s general credit, and NEE continues to operate and provide services to these entities, reflecting a shift toward indirect ownership and operational stewardship while managing financial exposure through structured financing and equity investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> PRODUCT <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Solar Generation Facilities (PRODUCT)",
        "Solar Generation Facilities (PRODUCT) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13983,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4142,
        "completion_tokens": 279,
        "total_tokens": 4421
      }
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "ACN's investment in Mutual Fund Debt Securities decreased from $379,989 in 2022 to $253,025 in 2023, reflecting a reduction of $126,964. In terms of valuation methodology, these investments were consistently classified under Level 2 of the fair value hierarchy in both years, indicating that they were valued using observable inputs other than quoted prices in active markets. There was no change in the hierarchy level for these investments from 2022 to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Mutual Fund Debt Securities (FIN_INST)",
        "Mutual Fund Debt Securities (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2576,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 115,
        "total_tokens": 1409
      }
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "Chevron's financial stake and involvement in Tengizchevroil (TCO) remained stable between 2022 and 2023, with Chevron maintaining a 50 percent equity ownership interest in TCO. In 2022, Chevron's investment in TCO was valued at $23,727 million, with equity in earnings of $2,831 million. By 2023, the carrying value of Chevron's investment in TCO increased slightly, with a difference of about $80 million between the carrying value and the underlying equity in TCO's net assets, attributed to Chevron's acquisition of its interest at a value higher than the book value. Additionally, Chevron provided a $4,500 million loan to TCO in 2023 to fund the development of the FGP/WPMP project, reflecting continued financial support and strategic involvement in TCO's operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Tengizchevroil (COMP)",
        "Tengizchevroil (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8640,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2781,
        "completion_tokens": 193,
        "total_tokens": 2975
      }
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "Between 2023 and 2024, Disney's relationship with ABC Network has evolved to reinforce its strategic positioning within Disney's broader entertainment ecosystem by enhancing integration across Disney's Direct-to-Consumer (DTC) platforms and content distribution channels. In 2023, ABC Network was explicitly identified as a key component of Disney's Linear Networks business, generating revenue through advertising and affiliate fees, and serving as a foundational pillar for the Company's domestic television operations. By 2024, ABC Network's content was further integrated into Hulu's SVOD service, where programming from ABC Network, Freeform, and FX Channels became available one day after linear airing, expanding its reach to streaming audiences. This integration reflects Disney's broader strategy to unify its content distribution across linear and digital platforms, leveraging ABC Network's content to drive engagement and subscriber growth for its DTC services like Hulu, Disney+, and Disney+ Hotstar, thereby strengthening its position in the competitive streaming landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "DIS (ORG) -> ABC Network (COMP)",
        "ABC Network (COMP) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8645,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2801,
        "completion_tokens": 272,
        "total_tokens": 3073
      }
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "Between 2022 and 2023, General Dynamics' Land Systems division has maintained the ASCOD as a key component of its portfolio, emphasizing its role as a highly versatile tracked combat vehicle with multiple international variants, including the Spanish Pizarro and the Austrian Ulan. In both years, the ASCOD is highlighted as a product offered by ELS (European Land Systems), a segment of Land Systems, to global customers, indicating sustained investment and production focus. However, the 2023 filing shows a broader emphasis on next-generation capabilities, such as the AJAX and robotic platforms like MUTT and TRX, suggesting a strategic shift toward advanced, autonomous systems while continuing to support legacy and international programs like ASCOD. This evolution reflects a dual focus: maintaining strong international defense contracts and investing in cutting-edge technologies to meet future battlefield demands.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Supplies]- ORG",
      "triplets_used": [
        "GD (ORG) -> ASCOD (PRODUCT)",
        "ASCOD (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5611,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2050,
        "completion_tokens": 231,
        "total_tokens": 2281
      }
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "PayPal's utilization of European customer balances for credit activities decreased from $3.0 billion in 2023 to $2.0 billion in 2024, representing a 33% reduction. In 2023, this amount accounted for 39% of European customer balances available for corporate use, while in 2024, it dropped to 26%, indicating a strategic shift in how the company is accessing credit funding. This decline suggests PayPal is either relying more on external funding sources, such as its agreement to sell installment receivables (which totaled $20.8 billion in 2024), or adjusting its liquidity strategy to maintain a stronger buffer for corporate obligations. The shift reflects a broader effort to diversify credit funding strategies, reduce dependency on customer balances, and align with the company’s goal of expanding credit products through external capital.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Credit Activities (FIN_INST)",
        "Credit Activities (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9836,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3108,
        "completion_tokens": 211,
        "total_tokens": 3319
      }
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "Between 2022 and 2024, the valuation and categorization of equity securities within NEE's Special Use Funds evolved significantly, reflecting a shift in transparency and investment composition. In 2022, the Special Use Funds were reported at a carrying amount of $906 million with an estimated fair value of $907 million, showing minimal deviation. By 2024, equity securities under the Special Use Funds were categorized into Level 1, Level 2, and Level 3, with NEE's equity securities valued at $2,614 million (Level 1), $3,321 million (Level 2), and $229 million (Level 3), totaling $6,164 million. This detailed breakdown indicates increased transparency and a more diversified investment composition, emphasizing a broader allocation across different valuation levels and asset types.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Special Use Funds (FIN_INST)",
        "Special Use Funds (FIN_INST) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6167,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2194,
        "completion_tokens": 197,
        "total_tokens": 2391
      }
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "From fiscal 2022 to fiscal 2023, Accenture's share purchase program evolved in both scope and utilization. In fiscal 2022, Accenture acquired 1,964,612 shares under the public open-market share purchase program for $576 million, while also acquiring 97,251 shares through employee-related transactions, primarily via share withholding for payroll tax obligations. By fiscal 2023, the company continued its public open-market share purchase program, with shares being held as treasury shares for potential use in employee benefits, including equity awards. Additionally, similar to 2022, shares were acquired through employee-related transactions, primarily via share withholding for payroll tax obligations under employee equity share plans, which did not impact the available authorization for the public program. The total available authorization for share purchases also increased significantly, reaching $6,129 million by late 2022, reflecting an expanded scope for both public and employee-related share repurchases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Announces]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Share Purchase Program (FIN_INST)",
        "Share Purchase Program (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3066,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 255,
        "total_tokens": 1684
      }
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "Between 2022 and 2023, Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC remained consistent in terms of its investment accounting approach, as Chevron continued to account for its interest in the joint venture using the equity method, as noted in 2023. In 2022, Chevron Phillips Chemical Company LLC was explicitly listed in the financial notes, indicating its significance as a separate entity with summarized financial data provided, suggesting it was not consolidated. The mutual ownership relationship between Chevron and Chevron Phillips Chemical Company LLC, as shown in the KG triplets, reflects a joint venture structure, and the absence of consolidation in both years highlights that Chevron maintained its equity-method investment approach throughout the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Chevron Phillips Chemical Company LLC (COMP)",
        "Chevron Phillips Chemical Company LLC (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3497,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 202,
        "total_tokens": 1736
      }
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "From 2022 to 2023, the role of Hydra-70 rockets in General Dynamics' Combat Systems segment has evolved from being a relatively smaller contract line item to a more strategically significant product in the segment's munitions portfolio. In 2022, the segment received a $175 million contract from the U.S. Army specifically for the production of Hydra-70 rockets, indicating initial engagement. By 2023, Hydra-70 rockets were highlighted as a market-leading product in the segment's global munitions offerings, with OTS (a division of GD) maintaining a leading position in their supply. Additionally, OTS received awards in 2023 to significantly expand its production capacity, which will support increased Hydra-70 output alongside other munitions, reflecting a broader strategic emphasis on scaling production to meet growing demand, particularly for U.S. Army artillery modernization efforts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Receives]-> PRODUCT <-[Supplies]- ORG",
      "triplets_used": [
        "GD (ORG) -> Hydra-70 Rockets (PRODUCT)",
        "Hydra-70 Rockets (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3126,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 223,
        "total_tokens": 1650
      }
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "Between 2023 and 2024, PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice remained consistent in terms of documentation status, as it was referenced in both filings under the same exhibit number (10.07+). In the 2023 filing, it was listed as part of the 2015 Equity Incentive Award Plan with an incorporated-by-reference date of May 14, 2015. In the 2024 filing, it was similarly referenced with the same incorporated-by-reference date and plan, indicating no substantive changes to the grant notice or its associated agreement during this period. However, the 2024 filing included an updated version of the 2015 Equity Incentive Award Plan itself, amended and restated as of May 28, 2024, which may imply broader plan-level updates, though the specific grant notice and agreement remained unchanged.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Global Restricted Stock Unit Award Grant Notice (ACCOUNTING_POLICY)",
        "Global Restricted Stock Unit Award Grant Notice (ACCOUNTING_POLICY) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15868,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4640,
        "completion_tokens": 205,
        "total_tokens": 4846
      }
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "From 2022 to 2024, Opdivo's role within Bristol-Myers Squibb's portfolio has shown a slight decline in revenue performance, with reported revenue of $7,523 million in 2022 (from Chunk 1), and no updated 2023 or 2024 revenue figures provided in the 2024 10-K excerpt. However, Opdivo has maintained a significant presence in BMY's oncology portfolio. In terms of regulatory approvals, Opdivo received a key FDA approval in March 2024 (Chunk 2) for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma in combination with cisplatin and gemcitabine, expanding its therapeutic applications and reinforcing its strategic importance in BMY's immunotherapy initiatives despite the revenue plateau.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Opdivo (PRODUCT)",
        "Opdivo (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5880,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2103,
        "completion_tokens": 183,
        "total_tokens": 2286
      }
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "Between 2022 and 2023, Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC (CPChem) evolved through continued project funding and investment structure adjustments. In 2022, CPChem advanced projects such as a second 1-hexene unit in Texas and a C3 splitter unit in Baytown, both expected to start up in 2023. By 2023, Chevron provided a $387 loan to CPChem to fund a portion of the Golden Triangle Polymers Project in Texas, where CPChem holds a 51% interest, indicating a strategic investment in expanding CPChem’s production capabilities. Chevron’s 50% ownership in CPChem remained consistent, reflecting a long-term commitment to the joint venture's growth and operational expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Chevron Phillips Chemical Company LLC (COMP)",
        "Chevron Phillips Chemical Company LLC (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5365,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2000,
        "completion_tokens": 182,
        "total_tokens": 2182
      }
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "Between 2023 and 2024, PayPal's protection programs saw an increase in financial commitments, as reflected in the allowance for transaction losses, which rose from $64 million at December 31, 2023, to $86 million at December 31, 2024. Similarly, the allowance for negative customer balances increased from $218 million to $256 million over the same period. These reserves are recorded in transaction and credit losses during the period the payment transaction is completed, as the protection programs are classified as assurance-type warranties under applicable accounting standards. The disclosures in both years highlight PayPal's continued commitment to mitigating financial risks for consumers and merchants through these programs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Protection Programs (ACCOUNTING_POLICY)",
        "Protection Programs (ACCOUNTING_POLICY) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7795,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2596,
        "completion_tokens": 183,
        "total_tokens": 2779
      }
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "Between 2022 and 2024, McDonald's has reinforced its strategic framing of franchising as a core business model, emphasizing its role as a franchisor and the importance of franchisee co-investment. In 2022, the company outlined its business structure, noting that restaurants are operated by either the Company or franchisees, including conventional franchisees and developmental licensees. By 2024, McDonald's explicitly stated that franchising is \"paramount to delivering great-tasting food, locally relevant customer experiences, and driving profitability,\" highlighting the mutual benefits of franchisee co-investment in equipment and operations. The company also underscored the value of franchisee collaboration in refining standards and innovations, while maintaining that ownership of real estate combined with franchisee co-investment contributes to high restaurant performance. This evolution reflects a stronger, more integrated partnership model with franchisees, positioning them as essential co-creators of value within the McDonald's System.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6573,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2291,
        "completion_tokens": 263,
        "total_tokens": 2554
      }
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "Between 2022 and 2023, the FDA's authorization of Marlboro HeatSticks advanced with the approval of three new tobacco-flavored varieties in January 2023, reflecting progress in Altria's regulatory efforts for its heated tobacco products. However, this progress was tempered by the ITC cease-and-desist order in September 2021, which led to the removal of IQOS devices and Marlboro HeatSticks from the U.S. market due to patent infringement, and by Altria's subsequent agreement to transfer U.S. commercialization rights to PMI in October 2022. These developments indicate both regulatory achievement and ongoing challenges, highlighting the complex landscape Altria faces in bringing heated tobacco products to market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> FDA Authorization (REGULATORY_REQUIREMENT)",
        "FDA Authorization (REGULATORY_REQUIREMENT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11992,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3653,
        "completion_tokens": 179,
        "total_tokens": 3833
      }
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "The valuation of ACN's mutual fund equity securities decreased from $239,293 million in 2022 to $196,226 million in 2023, as shown in the Level 1 and Level 2 fair value disclosures in both years. This decline suggests a potential shift in ACN's investment positioning, possibly indicating a strategic reduction in exposure to mutual fund equity securities or a market-driven valuation decrease in this asset category. The change aligns with the broader context of ACN's evolving investment portfolio, as reflected in its 10-K filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Mutual Fund Equity Securities (FIN_INST)",
        "Mutual Fund Equity Securities (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2433,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 133,
        "total_tokens": 1396
      }
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "Chevron's involvement in Angola LNG Limited remained consistent in both 2022 and 2023, with the company holding a 36.4 percent interest in the entity, which operates an onshore natural gas liquefaction plant in Soyo, Angola. In 2022, the focus was on continuing efforts to develop non-associated gas in offshore Angola to supply the Angola LNG plant, highlighting Chevron's investment in expanding feedstock sources. In 2023, the emphasis shifted slightly toward the operational and financial structure of the investment, as Chevron's 10-K noted the company's equity interest and its role in processing and liquefying natural gas for international markets, underscoring the strategic and financial significance of this investment within Chevron's global portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Angola LNG Limited (COMP)",
        "Angola LNG Limited (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7525,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2518,
        "completion_tokens": 191,
        "total_tokens": 2709
      }
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "MMM's investment in Certificates of Deposit/Time Deposits increased from $21 million in 2022 to $49 million in 2023, representing a $28 million increase. This growth is evident from the 2023 10-K data in Chunk 2, while the 2022 value is derived from Chunk 1, which reports $21 million for the same category. The increase is consistent with the knowledge graph pattern indicating an upward trend in MMM's investment in this financial instrument.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Certificates of Deposit/Time Deposits (FIN_INST)",
        "Certificates of Deposit/Time Deposits (FIN_INST) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8270,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2711,
        "completion_tokens": 111,
        "total_tokens": 2822
      }
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "McDonald's relationship with its franchisees, in terms of the percentage of franchised restaurants, increased from 93% in 2021 (with 37,295 out of 40,031 total restaurants franchised) to approximately 95% in 2024 (with 41,303 out of 43,477 total restaurants franchised). This evolution reflects the Company's continued emphasis on franchising as a core business model to drive profitability and maintain brand consistency. The business relationship with franchisees remains fundamental, supported by adherence to Global Brand Standards and collaborative innovation between Company-owned and franchised restaurants.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2022.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12553,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3768,
        "completion_tokens": 153,
        "total_tokens": 3921
      }
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "The 2015 Stock Compensation Plan for Non-Employee Directors was initially introduced by Altria Group, Inc. (MO) and was later amended and restated effective March 31, 2021, as disclosed in the 2022 10-K filing. Between 2022 and 2023, the plan underwent further structural changes, with an additional amendment and restatement effective October 26, 2022, as noted in the 2023 10-K filing. These amendments reflect ongoing adjustments to the plan's structure and governance, as MO continues to refine its compensation policies for non-employee directors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Amends]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "MO (ORG) -> 2015 Stock Compensation Plan for Non-Employee Directors (ACCOUNTING_POLICY)",
        "2015 Stock Compensation Plan for Non-Employee Directors (ACCOUNTING_POLICY) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16110,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4686,
        "completion_tokens": 138,
        "total_tokens": 4824
      }
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "Between fiscal years 2022 and 2023, Accenture's financial relationship with Duck Creek Technologies evolved in terms of investment valuation and reported financial impact as follows: In fiscal 2022, Accenture's investment in Duck Creek Technologies had a carrying amount of $138,902 and an estimated fair value of $223,166 for its approximately 16% ownership stake. In fiscal 2023, Accenture recorded a $253 million investment gain related to this stake, which positively impacted its adjusted effective tax rate and adjusted diluted earnings per share. This gain, along with the ongoing equity method accounting for its influence on Duck Creek, reflects a significant valuation increase and financial benefit to Accenture during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Duck Creek Technologies (COMP)",
        "Duck Creek Technologies (COMP) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5861,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2114,
        "completion_tokens": 185,
        "total_tokens": 2300
      }
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "Between 2022 and 2024, the therapeutic application of Breyanzi expanded significantly, with two new FDA approvals in 2024 that broadened its market potential. In March 2024, Breyanzi received accelerated approval for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who had received at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor. Additionally, in May 2024, Breyanzi was granted accelerated approval for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who had received at least two prior lines of systemic therapy. These approvals extend Breyanzi’s use beyond large B-cell lymphoma, as originally indicated in 2021, and position it to capture a broader patient population in hematologic malignancies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Breyanzi (PRODUCT)",
        "Breyanzi (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6823,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2343,
        "completion_tokens": 222,
        "total_tokens": 2565
      }
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "Between 2022 and 2023, 3M's approach to estimating and recording insurance receivables related to legal proceedings, particularly respirator mask/asbestos litigation, under ASC 450 remained consistent in principle but showed increased specificity in application. In 2022, 3M outlined its general methodology for accruing liabilities for legal claims that are both probable and reasonably estimable under ASC 450, emphasizing the role of management estimates and the involvement of the Audit Committee. By 2023, 3M provided a more detailed explanation of how it estimates insurance receivables, incorporating analysis of policy terms, case law, and prior experience, and explicitly tied these estimates to both accrued liabilities and defense-related expenses. Additionally, 3M noted a slight increase in the number of respirator mask/asbestos claimants, from approximately 4,028 in 2022 to 4,042 in 2023, reflecting ongoing exposure and the dynamic nature of these proceedings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "MMM (ORG) -> ASC 450, Contingencies (REGULATORY_REQUIREMENT)",
        "ASC 450, Contingencies (REGULATORY_REQUIREMENT) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9043,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2928,
        "completion_tokens": 244,
        "total_tokens": 3172
      }
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "Between 2022 and 2023, PepsiCo's relationship with the Naked brand evolved from ownership to a reduced financial stake and continued operational involvement as a distributor. In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners but retained a 39% noncontrolling interest in the newly formed joint venture, TBG, which operates across North America and Europe. Additionally, PepsiCo became the exclusive distributor for TBG's portfolio, including Naked, for small-format and foodservice customers with chilled direct-store-delivery. By 2023, this arrangement remained in place, with PepsiCo continuing to leverage its distribution network to support the Naked brand under the joint venture structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Distributes]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Naked (PRODUCT)",
        "Naked (PRODUCT) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9032,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2888,
        "completion_tokens": 183,
        "total_tokens": 3072
      }
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "Between 2023 and 2024, the accounting treatment and disclosure around the ExtraBucks Rewards program remained consistent in key aspects, particularly regarding the recognition of revenue and the determination of performance obligations. In both years, the Company recognized that ExtraBucks Rewards represent an additional performance obligation at the time of the initial transaction, and the transaction price is allocated between the initial transaction and the rewards based on the relative standalone selling price, informed by historical redemption patterns. Revenue allocated to ExtraBucks Rewards is recognized as the rewards are redeemed, with unredeemed rewards reflected as a contract liability at the end of each period. While the 2024 disclosure did not explicitly highlight any changes in methodology, it reiterated the same principles as 2023, indicating no material evolution in the accounting treatment during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> ExtraBucks Rewards (PRODUCT)",
        "ExtraBucks Rewards (PRODUCT) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_131",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_125",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8267,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2721,
        "completion_tokens": 234,
        "total_tokens": 2956
      }
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "Between 2023 and 2024, Netflix continued to rely on integrated payment partners as part of its cost of revenues, with both years explicitly mentioning payment processing fees to these partners as a component of other operating or operations costs. In 2023, the 10-K noted that payment processing fees, including those paid to integrated payment partners, were included in other operations costs, which also covered customer service and content availability expenses. Similarly, in 2024, the 10-K reaffirmed this dependency, stating that payment processing fees to integrated payment partners remained part of other operating costs. While the descriptions are consistent in both years, there is no explicit quantitative change provided in the cost of revenues section to indicate a shift in the degree of reliance; however, the continued inclusion suggests sustained dependency on these partners for payment processing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Integrated Payment Partners (COMP)",
        "Integrated Payment Partners (COMP) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4442,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1757,
        "completion_tokens": 229,
        "total_tokens": 1987
      }
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "From 2022 to 2023, 3M's approach to managing PFAS contamination in Minnesota has evolved in response to regulatory changes and updated health-based standards. In 2022, 3M was already engaged in remediation efforts under the 2007 Settlement Agreement with the MPCA, focusing on PFAS contamination at the Cottage Grove, Oakdale, and Woodbury sites, with remediation work largely completed at these locations. By 2023, the company faced new regulatory pressures, including a January 2024 update from the Minnesota Department of Health with more stringent Health-Based Values (HBVs) for PFOA and PFOS, prompting 3M to evaluate the impact on its obligations. Additionally, in 2023, MPCA issued a Notice of Violation related to PFAS in stormwater discharge at the Hutchinson facility, and a draft Clean Water Act permit for Cottage Grove with significantly revised PFAS limits, some below the limit of quantification. These developments indicate a shift toward more rigorous compliance and proactive engagement with regulators to address evolving standards and enforcement actions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Remediates]-> RISK_FACTOR <-[Treats]- ORG",
      "triplets_used": [
        "MMM (ORG) -> PFAS Sources (RISK_FACTOR)",
        "PFAS Sources (RISK_FACTOR) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12026,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3649,
        "completion_tokens": 268,
        "total_tokens": 3918
      }
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "Between 2022 and 2023, PepsiCo increased the notional value of its foreign currency derivatives from $3.0 billion to $3.8 billion, indicating a more aggressive approach to hedging foreign exchange risk. This aligns with the company’s strategy of using forward contracts and net investment hedges to manage exposure from international operations, foreign subsidiaries, and currency fluctuations. The increase suggests PepsiCo is expanding its hedging activities to mitigate the growing impact of foreign exchange volatility on its global operations. Additionally, the company maintained a low counterparty credit risk profile and did not trigger any collateral requirements, reinforcing the stability and effectiveness of its risk management framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Local Currency Contracts (ACCOUNTING_POLICY)",
        "Local Currency Contracts (ACCOUNTING_POLICY) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8617,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2806,
        "completion_tokens": 187,
        "total_tokens": 2994
      }
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "Between 2022 and 2023, ExxonMobil has evolved its approach to capitalizing on improving living standards by significantly expanding chemical production capacity and sharpening its geographic focus, particularly in high-growth markets like China. In 2022, the company completed a major ethane cracker project in Texas and made a final investment decision for a multi-billion-dollar chemical complex in Dayawan, China, to meet rising demand for performance chemicals. By 2023, ExxonMobil had added new production units in Baytown, Texas—specifically a 400,000 metric ton/year performance polymers line and a 350,000 metric ton/year linear alpha olefins unit—while advancing the Dayawan project, which will have a combined capacity of over 2.5 million metric tons/year of high-performance polyethylene and polypropylene. These strategic moves reflect a stronger geographic emphasis on the U.S. Gulf Coast and China, leveraging integration and proprietary technology to serve growing middle-class demand driven by improving living standards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> MACRO_CONDITION <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Improving Living Standards (MACRO_CONDITION)",
        "Improving Living Standards (MACRO_CONDITION) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6844,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2369,
        "completion_tokens": 259,
        "total_tokens": 2629
      }
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "From 2022 to 2023, 3M's investment in Certificates of Deposit/Time Deposits increased from $21 million to $49 million, as shown in the 2023 10-K. This rise, combined with a significant decline in Commercial Paper from $213 million to $0 and a reduction in total marketable securities from $261 million to $73 million, suggests a strategic shift toward more stable, short-term, and potentially lower-risk investment vehicles. The increase in Certificates of Deposit/Time Deposits indicates a preference for liquidity and capital preservation, reflecting a more conservative short-term investment approach in 2023 compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Certificates of Deposit/Time Deposits (FIN_INST)",
        "Certificates of Deposit/Time Deposits (FIN_INST) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1515,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1033,
        "completion_tokens": 157,
        "total_tokens": 1191
      }
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "From 2022 to 2023, Mastercard's approach to proprietary insights has evolved to emphasize **data responsibility and trust-building language**, reflecting a more principled and secure use of consumer and merchant data. In 2022, the 10-K filing described proprietary insights as services that draw on Mastercard's use of consumer and merchant data, with a focus on enabling secure and confident transactions. By 2023, the language was strengthened to highlight a **\"principled and responsible use of secure consumer and merchant data,\"** signaling a heightened commitment to data ethics and transparency. This shift underscores Mastercard's broader strategy to build trust in its data-driven services while reinforcing its role as a technology enabler in the global payments ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Provides]- ORG",
      "triplets_used": [
        "MA (ORG) -> Proprietary Insights (PRODUCT)",
        "Proprietary Insights (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9128,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2921,
        "completion_tokens": 195,
        "total_tokens": 3117
      }
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "Between 2022 and 2023, the factors influencing the accounting estimates for PEP’s pension and retiree medical plans evolved from being primarily impacted by the uncertainties related to the **COVID-19 pandemic** (as noted in 2022) to being affected by **ongoing conflicts in Ukraine and the Middle East**, as well as a **high interest rate and inflationary cost environment** in 2023. This shift indicates a broader and more complex external environment, where macroeconomic and geopolitical factors are increasingly influencing the assumptions and estimates used in managing these plans. The evolving factors highlight the growing sensitivity of pension and retiree medical liabilities to global economic volatility and financial market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Pension and Retiree Medical Plans (ACCOUNTING_POLICY)",
        "Pension and Retiree Medical Plans (ACCOUNTING_POLICY) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4568,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1811,
        "completion_tokens": 187,
        "total_tokens": 1998
      }
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross thousand acres in 2022 to 24,221 gross thousand acres in 2023, representing a reduction of 875 gross thousand acres. This decline, while modest, suggests a potential shift in the company's exploration focus or a completion of evaluation processes on certain properties, as indicated by the company's strategy to relinquish acreage when the exploration potential has been fully assessed. Despite the reduction, the continued presence of over 24 million gross acres, combined with the company's ability to secure extensions where necessary, reflects ongoing exploration potential in the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Exploration Potential (RISK_FACTOR)",
        "Exploration Potential (RISK_FACTOR) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5981,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2149,
        "completion_tokens": 170,
        "total_tokens": 2320
      }
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "From 2022 to 2023, 3M continued to use foreign currency contracts not designated in hedging relationships to offset the impacts of changes in value of non-functional currency denominated items, such as certain intercompany financing balances. In 2022, the dollar equivalent gross notional amount of such contracts was $3.7 billion as of December 31, 2021. By 2023, these contracts remained a key tool, though the specific notional amount for the end of 2022 was not provided in the 2023 filing; however, it was emphasized that fair value gains and losses on these contracts are recorded directly in earnings, as they are not designated in hedging relationships. This reflects a consistent approach in managing foreign currency exposure without qualifying for hedge accounting treatment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Hedges]-> FIN_INST <-[Impacts]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Non-Functional Currency Denominated Items (FIN_INST)",
        "Non-Functional Currency Denominated Items (FIN_INST) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6629,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2323,
        "completion_tokens": 196,
        "total_tokens": 2519
      }
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "Between 2022 and 2023, the role and emphasis of Cyber and Intelligence Solutions within Mastercard's value proposition has evolved to become a more central and strategic component of its offerings. In 2022, these solutions were listed among other value-added services, contributing to the company’s diverse revenue streams, including transaction-based and volume-based revenues. By 2023, Cyber and Intelligence Solutions were highlighted as a key element in enabling secure, confident, and efficient transactions across all stakeholders in the payments ecosystem, underscoring their importance in reinforcing Mastercard’s broader mission of making payments safe and smart. This shift reflects an increased focus on security and data-driven insights as critical differentiators in Mastercard’s technology-driven value proposition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Positively_Impacts]-> PRODUCT <-[Provides]- ORG",
      "triplets_used": [
        "MA (ORG) -> Cyber and Intelligence Solutions (PRODUCT)",
        "Cyber and Intelligence Solutions (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4578,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1787,
        "completion_tokens": 207,
        "total_tokens": 1994
      }
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "Between 2022 and 2023, the treatment and disclosure of **Income Tax Expense and Accruals** as a **critical accounting policy** for PepsiCo (PEP) remained consistent in its inclusion within the list of critical accounting policies. In 2022, it was explicitly listed as one of the four critical accounting policies and estimates, alongside revenue recognition, goodwill and other intangible assets, and pension and retiree medical plans. In 2023, it was similarly included in the list of critical accounting policies, with a dedicated section on page 58 of the 10-K filing. The 2023 filing also provided a detailed table of contents, indicating a structured and formalized approach to the disclosure of these policies. This consistency reflects the ongoing significance of income tax accounting in PepsiCo's financial reporting and the continued need for management judgment and estimation in this area.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Income Tax Expense and Accruals (ACCOUNTING_POLICY)",
        "Income Tax Expense and Accruals (ACCOUNTING_POLICY) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7073,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2419,
        "completion_tokens": 225,
        "total_tokens": 2644
      }
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "Between 2023 and 2024, Intel has advanced the Universal Chiplet Interconnect Express (UCIe) standard as a key enabler of its systems of chips strategy. In 2023, Intel demonstrated UCIe in silicon, showcasing its ability to facilitate high-performance communication between chiplets. By 2024, the company continued to drive the standard as part of its broader efforts to optimize systems of chips, integrating it with advanced packaging technologies and foundry services under its Open System Foundry model. This evolution aligns with Intel’s IDM 2.0 strategy, emphasizing collaboration, ecosystem integration, and leadership in next-generation semiconductor design and manufacturing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Universal Chiplet Interconnect Express Standard (PRODUCT)",
        "Universal Chiplet Interconnect Express Standard (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6368,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2253,
        "completion_tokens": 170,
        "total_tokens": 2424
      }
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "Between 2023 and 2024, CVS's accounting treatment for its Accelerated Share Repurchase (ASR) transactions evolved to explicitly recognize the ASR as an initial treasury stock transaction and a forward contract, with the forward contract classified as an equity instrument recorded within capital surplus. In 2023, the $2.0 billion ASR with Citibank was accounted for similarly, with 80% of shares received upfront and the remaining 20% received in February 2023. In 2024, the $3.0 billion ASR with Morgan Stanley followed the same accounting structure, with 85% of shares received in January 2024 and the remaining 15% received in March 2024, marking a slight shift in the percentage of shares received upfront. The completion timelines remained consistent, with the remaining shares typically received within one to two months after the initial payment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Repurchase Programs (ACCOUNTING_POLICY)",
        "Repurchase Programs (ACCOUNTING_POLICY) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6402,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2249,
        "completion_tokens": 213,
        "total_tokens": 2463
      }
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "From 2022 to 2023, UPS's financial exposure and reporting approach related to the Central States Pension Fund evolved in terms of actuarial estimates and sensitivity analysis. In 2022, UPS reported a $2.3 billion pre-tax actuarial loss related to coordinating benefits attributable to the Central States Pension Fund, reflecting its best estimate of potential additional benefits that may be required. By 2023, the sensitivity analysis highlighted the impact of a 25 basis point change in both the expected and actual return on assets, indicating a more granular assessment of how asset returns influence liability exposure. Additionally, UPS continued to disclose its dependence on the Central States Pension Fund, as the Fund’s obligations directly affect UPS’s potential coordinating benefits liability, as referenced in Note 5 of its 2023 audited financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Central States Pension Fund (FIN_INST)",
        "Central States Pension Fund (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5558,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2044,
        "completion_tokens": 218,
        "total_tokens": 2262
      }
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "Between 2022 and 2023, Mastercard has elevated the positioning of its Cyber and Intelligence Solutions by emphasizing their role in enabling secure, confident, and data-driven transactions across its global payments ecosystem. In 2022, these solutions were described as value-added services that allow all parties to transact easily and with confidence, leveraging principled use of consumer and merchant data. By 2023, the communication evolved to highlight that these solutions are designed to allow all parties to transact securely, easily, and with confidence, with a stronger emphasis on secure and responsible data use. This shift reflects a more proactive and stakeholder-focused value proposition, aligning with Mastercard’s broader investments in open banking and digital identity capabilities to strengthen its overall services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Provides]- ORG",
      "triplets_used": [
        "MA (ORG) -> Cyber and Intelligence Solutions (PRODUCT)",
        "Cyber and Intelligence Solutions (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6624,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2310,
        "completion_tokens": 209,
        "total_tokens": 2519
      }
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "In its 2022 SEC filing, PepsiCo's 4.450% Senior Note due 2046 was first referenced as Exhibit 4.4 to its Current Report on Form 8-K filed on October 14, 2015. By the 2023 filing, this note was again referenced under Exhibit 4.13, but now linked to a Current Report on Form 8-K filed on February 24, 2016, indicating an updated exhibit reference and a later documentation date. This evolution reflects PepsiCo's ongoing incorporation of the note into subsequent filings with updated referencing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "PEP (ORG) -> 4.450% Senior Note due 2046 (FIN_INST)",
        "4.450% Senior Note due 2046 (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12431,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3761,
        "completion_tokens": 123,
        "total_tokens": 3884
      }
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "Between 2023 and 2024, Intel's relationship with Positive Technologies has remained consistent in terms of engagement under OFAC licensing following U.S. sanctions. In both years, Intel disclosed in its 10-K filings that it continued to communicate with Positive Technologies regarding IT security research and coordinated disclosure of security vulnerabilities, in compliance with an OFAC license. These activities, authorized under the sanctions framework, do not generate gross revenues or net profits for Intel, and the company has maintained this limited, sanctioned engagement throughout the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Partners_With]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Positive Technologies (COMP)",
        "Positive Technologies (COMP) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3603,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 151,
        "total_tokens": 1698
      }
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained unchanged at $5,000 million between 2023 and 2024, as shown in both the 2023 and 2024 long-term debt schedules. This consistency indicates that the company has not refinanced or redeemed this particular long-term debt instrument during the period, suggesting stability in its long-term debt structure for this specific obligation. The continued presence of this large, fixed-rate note highlights CVS's reliance on long-term financing and its strategy of maintaining a diversified maturity profile to manage interest rate risk and liquidity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> 4.78% Senior Notes (FIN_INST)",
        "4.78% Senior Notes (FIN_INST) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_168",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_161",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5996,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2142,
        "completion_tokens": 151,
        "total_tokens": 2293
      }
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "The 0.835% Notes due 2032 (trading symbol: XOM32) were disclosed in both the 2022 and 2024 SEC 10-K filings of Exxon Mobil Corporation (XOM), indicating their continued status as securities registered on the New York Stock Exchange. In the 2022 filing, the notes were listed among XOM’s registered securities, and in the 2024 filing, they were similarly included, showing no change in their registration status or exchange listing over the two-year period. This consistency suggests the notes remained outstanding and actively traded during this time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> 0.835% Notes due 2032 (FIN_INST)",
        "0.835% Notes due 2032 (FIN_INST) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5212,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1937,
        "completion_tokens": 137,
        "total_tokens": 2074
      }
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "American Express's investment strategy toward U.S. Government treasury obligations evolved significantly between 2022 and 2024. In 2022, the company held $477 million in U.S. Government treasury obligations with maturities of less than 12 months and no unrealized losses, indicating a short-term focus. By 2024, the fair value of these obligations increased to $287 million, with a maturity distribution showing $189 million due within one year and $98 million due after one year but within five years, reflecting a shift toward a more balanced maturity profile. This evolution suggests a strategic adjustment to manage liquidity and yield, as American Express diversified the timing of its treasury holdings while maintaining a significant allocation to U.S. Government securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "AXP (ORG) -> U.S. Government treasury obligations (FIN_INST)",
        "U.S. Government treasury obligations (FIN_INST) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2022.pdf",
          "page_id": "page_120",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2918,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 195,
        "total_tokens": 1584
      }
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "Amazon introduced the 2.500% Note due 2050 on June 3, 2020, as disclosed in Chunk 1 (AMZN_10k_2022.pdf, page_72), which was incorporated by reference into its Current Report on Form 8-K filed on that date. This issuance is reflected in the knowledge graph as AMZN issuing the 2.500% Note due 2050. By 2024, as shown in Chunk 2 (AMZN_10k_2024.pdf, page_75), the note remained part of Amazon's outstanding securities, listed again under the same date and filing, indicating its continued existence and treatment in the company’s financial disclosures. There is no indication of repayment, refinancing, or material change in the note’s terms between 2022 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> 2.500% Note due 2050 (FIN_INST)",
        "2.500% Note due 2050 (FIN_INST) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12188,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3677,
        "completion_tokens": 165,
        "total_tokens": 3842
      }
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "Between 2022 and 2023, the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement increased from eight to eleven. In 2022 (as shown in Chunk 1), the agreement had been amended up to the Eighth Amendment, filed on March 10, 2022. By 2023 (as shown in Chunk 2), three additional amendments—the Ninth, Tenth, and Eleventh—were filed, with the Eleventh Amendment dated March 9, 2023. This reflects a clear progression in the number of amendments over the one-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Amends]-> FIN_INST <-[Amends_Agreement]- ORG",
      "triplets_used": [
        "COST (ORG) -> Co-Branded Credit Card Agreement (FIN_INST)",
        "Co-Branded Credit Card Agreement (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9474,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3007,
        "completion_tokens": 122,
        "total_tokens": 3129
      }
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "NVIDIA's approach to CUDA has evolved significantly between 2022 and 2024, with a stronger emphasis on integration with new computing architectures and expanding software ecosystems. In 2022, CUDA was positioned as a fundamental building block of NVIDIA's unified architecture, supporting diverse markets like Gaming, Data Center, and Automotive by enabling programmable, scalable solutions through software stacks developed internally or by third parties. By 2024, CUDA's role had expanded to support the broader NVIDIA data center platform, including CPUs and DPUs, and was central to the CUDA-X collection of acceleration libraries, APIs, and SDKs that power enterprise-grade AI software and AI training-as-a-service platforms like NVIDIA AI Enterprise and DGX Cloud. Additionally, CUDA's integration with the Blackwell architecture in 2025 enabled cutting-edge generative AI and accelerated computing workloads, demonstrating NVIDIA's continued leadership in leveraging CUDA to drive performance and innovation across both traditional and emerging computing domains.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Develops]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> CUDA (PRODUCT)",
        "CUDA (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11666,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3551,
        "completion_tokens": 267,
        "total_tokens": 3818
      }
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "Between 2023 and 2024, Pfizer's financial relationship with Paxlovid evolved significantly in terms of revenue recognition and contractual obligations. In 2023, Paxlovid's global revenue declined sharply by 92% to $1,279 million due to a non-cash revenue reversal of $3.5 billion in the fourth quarter, driven by the expected return of 6.5 million EUA-labeled treatment courses from the U.S. government, along with reduced international deliveries. By 2024, a $771 million favorable adjustment was recorded in the first quarter, reflecting the return of only 5.1 million courses by February 29, 2024, and an additional $442 million in revenue was recognized in the third quarter related to the U.S. Strategic National Stockpile (SNS). As of December 31, 2024, remaining performance obligations for Paxlovid totaled approximately $1 billion, with deliveries expected from 2025 through 2028, subject to potential renegotiation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Positively_Impacts]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Paxlovid (PRODUCT)",
        "Paxlovid (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 21959,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6126,
        "completion_tokens": 231,
        "total_tokens": 6358
      }
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "The availability and structure of shares under the 2003 Incentive Program evolved significantly between 2022 and 2024. In 2022, 65,754,069 shares were available for awards under the program, while by the end of 2024, this number had decreased to 47 million shares. The structure of awards remained consistent, offering restricted stock, stock options, and stock appreciation rights, with vesting periods typically split into two portions—50% vesting after three years and 50% after seven years, though some senior executives had longer vesting periods. Additionally, in 2024, the program was impacted by the Pioneer acquisition, which converted unvested Pioneer restricted stock units into ExxonMobil restricted stock units, further influencing the program's share usage and structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "XOM (ORG) -> 2003 Incentive Program (ACCOUNTING_POLICY)",
        "2003 Incentive Program (ACCOUNTING_POLICY) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5080,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1908,
        "completion_tokens": 196,
        "total_tokens": 2104
      }
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "Between 2022 and 2024, AdSense has continued to play a significant role in Google's advertising revenue streams, particularly as part of the broader Google Network, which includes AdMob and Google Ad Manager. In 2022, AdSense contributed to the $8.6 billion year-over-year revenue increase for the Google Network, driven by improvements in ad formats and delivery. By 2024, AdSense remains a key component of Google's advertising technology portfolio, supporting both performance and brand advertising across Google properties and partner sites. The company continues to invest in AI-driven advertising solutions, enhancing the effectiveness of AdSense and other platforms to deliver better results for advertisers while maintaining positive user experiences.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Positively_Impacts]-> PRODUCT <-[Generates_Revenue_From]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> AdSense (PRODUCT)",
        "AdSense (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6306,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2223,
        "completion_tokens": 189,
        "total_tokens": 2413
      }
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "The UPS Retirement Plan's benefit accrual structure evolved between 2022 and 2023 by ceasing future benefit accruals for non-union participants effective January 1, 2023, as stated in both the 2022 and 2023 10-K filings. This change meant that non-union participants hired prior to July 1, 2016, would no longer earn additional retirement benefits based on future service or compensation. Additionally, in 2022, UPS amended certain Canadian defined benefit pension plans to also cease future benefit accruals, effective December 31, 2023, reflecting a broader shift in the company's approach to future pension obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "UPS (ORG) -> UPS Retirement Plan (FIN_INST)",
        "UPS Retirement Plan (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9326,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2979,
        "completion_tokens": 155,
        "total_tokens": 3134
      }
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "Between 2022 and 2024, Amazon significantly expanded its short-term credit capacity, increasing its unsecured revolving credit facility from $7.0 billion (as of 2022) to a $15.0 billion facility (as of 2024), with an additional $5.0 billion 364-day revolving credit facility added in October 2024. The interest rate terms improved slightly, with the facility spreads decreasing from 0.50% (2022) to 0.45% (2024), and the commitment fees dropping from 0.04% to 0.03%. While no borrowings were outstanding under the primary credit facilities in 2022, 2023, or 2024, Amazon had small amounts of borrowings under other short-term credit facilities, rising from no specific amounts mentioned in 2022 to $147 million and $151 million in 2023 and 2024, respectively. This evolution reflects Amazon’s proactive management of liquidity and access to flexible, cost-effective credit.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Borrows]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Short-Term Credit Facilities (FIN_INST)",
        "Short-Term Credit Facilities (FIN_INST) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3733,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1589,
        "completion_tokens": 218,
        "total_tokens": 1807
      }
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "Between 2022 and 2023, Costco continued to use variable-priced contracts for energy purchases, including electricity, natural gas, and fuel for gas stations, on an index basis. In 2022, these contracts were described as part of Costco's strategy to partially mitigate commodity price risk, particularly for U.S. and Canadian operations, while also entering into fixed-price contracts for certain facilities. In 2023, the company reiterated this approach, emphasizing the use of both fixed-price and variable-priced contracts, with the latter still qualifying for the 'normal purchases and normal sales' exception and thus not requiring mark-to-market adjustments. This consistency in strategy suggests that Costco is balancing cost management with risk mitigation, leveraging variable-priced contracts to align with market conditions while using fixed-price contracts to hedge against price volatility, reflecting a pragmatic and flexible commodity price risk management approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into]-> FIN_INST <-[Uses]- ORG",
      "triplets_used": [
        "COST (ORG) -> Variable-Priced Contracts (FIN_INST)",
        "Variable-Priced Contracts (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8168,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2691,
        "completion_tokens": 245,
        "total_tokens": 2936
      }
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "Between 2022 and 2024, NVIDIA AI Enterprise evolved from being a component of NVIDIA's Compute & Networking segment to becoming a more prominent and strategic offering within its data center platform. In 2022, it was listed as part of the segment's offerings, including data center platforms for AI and accelerated computing. By 2024, NVIDIA AI Enterprise was highlighted as a comprehensive, enterprise-grade AI software suite offered for paid licenses, integrated with other key data center solutions like NVIDIA vGPU and NVIDIA DGX Cloud. This shift reflects NVIDIA's strategic emphasis on expanding its full-stack AI platform, combining hardware and software to deliver scalable, enterprise AI solutions, aligning with the broader evolution of its data center offerings to include CPUs, DPUs, and the Blackwell architecture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> NVIDIA AI Enterprise (PRODUCT)",
        "NVIDIA AI Enterprise (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8574,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2781,
        "completion_tokens": 206,
        "total_tokens": 2988
      }
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "Between 2023 and 2024, Pfizer’s contractual obligations related to Paxlovid evolved significantly, reflecting a shift in the product’s role and revenue impact. In 2023, Paxlovid was primarily sold to government agencies globally, with a non-cash revenue reversal of $3.5 billion in the fourth quarter due to the expected return of 6.5 million treatment courses by the U.S. government. By 2024, this expectation was revised downward to 5.1 million returned courses, resulting in a $771 million favorable adjustment in the first quarter and $442 million in new revenue from the U.S. Strategic National Stockpile (SNS) in the third quarter. As of December 31, 2024, remaining performance obligations for Paxlovid totaled approximately $1 billion, indicating ongoing but reduced future revenue expectations compared to earlier projections. This evolution suggests a declining but still material role for Paxlovid in Pfizer’s revenue outlook, with government contracts continuing to shape its financial impact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Paxlovid (PRODUCT)",
        "Paxlovid (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8243,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2701,
        "completion_tokens": 251,
        "total_tokens": 2953
      }
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "Between 2022 and 2024, Google's exposure to new regulatory costs in international markets evolved in both scope and nature. In 2022, the focus was on regulatory challenges tied to data privacy (e.g., data transfers between the EU and UK) and customer requirements, with an emphasis on the potential for increased costs and operational complexity due to an evolving foreign policy landscape. By 2024, the scope broadened to include geopolitical tensions (e.g., conflicts in the Middle East and Ukraine), sanctions, import/export controls, and political instability, which introduced additional risks such as business continuity disruptions, compliance hurdles, and uncertainty in regulatory outcomes. The nature of the risk also shifted to include potential litigation and liabilities under local laws with unclear legal precedents, reflecting a more complex and unpredictable regulatory environment globally.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> New Regulatory Costs (RISK_FACTOR)",
        "New Regulatory Costs (RISK_FACTOR) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11079,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3425,
        "completion_tokens": 227,
        "total_tokens": 3652
      }
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "Between 2022 and 2023, UPS's approach to funding postretirement medical benefits has remained consistent, with expected benefit payments continuing to be funded from both plan trusts and corporate assets. The 2022 and 2023 disclosures both emphasize adherence to applicable laws and regulations, including city ordinances to which UPS is subject, and indicate no material change in the funding strategy for these benefits during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "triplets_used": [
        "UPS (ORG) -> City Ordinances (REGULATORY_REQUIREMENT)",
        "City Ordinances (REGULATORY_REQUIREMENT) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1205,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 954,
        "completion_tokens": 110,
        "total_tokens": 1064
      }
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "NVIDIA AI Enterprise, introduced in 2022 as part of NVIDIA’s Compute & Networking segment, initially served as a software component for AI development and deployment. By 2024, its role and scope had expanded significantly, evolving into a comprehensive software suite designed to simplify the development and deployment of production-grade, end-to-end generative AI applications. This broader iteration includes tools like NVIDIA NIM, NeMo, and AI Blueprints, which enhance model efficiency, customization, and deployment. Additionally, NVIDIA AI Enterprise is now supplied as part of a fully managed AI-training-as-a-service platform, DGX Cloud, and is integrated with NVIDIA’s end-to-end AI infrastructure, reinforcing its central role in NVIDIA’s AI strategy and ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Supplies]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> NVIDIA AI Enterprise (PRODUCT)",
        "NVIDIA AI Enterprise (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11151,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3423,
        "completion_tokens": 194,
        "total_tokens": 3617
      }
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "ExxonMobil's proved reserves through equity companies increased significantly from 2022 to 2024, with the oil-equivalent total rising from 143 million bbls in 2022 to 1,481 million bbls in 2024. This growth is primarily driven by substantial reserves in Asia, which accounted for 1,276 million bbls in 2024. The strategic positioning reflects a focus on high-potential regions, particularly in Asia, where ExxonMobil's equity stakes contribute meaningfully to its global reserves, indicating a long-term commitment to securing resources in key geographic markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Equity Companies (COMP)",
        "Equity Companies (COMP) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10810,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3343,
        "completion_tokens": 140,
        "total_tokens": 3483
      }
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "The financial relationship with Google Network Partners between 2022 and 2024 has evolved in terms of both revenue generation and cost structure. In 2022, Google Network Partners were integral to advertising revenue generation, particularly through AdMob, AdSense, and Google Ad Manager, with Google typically reporting these revenues on a gross basis, indicating a principal role. By 2024, Google continued to generate significant advertising revenues from Google Network properties, and these remained a major source of cash from operating activities. However, the cost structure also reflects increased payments to Google Network partners as a primary use of cash, suggesting a continued and possibly growing financial dependency on these partners for both revenue generation and operational expenses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Supplies]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Network Partners (COMP)",
        "Google Network Partners (COMP) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7047,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2406,
        "completion_tokens": 201,
        "total_tokens": 2607
      }
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "Between 2022 and 2023, UPS continued to manage its foreign currency exchange risk using undesignated foreign currency forward contracts to economically offset remeasurement and settlement risks on foreign currency assets and liabilities. In 2022, UPS noted that these contracts, along with interest rate swaps and investment market price forward contracts, were used to mitigate the effects of market valuation changes, with periodic terminations and offsetting positions to eliminate valuation impacts. By 2023, the company clarified that derivative instruments not designated as hedges, including these foreign currency forward contracts, were recorded at fair value with unrealized gains and losses directly impacting earnings, thereby contributing to earnings volatility. The continued use of offsetting positions with different counterparties suggests a consistent strategy, though the direct fair value accounting in 2023 likely increased the visibility and volatility of these impacts on earnings compared to prior periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Offsetting Foreign Currency Positions (FIN_INST)",
        "Offsetting Foreign Currency Positions (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_159",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2427,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 257,
        "total_tokens": 1528
      }
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "Between 2022 and 2023, Costco's membership format has remained a central pillar of its profitability strategy, reinforcing member loyalty and generating consistent fee revenue. In 2022, the company emphasized the importance of growing its membership base, increasing Executive member penetration, and maintaining high renewal rates to drive profitability. By 2023, this focus continued, with additional emphasis on the potential challenges to renewal rates in newer markets and the impact of warehouse openings in existing markets on paid membership growth. Both years underscore the critical role of the membership model in sustaining Costco’s low-margin, high-volume business, as fee revenue provides a stable income stream while fostering long-term customer relationships.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "COST (ORG) -> Membership Format (ACCOUNTING_POLICY)",
        "Membership Format (ACCOUNTING_POLICY) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9415,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3007,
        "completion_tokens": 193,
        "total_tokens": 3201
      }
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "NVIDIA's approach to CUDA has evolved significantly between 2022 and 2024, with a stronger emphasis on integration within the broader data center platform and software ecosystem. In 2022, CUDA was highlighted as a foundational component of NVIDIA's AI and accelerated computing ecosystem, supporting millions of developers and enabling AI deployment across diverse markets. By 2024, CUDA had become a core element of NVIDIA's full-stack data center platform, complementing hardware expansions like CPUs and DPUs, and supporting enterprise-grade AI software such as NVIDIA AI Enterprise and vGPU. Additionally, CUDA's role in enabling advanced AI and graphics workloads was further enhanced with the launch of the Blackwell architecture in 2025, which integrates CUDA with next-generation AI and rendering technologies to deliver unprecedented performance and efficiency across data center and gaming applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Develops]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> CUDA (PRODUCT)",
        "CUDA (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11693,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3559,
        "completion_tokens": 228,
        "total_tokens": 3787
      }
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "Pfizer's financial commitment and contractual obligations related to Paxlovid evolved significantly from 2023 to 2024, with expected future revenue and delivery timelines reflecting adjustments in U.S. government inventory returns and updated contractual commitments. In 2023, a $3.5 billion non-cash revenue reversal was recorded due to the expected return of 6.5 million EUA-labeled treatment courses by the U.S. government. By 2024, this was revised downward to 5.1 million returned courses, resulting in a $771 million favorable adjustment in the first quarter. As of December 31, 2024, remaining performance obligations for Paxlovid totaled approximately $1 billion, with delivery expected from 2025 through 2028, subject to potential renegotiation. These figures highlight the evolving financial exposure and delivery expectations tied to Paxlovid under long-term supply contracts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Paxlovid (PRODUCT)",
        "Paxlovid (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14180,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4188,
        "completion_tokens": 221,
        "total_tokens": 4410
      }
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "ExxonMobil's strategic emphasis on Guyana has evolved significantly between 2022 and 2024, as reflected in its disclosures on reserves development and advantaged asset reporting. In 2022, Guyana was highlighted as one of the key regions contributing to the addition of 1.3 billion oil-equivalent barrels of proved undeveloped reserves, driven by extensions and discoveries. The company invested $8.0 billion in 2021 to advance such reserves, with Guyana being a focal point for development. By 2024, Guyana had been explicitly designated as an \"Advantaged Asset\" in ExxonMobil’s updated earnings driver framework, underscoring its strategic and financial importance as a high-growth, high-return asset contributing to earnings through volume and mix improvements. This evolution reflects a shift from reserves development to a broader strategic integration of Guyana into ExxonMobil’s advantaged growth portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Guyana (GPE)",
        "Guyana (GPE) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8770,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2825,
        "completion_tokens": 228,
        "total_tokens": 3054
      }
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "The planned utilization of the ATR 72-600F aircraft decreased significantly from 2022 to 2024, with its total planned deliveries dropping from 24 aircraft through 2026 in 2022 to just 10 aircraft through 2028 in 2024. This decline indicates a reduced role for the ATR 72-600F in FedEx's fleet strategy, as the company appears to be shifting focus toward other aircraft like the Cessna SkyCourier 408 and B767F, which show increased planned utilization over the same period. The reduction in ATR 72-600F utilization reflects a strategic realignment of the fleet to better meet operational needs and efficiency goals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> ATR 72-600F (PRODUCT)",
        "ATR 72-600F (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1669,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1054,
        "completion_tokens": 153,
        "total_tokens": 1208
      }
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "Between 2022 and 2024, NVIDIA's approach to offering Omniverse evolved from a virtual world simulation and collaboration platform for 3D workflows into a more integrated and enterprise-focused development platform and operating system for building and running virtual world simulation applications. In 2022, Omniverse was highlighted as a tool for enterprise and individual use, with applications in virtual car showrooms, surgical training, and architectural walkthroughs. By 2024, Omniverse was positioned as a core component of NVIDIA’s broader AI and simulation ecosystem, supporting digital twins of factories, real-time 3D product configurators, and testing of autonomous systems, all powered by NVIDIA’s accelerated computing infrastructure. This evolution reflects NVIDIA’s strategy to extend its AI platform leadership by embedding Omniverse more deeply into industrial and enterprise workflows, leveraging its full-stack computing capabilities including GPUs, CPUs, and cloud infrastructure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Omniverse (PRODUCT)",
        "Omniverse (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11666,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3551,
        "completion_tokens": 250,
        "total_tokens": 3802
      }
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "Between 2022 and 2023, Google Play's role in generating non-advertising revenue has remained a key contributor, primarily through the sales of apps, in-app purchases, and digital content. In 2022, Google Play was highlighted as one of the core products driving the growth of non-advertising revenues, which are expected to continue increasing as Google expands offerings like Google Cloud and hardware. By 2023, Google Play was specifically categorized under the \"platforms\" segment within Google Subscriptions, Platforms, and Devices, emphasizing its role in monetizing digital content and app transactions. Additionally, content acquisition costs for Google Play were noted in 2023, indicating continued investment in licensing and maintaining the platform's offerings. Thus, Google Play has consistently played a central role in non-advertising revenue growth, with its contribution becoming more explicitly segmented and operationally detailed in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Play (PRODUCT)",
        "Google Play (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8270,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2690,
        "completion_tokens": 239,
        "total_tokens": 2929
      }
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "Between 2022 and 2023, AIG continued to apply expected loss ratio methods in its workers' compensation reserving, particularly for guaranteed cost and excess of deductible business, though with evolving emphasis. In 2022, expected loss ratio methods were given significant weight only in the most recent accident year for guaranteed cost business, while for excess of deductible business, they were weighted heavily in the most recent five accident years. AIG also noted that the increasing proportion of large deductible business had slowed claim reporting patterns. By 2023, the methodology remained consistent, with AIG continuing to group guaranteed cost and excess of deductible business separately and applying expected loss ratio methods in line with prior practices, while also accounting for risk-sharing structures and state-specific development patterns. The 2023 filing reaffirmed the long-tail nature of the business and the continued use of expected loss ratios in conjunction with loss development and frequency/severity methods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Expected Loss Ratio Methods (ACCOUNTING_POLICY)",
        "Expected Loss Ratio Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_260",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6056,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2176,
        "completion_tokens": 261,
        "total_tokens": 2437
      }
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "Cisco's product category segmentation evolved significantly between fiscal 2022 and fiscal 2024. In fiscal 2022, Cisco introduced a new segmentation that included the \"Collaboration\" category, among others such as Secure, Agile Networks, Internet for the Future, End-to-End Security, and Optimized Application Experiences. By fiscal 2024, Cisco further refined its product categories, simplifying them to include Networking, Security, Collaboration, and Observability, with prior periods' data conformed to this new structure. The continued inclusion of the Collaboration category, particularly in relation to products like Webex, reflects Cisco's strategic emphasis on collaboration solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Webex (PRODUCT)",
        "Webex (PRODUCT) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1425,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 987,
        "completion_tokens": 173,
        "total_tokens": 1161
      }
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "Amgen's disclosure regarding the 3.125% 2025 Notes remained consistent in terms of the notional amount of $1,000 million from 2022 to 2023, as shown in both disclosures. However, in 2023, Amgen provided additional detail by disclosing the interest rate framework, specifying that the effective interest rate for the 3.125% 2025 Notes is tied to SOFR + 2.1%, reflecting a shift toward transparently linking the notes' interest rate to a benchmark rate. This evolution in disclosure enhances clarity on the financial presentation and the underlying interest rate mechanism.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 3.125% 2025 Notes (FIN_INST)",
        "3.125% 2025 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_144",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5559,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2031,
        "completion_tokens": 142,
        "total_tokens": 2174
      }
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region declined from 764 billion cubic feet at the end of 2021 to 326 billion cubic feet by the end of 2022, and further decreased to 312 billion cubic feet by the end of 2023. However, by the end of 2024, reserves slightly rebounded to 296 billion cubic feet. This trend, marked by significant reductions followed by a modest recovery, suggests a strategic shift or operational challenges in the region. The decline may indicate a reduced focus on natural gas development in Asia Pacific/Middle East, or a reallocation of capital to other regions with higher growth potential, as evidenced by the increased activity in the Lower 48 and Canada in the 2024 data.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Asia Pacific/Middle East (GPE)",
        "Asia Pacific/Middle East (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_174",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 21358,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5989,
        "completion_tokens": 180,
        "total_tokens": 6169
      }
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "Alphabet's repurchase activity of Class C Capital Stock increased from $59.3 billion in 2022 to $62.2 billion in 2023, as disclosed in the 2023 10-K filing. In the 2022 10-K, repurchases of capital stock amounted to $18.396 billion in total stockholders' equity impact. This upward trend in repurchase spending, along with the additional $70.0 billion repurchase authorization in April 2023 (with $36.3 billion remaining as of December 31, 2023), indicates a strategic focus on returning capital to shareholders and optimizing capital allocation. The increased repurchase activity reflects Alphabet's confidence in its financial position and a commitment to enhancing shareholder value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class C Capital Stock (FIN_INST)",
        "Class C Capital Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10082,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3168,
        "completion_tokens": 171,
        "total_tokens": 3340
      }
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "Between 2022 and 2023, AIG expanded the use of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, in addition to their continued application in U.S. Property. In 2022, frequency/severity methods were used for short-tail classes like U.S. Property, where they were applied in combination with loss development and IBNR factor methods. By 2023, AIG began using a combination of loss development, frequency/severity, and expected loss ratio methods for Workers' Compensation, reflecting the line’s long-tail nature and the need for more nuanced modeling due to risk-sharing features like high deductibles and self-insured retentions. The inclusion of frequency/severity methods in Workers' Compensation underscores AIG’s evolving approach to better capture the variability and emergence patterns of claims in more complex and long-tail exposures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Frequency/Severity Methods (ACCOUNTING_POLICY)",
        "Frequency/Severity Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_273",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5417,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2014,
        "completion_tokens": 222,
        "total_tokens": 2236
      }
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "Amgen's financial relationship with BeiGene evolved from 2022 to 2023 with a continued focus on cost recovery, product sales, and profit and loss sharing under their collaboration. In 2023, Amgen recovered $109 million in R&D costs from BeiGene, a decrease from $199 million in 2022, while product sales to BeiGene increased to $125 million from $64 million in 2022. Profit and loss sharing expenses also declined to $40 million in 2023 from $53 million in 2022. These figures reflect the ongoing commercialization of products in China and the shared financial obligations under the collaboration agreement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> BeiGene (COMP)",
        "BeiGene (COMP) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_131",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8678,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2803,
        "completion_tokens": 151,
        "total_tokens": 2955
      }
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "From 2022 to 2024, COP's natural gas reserves in the Asia Pacific/Middle East region declined from 326 billion cubic feet at the end of 2022 to 296 billion cubic feet at the end of 2024. During this period, revisions reduced reserves by 30 billion cubic feet (from -2 in 2022 to +9 in 2024), production further reduced reserves by 51 billion cubic feet in 2022, 24 billion cubic feet in 2023, and 25 billion cubic feet in 2024. Notably, in 2024, purchases increased reserves by 47 billion cubic feet, while extensions and discoveries added 67 billion cubic feet in 2023 and 67 billion cubic feet in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Asia Pacific/Middle East (GPE)",
        "Asia Pacific/Middle East (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_166",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 18705,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5328,
        "completion_tokens": 151,
        "total_tokens": 5479
      }
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "FedEx's planned usage of the B767F aircraft remained at 14 units in 2023 and 2024, as outlined in the 2022 10-K filing. However, by 2025, the 2024 10-K filing shows a reduction to 11 units in 2025 and further declines to just 3 units by 2026, with no planned additions thereafter. This indicates a strategic shift in fleet planning, where FedEx is gradually phasing out the B767F in favor of other aircraft like the Cessna SkyCourier 408 and ATR 72-600F, likely to optimize efficiency and align with evolving operational needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> B767F (PRODUCT)",
        "B767F (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1668,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1045,
        "completion_tokens": 131,
        "total_tokens": 1177
      }
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "Between 2022 and 2023, AIG expanded the application of Expected Loss Ratio (ELR) Methods to additional lines of business, particularly in U.S. Workers' Compensation, as noted in the 2023 10-K. In 2022, ELR methods were primarily used for the latest accident year in aviation exposures and other short-tail lines, where they were combined with loss development methods due to the high severity and variability of claims. By 2023, AIG integrated ELR methods into a broader reserving approach for Workers' Compensation, a long-tail line, in combination with loss development and frequency/severity methods. This evolution reflects AIG's response to the increasing complexity and risk-sharing structures in its portfolios, such as high deductibles and self-insured retentions, which necessitate more nuanced and forward-looking reserve estimation techniques.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Expected Loss Ratio Methods (ACCOUNTING_POLICY)",
        "Expected Loss Ratio Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_273",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5417,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2010,
        "completion_tokens": 213,
        "total_tokens": 2223
      }
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "Between 2022 and 2024, Cisco's positioning around Enterprise Data Center Transformation has evolved to emphasize strategic alliances and adapt to a more competitive landscape. In 2022, Cisco highlighted the convergence of technologies in the enterprise data center and noted that some strategic alliance partners were acquiring or forming alliances with competitors, increasing competitive pressures. By 2024, Cisco continued to underscore the importance of strategic alliances for industry advancement and new market creation, while also acknowledging the growing complexity of managing these relationships due to overlapping competitive interests. The competitive landscape remained intense, with new entrants, price-focused rivals from Asia, and the ongoing convergence of computing, networking, and software technologies intensifying the challenges in the enterprise data center space.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Discloses]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Enterprise Data Center Transformation (CONCEPT)",
        "Enterprise Data Center Transformation (CONCEPT) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11532,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3539,
        "completion_tokens": 222,
        "total_tokens": 3761
      }
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "Between 2022 and 2023, the effective interest rate and notional amount for the 3.125% 2025 Notes remained consistent in terms of notional amount at $1,000 million, and the effective interest rate was set at SOFR + 2.1%. In 2022, the notes were part of interest rate swap terminations and replacements due to historically low interest rates, which led to cash receipts and new swap agreements at current rates. By 2023, these swaps were reflected in the updated effective interest rates disclosed in the 10-K, showing the continued application of the SOFR-based rate structure for the 3.125% 2025 Notes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 3.125% 2025 Notes (FIN_INST)",
        "3.125% 2025 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_144",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1876,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1100,
        "completion_tokens": 150,
        "total_tokens": 1251
      }
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "From 2022 to 2024, Cisco has elevated AppDynamics within its product portfolio, particularly emphasizing its role in observability offerings. In 2022, AppDynamics was highlighted as a key element in Cisco's full-stack observability strategy, enabling customers to monitor application performance within hybrid and multicloud environments. By 2024, Cisco had restructured its product revenue reporting to include a dedicated \"Observability\" category, signaling a strategic shift to centralize and expand its observability solutions. This evolution reflects Cisco's growing focus on integrating and scaling AppDynamics as a core component of its broader observability platform, aligning with customer demands for real-time insights and performance monitoring across increasingly complex digital infrastructures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> AppDynamics (PRODUCT)",
        "AppDynamics (PRODUCT) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6162,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2182,
        "completion_tokens": 202,
        "total_tokens": 2385
      }
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "From 2022 to 2023, the notional amount associated with the 4.663% 2051 Notes increased to $1,500 million, and the effective interest rate for these notes was reported as SOFR + 4.3% in 2023. In 2022, while the specific effective interest rate for the 4.663% 2051 Notes was not explicitly stated, it was part of a group of notes with $5.2 billion in notional amounts for which interest rate swaps were terminated and re-entered at then-current rates, indicating a shift in interest rate risk management strategy that likely contributed to the updated effective rate in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 4.663% 2051 Notes (FIN_INST)",
        "4.663% 2051 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_144",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1876,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1099,
        "completion_tokens": 143,
        "total_tokens": 1242
      }
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "Between 2022 and 2023, AIG's use of expected loss ratio methods has continued to be applied, particularly in long-tail lines of business like U.S. Workers' Compensation, where a combination of loss development, frequency/severity, and expected loss ratio methods are used. In 2023, AIG further refined its segmentation criteria by grouping guaranteed cost and excess of deductible business separately, and then further segmenting by state, industry subset, deductible size, and claim handling (AIG vs. third-party administrator). This reflects an evolution in applying more granular segmentation to account for the complexity and unique characteristics of risk-sharing programs, which has implications for loss emergence patterns due to the increased proportion of large deductible business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Expected Loss Ratio Methods (ACCOUNTING_POLICY)",
        "Expected Loss Ratio Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2336,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 197,
        "total_tokens": 1435
      }
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "Between 2023 and 2024, PepsiCo continued its engagement with the 2.850% Senior Notes due 2026, as reflected in both its 2023 and 2024 10-K filings. In 2023, the 2.850% Senior Notes were part of a broader set of notes authorized by the Board of Directors, indicating an ongoing debt issuance strategy. By 2024, PepsiCo expanded its debt issuance strategy, introducing a more extensive array of notes, including additional 2026-due notes such as the 7.29%, 7.44%, and 4.550% Senior Notes, alongside new long-term notes maturing through 2060. This evolution reflects PepsiCo's continued use of diversified debt instruments to manage its capital structure and funding needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "PEP (ORG) -> 2.850% Senior Notes due 2026 (FIN_INST)",
        "2.850% Senior Notes due 2026 (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 22508,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6286,
        "completion_tokens": 167,
        "total_tokens": 6453
      }
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "Cisco's exposure to channel partner financing guarantees increased slightly from $1.3 billion as of July 31, 2021, to $1.4 billion as of July 30, 2022, but no updated balance is explicitly provided for fiscal 2024. However, the 2024 10-K reaffirms that these guarantees are part of the company's ordinary business operations, with payments under such arrangements historically not being material. The continued use of financing guarantees, coupled with the company's reassessment of variable interest entities and its strong liquidity position, indicates a measured and controlled approach to financial risk management. This suggests that Cisco is actively managing its exposure while supporting channel partner working capital needs, aligning with its broader strategy of balancing operational support with financial prudence.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Financing Guarantees (FIN_INST)",
        "Financing Guarantees (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6143,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2186,
        "completion_tokens": 206,
        "total_tokens": 2393
      }
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "Between 2022 and 2023, the 2.45% 2030 Notes issued by AMGN remained outstanding, with a notional amount of $1,000 million as disclosed in the 2023 10-K. In 2022, AMGN had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion related to these notes, effectively converting their fixed 2.45% interest rate to a floating rate of SOFR + 1.3%, as reflected in the 2023 filing. There is no indication of redemption or repayment of these notes in 2023, and the interest rate structure remained unchanged, continuing to reflect the hedged SOFR-based rate.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 2.45% 2030 Notes (FIN_INST)",
        "2.45% 2030 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_131",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_144",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5375,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1969,
        "completion_tokens": 146,
        "total_tokens": 2115
      }
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "Between 2022 and 2023, FedEx's relationship with Pass-Through Certificates evolved significantly in terms of financial guarantees and obligations. In 2022, FedEx Express issued $970 million in Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx, with the obligations secured by 19 Boeing aircraft valued at $1.8 billion. However, by 2023, FedEx disclosed that the pass-through certificates are no longer direct obligations of, or guaranteed by, FedEx or FedEx Express, indicating a change in the structure or terms of these financial instruments. This shift suggests a reduction in FedEx's direct financial exposure, although the company still makes payments under leveraged operating leases related to these certificates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Pass-Through Certificates (FIN_INST)",
        "Pass-Through Certificates (FIN_INST) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3982,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1639,
        "completion_tokens": 192,
        "total_tokens": 1832
      }
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "From 2023 to 2024, Mastercard increased its use of risk mitigation arrangements to manage gross settlement exposure, as evidenced by the rise from $12,167 million in 2023 to $13,466 million in 2024. This increase, alongside a modest rise in gross settlement exposure from $75,023 million to $78,385 million, indicates a more proactive and conservative risk management strategy, where the company is enhancing safeguards—such as cash collateral and credit enhancements—for customers that do not meet its risk standards. This aligns with Mastercard's ongoing commitment to regularly reviewing and strengthening its risk management methodology to ensure the adequacy of its risk mitigation framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> RISK_FACTOR <-[Increases]- ORG",
      "triplets_used": [
        "MA (ORG) -> Risk Mitigation Arrangements (RISK_FACTOR)",
        "Risk Mitigation Arrangements (RISK_FACTOR) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4064,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1672,
        "completion_tokens": 174,
        "total_tokens": 1846
      }
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "Between 2022 and 2024, Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments increased significantly. In 2022, these liabilities totaled $48 million, while in 2024, they rose to $146 million. This increase suggests that Nike has expanded its use of these hedging instruments, likely to manage its growing exposure to foreign currency fluctuations, indicating a more active hedging strategy to mitigate financial risks associated with international operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Foreign Exchange Forwards and Options (FIN_INST)",
        "Foreign Exchange Forwards and Options (FIN_INST) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4733,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1846,
        "completion_tokens": 126,
        "total_tokens": 1973
      }
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "Between 2022 and 2023, Bounty's representation within P&G's Baby, Feminine & Family Care segment evolved from being mentioned as part of the \"family care business\" in the 2022 10-K (Chunk 1) to being explicitly listed as a major brand in the 2023 10-K (Chunk 2) under the same segment. In 2022, Bounty was referenced in a general context of family care products, while in 2023, it was highlighted alongside prominent brands like Always, Tampax, and Charmin, suggesting an increase in brand visibility and strategic emphasis within the segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG",
      "triplets_used": [
        "PG (ORG) -> Bounty (PRODUCT)",
        "Bounty (PRODUCT) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6216,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2194,
        "completion_tokens": 135,
        "total_tokens": 2330
      }
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "Between fiscal 2022 and fiscal 2023, Oracle's approach to its hardware business, particularly Oracle Engineered Systems, shows a shift in strategic emphasis and revenue recognition practices. In fiscal 2022, Oracle's hardware business, including Engineered Systems, recognized hardware and related software revenues at the point of delivery, with hardware support revenues recognized ratably over the contractual term. By fiscal 2023, Oracle continued this practice but emphasized the combined performance obligation model for hardware and related software, recognizing revenue at the point of delivery when ownership transfers. Strategically, Oracle maintained a focus on Oracle Engineered Systems while acknowledging the competitive pressures from cloud infrastructure and the need for ongoing R&D investment to enhance existing and develop new hardware offerings. This reflects a continued but evolving strategic emphasis on hardware as a complementary part of Oracle’s broader IT ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Engineered Systems (PRODUCT)",
        "Oracle Engineered Systems (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7085,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2423,
        "completion_tokens": 248,
        "total_tokens": 2672
      }
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "ERLEADA's sales increased from $1,291 million in 2022 to $2,387 million in 2023, representing a 26.9% growth year-over-year. This significant increase, compared to its 70.0% growth in 2021 (from $760 million to $1,291 million), indicates a strong and sustained market trajectory for the product, reflecting successful market penetration and continued demand for JNJ's oncology offering.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> ERLEADA (PRODUCT)",
        "ERLEADA (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7918,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2609,
        "completion_tokens": 96,
        "total_tokens": 2705
      }
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "From 2023 to 2024, the competitive and dependency dynamics between CMCSA and local broadcast television stations have shifted, reflecting evolving media distribution and content strategies. In 2023, CMCSA's Media segment competed directly with local broadcast stations for viewership and advertising revenue, while also relying on them for the distribution of broadcast network programming through affiliations. By 2024, CMCSA faced increasing programming expenses, particularly due to retransmission consent demands from local broadcast stations, which now require negotiation rather than mandatory carriage. This shift has heightened CMCSA’s financial dependency on these stations, as it must secure carriage agreements to maintain distribution reach, while simultaneously competing with them in the broader media landscape. The growing costs and uncertainty in renewing these agreements underscore a more complex and interdependent relationship, where CMCSA must balance competitive pressures with operational reliance on local broadcast stations for content distribution.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Local Broadcast Television Stations (COMP)",
        "Local Broadcast Television Stations (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11488,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3531,
        "completion_tokens": 268,
        "total_tokens": 3799
      }
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "The value of Held-to-Maturity (HTM) securities held by MA decreased significantly from $306 million in 2023 to $38 million in 2024, while Available-for-sale (AFS) securities increased slightly from $286 million in 2023 to $292 million in 2024. This shift indicates a strategic reallocation of investments, with MA reducing its long-term, interest-rate-sensitive HTM holdings and maintaining a more flexible AFS portfolio, likely to enhance liquidity or adapt to changing market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "MA (ORG) -> HTM securities (FIN_INST)",
        "HTM securities (FIN_INST) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 882,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 861,
        "completion_tokens": 122,
        "total_tokens": 984
      }
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "Between 2022 and 2023, the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment underwent a notable shift in product categorization. In 2022, Always was listed under the \"Feminine Care\" sub-category, which included \"Adult Incontinence\" and \"Feminine Care.\" By 2023, the segment reclassified its product categories, and Always was specifically positioned under the \"Feminine Care\" sub-category with a focus on \"Adult Incontinence\" and \"Menstrual Care.\" Additionally, the \"Baby Care\" sub-category was removed from the segment in 2023, which had previously included \"Baby Wipes, Taped Diapers and Pants.\" This reclassification reflects a strategic realignment of the segment's focus and the specific role of the Always brand within it.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG",
      "triplets_used": [
        "PG (ORG) -> Always (PRODUCT)",
        "Always (PRODUCT) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5039,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1908,
        "completion_tokens": 193,
        "total_tokens": 2102
      }
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "Between 2022 and 2023, Oracle's positioning and financial contribution of Oracle Engineered Systems remained consistent as a key component of its hardware business, representing 6% of total revenues in both fiscal 2023 and 2024. In 2022, Oracle Engineered Systems were explicitly identified as a major hardware product line, with revenue recognized at the point of delivery when ownership transferred to the customer. By 2023, the company maintained this revenue recognition model for hardware, emphasizing the interdependence of hardware and related software components. Strategically, Oracle continued to invest in research and development for hardware improvements and new offerings, while acknowledging the lower operating margins of the hardware business compared to cloud and license segments. The strategic emphasis on Oracle Engineered Systems remained aligned with Oracle's broader hardware portfolio, supporting enterprise IT infrastructure needs amid evolving customer preferences toward cloud solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Engineered Systems (PRODUCT)",
        "Oracle Engineered Systems (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9343,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2986,
        "completion_tokens": 253,
        "total_tokens": 3240
      }
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "Between 2023 and 2024, Comcast’s relationship with representation firms in its advertising sales strategy has evolved to incorporate more structured and formalized arrangements. In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of allocated advertising units, recording revenue net of agency commissions. By 2024, the company expanded this approach by entering into representation agreements under which it sells advertising on behalf of third parties, maintaining its role as principal in these arrangements and recording the advertising revenue while paying fees to the third parties in operating expenses. This shift reflects a more integrated and strategic use of representation firms to enhance advertising sales efforts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Representation Firms (COMP)",
        "Representation Firms (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12107,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3659,
        "completion_tokens": 194,
        "total_tokens": 3854
      }
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "Between fiscal 2022 and fiscal 2023, Oracle’s approach to its industry-specific hardware offerings evolved in both revenue recognition and strategic emphasis. In fiscal 2022, hardware revenue was recognized as products and related software were made available to customers, with support services recognized ratably over the contract term. By fiscal 2023, Oracle clarified that revenues for hardware and its related software are recognized at the point in time when the hardware is delivered and ownership transferred, reflecting a shift toward a more performance-based recognition model. Strategically, Oracle maintained industry-specific hardware as part of its broader hardware portfolio but emphasized continued R&D investments to enhance existing products and develop new offerings. Additionally, the acquisition of Cerner in fiscal 2023 signaled a broader strategic intent to integrate hardware with industry-specific solutions, particularly in sectors like healthcare, reinforcing Oracle’s commitment to tailored infrastructure solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Industry-Specific Hardware (PRODUCT)",
        "Industry-Specific Hardware (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7085,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2422,
        "completion_tokens": 261,
        "total_tokens": 2683
      }
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "Between 2022 and 2023, IMBRUVICA (ibrutinib) sales declined by 13.7%, from $3.784 billion to $3.264 billion, as reported in JNJ's 2023 10-K. In 2022, IMBRUVICA had shown growth driven by market leadership and share gains, but this was partially offset by competitive pressures from novel oral agents and disruptions due to the COVID-19 pandemic, as detailed in the 2022 10-K. The 2023 results reflect continued competitive pressures and a shift in market dynamics, contributing to the notable sales decline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> IMBRUVICA (PRODUCT)",
        "IMBRUVICA (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7367,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2469,
        "completion_tokens": 126,
        "total_tokens": 2596
      }
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "From 2023 to 2024, Comcast's involvement with Universal Beijing Resort remained consistent in terms of ownership structure, with Comcast retaining a 30% interest and consolidating the entity due to its power to direct activities impacting economic performance. In terms of debt levels, Universal Beijing Resort's outstanding debt decreased slightly from $3.5 billion in 2023 to $3.4 billion in 2024, with the term loan principal declining from $3.1 billion to $3.0 billion. Financial risk exposure remained tied to Comcast's 30% ownership, with no liquidity arrangements or guarantees in place. The resort’s assets and liabilities were reported at $7.8 billion and $7.2 billion in 2023, and $7.3 billion and $7.0 billion in 2024, respectively, reflecting a modest reduction in net liabilities over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Constructs]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Universal Beijing Resort (COMP)",
        "Universal Beijing Resort (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7190,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2440,
        "completion_tokens": 202,
        "total_tokens": 2642
      }
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "From 2022 to 2023, FedEx's financial commitment for future lease payments related to build-to-suit facilities and equipment significantly decreased from $3.4 billion to $0.9 billion in undiscounted future payments. This reduction suggests a potential shift or slowdown in the company's expansion plans through build-to-suit leasing during this period. Additionally, the fact that these leases are not yet commenced and are structured with pass-through certificates—entities not directly obligating or guaranteed by FedEx—indicates a continued strategy to manage capital expenditures and financial obligations through third-party financing structures, thereby limiting direct liability exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Pass-Through Certificates (FIN_INST)",
        "Pass-Through Certificates (FIN_INST) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3039,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 173,
        "total_tokens": 1586
      }
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "Between 2023 and 2024, Mastercard's relationship with Dynamic Yield LTD remained consistent, as Dynamic Yield was fully acquired by Mastercard in April 2022 for $325 million, with $200 million in goodwill. This acquisition, referenced in both the 2023 and 2024 10-K filings, indicates that Mastercard continued to integrate Dynamic Yield into its operations, leveraging its capabilities in personalization and digital commerce. The consistent mention of the acquisition in both years, alongside Mastercard's 2024 acquisition of Recorded Future for $2.7 billion, highlights the company's strategic focus on expanding its digital identity, fraud prevention, and cybersecurity capabilities through targeted acquisitions during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "MA (ORG) -> Dynamic Yield LTD (COMP)",
        "Dynamic Yield LTD (COMP) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7884,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2612,
        "completion_tokens": 184,
        "total_tokens": 2796
      }
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "The Severance Plan for Senior Officers at Lowe's was last amended and restated on May 29, 2020, as disclosed in the 2022 10-K filing under Exhibit 10.29, with that version incorporated by reference from a Form 10-Q filed on August 26, 2020. In the 2024 10-K filing, Exhibit 10.28 shows that the plan was further amended and restated on May 26, 2022, and this updated version was incorporated by reference from a Form 10-Q filed on November 27, 2024. Thus, between 2022 and 2024, the plan underwent a significant amendment in May 2022, with the most recent filing occurring in late 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Severance Plan for Senior Officers (ACCOUNTING_POLICY)",
        "Severance Plan for Senior Officers (ACCOUNTING_POLICY) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10034,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3166,
        "completion_tokens": 146,
        "total_tokens": 3313
      }
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "The fair value of Netflix's 6.375% Senior Notes decreased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This decline suggests a deterioration in market perceptions of Netflix's debt over the period, likely reflecting concerns about the company's financial health, credit risk, or broader market conditions affecting bond valuations. The reduction in fair value indicates that investors were willing to pay less for the notes by the end of 2023 compared to 2021, signaling a less favorable view of Netflix's creditworthiness or higher discount rates in the market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> 6.375% Senior Notes (FIN_INST)",
        "6.375% Senior Notes (FIN_INST) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6978,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2401,
        "completion_tokens": 150,
        "total_tokens": 2551
      }
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "IMBRUVICA's sales performance declined from $4,369 million in 2022 to $3,264 million in 2023, representing a 13.7% decrease. This decline contrasts with its 5.8% growth in 2022 compared to 2021, indicating a weakening market position in the oncology segment in 2023. The drop in sales, especially when compared to the 10.5% overall growth in oncology sales for JNJ in 2023, suggests that IMBRUVICA faced increased competition or market challenges, as other oncology products like DARZALEX and ERLEADA showed strong growth during the same period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> IMBRUVICA (PRODUCT)",
        "IMBRUVICA (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7918,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2613,
        "completion_tokens": 136,
        "total_tokens": 2749
      }
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "Between 2022 and 2024, LOW’s inventory reserves evolved as follows: the LCNRV reserve decreased by $23 million to $222 million as of January 31, 2025, while the inventory shrink reserve increased by $2 million to $427 million by the same date. In 2022, the LCNRV reserve was $168 million, and the shrink reserve was $414 million. These changes reflect management’s ongoing assessments of inventory levels, sales trends, and historical shrinkage results. The implications for net earnings were significant, as a 10% change in the LCNRV reserve or shrinkage rate in 2024 could have affected net earnings by approximately $17 million and $32 million, respectively, highlighting the sensitivity of these reserves to actual results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Changes]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Accrual Rates (ACCOUNTING_POLICY)",
        "Accrual Rates (ACCOUNTING_POLICY) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9228,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2945,
        "completion_tokens": 181,
        "total_tokens": 3127
      }
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "From 2022 to 2023, Qulipta transitioned from a newly launched product to a commercially successful one, reflecting significant progress in its development and market adoption. In 2022, Qulipta generated $158 million in revenue in the United States and $158 million internationally, marking its initial commercialization phase. By 2023, its revenue surged to $405 million in the U.S. and $408 million internationally, representing a more than 150% increase in total revenue. This growth underscores Qulipta’s successful development and commercialization, supported by AbbVie’s role as its developer and commercial producer.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Develops]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Qulipta (PRODUCT)",
        "Qulipta (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10058,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3147,
        "completion_tokens": 155,
        "total_tokens": 3302
      }
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, as both years' 10-K filings describe the same indemnification and reimbursement agreement under which Resideo's subsidiary is obligated to pay Honeywell 90% of its annual net environmental spending, up to a $140 million cap, until December 31, 2043, or until the third consecutive year with payments under $25 million. This continuity suggests that Honeywell continues to transfer a significant portion of its environmental risk exposure to Resideo, thereby mitigating potential material impacts on its consolidated financial position and cash flows.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Pays]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "HON (ORG) -> Resideo Subsidiary (COMP)",
        "Resideo Subsidiary (COMP) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2883,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 170,
        "total_tokens": 1536
      }
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "Target's definition of 'original maturity' for cash equivalents has remained consistent between 2022 and 2024, as both years define cash equivalents as highly liquid investments with an original maturity of three months or less from the time of purchase, and include receivables from credit and debit card transactions that typically settle in five days or less. This consistency suggests that Target has not altered its cash management strategy in terms of liquidity requirements for cash equivalents during this period, maintaining a focus on short-term, highly liquid assets to ensure financial flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Defines]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Original Maturity (ACCOUNTING_POLICY)",
        "Original Maturity (ACCOUNTING_POLICY) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1373,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1000,
        "completion_tokens": 152,
        "total_tokens": 1153
      }
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "The valuation of NVDA's 3.50% Notes Due 2040 decreased slightly from $870 million in 2023 to $851 million in 2024, as shown in the 2023 and 2024 10-K filings. In 2024, these notes were classified with an expected remaining term of 15.2 years and an effective interest rate of 3.54%, with a carrying amount of $1,000 million. This suggests that NVDA maintains a long-term debt strategy focused on securing stable, long-duration financing at moderate interest rates, as evidenced by the continued inclusion of these notes in its long-term debt portfolio and the consistent net carrying amounts across periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> 3.50% Notes Due 2040 (FIN_INST)",
        "3.50% Notes Due 2040 (FIN_INST) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4823,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1852,
        "completion_tokens": 151,
        "total_tokens": 2004
      }
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "Between 2022 and 2023, Venclexta's total global revenue increased from $2,009 million to $2,288 million, representing a growth rate of 13.9%. This growth was driven by a 7.8% increase in U.S. revenue (from $1,009 million to $1,087 million) and a stronger 20.1% increase in international revenue (from $1,000 million to $1,201 million). As the manufacturer and distributor of Venclexta, AbbVie includes its global sales in its net revenues, with Genentech sharing in U.S. profits and royalties applied to international sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Venclexta (PRODUCT)",
        "Venclexta (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10547,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3269,
        "completion_tokens": 131,
        "total_tokens": 3400
      }
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "Between 2022 and 2023, Netflix’s approach to its Executive Severance and Retention Incentive Plan was updated through an amendment effective January 1, 2024, as disclosed in the 2023 SEC filing. In 2022, the plan was listed as the “Amended and Restated Executive Severance and Retention Incentive Plan,” with the most recent version filed on September 10, 2021. By 2023, a new version titled “Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024” was filed on December 8, 2023, indicating a plan amendment with an effective date in early 2024. This evolution reflects Netflix’s ongoing adjustments to its executive compensation and retention strategies, as connected through the ORG-ACCOUNTING_POLICY relationship in the knowledge graph.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Executive Severance and Retention Incentive Plan (ACCOUNTING_POLICY)",
        "Executive Severance and Retention Incentive Plan (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 18633,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5329,
        "completion_tokens": 195,
        "total_tokens": 5525
      }
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "From 2022 to 2024, Lowe's documentation and structure of its Benefit Restoration Plan evolved by being formally amended and restated as of January 1, 2025, as indicated in the 2024 10-K filing. In 2022, the Benefit Restoration Plan was described as a supplement to the 401(k) Plan for employees whose benefits were restricted by IRS provisions, allowing for salary deferrals and employer contributions in the form of a Company Match. The 2024 filing shows a more formalized and updated structure, suggesting a continued commitment to supporting employee retirement benefits beyond the limitations of the 401(k) Plan. This evolution reflects Lowe's ongoing approach to providing competitive and comprehensive retirement benefits to eligible employees.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Maintains]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Benefit Restoration Plan (ACCOUNTING_POLICY)",
        "Benefit Restoration Plan (ACCOUNTING_POLICY) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6816,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2362,
        "completion_tokens": 187,
        "total_tokens": 2550
      }
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "NVDA's financial obligations related to the 0.584% Notes Due 2024 increased slightly between fiscal years 2023 and 2024, from $1,185 million as of January 29, 2023, to $1,228 million as of January 28, 2024. However, in fiscal year 2025, NVDA repaid these notes, as disclosed in the 2024 10-K filing, indicating that the obligation was fully resolved by January 26, 2025.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> 0.584% Notes Due 2024 (FIN_INST)",
        "0.584% Notes Due 2024 (FIN_INST) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4701,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1807,
        "completion_tokens": 92,
        "total_tokens": 1900
      }
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "Between 2022 and 2023, Mavyret's global revenue decreased by 7.2% (from $1,541 million in 2022 to $1,430 million in 2023). In the United States, Mavyret's revenue declined by 12.7% (from $755 million in 2022 to $659 million in 2023), while international revenue saw a modest decline of 1.9% (from $786 million in 2022 to $771 million in 2023). This performance reflects a broader trend of declining sales for several of AbbVie's key products, as highlighted in the 2023 10-K, and underscores the competitive pressures in the pharmaceutical market for AbbVie’s products, including Mavyret, which is produced by AbbVie.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Decreases]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Mavyret (PRODUCT)",
        "Mavyret (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11942,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3623,
        "completion_tokens": 154,
        "total_tokens": 3777
      }
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "Between 2022 and 2024, Netflix remained in compliance with the covenant limitations related to its Senior Notes, as noted in its 2022, 2023, and 2024 filings. The covenants continued to restrict activities such as creating liens, entering into sale and lease-back transactions, and consolidating or merging with other entities. In 2024, Netflix repaid $400 million in aggregate principal of its 5.750% Senior Notes upon maturity, demonstrating its ongoing ability to meet repayment obligations. The scope of restrictions remained consistent, with limitations on indebtedness and asset transfers, and the Company confirmed compliance as of December 31, 2024, reinforcing its adherence to these regulatory requirements throughout the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Covenant Limitations (REGULATORY_REQUIREMENT)",
        "Covenant Limitations (REGULATORY_REQUIREMENT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3000,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 184,
        "total_tokens": 1596
      }
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "Between 2022 and 2023, Honeywell's approach to the Safety and Retail product line evolved through a strategic realignment. In July 2022, the Safety and Retail business unit, which included the gas detection and safety business, was combined with the Advanced Sensing Technologies business unit to form the Sensing and Safety Technologies business unit within the Safety and Productivity Solutions segment. This structural change, introduced in 2023, reflects a broader integration of safety and sensing capabilities, aiming to enhance product offerings and operational efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "HON (ORG) -> Safety and Retail (PRODUCT)",
        "Safety and Retail (PRODUCT) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5818,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2098,
        "completion_tokens": 145,
        "total_tokens": 2243
      }
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "Between 2023 and 2024, the status of Class B-2 Common Stock evolved significantly in terms of convertibility and corporate governance impact. In 2023, Class B-2 Common Stock was noted to become convertible into Class A Common Stock, with such conversions potentially increasing the outstanding shares of Class A Common Stock and diluting the voting power of existing Class A stockholders. Additionally, holders of Class B-2 Common Stock retained limited voting rights on significant corporate actions, such as mergers or consolidations, and could influence decisions that may conflict with the interests of Class A stockholders. By 2024, however, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, indicating a structural shift in the capital structure and effectively removing the direct governance influence of Class B-2 holders. This change likely streamlined corporate governance by reducing the number of distinct voting classes and aligning more shares under the Class A structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Class B-2 Common Stock (FIN_INST)",
        "Class B-2 Common Stock (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4441,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1754,
        "completion_tokens": 260,
        "total_tokens": 2014
      }
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "Between 2023 and 2024, The Home Depot has evolved its approach to enhancing the ease of shopping experience by expanding both digital and in-store capabilities to create a more interconnected and frictionless customer journey. In 2023, the company focused on improving digital navigation, mobile app functionality, and in-store features such as wayfinding signage, self-checkout options, and associate compensation to enhance engagement and convenience. By 2024, these efforts were further refined, with additional investments in digital platforms to improve search capabilities, product content, and personalized experiences, while also emphasizing the integration of physical and digital touchpoints across the entire customer journey—from inspiration to post-purchase support. These enhancements reflect a strategic shift toward meeting evolving customer expectations for speed, personalization, and seamless omnichannel interactions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> CONCEPT <-[Impacted_By]- ORG",
      "triplets_used": [
        "HD (ORG) -> Ease of Shopping Experience (CONCEPT)",
        "Ease of Shopping Experience (CONCEPT) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10770,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3340,
        "completion_tokens": 234,
        "total_tokens": 3575
      }
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "The structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024 by introducing new forms of equity awards, including the \"Cliff-Vested Restricted Stock Unit Agreement\" and the \"Performance Award Performance Share Unit Agreement,\" as detailed in the 2024 filings. In 2022, the plan included awards such as Restricted Stock Units, Performance-Based Restricted Stock Units, and Performance Share Units, with updated agreements filed in 2024. These changes reflect a continued emphasis on performance-based and time-vested equity compensation for executives and employees.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "TGT (ORG) -> LT Incentive Plan (ACCOUNTING_POLICY)",
        "LT Incentive Plan (ACCOUNTING_POLICY) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16997,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4903,
        "completion_tokens": 148,
        "total_tokens": 5052
      }
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "Qulipta was FDA approved in September 2021 for the preventive treatment of episodic migraine in adults, as disclosed in Chunk 1. From 2021 to 2023, its commercial performance showed significant growth, as seen in Chunk 2: Qulipta generated $0 in revenue in 2021, $158 million in 2022, and $405 million in 2023 in the United States, with international sales also contributing $3 million in 2023, reflecting more than 100% year-over-year growth in both periods. This rapid revenue increase highlights Qulipta's strong market acceptance and commercial success following its FDA approval.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Qulipta (PRODUCT)",
        "Qulipta (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11236,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3437,
        "completion_tokens": 146,
        "total_tokens": 3583
      }
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "Between the 2022 and 2024 SEC filings, Netflix's treatment and disclosure of the 2020 Stock Plan evolved in terms of structural description and equity compensation activities. In 2022, the 2020 Stock Plan was referenced in the exhibit list as a Def 14A filing from April 22, 2020, indicating its formal introduction and regulatory compliance. By 2024, the 2020 Stock Plan was more explicitly described as a stockholder-approved plan, providing for the grant of incentive and nonstatutory stock options, stock appreciation rights, restricted stock, and restricted stock units to employees, directors, and consultants. Additionally, the 2024 filing expanded on equity compensation activities, detailing both time-based and performance-based restricted stock unit awards, including vesting schedules and performance-based criteria, reflecting a more comprehensive and transparent disclosure of the plan's operational structure and usage.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> 2020 Stock Plan (ACCOUNTING_POLICY)",
        "2020 Stock Plan (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11437,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3519,
        "completion_tokens": 233,
        "total_tokens": 3753
      }
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "Between 2022 and 2023, the company (BA) continued to classify its aluminum purchase agreements as derivative instruments for accounting purposes, recognizing their role in managing long-term strategic sourcing and non-U.S. business requirements. In 2022, these agreements were explicitly identified as derivative instruments, used to hedge against commodity price fluctuations. In 2023, the company provided additional detail, noting that these agreements offset quantities and are priced at prevailing market prices, reinforcing their strategic use rather than speculative intent. Both years emphasized that these instruments did not receive hedge accounting treatment, indicating a consistent approach to their classification and a focus on operational risk management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "BA (ORG) -> Aluminum Purchase Agreements (FIN_INST)",
        "Aluminum Purchase Agreements (FIN_INST) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2422,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 192,
        "total_tokens": 1450
      }
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "Between 2023 and 2024, the disclosure and treatment of the Directors' Code of Conduct by BNY Mellon remained consistent in terms of scope, as it continued to apply to all directors and was explicitly referenced in both years' 10-K filings under the \"Code of Ethics\" section. However, there was an improvement in accessibility: in 2023, the Directors' Code of Conduct was posted at a URL ending in `directors-code-of-conduct.pdf`, while in 2024, it was available at a slightly revised URL ending in `directors-code-ofconduct.pdf`. This suggests a minor update in the web structure or naming convention, but the core policy and its availability online were maintained, ensuring continued transparency and compliance with disclosure obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "BK (ORG) -> Directors' Code of Conduct (ACCOUNTING_POLICY)",
        "Directors' Code of Conduct (ACCOUNTING_POLICY) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5018,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1904,
        "completion_tokens": 185,
        "total_tokens": 2090
      }
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "In 2023, HD issued $750 million in 4.95% Senior Notes due September 30, 2026, as part of a broader November 2023 financing initiative that included three tranches of senior notes. By 2024, these 4.95% Senior Notes are reflected in HD’s long-term debt with a carrying amount of $745 million as of January 28, 2024, and are expected to remain at $747 million by February 2, 2025. The stability in the value of these notes, along with the issuance of additional long-term debt across varying maturities, suggests a strategy to extend debt maturities and manage interest costs, thereby maintaining liquidity and financial flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "HD (ORG) -> 4.95% Senior Notes (FIN_INST)",
        "4.95% Senior Notes (FIN_INST) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12604,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3793,
        "completion_tokens": 157,
        "total_tokens": 3950
      }
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "Between 2021 and 2023, Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolved as follows: In 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc. By the end of 2023, the net book value of the investment was reported at $1.1 billion, consistent with the $1.1 billion net book value as of December 31, 2022, indicating no significant change in valuation during 2023. This suggests that while the investment experienced a notable price adjustment in 2021, its value remained stable in subsequent years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Holds]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Beijing Unisoc Technology Ltd (COMP)",
        "Beijing Unisoc Technology Ltd (COMP) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2513,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 149,
        "total_tokens": 1432
      }
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "From 2022 to 2023, AbbVie's engagement with Qulipta advanced significantly in both regulatory and commercial development. In 2022, Qulipta was among the products for which AbbVie received regulatory approvals, leading to the reclassification of related intangible assets from research and development to developed product rights. In 2023, AbbVie achieved key regulatory milestones, securing FDA approval in April and EC approval in August for Qulipta’s preventive treatment of chronic and episodic migraine in adults, respectively. These approvals marked the transition of Qulipta from a development-stage asset to a commercially available product, reflecting its successful regulatory and commercial progression.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Develops]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Qulipta (PRODUCT)",
        "Qulipta (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2977,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 178,
        "total_tokens": 1553
      }
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "Between 2022 and 2023, Boeing's framing of 'upgrades and conversions' within the Global Services segment remained consistent in its description as a core service offering, as both filings describe it as part of the full spectrum of services provided to commercial and defense customers. However, the 2023 filing places a slightly more prominent strategic emphasis by including it in the detailed listing of services under the Global Services segment early in the 10-K, suggesting a continued focus on this area as a key component of Boeing’s post-pandemic service strategy. The 2022 filing, while also listing 'upgrades and conversions,' does so in a broader context that includes other services, reflecting a more generalized overview. The consistent mention of this service in both years, alongside Boeing's intellectual property and supply chain capabilities, underscores its importance in sustaining aerospace platforms and systems for both commercial and defense customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Provides]- ORG",
      "triplets_used": [
        "BA (ORG) -> Upgrades and Conversions (PRODUCT)",
        "Upgrades and Conversions (PRODUCT) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6855,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2364,
        "completion_tokens": 244,
        "total_tokens": 2608
      }
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "Between 2021 and 2023, Intel's financial relationship with Beijing Unisoc Technology Ltd. evolved with a significant increase in the valuation of its investment. As of December 26, 2020, Intel's investment in Unisoc was valued at $658 million, which rose to $1.1 billion by December 25, 2021, reflecting a $442 million increase. In 2021, Intel also recognized $471 million in observable price adjustments related to the investment. By the end of 2023, the net book value of the investment remained at $1.1 billion, consistent with its 2022 valuation, indicating stable recognition of the investment's value over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Holds]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Beijing Unisoc Technology Ltd (COMP)",
        "Beijing Unisoc Technology Ltd (COMP) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6804,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2349,
        "completion_tokens": 155,
        "total_tokens": 2505
      }
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "Between 2023 and 2024, the role of Self-Service Lockers within Home Depot's interconnected shopping experience has evolved from being a convenience feature to a more integral part of the company's fulfillment strategy. In 2023, Self-Service Lockers were introduced as part of in-store convenience enhancements, enabling customers to access online orders and facilitating curbside pickup. By 2024, they were explicitly highlighted as a key component of Home Depot's retail programs, complementing BOPIS (Buy Online, Pick Up In Store) and serving as a convenient, contactless pickup option at the front entrance of many stores. This evolution reflects Home Depot's broader investment in integrating digital and physical experiences to meet customer expectations for speed, reliability, and convenience in fulfillment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "HD (ORG) -> Self-Service Lockers (PRODUCT)",
        "Self-Service Lockers (PRODUCT) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10628,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3290,
        "completion_tokens": 203,
        "total_tokens": 3493
      }
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "From 2023 to 2024, Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities has increased in detail and specificity. In 2023, the disclosure outlined the types of claims covered and the use of self-insurance and risk management mechanisms, such as a captive insurance subsidiary and reinsurance program, but did not elaborate on the estimation methodology itself. In contrast, the 2024 disclosure provides a more comprehensive explanation, specifying that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024 highlights the unpredictability of claim costs due to inflation, regulatory changes, and unforeseen developments, and notes that adjustments to estimates have historically been immaterial. This evolution reflects a more transparent and methodologically detailed approach in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "COST (ORG) -> Insurance/Self-insurance Liabilities (ACCOUNTING_POLICY)",
        "Insurance/Self-insurance Liabilities (ACCOUNTING_POLICY) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5195,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1958,
        "completion_tokens": 231,
        "total_tokens": 2189
      }
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "The financial impact of the Aldevron acquisition on inventory-related costs evolved from a $59 million increase in cost of sales in 2021 (due to fair value adjustments to inventory) to a $87 million charge in 2023, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This reflects a shift from initial acquisition-related inventory adjustments in 2021 to operational inventory challenges in 2023, highlighting the evolving nature of inventory costs post-acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Involved_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Aldevron (COMP)",
        "Aldevron (COMP) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8652,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2783,
        "completion_tokens": 126,
        "total_tokens": 2909
      }
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "Between 2023 and 2024, Costco has consistently recognized shop card liabilities as a liability in its consolidated balance sheets, net of estimated breakage, with revenue from shop cards recognized upon redemption. The treatment of these liabilities has not changed significantly in terms of accounting methodology, as both years reflect the same approach of accounting for outstanding shop card balances as a liability, based on historical redemption data. However, the increase in shop card liabilities (implied by the context of consistent recognition and inclusion in other current liabilities) suggests that Costco is managing a growing base of unclaimed balances, likely due to the non-expiring nature of the cards and the potential for unredeemed balances. This indicates a conservative and consistent approach to recognizing liabilities for unclaimed balances, aligning with the broader treatment of breakage in other areas like membership rewards and co-branded credit card rebates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Sells]- ORG",
      "triplets_used": [
        "COST (ORG) -> Shop Cards (PRODUCT)",
        "Shop Cards (PRODUCT) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8576,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2781,
        "completion_tokens": 247,
        "total_tokens": 3029
      }
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "From 2022 to 2023, Intel's Foundry Services (IFS) evolved significantly in terms of strategic partnerships and customer engagement. In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing leading-edge packaging, process technology, and a robust IP portfolio, while focusing on attracting strategic partners and customers globally. By 2023, IFS had secured four design wins on Intel 18A, including a major high-performance computing customer with a large prepayment, and expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements, including multigenerational partnerships with ARM and Synopsys. Additionally, Intel expanded its RAMP-C program partnerships, enabling customers like Nvidia and Microsoft to develop on Intel 18A, and announced a commercial agreement with Tower for analog processing in New Mexico, significantly enhancing its customer and ecosystem engagement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Foundry Services (PRODUCT)",
        "Foundry Services (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7237,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2459,
        "completion_tokens": 234,
        "total_tokens": 2693
      }
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "Between 2022 and 2023, DHR's financial relationship with Aldevron evolved significantly in terms of goodwill and net cash consideration. In 2022, DHR recorded approximately $6.1 billion of goodwill related to the Aldevron acquisition. By 2023, the goodwill associated with Aldevron had increased to $6,149 million, reflecting continued integration and valuation adjustments. Additionally, the net cash consideration for Aldevron in 2023 was $9,561 million, as shown in the provided table, indicating the substantial cash outflow DHR incurred to acquire Aldevron. These figures highlight the significant financial commitment and ongoing value recognition of the Aldevron acquisition in DHR's consolidated financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Aldevron (COMP)",
        "Aldevron (COMP) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6133,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2166,
        "completion_tokens": 181,
        "total_tokens": 2348
      }
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "The maturity date of the AT&T Inc. 1.800% Global Notes has changed from September 5, 2026, as listed in the 2022 SEC filing, to September 14, 2039, in the 2024 SEC filing. This significant extension of the maturity date indicates a shift in AT&T's debt structure toward longer-term financing, which could suggest the company is managing its debt maturities to reduce short-term liquidity pressures and stabilize its capital structure over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> 1.800% Global Notes due September 14,2039 (FIN_INST)",
        "1.800% Global Notes due September 14,2039 (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_2",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_2",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5851,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2121,
        "completion_tokens": 111,
        "total_tokens": 2232
      }
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "Target has remained in compliance with its debt leverage covenant in both 2023 and 2024, as stated in both years’ 10-K filings. In 2023, the company maintained compliance with covenants related to secured debt levels and the debt leverage covenant, with no practical effect on its dividend-paying ability. In 2024, Target reiterated its compliance with these covenants, including the debt leverage covenant, and emphasized its expectation to continue compliance. \n\nStructural changes to Target’s credit facilities may have supported this compliance. In October 2023, Target replaced its prior 364-day credit facility with a new $1.0 billion 364-day unsecured revolving credit facility, which expired in October 2024 and was replaced again in October 2024 with a new $1.0 billion facility expiring in October 2025. Additionally, the company extended its existing $3.0 billion unsecured revolving credit facility to October 2028. These updated facilities, combined with no outstanding balances under either facility during 2023 and 2024, likely provided greater financial flexibility and liquidity, contributing to continued covenant compliance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Debt Leverage Covenant (REGULATORY_REQUIREMENT)",
        "Debt Leverage Covenant (REGULATORY_REQUIREMENT) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6752,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2346,
        "completion_tokens": 285,
        "total_tokens": 2632
      }
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "From 2022 to 2023, Intel's approach to expanding digital readiness for global populations evolved under its RISE strategy by strengthening external collaboration and embedding inclusivity into broader industry practices. In 2022, Intel emphasized the importance of digital readiness as part of its commitment to inclusive innovation, partnering with other technology companies to launch the Alliance for Global Inclusion and develop an Inclusion Index. By 2023, Intel advanced this initiative by contributing to and being recognized in the third Global Inclusion Index survey, which transitioned to a benchmarking index to highlight best practices and identify areas for improvement across industries. These efforts reflect Intel’s growing focus on leveraging its scale and expertise to drive systemic change, aligning with its RISE goals to expand digital readiness and foster inclusive leadership and technology access globally.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enhances]-> CONCEPT <-[Expands]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Digital Readiness (CONCEPT)",
        "Digital Readiness (CONCEPT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11447,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3509,
        "completion_tokens": 232,
        "total_tokens": 3741
      }
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "Between 2023 and 2024, Emerson's relationship with Micromine evolved from an initial acquisition agreement to termination, with significant financial implications. In 2023, AspenTech (a subsidiary of Emerson) entered into an agreement to acquire Micromine for approximately $623 million, but the deal was terminated on August 1, 2023, due to regulatory uncertainties in Russia. Emerson did not pay a termination fee, but incurred a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. Additionally, the termination led to the recognition of a $56 gain in 2023 from the termination of these contracts. By 2024, the financial impact of the terminated Micromine deal had been fully accounted for, and no further material expenses were recorded related to this transaction.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Agreement]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "EMR (ORG) -> Micromine (COMP)",
        "Micromine (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4322,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1711,
        "completion_tokens": 208,
        "total_tokens": 1919
      }
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "The availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) decreased from approximately 17 million shares in fiscal 2022 to approximately 15 million shares in fiscal 2023. Additionally, the average purchase price of shares under the U.S. ESPP dropped from $305.14 in fiscal 2022 to $277.19 in fiscal 2023, reflecting a decline in the stock's fair market value during the respective purchase periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Subject_To]- ORG",
      "triplets_used": [
        "HD (ORG) -> U.S. ESPP (FIN_INST)",
        "U.S. ESPP (FIN_INST) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2845,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 107,
        "total_tokens": 1462
      }
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "Between 2022 and 2023, DHR's impairment triggers and associated charges shifted both in timing and segment focus, reflecting evolving risks in its intangible asset portfolio. In 2022, no impairments were recorded, whereas in 2023, impairment triggers emerged in the Biotechnology and Diagnostics segments during the second and fourth quarters, resulting in a significant $77 million in impairment charges. In contrast, 2021 saw impairment triggers in the Diagnostics segment alone, with a much smaller charge of $10 million. This shift indicates a growing risk exposure in the Biotechnology segment, likely due to the nature of technology-based intangible assets being more susceptible to market and operational changes. The increasing magnitude of impairment charges from $10 million in 2021 to $77 million in 2023 also suggests a broader and more severe impact on intangible asset values, signaling heightened volatility and uncertainty in DHR's asset portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Identifies]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Impairment Triggers (RISK_FACTOR)",
        "Impairment Triggers (RISK_FACTOR) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6390,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2257,
        "completion_tokens": 241,
        "total_tokens": 2498
      }
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023, indicating a rise in the company's involvement in business transactions tied to trade contracts. This increase suggests greater engagement in trade-related activities or a broader reliance on letters of credit to support such transactions during fiscal 2023. Additionally, the company's acquisition activities in 2023, involving $1.5 billion in cash and $998 million in goodwill, may have contributed to the heightened use of trade-related financial instruments, reflecting strategic growth initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "HD (ORG) -> Trade Contracts (FIN_INST)",
        "Trade Contracts (FIN_INST) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1946,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 158,
        "total_tokens": 1298
      }
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "The 0.300% Notes due 2028 were first disclosed in IBM's 2020 SEC filings as Exhibits 4.1 to Form 8-K filed on February 10, 2020, indicating their issuance. By 2024, these notes were explicitly listed in IBM's 2024 10-K on page 1 under the \"Title of each class\" section with the trading symbol IBM28B and registered on the New York Stock Exchange, confirming their ongoing status as publicly traded financial instruments. This evolution demonstrates IBM's consistent and transparent disclosure of its financial instruments, with detailed incorporation by reference in earlier filings and continued recognition in the latest filings, reflecting adherence to SEC reporting standards and ongoing market visibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Issues_Financial_Instrument]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 0.300% Notes due 2028 (FIN_INST)",
        "0.300% Notes due 2028 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10192,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3197,
        "completion_tokens": 177,
        "total_tokens": 3375
      }
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024 in terms of both disclosure and registration. In 2023, the notes were disclosed as Exhibits 4.4 to Form 8-K filed January 30, 2019, and incorporated by reference in the 10-K filing. By 2024, the 1.750% Notes due 2031 were explicitly listed in the 2024 10-K under the section detailing registered securities, with the trading symbol \"IBM31\" and registered on the New York Stock Exchange. This indicates that the notes remained registered on a stock exchange but were more directly highlighted in 2024 disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Issues_Financial_Instrument]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 1.750% Notes due 2031 (FIN_INST)",
        "1.750% Notes due 2031 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10192,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3194,
        "completion_tokens": 146,
        "total_tokens": 3341
      }
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "Between 2023 and 2024, Eli Lilly's financial relationship with Zyprexa evolved significantly through the sale of rights for the olanzapine portfolio, including Zyprexa, which contributed $1.45 billion in revenue outside the U.S. in 2023. In 2024, this transaction was recognized as part of collaboration and other revenue, reflecting a shift in business model approach toward revenue recognition from the sale of intellectual property rights and collaborations, as disclosed in Note 4. This transition highlights a strategic move from traditional product sales to monetizing intellectual property through rights sales and partnerships.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Zyprexa (PRODUCT)",
        "Zyprexa (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2451,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 158,
        "total_tokens": 1405
      }
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "From 2023 to 2024, the Mobility Preferred Interests were fully repurchased by T, with all outstanding interests redeemed by April 2023, leaving none outstanding as of December 31, 2023. Prior to repurchase, the redemption obligations caused the reclassification of the interests from equity to a liability at fair value, impacting T’s balance sheet with $2,670 in current liabilities and $2,670 in noncurrent liabilities as of December 31, 2022. This reclassification also affected earnings per share calculations, as the potential settlement in stock under ASU 2020-06 required inclusion in diluted EPS for periods prior to repurchase. However, in 2022, the effect of dilutive potential shares was antidilutive due to a net loss, and adjustments to the carrying value of noncontrolling interest increased income attributable to common stock by $663. By 2024, with all Mobility Preferred Interests repurchased, these impacts on earnings per share calculations were fully resolved.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Reclassifies]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "T (ORG) -> Mobility Preferred Interests (FIN_INST)",
        "Mobility Preferred Interests (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 24069,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6674,
        "completion_tokens": 245,
        "total_tokens": 6919
      }
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "IBM's 0.875% Notes due 2030 were first disclosed in its 2023 10-K filing as part of a group of notes issued and filed under Form 8-K on February 8, 2022, with the instrument details included in Exhibit 4.1. By 2024, as shown in the 2024 10-K, these notes were explicitly listed with the trading symbol \"IBM30A\" and registered on the New York Stock Exchange, indicating a formal listing and registration status. This evolution reflects IBM's updated disclosure practices, where the notes are now individually recognized and publicly traded, enhancing transparency and investor accessibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Issues_Financial_Instrument]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 0.875% Notes due 2030 (FIN_INST)",
        "0.875% Notes due 2030 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10192,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3195,
        "completion_tokens": 147,
        "total_tokens": 3342
      }
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "From 2023 to 2024, the structure and distribution terms of the Telco Preferred Interests evolved with the expansion of the Telco LLC issuance, increasing the total cumulative preferred interests from $2,000 (Telco Class A-1) in 2020 to $7,250 by 2024, including the addition of Telco Class A-2 and A-3 in 2023. The initial distribution rates for the newer classes (6.85%) were higher than the original 4.25%, and all classes were subject to reset every seven years, with the 6.85% class resetting on November 1, 2027. These instruments, like the Mobility and Tower preferred interests, did not restrict AT&T’s ability to pay dividends or repurchase shares, indicating a strategic use of preferred equity to maintain financial flexibility while accessing long-term, non-dilutive capital. The continued issuance and restructuring of preferred interests reflect AT&T’s preference for leveraging preferred equity instruments to finance asset holdings while preserving control and liquidity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> Telco Preferred Interests (FIN_INST)",
        "Telco Preferred Interests (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9157,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2945,
        "completion_tokens": 246,
        "total_tokens": 3191
      }
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "Between 2022 and 2023, Capital One's involvement in multifamily commercial real estate loans, particularly under loss sharing agreements with government-sponsored enterprises (GSEs), has shown an increase in risk exposure. In 2022, the liability recognized for these loss sharing agreements was $82 million, which rose to $137 million by the end of 2023. This increase reflects a higher level of retained credit risk following the sale of originated loans to GSEs. Additionally, Capital One continues to originate and service these loans with the intent to sell them, maintaining underwriting standards that assess borrower financials, collateral, and market conditions to manage risk exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Originates]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "COF (ORG) -> Multifamily Commercial Real Estate Loans (FIN_INST)",
        "Multifamily Commercial Real Estate Loans (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_217",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6183,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2212,
        "completion_tokens": 173,
        "total_tokens": 2385
      }
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "From 2022 to 2023, Amazon's co-branded credit card programs increased in strategic significance due to evolving regulatory requirements, particularly around data security, authentication, and compliance with payment card association rules. In 2022, the programs were noted as a potential risk due to their impact on operating results if renewed on less favorable terms or terminated, along with the costs of implementing enhanced authentication processes. By 2023, the regulatory landscape had expanded to include additional obligations such as data localization and stricter compliance with network security and consumer protection laws. These new compliance obligations could lead to higher transaction fees, increased operating costs, and potential disruptions if Amazon failed to meet evolving standards, thereby heightening the regulatory risks and their potential adverse impact on operating results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Co-Branded Credit Card Programs (PRODUCT)",
        "Co-Branded Credit Card Programs (PRODUCT) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11185,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3461,
        "completion_tokens": 226,
        "total_tokens": 3687
      }
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "Between 2022 and 2024, PM's financial relationship with RBH evolved significantly, primarily due to RBH's deconsolidation from PM's financial statements in March 2019 under the CCAA proceedings, as detailed in the 2022 10-K filing. As of 2022, RBH's financial results were no longer consolidated into PM's, and PM transitioned to accounting for its investment in RBH as an equity investment, reflecting the ongoing CCAA restructuring and legal uncertainties. By 2024, PM continued to assess the valuation of its equity investment in RBH, with significant judgment required in estimating the fair value, particularly due to uncertainties surrounding the Canadian tobacco litigation and the potential global settlement. The 2024 10-K highlights that PM's auditors considered the impairment assessment of the RBH investment a critical audit matter, emphasizing the complexity of assumptions related to discount rates, sales volumes, and the tax treatment of any settlement. Thus, while RBH was deconsolidated in 2019, PM's financial statements continue to reflect valuation and impairment considerations for its stake in RBH through 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Deconsolidated From]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PM (ORG) -> RBH (COMP)",
        "RBH (COMP) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_148",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9712,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3069,
        "completion_tokens": 283,
        "total_tokens": 3353
      }
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "Between 2023 and 2024, Baqsimi's financial performance showed a significant increase in revenue contribution, rising from $677.6 million in 2023 to a substantial undisclosed amount in 2024, as highlighted by its notable mention in LLY's 2024 10-K under collaboration and other revenue, particularly tied to the 2023 sale of rights for Baqsimi. This strategic move reinforced Baqsimi's role within LLY's product portfolio, positioning it as a key asset in revenue diversification and partnership-driven growth. The product's inclusion in major revenue-disclosure sections underscores its growing strategic importance to LLY's overall financial and business strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Baqsimi (PRODUCT)",
        "Baqsimi (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5070,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1910,
        "completion_tokens": 166,
        "total_tokens": 2076
      }
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "From 2022 to 2024, the composition of Union Pacific's Total Highway Revenue Equipment has shifted significantly, with a notable decrease in both owned and leased containers and chassis. In 2022, Union Pacific owned 48,962 containers and 29,875 chassis, with 1,856 containers and 14,148 chassis leased, totaling 94,841 units. By 2024, the number of owned containers dropped to 46,375 (a 5.7% decrease), and leased containers fell to 288 (an 89.8% decrease). Chassis ownership also declined sharply to 4,356 (a 85.3% decrease), while leased chassis dropped to 1,197 (an 84.5% decrease), resulting in a total of 52,216 highway revenue equipment units in 2024. This indicates a substantial reduction in both owned and leased equipment, particularly in containers, reflecting a significant change in the company's asset composition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Leases]-> PRODUCT <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Total Highway Revenue Equipment (PRODUCT)",
        "Total Highway Revenue Equipment (PRODUCT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_8",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 992,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 900,
        "completion_tokens": 206,
        "total_tokens": 1107
      }
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "Between 2022 and 2023, Capital One (COF) maintained securitized debt obligations as a key component of its funding structure, as disclosed in its 2023 10-K filing. As of December 31, 2023, securitized debt obligations totaled $18,043 million in carrying value, indicating a continued reliance on this funding source. While the 2022 filing does not explicitly state the 2022 securitized debt obligations figure, it does confirm that securitized debt obligations are part of COF’s broader funding strategy, which includes deposits, senior and subordinated notes, and other short-term borrowings. This suggests that securitized debt obligations remained a consistent, though not dominant, element of COF’s funding mix during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Raises]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "COF (ORG) -> Securitized Debt Obligations (FIN_INST)",
        "Securitized Debt Obligations (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_210",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5054,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1911,
        "completion_tokens": 183,
        "total_tokens": 2095
      }
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "Between 2023 and 2024, the nature of LLY's revenue from Zyprexa shifted significantly. In 2023, Zyprexa revenue was primarily derived from direct product sales, as indicated by the inclusion of the sale of the rights for the olanzapine portfolio. By 2024, the revenue from Zyprexa was recognized under collaboration and other arrangements, specifically from the 2023 sales of rights for the olanzapine portfolio, which were included in collaboration and other revenue. This reflects a transition from product sales revenue to revenue recognition through licensing and collaboration agreements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Zyprexa (PRODUCT)",
        "Zyprexa (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1806,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1084,
        "completion_tokens": 148,
        "total_tokens": 1233
      }
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "From 2022 to 2024, Federal Government Securities in the pension plan have consistently been classified as Level 2 investments, based on their valuation using a bid evaluation process with bid data provided by independent pricing sources. In 2022, these securities were reported at a fair value of $742 million under Level 2, while in 2024, the methodology remained unchanged, reaffirming their Level 2 classification. There was no shift in valuation methodology or classification during this period, indicating consistent treatment in the plan’s financial disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Federal Government Securities (FIN_INST)",
        "Federal Government Securities (FIN_INST) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6994,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2388,
        "completion_tokens": 142,
        "total_tokens": 2530
      }
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "Capital One's utilization of credit score data for product segmentation decisions remained consistent from 2022 to 2023, as both years' filings indicate that borrower credit scores were used to drive such decisions, particularly for subprime classification and competitive benchmarking. The continued emphasis on credit scores in segmentation reflects a stable credit risk modeling strategy focused on leveraging borrower risk profiles to inform underwriting and portfolio management. This consistency suggests a deliberate and ongoing reliance on credit bureau data to refine risk-based product offerings and optimize credit line management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY <-[Impacts]- ORG",
      "triplets_used": [
        "COF (ORG) -> Product Segmentation Decisions (ACCOUNTING_POLICY)",
        "Product Segmentation Decisions (ACCOUNTING_POLICY) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3551,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 160,
        "total_tokens": 1707
      }
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "From 2022 to 2023, Amazon's strategic positioning of AWS evolved to emphasize its central role in the company's broader business segments and investment priorities. In 2022, AWS was highlighted as a key area of investment, with Amazon focusing on expanding its on-demand technology services to support geographic expansion and cross-functional operations. By 2023, AWS was formally recognized as one of Amazon's three core business segments—alongside North America and International—reflecting its growing strategic and financial significance. This shift underscores AWS's transition from being a key investment area to a standalone, critical business unit, aligning with Amazon's broader focus on serving developers, enterprises, and innovation-driven growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> AWS Services (PRODUCT)",
        "AWS Services (PRODUCT) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9637,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3048,
        "completion_tokens": 190,
        "total_tokens": 3238
      }
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved significantly between 2022 and 2024, primarily through deconsolidation and a shift in accounting treatment. In 2022, RBH was deconsolidated from PM's financial statements following its CCAA restructuring filing in 2019, with a stay on tobacco-related litigation in Canada up to March 2022. By 2024, PMI transitioned from a consolidated subsidiary to holding an equity investment in RBH, as outlined in the 2024 10-K. This shift led to a non-cash impairment charge of $2,316 million in 2024 due to the Proposed Plan in the CCAA proceedings, which included a CAD 32.5 billion aggregate settlement, with unresolved allocation among RBH and its co-defendants. The potential financial exposure for PMI remains tied to the final allocation and approval of the settlement, with the impairment reflecting the risk of a significant reduction in the value of its investment in RBH.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Deconsolidated From]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "PM (ORG) -> RBH (COMP)",
        "RBH (COMP) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9746,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3083,
        "completion_tokens": 243,
        "total_tokens": 3327
      }
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "From 2022 to 2024, Biktarvy has remained a cornerstone of GILD's HIV product portfolio, with its revenue contribution showing a consistent trend. In 2022, Biktarvy generated $8,624 million in total revenue, representing a slight increase from $7,259 million in 2021. However, by 2024, the risk factors outlined in GILD’s 10-K highlight potential threats to the product’s sustained commercial success, particularly from competitive pressures and the possibility of nucleoside-based therapies like TAF losing favor in treatment paradigms. These risks could impact Biktarvy’s future revenue and market position, despite its strong historical performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Biktarvy (PRODUCT)",
        "Biktarvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 37170,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 9927,
        "completion_tokens": 162,
        "total_tokens": 10090
      }
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "From 2022 to 2024, Union Pacific Railroad's (UPRR) financial stake in TTX increased from $1.6 billion in 2022 to $1.9 billion in 2024, reflecting a growing investment in the jointly owned rail car pooling company. UPRR maintains a 37.03% economic interest in TTX, which it accounts for using the equity method. Concurrently, UPRR's car hire expenses from TTX rose from $402 million in 2022 to $432 million in 2024, indicating increased operational reliance on TTX's rail car services. Accounts payable to TTX also increased from $57 million in 2022 to $70 million in 2024, further highlighting the evolving financial and operational relationship between UPRR and TTX.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "UNP (ORG) -> TTX (COMP)",
        "TTX (COMP) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2836,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 166,
        "total_tokens": 1511
      }
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "From 2022 to 2023, Tesla shifted its approach to scaling Solar Roof production by expanding installer training initiatives and addressing supply chain risks more proactively. In 2022, Tesla focused on onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. By 2023, the company emphasized the need to hire and train skilled employees to operate manufacturing facilities, highlighting the importance of a trained workforce for scaling production. Additionally, Tesla acknowledged increased supply chain risks, including component shortages and supplier challenges, and outlined the need to secure alternate sources or develop in-house replacements to mitigate disruptions. This evolution reflects a more strategic and risk-aware approach to scaling Solar Roof production.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Solar Roof (PRODUCT)",
        "Solar Roof (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12154,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3678,
        "completion_tokens": 209,
        "total_tokens": 3887
      }
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "Between 2022 and 2023, The Coca-Cola Company's relationship with fountain retailers in the United States remained consistent in that the Company continued to manufacture and sell fountain syrups directly to authorized fountain wholesalers and some fountain retailers, as outlined in both the 2022 and 2023 filings. In 2022, it was noted that U.S. bottlers generally are not authorized to manufacture fountain syrups, and the Company retained control over this function. In 2023, this structure was reaffirmed, with the Company continuing to produce fountain syrups and distribute them through its network of authorized wholesalers and retailers for use in immediate consumption. This indicates that the Company maintained a direct role in the production and distribution of fountain syrups in the U.S., without significant changes in this relationship during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "KO (ORG) -> Fountain Retailers (COMP)",
        "Fountain Retailers (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10338,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3233,
        "completion_tokens": 217,
        "total_tokens": 3450
      }
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024 in terms of both financial instrument classification and registration details. In 2022, the notes were disclosed as part of IBM’s broader debt offerings, with their instrument details incorporated by reference from Form 8-K filed on May 22, 2017 (Chunk 1). By 2024, the 0.950% Notes due 2025 were explicitly listed in IBM’s 10-K under registered debt instruments, trading under the symbol \"IBM25B\" on the New York Stock Exchange (Chunk 2). This indicates a formal classification and ongoing registration of the notes as a distinct financial instrument, reflecting IBM’s continued adherence to SEC disclosure requirements and market transparency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Issues_Financial_Instrument]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 0.950% Notes due 2025 (FIN_INST)",
        "0.950% Notes due 2025 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8912,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2881,
        "completion_tokens": 182,
        "total_tokens": 3064
      }
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "From 2022 to 2024, GILD's strategic positioning of Biktarvy has evolved in terms of both competitive differentiation and financial risk exposure within the HIV treatment market. In 2022, Biktarvy was highlighted as a key product in GILD's portfolio, reflecting its importance in the company’s focus on treating life-threatening diseases like HIV. However, by 2024, GILD disclosed heightened financial risk exposure due to the concentration of revenue from HIV products, including Biktarvy, and the potential for market share erosion from competitive products and generics. This underscores the company’s ongoing challenge to maintain differentiation in a competitive HIV treatment landscape while managing the financial risks associated with reliance on nucleoside-based therapies like TAF, which are central to Biktarvy’s formulation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Biktarvy (PRODUCT)",
        "Biktarvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10222,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3199,
        "completion_tokens": 208,
        "total_tokens": 3408
      }
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "Between 2022 and 2023, Lockheed Martin continued evolving its approach to defined contribution retirement savings plans by further reducing its defined benefit pension obligations through pension obligation transfers. In 2022, the company transferred $4.3 billion of gross defined benefit pension obligations for approximately 13,600 retirees and beneficiaries via group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. This followed a similar 2021 transaction where $4.9 billion in obligations for 18,000 retirees were transferred, resulting in a $1.7 billion charge. In 2023, Lockheed Martin made a voluntary offering that led to $414 million in settlement payments for approximately 6,500 participants, further reducing its pension liabilities. These actions reflect the company’s ongoing strategy to mitigate financial volatility and reduce the size of its net pension obligations by shifting responsibilities to insurance companies and transitioning employees to defined contribution plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Defined Contribution Retirement Savings Plans (FIN_INST)",
        "Defined Contribution Retirement Savings Plans (FIN_INST) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8645,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2827,
        "completion_tokens": 257,
        "total_tokens": 3084
      }
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "Between 2022 and 2024, IBM's debt instruments maturing in 2025 remained consistent in terms of the 2.875% Notes due 2025, as both the 2022 and 2024 filings list these notes under the same trading symbol (IBM25A) and registered on the New York Stock Exchange. However, the overall composition of 2025-maturing instruments evolved, with the 7.00% Debentures due 2025 remaining unchanged, while no new 2025-maturing notes were added beyond the existing 2.875% and 0.950% Notes listed in both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Financial_Instrument]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 2.875% Notes due 2025 (FIN_INST)",
        "2.875% Notes due 2025 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2022.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5845,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2105,
        "completion_tokens": 123,
        "total_tokens": 2229
      }
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "From 2022 to 2024, Biktarvy has maintained strategic importance within Gilead's HIV portfolio as a key revenue driver, with continued global growth noted in 2022. However, its risk profile has increased due to competitive pressures and evolving treatment paradigms. The 2024 filing highlights the vulnerability of Gilead's HIV products, including Biktarvy, to market share erosion from generics and new competitors, as well as potential shifts away from nucleoside-based therapies like TAF. These factors underscore the need for Gilead to innovate and maintain its competitive edge to sustain Biktarvy's role in its portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Biktarvy (PRODUCT)",
        "Biktarvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7413,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2500,
        "completion_tokens": 156,
        "total_tokens": 2656
      }
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "Between the end of fiscal year 2022 and the end of fiscal year 2023, the balance of the U.S. litigation escrow account increased from $1,449 million to $1,764 million. During fiscal year 2023, Visa deposited $1,000 million into the account, while payments to opt-out merchants, net of interest, amounted to $685 million. In fiscal year 2022, the balance at the beginning of the period was $1,764 million, and the account received $1,500 million in deposits, with net payments of $175 million, resulting in an ending balance of $3,089 million. Thus, the account balance declined in 2022 due to higher net outflows, but increased in 2023 due to a larger deposit contribution relative to payments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Deposits]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Litigation Escrow Account (FIN_INST)",
        "Litigation Escrow Account (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4465,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1770,
        "completion_tokens": 173,
        "total_tokens": 1943
      }
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "Between 2022 and 2023, fountain syrups have remained a key component of Coca-Cola's North America operating segment, as the company continues to manufacture fountain syrups in the United States and sell them to fountain retailers or authorized fountain wholesalers and bottling partners, who then distribute them to fountain retailers. In both years, these fountain syrup sales are explicitly included in the North America operating segment, indicating no change in the segment's responsibility for manufacturing and distributing fountain syrups. The role of fountain syrups is also highlighted as part of the broader concentrate operations, which are connected to Coca-Cola through a mutual dependency, as shown in the knowledge graph triplets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "KO (ORG) -> Fountain Syrups (PRODUCT)",
        "Fountain Syrups (PRODUCT) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6141,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2182,
        "completion_tokens": 186,
        "total_tokens": 2369
      }
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "Between 2022 and 2024, IBM's debt instruments maturing in 2025 remained consistent in terms of the 0.950% Notes due 2025, as both the 2022 and 2024 filings list these notes under the New York Stock Exchange with the trading symbol IBM25B. However, the overall composition of IBM's 2025-maturing debt has evolved: in 2024, IBM issued additional notes due in 2025, such as the 2.875% Notes (IBM25A), which were not listed in 2022. This indicates an expansion in IBM's 2025 debt offerings, with the 0.950% Notes due 2025 remaining a consistent component of the 2025 maturity profile.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Financial_Instrument]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 0.950% Notes due 2025 (FIN_INST)",
        "0.950% Notes due 2025 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2022.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5845,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2105,
        "completion_tokens": 145,
        "total_tokens": 2250
      }
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "Between 2022 and 2024, Disney's strategic approach to cruise ships evolved from addressing economic and operational challenges to actively expanding its cruise ship fleet as part of broader Experiences segment investments. In 2022, Disney acknowledged the potential impact of economic conditions on cruise ship operations, noting that declining economic conditions could affect attendance and demand for travel experiences, including cruise ships. Additionally, the company highlighted the importance of adapting to shifting consumer preferences and the need to realign costs across its businesses. By 2024, Disney had shifted to a more proactive strategy, announcing plans for additional expansion of its cruise ship fleet as part of its investment in the Experiences segment. This reflects a strategic pivot from mitigating external pressures to capitalizing on growth opportunities in its cruise ship operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Cruise Ships (PRODUCT)",
        "Cruise Ships (PRODUCT) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13096,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3903,
        "completion_tokens": 228,
        "total_tokens": 4132
      }
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "From 2022 to 2023, Lockheed Martin (LMT) continued its strategic use of pension risk transfer transactions to mitigate the financial volatility associated with its defined benefit pension plans. In 2022, LMT had previously executed a $4.9 billion transaction in 2021, purchasing group annuity contracts (GACs) to transfer pension obligations for approximately 18,000 U.S. retirees and beneficiaries, resulting in a noncash pension settlement charge of $1.7 billion. By 2023, LMT reiterated its intent to evaluate additional pension risk transfer transactions, acknowledging that such actions could lead to noncash settlement charges in future reporting periods. These transactions, funded using assets from the master retirement trust, aim to reduce LMT’s exposure to pension liabilities, eliminate volatility for retirees, and lower annual PBGC premiums. However, the 2023 filing also highlighted the potential risks, including the possibility of future contributions to the pension trust and the financial impact of noncash charges, underscoring the ongoing strategic intent to manage pension risk while balancing potential short-term earnings impacts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Announces]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Pension Risk Transfer Transactions (FIN_INST)",
        "Pension Risk Transfer Transactions (FIN_INST) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11741,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3585,
        "completion_tokens": 288,
        "total_tokens": 3873
      }
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "Between 2022 and 2023, Tesla's relationship with its financing partners has shown evolving dynamics in accounts receivable management and leasing program risks. In 2022, Tesla highlighted that its accounts receivable includes amounts from financing partners offering customer financing products, with balances influenced by payment terms and government rebate processing timelines. By 2023, Tesla expanded on the risks associated with its leasing programs, emphasizing the need to manage compliance, residual value projections, and credit risks, particularly as the program grows. The 2023 filing also noted the potential financial impact of lease returns and the reliance on securing adequate financing or business partners to sustain the leasing program's growth, indicating a heightened awareness and strategic focus on managing these financial exposures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Financing Partners (COMP)",
        "Financing Partners (COMP) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9113,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2919,
        "completion_tokens": 214,
        "total_tokens": 3134
      }
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "Between 2022 and 2023, Coca-Cola shifted its fountain syrup distribution strategy by centralizing fountain syrup production in the United States, where the Company directly manufactures and sells fountain syrups to authorized fountain wholesalers and retailers, rather than authorizing U.S. bottlers to produce them. This contrasts with international operations, where bottlers are typically authorized to manufacture fountain syrups for sale to fountain retailers or wholesalers. In 2022, it was noted that U.S. bottlers generally do not produce fountain syrups, and the Company retains control over their production and distribution. By 2023, this structure was reaffirmed, emphasizing Coca-Cola’s role in supplying fountain syrups to wholesalers and retailers, with bottlers primarily focused on finished beverage production. Fountain wholesalers, as partners of Coca-Cola, play a key role in distributing fountain syrups to retailers, maintaining a mutual dependency highlighted in the knowledge graph.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "KO (ORG) -> Fountain Wholesalers (COMP)",
        "Fountain Wholesalers (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10338,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3230,
        "completion_tokens": 251,
        "total_tokens": 3481
      }
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved in both receivables and new investment activities. Receivables from the ATMP JV increased from $9 million as of December 30, 2023, to $12 million as of December 28, 2024. Additionally, in October 2024, AMD made a new investment by entering into a $100 million one-year term loan agreement with one of the ATMP JVs, secured by the JV's receivable balance due from AMD. This loan reflects an expanded financial engagement beyond typical trade receivables.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Receivables_From]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "AMD (ORG) -> ATMP JV (COMP)",
        "ATMP JV (COMP) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4998,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1882,
        "completion_tokens": 132,
        "total_tokens": 2014
      }
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "Between 2022 and 2023, Lockheed Martin continued to evolve its approach to managing its nonqualified defined benefit pension plans by executing significant pension obligation settlements aimed at reducing the volatility and size of its net pension liabilities. In 2022, the company transferred $4.3 billion of pension obligations for approximately 13,600 retirees and beneficiaries through group annuity contracts, recognizing a $1.5 billion noncash pension settlement charge. This followed a similar 2021 transaction involving $4.9 billion in obligations for 18,000 retirees, which resulted in a $1.7 billion charge. In 2023, Lockheed Martin further reduced its pension obligations by offering a voluntary settlement to approximately 6,500 former employees, resulting in $414 million in payments and a corresponding reduction in the benefit obligation. These actions reflect a strategic shift to transfer long-term liabilities to third-party insurers and settle obligations directly, thereby mitigating future financial exposure and volatility associated with its defined benefit pension plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Nonqualified Defined Benefit Pension Plans (FIN_INST)",
        "Nonqualified Defined Benefit Pension Plans (FIN_INST) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8645,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2828,
        "completion_tokens": 273,
        "total_tokens": 3102
      }
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved as follows: AMD's equity income from the ATMP JV increased from $16 million in 2023 to $33 million in 2024. Additionally, AMD made a cash contribution of $17 million to the ATMP JV on August 8, 2024, in proportion to its 15% equity interest. As a result, the carrying value of AMD's investment in the ATMP JV rose from $99 million as of December 30, 2023, to $149 million as of December 28, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Receivables_From]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "AMD (ORG) -> ATMP JV (COMP)",
        "ATMP JV (COMP) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4740,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1815,
        "completion_tokens": 118,
        "total_tokens": 1933
      }
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson's financial stake and ownership relationship with Kenvue evolved significantly. In May 2023, Kenvue completed its IPO, and Johnson & Johnson retained 89.6% ownership. By August 23, 2023, Johnson & Johnson further reduced its stake through an exchange offer, divesting 80.1% of its ownership and retaining 9.5% of Kenvue's shares, valued at $4.3 billion. This exchange generated a $21.0 billion non-cash gain, including a $2.8 billion gain on the retained shares, and led to the deconsolidation of Kenvue. By December 31, 2023, the retained stake had declined in value to $3.9 billion. In May 2024, Johnson & Johnson completed a Debt-for-Equity Exchange, using $3.6 billion in commercial paper to exchange for its remaining 182.3 million shares of Kenvue stock, resulting in a $0.4 billion loss and the complete divestiture of its ownership in Kenvue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> Kenvue (COMP)",
        "Kenvue (COMP) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7972,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2633,
        "completion_tokens": 222,
        "total_tokens": 2856
      }
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "Between 2022 and 2023, AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent, as both entities were still included in AT&T's guarantee agreements for long-term debt obligations. In the 2022 10-K filing, Southwestern Bell Telephone Co. was explicitly listed as a subsidiary under the guaranty of obligations (Chunk 1, 4-b and 4-c). Similarly, the 2023 10-K filing (Chunk 2) reiterated the same guarantee agreements, with Southwestern Bell Telephone Co. again named as a covered entity under the same sections (4-b and 4-c). This continuity indicates that Southwestern Bell Telephone Co. remained a guaranteed subsidiary under AT&T’s debt instruments during this period, reflecting the ongoing corporate structure and financial obligations between the two entities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> Southwestern Bell Telephone Co. (COMP)",
        "Southwestern Bell Telephone Co. (COMP) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_141",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 17574,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5042,
        "completion_tokens": 201,
        "total_tokens": 5244
      }
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "From 2022 to 2023, Lockheed Martin's involvement in hypersonics programs has evolved to reflect a stronger strategic positioning and expanded development responsibilities. In 2022, the company emphasized the importance of hypersonics programs as a key growth area, noting that their development and funding are heavily dependent on U.S. Government authorization and budget priorities. The 10-K highlighted the vulnerability of such programs to shifting funding environments and the need for successful transition from development to production. By 2023, Lockheed Martin explicitly listed hypersonics programs under its Space business segment, detailing active development efforts with the U.S. Army and Navy to design and build hypersonic strike weapons. This shift demonstrates a more defined and operational role in the hypersonics domain, with the company now clearly outlining its program responsibilities and technological focus.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Hypersonics Programs (PRODUCT)",
        "Hypersonics Programs (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10895,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3369,
        "completion_tokens": 233,
        "total_tokens": 3603
      }
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "From fiscal year 2022 to fiscal year 2023, the balance of the U.S. litigation escrow account increased from $1.4 billion as of September 30, 2022, to $1.764 billion as of September 30, 2023. During fiscal 2022, V deposited $850 million into the account, while in fiscal 2023, the company deposited $1.0 billion. The growth in the account balance was also influenced by payments made to opt-out merchants, which were $685 million in fiscal 2023, compared to unspecified amounts in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Litigation Escrow Account (FIN_INST)",
        "Litigation Escrow Account (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6591,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2299,
        "completion_tokens": 121,
        "total_tokens": 2420
      }
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "From 2022 to 2024, the role and positioning of Outdoor Garden within HD's product strategy has evolved in both classification and relative importance. In 2022, Outdoor Garden was a standalone product category with net sales of $10,317 million, representing 6.8% of total net sales. By 2024, Outdoor Garden was reclassified under the \"Hardlines\" merchandising department, grouped with Hardware, Indoor Garden, Power, and Storage& Organization, suggesting a strategic consolidation of related product lines. This reclassification, combined with its continued presence as a distinct product offering under HD, reflects a shift in how HD organizes and potentially markets its product portfolio, emphasizing operational efficiency and customer-focused departmental groupings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "HD (ORG) -> Outdoor Garden (PRODUCT)",
        "Outdoor Garden (PRODUCT) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2755,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 192,
        "total_tokens": 1518
      }
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "AMD has maintained its emphasis on an engaging and open environment as its global workforce expanded from approximately 26,000 employees in 2023 to 28,000 employees in 2024, as stated in both the 2023 and 2024 10-K filings. The company continues to highlight a culture of innovation, diverse perspectives, and collaboration as foundational to its mission and employee engagement. This consistent focus on fostering an inclusive and creative workplace suggests that AMD views its culture as a key component of its talent retention strategy, particularly in the competitive semiconductor industry where attracting and retaining skilled professionals is critical. By reinforcing this environment, AMD aims to sustain high employee engagement and drive innovation across its global operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Focuses_On]-> CONCEPT <-[Depends_On]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Engaging and Open Environment (CONCEPT)",
        "Engaging and Open Environment (CONCEPT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8816,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2869,
        "completion_tokens": 197,
        "total_tokens": 3067
      }
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "Between 2022 and 2023, AT&T's relationship with The Ohio Bell Telephone Company remained consistent in terms of guarantee obligations, as both the 2022 and 2023 10-K filings list The Ohio Bell Telephone Company as one of the entities whose obligations are guaranteed by AT&T. Specifically, in both years, The Ohio Bell Telephone Company is included in the list of subsidiaries or affiliates under the guarantees provided by AT&T, as outlined in the guaranty exhibits (4-c in 2022 and 4-c in 2023). This indicates that AT&T continued to assume financial responsibility for The Ohio Bell Telephone Company’s obligations during this period, reflecting a stable and ongoing parent-subsidiary relationship with no material changes in the guarantee structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> The Ohio Bell Telephone Company (COMP)",
        "The Ohio Bell Telephone Company (COMP) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_141",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 17574,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5034,
        "completion_tokens": 188,
        "total_tokens": 5223
      }
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "Between 2023 and 2024, GE's financial relationship with AerCap, particularly in terms of gains on retained and sold ownership interests, showed a significant shift. In 2023, GE reported $5.7 billion in gains on retained and sold ownership interests, with AerCap being a primary contributor. However, in 2024, GE experienced a $5.2 billion decrease in such gains, also largely driven by its AerCap and GE HealthCare investments. This decline in gains contributed to a $2.5 billion decrease in continuing earnings for 2024 compared to 2023, despite other offsetting factors like higher segment profit and gains from the sale of non-core assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "GE (ORG) -> AerCap (COMP)",
        "AerCap (COMP) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3460,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 160,
        "total_tokens": 1659
      }
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "Home Depot's strategic use of HD Supply between 2022 and 2024 has evolved to more directly support its focus on professional customers and MRO (Maintenance, Repair, and Operations) services. In 2022, HD Supply was highlighted as a key subsidiary that provides MRO products and value-added services to multifamily, hospitality, healthcare, and government housing facilities, signaling a foundational role in serving the professional market. By 2024, this role had expanded, with HD Supply being integrated into broader initiatives to serve Pros, including enhanced fulfillment options, trade credit offerings, and an expanded product assortment. Additionally, the 2024 acquisition of SRS, which targets specialty trade contractors, further complements HD Supply’s MRO capabilities, reinforcing Home Depot’s commitment to deepening its service offerings and market reach for professional customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "HD (ORG) -> HD Supply (COMP)",
        "HD Supply (COMP) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10159,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3174,
        "completion_tokens": 224,
        "total_tokens": 3398
      }
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "Between 2023 and 2024, AMD's reliance on cross-licensing agreements has remained consistent as a strategic component of its intellectual property (IP) management, as disclosed in both the 2023 and 2024 10-K filings. AMD continues to engage in numerous cross-licensing and technology exchange agreements, enabling the transfer and receipt of technology and IP rights with other companies, which is typical in the semiconductor industry. In terms of patent portfolio size, AMD reported approximately 18,500 patent matters globally as of December 30, 2023, increasing to approximately 18,800 as of December 28, 2024, reflecting a modest growth in its IP assets. This growth, combined with ongoing cross-licensing activities, supports AMD’s ability to innovate and maintain competitive technology exchange, reinforcing its position in high-performance computing and adaptive technologies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Cross-Licensing Agreements (ACCOUNTING_POLICY)",
        "Cross-Licensing Agreements (ACCOUNTING_POLICY) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8816,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2860,
        "completion_tokens": 221,
        "total_tokens": 3081
      }
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "From 2023 to 2024, Johnson & Johnson's financial stake and strategic relationship with Kenvue evolved significantly. In 2023, following Kenvue's IPO and an exchange offer, Johnson & Johnson retained a 9.5% stake in Kenvue, valued at $4.3 billion and recorded in other assets. This stake generated a $0.4 billion expense through December 31, 2023, and contributed to a $21.0 billion non-cash gain on the exchange offer, including a $2.8 billion gain on the retained shares. By 2024, Johnson & Johnson completed a Debt-for-Equity Exchange in the fiscal second quarter, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion in commercial paper, resulting in a $0.4 billion loss and the complete disposal of its stake in Kenvue. This marked the end of Johnson & Johnson's ownership and strategic relationship with Kenvue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> Kenvue (COMP)",
        "Kenvue (COMP) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8373,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2734,
        "completion_tokens": 212,
        "total_tokens": 2946
      }
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "Between 2022 and 2023, Indiana Bell Telephone Co. Inc. remained included in AT&T's guarantee disclosures, as both the 2022 and 2023 10-K filings list Indiana Bell Telephone Co. Inc. among the subsidiaries whose obligations are guaranteed by AT&T. Specifically, in both years, Indiana Bell is referenced in the guaranty section (4-c) as a subsidiary whose obligations are guaranteed under the same exhibit (Exhibit 4-d to Form 10-K for the period ending December 31, 2011), indicating no change in the nature or inclusion of the guarantee during this period. This reflects AT&T’s ongoing responsibility for Indiana Bell’s obligations as part of its consolidated structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> Indiana Bell Telephone Co. Inc. (COMP)",
        "Indiana Bell Telephone Co. Inc. (COMP) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_141",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 17574,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5034,
        "completion_tokens": 167,
        "total_tokens": 5202
      }
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "From 2023 to 2024, GE's financial relationship with AerCap evolved significantly in terms of cash involvement and investment gains. In 2023, GE paid net cash of $203 million to AerCap, reflecting ongoing operational ties such as product leases and services. By 2024, GE reported a decrease in gains on retained and sold ownership interests, with a specific mention of the AerCap investment as a contributing factor to a $5.2 billion decline in gains. This suggests a reduction in the value or realization of investment gains related to AerCap during 2024, marking a shift from the cash outflow in 2023 to a decline in investment-related earnings in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "GE (ORG) -> AerCap (COMP)",
        "AerCap (COMP) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2038,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 163,
        "total_tokens": 1299
      }
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "From 2022 to 2024, The Home Depot has evolved its approach to store appearance and competition by increasingly integrating digital capabilities to enhance customer experience and maintain a competitive edge. In 2022, the company emphasized store appearance and in-store services as key competitive factors, focusing on improving the shopping experience through better merchandising, tool rentals, and service offerings. By 2024, this strategy expanded to include a stronger emphasis on an interconnected, frictionless shopping experience across physical and digital channels. The Home Depot invested in digital platforms to improve search functionality, product information, and fulfillment options, enabling customers to seamlessly transition between online research and in-store visits. This digital integration, combined with continued attention to store presentation, reflects a broader strategy to meet evolving customer expectations and stay competitive in a rapidly changing retail landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> CONCEPT <-[Impacted_By]- ORG",
      "triplets_used": [
        "HD (ORG) -> Store Appearance (CONCEPT)",
        "Store Appearance (CONCEPT) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11002,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3396,
        "completion_tokens": 249,
        "total_tokens": 3646
      }
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV has shown notable evolution, particularly in terms of resales and new financial arrangements. AMD's purchases from the ATMP JV remained consistent at $1.7 billion in both 2024 and 2023, with payables increasing from $363 million to $476 million over the same period. Resales to the ATMP JV increased significantly from $14 million in 2023 to $121 million in 2024. Additionally, in October 2024, AMD entered into a $100 million one-year term loan agreement with one of the ATMP JVs, secured by the JV's receivable balance from AMD, marking a new financial arrangement that reflects AMD's continued support and strategic engagement with the joint venture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "AMD (ORG) -> ATMP JV (COMP)",
        "ATMP JV (COMP) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3770,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 180,
        "total_tokens": 1754
      }
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson has enhanced its privacy compliance programs in response to evolving privacy laws and international data flow regulations. In 2023, the Company acknowledged the growing risks from global tensions and cyber threats, emphasizing the need for compliance with privacy laws and controls to manage cross-border data flows and prevent breaches. By 2024, JNJ expanded its focus, recognizing the increasing sophistication of cyber threats and the impact of AI, while reinforcing its compliance programs to address new legislative actions and stricter enforcement of data localization and international data transfer requirements. These updates reflect a proactive adaptation to the regulatory landscape and the Company’s ongoing commitment to mitigating privacy-related risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> Privacy Compliance Programs (ACCOUNTING_POLICY)",
        "Privacy Compliance Programs (ACCOUNTING_POLICY) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6911,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2387,
        "completion_tokens": 202,
        "total_tokens": 2589
      }
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "Between 2023 and 2024, GE's financial exposure to Bank BPH, particularly in terms of estimated borrower litigation losses and related valuation allowances, has shown a reduction. As of December 31, 2023, total estimated losses related to borrower litigation were $2,669 million, with $1,712 million in valuation allowances against financing receivables and $957 million in other liabilities. By December 31, 2024, these losses decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance as of December 31, 2024, completely offset the financing receivables balance due to a settlement program, indicating a strategic effort to mitigate exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "GE (ORG) -> Bank BPH (COMP)",
        "Bank BPH (COMP) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7452,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2498,
        "completion_tokens": 183,
        "total_tokens": 2682
      }
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "HD's treatment and positioning of the Indoor Garden product line evolved significantly from 2022 to 2024. In 2022, the Indoor Garden category generated $15,546 million in net sales, representing 10.3% of total sales, indicating its strong financial performance and importance within the company's portfolio. By 2024, the Indoor Garden was reclassified under the \"Hardlines\" merchandising department, which also includes Hardware, Outdoor Garden, Power, and Storage& Organization, suggesting a strategic shift in how the product line is merchandised and marketed. This repositioning likely reflects HD's effort to better align the product with related categories and optimize its sales and operational strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "HD (ORG) -> Indoor Garden (PRODUCT)",
        "Indoor Garden (PRODUCT) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2755,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 178,
        "total_tokens": 1513
      }
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "From 2022 to 2024, Colgate-Palmolive has evolved its sourcing strategies to manage cost volatility by increasingly integrating them with proactive cost efficiency and risk mitigation measures in response to ongoing commodity price fluctuations. In 2022, the company utilized sourcing strategies as part of a broader approach to manage market risks, including foreign currency and commodity price volatility, alongside derivative instruments and pricing adjustments. By 2024, the company expanded its use of sourcing strategies to address rising material and logistics costs, particularly for commodities like resins, oils, and agricultural products, while also emphasizing cost containment through productivity initiatives and limited commodity hedging. This evolution reflects a more integrated approach to managing cost volatility, combining strategic sourcing with broader funding-the-growth efforts to sustain profitability amid ongoing inflationary pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Utilizes]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "CL (ORG) -> Sourcing Strategies (ACCOUNTING_POLICY)",
        "Sourcing Strategies (ACCOUNTING_POLICY) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9301,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2974,
        "completion_tokens": 241,
        "total_tokens": 3215
      }
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "TREMFYA's sales performance improved significantly between 2023 and 2024, increasing from $3.147 billion to $3.670 billion, representing a 16.6% total growth. This growth was primarily driven by market expansion and sustained strength in Psoriasis and Psoriatic Arthritis (PsO/PsA), as noted in the 2023 report. Additionally, the 2024 data shows an 18.1% operational increase, indicating strong underlying performance, although a 1.5% negative currency impact slightly offset the growth. These factors collectively highlight TREMFYA's continued success within JNJ's Immunology portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> TREMFYA (PRODUCT)",
        "TREMFYA (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8776,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2817,
        "completion_tokens": 146,
        "total_tokens": 2964
      }
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "The structural change in Disney's relationship with A&E from 2022 to 2023, as reflected in the 10-K filings, resulted in a shift in how subscriber numbers and financial stakes were reported. In 2022, Disney reported A&E's domestic subscribers as 69 million (Chunk 1), but by 2023, this number was revised to 58 million (Chunk 2), indicating a decline likely due to changes in measurement methodologies or distribution models. Financially, Disney maintains a 50% stake in A+E, with its share of A+E's financial results reported under \"Equity in the income of investees\" (Chunk 2), highlighting the ongoing partnership and shared ownership structure with Hearst.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DIS (ORG) -> A&E (COMP)",
        "A&E (COMP) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2356,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 165,
        "total_tokens": 1387
      }
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "Between 2023 and 2024, the financial impact of GE's relationship with AerCap shifted significantly. In 2023, GE reported a realized and unrealized gain of $129 million related to its investment in and note with AerCap, as shown in the 2023 financial data. However, in 2024, GE experienced a notable decrease in gains on retained and sold ownership interests, which was primarily attributed to its GE HealthCare and AerCap investments, contributing to a $5.2 billion decline in this category. This indicates that the value or performance of GE's stake in AerCap, which had previously shown gains, likely declined or was partially sold off in 2024, leading to a negative financial impact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "GE (ORG) -> AerCap (COMP)",
        "AerCap (COMP) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2450,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 171,
        "total_tokens": 1416
      }
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "Between 2022 and 2024, Mastercard has enhanced its multi-layered security approach by explicitly addressing risks associated with third-party service providers, as highlighted in the 2024 10-K. In 2022, the company emphasized a robust security program with multiple layers of protection, including fraud scoring, tokenization, and collaboration with industry stakeholders to establish technical standards. By 2024, Mastercard explicitly expanded its focus to include monitoring and responding to threats related to third-party providers, indicating a strategic evolution to counter increasingly complex cybersecurity risks. This evolution reflects Mastercard’s proactive response to emerging threats by integrating third-party risk management into its broader security framework, ensuring resilience across its global payment ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has]-> ACCOUNTING_POLICY <-[Implements]- ORG",
      "triplets_used": [
        "MA (ORG) -> Multi-Layered Security Approach (ACCOUNTING_POLICY)",
        "Multi-Layered Security Approach (ACCOUNTING_POLICY) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10718,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3363,
        "completion_tokens": 209,
        "total_tokens": 3572
      }
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "Target Corporation has remained in compliance with its debt leverage covenant in both 2022 and 2023, despite changes to its credit facilities. In 2022, Target had a $3.0 billion unsecured revolving credit facility expiring in October 2026, which replaced the prior $2.5 billion facility set to expire in 2023. By 2023, Target obtained a new $1.0 billion 364-day unsecured credit facility expiring in October 2024 and extended its existing $3.0 billion five-year facility to expire in October 2028. Both years, no balances were outstanding under the credit facilities, and the company affirmed its compliance with the debt leverage covenant as part of its ongoing adherence to regulatory requirements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Debt Leverage Covenant (REGULATORY_REQUIREMENT)",
        "Debt Leverage Covenant (REGULATORY_REQUIREMENT) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6366,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2246,
        "completion_tokens": 175,
        "total_tokens": 2421
      }
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "From 2023 to 2024, the nature of risks associated with Salesforce's AI offerings, including generative AI like Agentforce, has evolved from a general focus on brand and reputational risks tied to innovation and ethical policies to a more specific and heightened emphasis on the technical, regulatory, and compliance challenges of deploying AI technologies. In 2023, the risks were primarily framed around the potential reputational harm from social and ethical issues, including how AI might be used or misused by customers or employees, and the broader implications for brand trust and regulatory exposure. By 2024, the risks have expanded to include the specific challenges of AI development and deployment, such as accuracy, bias, toxicity, privacy, and data provenance, particularly as Salesforce moves from AI content classification to content generation. Additionally, the 2024 filing highlights the increased costs and resource demands associated with ensuring ethical AI implementation, including compliance, governance, and the development of proprietary datasets and models. This evolution reflects a growing recognition of the operational and financial implications of AI, as well as the need for more robust frameworks to manage the risks inherent in generative AI and agentic AI offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "CRM (ORG) -> Sales Cloud (PRODUCT)",
        "Sales Cloud (PRODUCT) -> CRM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13117,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3913,
        "completion_tokens": 325,
        "total_tokens": 4238
      }
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "Between fiscal years 2023 and 2024, Lowe's significantly enhanced its delivery capability for parcel-eligible items. In 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates, and the company expanded its gig network to enable same-day delivery from stores. By 2024, the delivery speed was further improved to \"two business days or less\" for most parcel-eligible items, and the gig provider network was expanded nationwide to support same-day delivery. Additionally, Lowe's completed the rollout of its market-based delivery model in 2024, enhancing distribution efficiency and enabling next-day delivery for major appliances in nearly every U.S. zip code. These improvements reflect Lowe's ongoing investment in its supply chain to meet evolving customer expectations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Delivers]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Parcel-Eligible Items (PRODUCT)",
        "Parcel-Eligible Items (PRODUCT) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9879,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3107,
        "completion_tokens": 204,
        "total_tokens": 3312
      }
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "The financial impact of the Dermstore LLC sale on Target's consolidated revenues and operating income remained minimal from 2022 to 2023, as Dermstore represented less than 1 percent of both consolidated revenues and operating income in both years. The sale, completed in February 2021 for $356 million in cash with a $335 million pretax gain, did not significantly affect Target's financial performance in the subsequent years, despite broader changes in sales trends and cost structures in 2023, such as declines in discretionary categories and reduced freight costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> COMP <-[Involved_In]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Dermstore LLC (COMP)",
        "Dermstore LLC (COMP) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4496,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1755,
        "completion_tokens": 142,
        "total_tokens": 1897
      }
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "Between 2023 and 2024, Salesforce's Data Cloud has evolved from being a foundational data unification tool to a more strategically central component within its broader service ecosystem. In 2023, Data Cloud was positioned as a hyperscale, trusted data engine that delivers a 360-degree customer view, enabling personalized experiences by integrating customer data across Sales, Marketing, and Commerce offerings. By 2024, its role has expanded to support consumption-based pricing models and is highlighted as a key differentiator in a competitive landscape where AI integration and data-driven insights are critical. This evolution reflects Salesforce's broader strategy to leverage Data Cloud as a core enabler of AI-powered analytics, cross-service integration, and scalable customer engagement, while also addressing the uncertainties and risks associated with new market offerings and competitive pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "CRM (ORG) -> Data Cloud (PRODUCT)",
        "Data Cloud (PRODUCT) -> CRM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11885,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3614,
        "completion_tokens": 228,
        "total_tokens": 3842
      }
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in the designation and financial impact of these instruments. In 2023, these swaps were designated as cash flow hedges, with gains and losses recorded in other comprehensive income and impacting earnings accordingly. By 2024, the Company shifted its accounting approach, treating fixed-to-floating interest rate swaps as fair value hedges under the shortcut method, which assumes perfect hedge effectiveness and results in no net impact on earnings from the derivatives' fair value changes. Both years involved similar notional amounts and settlement payments, such as $247 million received for $2.0 billion in swaps related to the 2023 Notes, but the 2024 reporting reflects a change in hedge designation and financial statement treatment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Settles]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Forward Interest Rate Swap Contracts (FIN_INST)",
        "Forward Interest Rate Swap Contracts (FIN_INST) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2763,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 213,
        "total_tokens": 1557
      }
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "From 2022 to 2023, Target's strategy around its owned brands has evolved to place a stronger emphasis on strengthening and expanding its owned brands portfolio as a core element of its growth strategy. In 2022, owned and exclusive brands accounted for approximately one-third of sales, showcasing their significant contribution to the company's revenue. By 2023, Target explicitly highlighted the importance of owned brands in its strategic objectives, aiming to delight customers with newness, style, and value by curating and enhancing its owned brands portfolio. This shift reflects a more intentional focus on leveraging owned brands to drive traffic, sales, and market share growth, while also differentiating Target in a competitive retail landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Expands]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Owned Brands (PRODUCT)",
        "Owned Brands (PRODUCT) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5908,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2110,
        "completion_tokens": 189,
        "total_tokens": 2299
      }
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "From 2022 to 2023, GM has significantly advanced its approach to software-enabled services by expanding its service offerings and accelerating platform deployment. In 2022, GM was already providing software-enabled services as part of its broader operations, including services like OnStar, which supports safety, connectivity, and driver assistance. By 2023, GM introduced a more robust end-to-end software platform, enabling over-the-air delivery of features, apps, and services, with select models like the 2024 Cadillac LYRIQ and Chevrolet Silverado EV already utilizing this platform. This evolution indicates a strategic shift toward scalable digital solutions, as GM invests in software-defined vehicles and expands its digital ecosystem to enhance customer experience and vehicle functionality over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GM (ORG) -> Software-Enabled Services (PRODUCT)",
        "Software-Enabled Services (PRODUCT) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9857,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3126,
        "completion_tokens": 203,
        "total_tokens": 3329
      }
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category increased from fiscal 2022 to fiscal 2023. In fiscal 2022, ThousandEyes contributed to an 11% increase, or $75 million, in the Optimized Application Experiences category. By fiscal 2023, ThousandEyes continued to drive growth, contributing to a 14% increase, or $80 million, in the Observability product category. This reflects sustained performance and a growing role for ThousandEyes in Cisco’s observability offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Increases]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> ThousandEyes (PRODUCT)",
        "ThousandEyes (PRODUCT) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3849,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1602,
        "completion_tokens": 135,
        "total_tokens": 1737
      }
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "In the 2023 10-K filing, Amendment No. 4 to the Lockheed Martin Executive Severance Plan was listed as Exhibit 10.34, incorporated by reference to the September 25, 2022, 10-Q, indicating it had already been publicly disclosed. By the 2024 10-K filing, Amendment No. 4 remained included as Exhibit 10.36, again referencing the same September 25, 2022, 10-Q, suggesting no new amendments were made and that the company maintained its prior disclosure. This consistency in referencing the same exhibit across both filings indicates a deliberate strategy to retain transparency regarding the amendment while avoiding redundant updates, reflecting a stable and well-documented executive compensation policy framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Announces]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Amendment No. 4 to Executive Severance Plan (ACCOUNTING_POLICY)",
        "Amendment No. 4 to Executive Severance Plan (ACCOUNTING_POLICY) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10707,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3352,
        "completion_tokens": 178,
        "total_tokens": 3530
      }
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "From 2023 to 2024, JPMorgan maintained compliance with capital ratio requirements, particularly in its Tier 1 leverage ratio and Standardized CET1 capital ratio. In 2023, the Standardized CET1 capital ratio was 15.0%, and the Tier 1 capital ratio was 16.6%, both exceeding the regulatory requirement of 11.4% and 12.9%, respectively. In 2024, the Tier 1 leverage ratio remained stable at 7.2%, meeting the 4.0% regulatory requirement, while the Standardized Leverage Ratio (SLR) was reported at 6.1%, surpassing the 5.0% threshold. This demonstrates JPMorgan's consistent adherence to and often exceeding of regulatory capital standards during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "JPM (ORG) -> Capital Ratio Requirements (REGULATORY_REQUIREMENT)",
        "Capital Ratio Requirements (REGULATORY_REQUIREMENT) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3176,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 163,
        "total_tokens": 1618
      }
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "Between 2022 and 2023, GM Financial's role in General Motors' operations has evolved to become a distinct and separately reported segment within the consolidated financial statements, reflecting its importance in providing automotive financing services. In 2022, GM Financial was mentioned as part of the broader business structure, supporting retail and fleet customers through the dealer network. By 2023, GM Financial was explicitly listed as one of the company’s key operating segments, alongside GMNA, GMI, and Cruise, with its financial results adjusted to account for deferred tax impacts and intercompany transactions within the consolidated group. This shift indicates a more integrated and transparent presentation of GM Financial’s performance and its role in the company’s overall financial strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "GM (ORG) -> Automotive Financing Services (PRODUCT)",
        "Automotive Financing Services (PRODUCT) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7712,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2584,
        "completion_tokens": 203,
        "total_tokens": 2787
      }
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "Between 2022 and 2024, COST has consistently recognized step-rent provisions, including periodic rent increases based on price indices or sales volume, as variable lease payments under its lease accounting policy. In 2022, the Company stated that such increases are recognized on a straight-line basis over the lease term, including any extension options reasonably certain to be exercised. By 2024, the disclosure clarified that these increases are explicitly treated as variable lease payments, aligning with updated accounting guidance. This evolution reflects a more precise application of lease accounting standards, ensuring that variable payments tied to indices or sales are appropriately accounted for in the financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "COST (ORG) -> Step-Rent Provisions (ACCOUNTING_POLICY)",
        "Step-Rent Provisions (ACCOUNTING_POLICY) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6525,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2296,
        "completion_tokens": 184,
        "total_tokens": 2481
      }
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "From 2023 to 2024, the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans show a slight decrease in the 2025 expected payout, from $1,860 million in 2023 to $1,800 million in 2024. However, the long-term obligations from 2029 to 2033 (or 2034 in the 2024 report) decreased marginally from $10,020 million to $9,990 million, indicating a relatively stable long-term funding outlook despite minor annual adjustments in the intermediate years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Increases]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Qualified defined benefit pension plans (ACCOUNTING_POLICY)",
        "Qualified defined benefit pension plans (ACCOUNTING_POLICY) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 976,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 924,
        "completion_tokens": 120,
        "total_tokens": 1044
      }
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "Between 2023 and 2024, JPMorgan Chase's disclosures on its resolution plan obligations remained consistent in highlighting the impact on liquidity risk management and funding costs. In both years, the firm emphasized that actions taken to address resolution plan obligations could lead to higher funding costs, particularly when accessing stable, lower-cost funding sources like deposits or Federal Home Loan Bank borrowings is constrained. In 2023, JPMorgan Chase noted that these obligations could influence its liquidity management strategies, including the pre-positioning of liquidity in material subsidiaries. In 2024, similar language was reiterated, underscoring the continued relevance of resolution plan requirements in shaping its liquidity and funding decisions amid evolving regulatory and market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "JPM (ORG) -> Resolution Plan Obligations (REGULATORY_REQUIREMENT)",
        "Resolution Plan Obligations (REGULATORY_REQUIREMENT) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10270,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3238,
        "completion_tokens": 205,
        "total_tokens": 3443
      }
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "Between 2022 and 2023, Optum Rx's financial structure showed growth in accounts receivable, increasing from $7.1 billion to $8.6 billion, indicating a rise in outstanding payments for pharmacy care services. Revenue recognition for Optum Rx primarily occurs at the point of prescription dispensing, with product revenues including pharmaceutical costs, dispensing fees, and co-payments. In 2023, the Company continued to report product and service revenues on a gross basis due to its primary obligation to pay network pharmacies, consistent with prior periods. Additionally, Optum Rx's role in managing a broad range of prescription drug spend, including specialty pharmaceuticals, supports its position as a key component of UnitedHealth Group's pharmacy care services, as controlled by UNH and producing outcomes for the broader organization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Controls]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Pharmacy Care Services (PRODUCT)",
        "Pharmacy Care Services (PRODUCT) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2023.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10403,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3245,
        "completion_tokens": 211,
        "total_tokens": 3456
      }
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "Between 2022 and 2024, UPS's quantitative exposure to Floating to Fixed Interest Rate Swaps increased significantly, from $28 million in 2022 to being a key component of its interest rate risk management strategy by 2024. In 2022, UPS had minimal exposure to these swaps, as shown in the data, while it maintained a larger position in Fixed to Floating Interest Rate Swaps. By 2024, UPS expanded its use of interest rate swaps to manage its debt portfolio, specifically using Floating to Fixed Interest Rate Swaps to hedge against forecasted floating-rate interest payment obligations, as outlined in its Risk Management Policies. This strategic shift reflects UPS's proactive approach to managing interest rate risk by adjusting its mix of fixed and floating rate debt to optimize its overall cost of borrowing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Designates]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Floating to Fixed Interest Rate Swaps (FIN_INST)",
        "Floating to Fixed Interest Rate Swaps (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_155",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_136",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4615,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1806,
        "completion_tokens": 203,
        "total_tokens": 2009
      }
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "Between 2022 and 2023, GM's financial relationship with LG Energy Solution (LGES) evolved significantly, particularly in the context of joint venture activities and recall-related costs. In 2022, GM highlighted its joint venture with LGES, Ultium Cells LLC, which was focused on mass-producing battery cells for EVs, including the Chevrolet Silverado EV and GMC Sierra, with plans for multiple U.S.-based production plants. By 2023, the relationship was impacted by the Chevrolet Bolt recall, which was expanded to include all 2017-2022 model year Bolt EVs and EUVs due to battery defects traced to LGES. As a result, GM accrued a total of $2.6 billion through December 31, 2023, for recall-related costs, with $1.6 billion in receivables from LG (LGES and LGE) for reimbursement, leaving a remaining accrual of $0.6 billion. Additionally, the commercial negotiations with LG resolved other matters related to the Ultium joint venture, indicating a shift in the partnership from collaborative production to financial resolution of liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Pays]- ORG",
      "triplets_used": [
        "GM (ORG) -> LG Energy Solution (COMP)",
        "LG Energy Solution (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11406,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3490,
        "completion_tokens": 260,
        "total_tokens": 3751
      }
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "From fiscal 2022 to fiscal 2023, the revenue contribution from ThousandEyes within the Observability product category increased. In fiscal 2022, ThousandEyes and monitoring and analytics offerings drove a 14% increase, or $80 million, in Observability revenue. In fiscal 2023, ThousandEyes continued to contribute to growth, with the Observability category seeing a 27% increase, or $176 million, in revenue, although the specific contribution from ThousandEyes in 2023 was not quantified separately. This reflects the ongoing importance of ThousandEyes in driving growth in the Observability portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Increases]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> ThousandEyes (PRODUCT)",
        "ThousandEyes (PRODUCT) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5925,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2112,
        "completion_tokens": 150,
        "total_tokens": 2263
      }
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "UPS's relationship with the 7.620% Debentures has remained consistent in terms of interest payment structure, with semi-annual interest payments in April and October, as noted in the 2024 filing. However, the redemption terms have been clarified in 2024, specifying that the debentures are redeemable at UPS's option at a price equal to the greater of the principal amount plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. The 2022 filing listed the debentures with a principal of $276 million and a 2030 maturity but did not provide specific redemption terms, which were detailed in the 2024 filing. Thus, the evolution lies in the explicit disclosure of the redemption mechanism in 2024, while the interest payment structure has remained unchanged.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Pays_Interest_On]- ORG",
      "triplets_used": [
        "UPS (ORG) -> 7.620% Debentures (FIN_INST)",
        "7.620% Debentures (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_118",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9242,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2951,
        "completion_tokens": 213,
        "total_tokens": 3164
      }
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "From 2022 to 2023, the total fair value of MET's Fixed Maturity Securities AFS increased significantly, from a carrying amount of $2,164 million in 2022 to a total fair value of $6,714 million in 2023. In terms of composition, U.S. government bonds held by MET rose from $1,537 million in 2023 compared to $1,575 million (implied from 2022 data in the first chunk), while corporate securities increased from $2,699 million in 2022 to $3,083 million in 2023, reflecting a notable shift toward higher corporate securities holdings and a more diversified portfolio in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MET (ORG) -> Fixed Maturity Securities AFS (FIN_INST)",
        "Fixed Maturity Securities AFS (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_250",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_308",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8023,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2660,
        "completion_tokens": 142,
        "total_tokens": 2802
      }
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "From 2022 to 2023, General Motors' (GM) relationship with Ultium Cells LLC evolved both financially and regulatory-wise. Financially, GM made a $0.5 billion investment in Ultium Cells LLC in 2022, as noted in the 2022 10-K. By 2023, this partnership led to regulatory implications, as GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC's import activities. This resulted in a settlement with the EPA in November 2023, involving civil penalties estimated at approximately $5.1 million, which are jointly and severally assessed on GM and Ultium Cells LLC. These developments highlight both the financial commitment and the regulatory challenges associated with GM's investment and partnership with Ultium Cells LLC.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Partners_With]- ORG",
      "triplets_used": [
        "GM (ORG) -> Ultium Cells LLC (COMP)",
        "Ultium Cells LLC (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4665,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1804,
        "completion_tokens": 193,
        "total_tokens": 1997
      }
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "Between 2022 and 2024, the company has maintained the use of variable-priced contracts for natural gas and fuel purchases, entering into these contracts on an index basis, primarily for natural gas and fuel at its gas stations. In 2022, the company noted that it uses variable-priced contracts alongside fixed-price contracts to partially mitigate energy price fluctuations, particularly for electricity and natural gas in its U.S. and Canadian operations. By 2024, the company continued this practice, with the added clarification that these variable-priced contracts meet the characteristics of derivative instruments but generally qualify for the \"normal purchases and normal sales\" exception, thus requiring no mark-to-market adjustments. This indicates a consistent strategy in managing energy costs through variable-priced contracts, with no significant change in approach between the two periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Uses]- ORG",
      "triplets_used": [
        "COST (ORG) -> Variable-Priced Contracts (FIN_INST)",
        "Variable-Priced Contracts (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9576,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3028,
        "completion_tokens": 225,
        "total_tokens": 3254
      }
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "Cisco's financial reporting approach for the APJC segment remained consistent between fiscal 2022 and fiscal 2023 in terms of the expense categories excluded from segment performance measurement. In both years, the company did not allocate research and development, sales and marketing, or general and administrative expenses to the APJC segment, as these are not used by management to assess segment performance. Additionally, expenses such as amortization and impairment of acquisition-related intangible assets, share-based compensation, litigation settlements, asset impairments, restructurings, and certain other charges were also excluded from the gross margin measurement for the APJC segment in both fiscal years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> APJC (GPE)",
        "APJC (GPE) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3070,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 180,
        "total_tokens": 1591
      }
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "From 2022 to 2023, UNH's approach to managing medical cost trends has evolved to focus more actively on mitigating rising outpatient procedure costs for seniors by engaging physicians and consumers in making clinically sound, cost-effective care decisions. In 2022, the company highlighted the risks of underestimating medical costs and the importance of accurate pricing and cost management, particularly in the context of the ongoing pandemic's impact on deferred care and increased demand for services. By 2023, UNH shifted toward a more proactive strategy, emphasizing the use of data and analytics to guide care delivery in the most efficient settings, including in-clinic, in-home, and virtual care. This reflects a broader transition toward value-based care models aimed at improving quality while managing costs, especially for senior populations experiencing higher outpatient utilization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Guides_On]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Medical Cost Management (PRODUCT)",
        "Medical Cost Management (PRODUCT) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2023.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10678,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3316,
        "completion_tokens": 224,
        "total_tokens": 3541
      }
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "Between 2022 and 2024, UPS has expanded and refined its time-definite delivery services by enhancing service scope and deepening network integration. In 2022, UPS emphasized its integrated global smart logistics network, which supports time-definite delivery services for express letters, documents, and packages via air and ground, with a focus on optimizing efficiency and asset utilization. By 2024, the company further developed its time-definite delivery portfolio, offering same-day pickup options and a broader range of guaranteed delivery services, including same-day, next-day, two-day, and three-day options in the U.S., as well as international day- and time-definite services. Additionally, UPS integrated its delivery network by insourcing UPS SurePost residential deliveries starting in 2025, enhancing control and service reliability. These developments reflect UPS's strategic evolution toward a more cohesive, customer-centric delivery ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Time-Definite Delivery (PRODUCT)",
        "Time-Definite Delivery (PRODUCT) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8448,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2751,
        "completion_tokens": 240,
        "total_tokens": 2992
      }
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "Between 2022 and 2023, Lowe's Companies, Inc.'s treatment of its 2.50% Notes maturing in April 2026 remained consistent, as both the 2022 and 2023 10-K filings reference the Thirteenth Supplemental Indenture dated April 20, 2016, which includes these notes as part of the debt instruments issued by Lowe's. The 2022 filing (Chunk 1) and the 2023 filing (Chunk 2) both list the 2.50% Notes maturing in April 2026 under the same indenture, indicating no change in the terms or recognition of these notes during the period. The notes are consistently identified as part of Lowe's long-term debt obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues]- ORG",
      "triplets_used": [
        "LOW (ORG) -> 2.50% Notes (FIN_INST)",
        "2.50% Notes (FIN_INST) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10519,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3264,
        "completion_tokens": 151,
        "total_tokens": 3415
      }
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "From 2022 to 2024, the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure has remained a persistent risk, with evolving implications. In 2022, Costco highlighted that sovereign debt crises could affect demand for its products, necessitate changes in product mix, and increase the cost or difficulty of purchasing inventory, particularly due to trade tensions between China and the U.S. and inflationary pressures. By 2024, the company reiterated these concerns, emphasizing that unsettled financial markets and sovereign debt crises continued to pose risks to its sourcing and cost structure, with potential effects on net sales, gross margin, and the ability to pass through cost increases to members without negatively impacting demand. Additionally, both years underscored the vulnerability of suppliers to macroeconomic conditions, which could disrupt supply chains and lead to higher merchandise costs or quality issues, further affecting Costco’s operations and profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> MACRO_CONDITION <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "COST (ORG) -> Sovereign Debt Crises (MACRO_CONDITION)",
        "Sovereign Debt Crises (MACRO_CONDITION) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9275,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2960,
        "completion_tokens": 253,
        "total_tokens": 3214
      }
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "The number of shares available for future grants under the 2020 Stock Incentive Plan decreased from 64 million as of December 31, 2021, to 53 million as of December 31, 2023, representing a reduction of 11 million shares over the two-year period. This decline suggests that UnitedHealth Group has issued a significant number of share-based awards during this time, which reflects active use of the plan to incentivize employees. However, the continued availability of 53 million shares as of 2023 still indicates a substantial capacity for issuing new share-based awards, supporting the company’s ongoing ability to compensate and retain talent through equity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "UNH (ORG) -> 2020 Stock Incentive Plan (ACCOUNTING_POLICY)",
        "2020 Stock Incentive Plan (ACCOUNTING_POLICY) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2839,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 165,
        "total_tokens": 1542
      }
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "Between 2022 and 2024, the expiration date of the collective bargaining agreement for the IAM National Pension Fund / National Pension Plan was extended from July 31, 2024, in 2022 to July 31, 2029, in 2024. Additionally, UPS continued to be a significant contributor to the plan, providing more than 5% of total contributions for all years (2021–2024), as disclosed in the annual filings with the Department of Labor. This highlights the ongoing and substantial financial relationship between UPS and the IAM National Pension Fund / National Pension Plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Contributes_To]- ORG",
      "triplets_used": [
        "UPS (ORG) -> IAM National Pension Fund / National Pension Plan (FIN_INST)",
        "IAM National Pension Fund / National Pension Plan (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3491,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 139,
        "total_tokens": 1671
      }
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "Between fiscal years 2022 and 2023, the terms and availability under LOW's 2020 Credit Agreement evolved as follows: In 2022, the 2020 Credit Agreement was amended in December 2021 to increase its availability to $2.0 billion and extend its maturity to March 2025. By 2023, the 2020 Credit Agreement was further amended and restated in September 2023 as the 2023 Credit Agreement, which extended its term to September 2028. The combined availability with the Third Amended and Restated Credit Agreement remained at $4.0 billion in both 2022 and 2023, with no outstanding borrowings under the agreements as of the respective fiscal year-ends.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into]-> FIN_INST <-[Amends]- ORG",
      "triplets_used": [
        "LOW (ORG) -> 2020 Credit Agreement (FIN_INST)",
        "2020 Credit Agreement (FIN_INST) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4850,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1842,
        "completion_tokens": 160,
        "total_tokens": 2003
      }
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "Between 2022 and 2024, MDLZ's notional amount for Net Investment Hedge Derivative Contracts increased significantly. In 2022, the notional amount was $3,915 million, which rose to $7,456 million in 2023 and further increased to $8,647 million in 2024. This upward trend indicates a growing use of these derivative contracts as part of MDLZ's hedging strategy during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Net Investment Hedge Derivative Contracts (FIN_INST)",
        "Net Investment Hedge Derivative Contracts (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4419,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1753,
        "completion_tokens": 94,
        "total_tokens": 1847
      }
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "Between 2022 and 2024, Microsoft 365's integration with AI technologies evolved from being AI-backed tools to becoming an \"AI first platform.\" In 2022, Microsoft 365 focused on empowering employees with AI tools to enhance creativity, collaboration, and data protection. By 2024, the platform introduced **Microsoft Copilot**, which combines AI with business data in the Microsoft Graph and Microsoft 365 applications. New capabilities in 2024 included **Copilot for Microsoft 365**, **role-based Copilots** (Sales, Service, Finance), **Copilot Studio** for customization, and **Copilot Pro**, a consumer subscription service offering enhanced AI assistance in Microsoft 365 apps and on the web. These advancements significantly enhanced productivity and collaboration by providing role-specific insights, workflow automation, and personalized AI support.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Microsoft 365 (PRODUCT)",
        "Microsoft 365 (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8721,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2829,
        "completion_tokens": 213,
        "total_tokens": 3043
      }
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "Between 2022 and 2024, 3M's approach to PFAS discharge characterization in its Decatur, Alabama wastewater permits evolved from identifying and disclosing incomplete PFAS characterization in 2019 to actively seeking regulatory approval to expand its NPDES permit to include additional PFAS compounds. In 2022, 3M had already disclosed that its NPDES permit did not fully characterize PFAS discharges and had temporarily idled certain processes while installing wastewater treatment controls. By 2024, the company had submitted an application to ADEM to modify the NPDES permit to include the additional PFAS, and was in the process of upgrading and optimizing wastewater treatment systems to address these discharges. Despite these actions, ADEM had not yet acted on the permit modification request by 2024, indicating ongoing regulatory review and engagement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discovers]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "MMM (ORG) -> PFAS Discharge (RISK_FACTOR)",
        "PFAS Discharge (RISK_FACTOR) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11709,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3568,
        "completion_tokens": 215,
        "total_tokens": 3783
      }
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "Lowe's Companies, Inc. issued the 4.550% Notes as part of its Fifteenth Supplemental Indenture on April 5, 2019, with a maturity date of April 5, 2049, as detailed in both the 2022 and 2023 10-K filings. There is no indication of any material change to the terms or status of these notes between 2022 and 2023, as both filings consistently reference the same indenture and note details.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues]- ORG",
      "triplets_used": [
        "LOW (ORG) -> 4.550% Notes (FIN_INST)",
        "4.550% Notes (FIN_INST) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10519,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3250,
        "completion_tokens": 96,
        "total_tokens": 3346
      }
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "Between 2022 and 2024, MDLZ's financial relationship with KDP evolved primarily through a change in accounting for its investment. In 2023, MDLZ recorded a pre-tax gain of $493 million ($368 million after-tax) on equity method transactions related to its investment in KDP prior to the change in accounting. In 2024, the gain on marketable securities sold during the period reflected the difference between the sale proceeds and the carrying value of the equity securities at the time of the accounting change. This indicates a significant shift in how MDLZ accounted for its stake in KDP, resulting in substantial gains being recognized during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> KDP (COMP)",
        "KDP (COMP) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5859,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2098,
        "completion_tokens": 164,
        "total_tokens": 2262
      }
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "Between 2022 and 2024, the scale and positioning of Xbox Game Pass have significantly evolved. In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party console and PC titles, emphasizing Microsoft’s growing focus on gaming as a core strategic area. By 2024, the service had expanded to include over 400 titles, reflecting Microsoft’s continued investment in content and its vision to redefine entertainment through cloud-based and subscription models. This growth aligns with Microsoft’s broader strategy to lead in cloud services, AI-driven experiences, and cross-platform gaming, positioning Xbox Game Pass as a central pillar of its gaming ecosystem and a key driver for user engagement and business expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Xbox Game Pass (PRODUCT)",
        "Xbox Game Pass (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9416,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2992,
        "completion_tokens": 187,
        "total_tokens": 3180
      }
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "The structure and disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan remained consistent from 2022 to 2024, as both filings reference the same version of the agreement incorporated by reference from the 2018 Form 10-K (specifically, deferred stock units granted on or after January 1, 2019). There is no indication of amendments or changes to the agreement form during this period, despite the 2021 and 2023 amendments to the broader plan. This suggests that the specific terms governing deferred stock units for non-employee directors were not modified between 2022 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Deferred Stock Unit Award Agreement (FIN_INST)",
        "Deferred Stock Unit Award Agreement (FIN_INST) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_144",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4880,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1883,
        "completion_tokens": 163,
        "total_tokens": 2046
      }
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "Between 2023 and 2024, the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio shows a slight increase in origination costs, rising from $100 million in 2023 to $112 million in 2024, indicating a $12 million growth in direct origination costs. Additionally, the geographic concentration in California decreased marginally from 43% in 2023 to 42% in 2024, while the performance of these loans remained consistent with the overall portfolio. Both years reported no loans accruing interest that were 90 days or more past due, underscoring the stability of the portfolio during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> First Mortgages and HELOCs (FIN_INST)",
        "First Mortgages and HELOCs (FIN_INST) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1664,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1072,
        "completion_tokens": 152,
        "total_tokens": 1224
      }
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "Nike's strategic emphasis on Dri-FIT technology remained consistent between fiscal 2023 and fiscal 2024, as both years' 10-K filings highlight continued innovation and integration of Dri-FIT into product design as part of Nike's broader commitment to enhancing athletic performance and consumer experience. In both years, the product research, design, and development sections emphasize leveraging technologies like Dri-FIT across existing product categories to meet consumer preferences. While no new specific developments for Dri-FIT were outlined in fiscal 2024 compared to fiscal 2023, the ongoing focus on incorporating Dri-FIT alongside other technologies such as Nike Air, Zoom, and Flyknit underscores its sustained importance in Nike's innovation strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Expands]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Dri-FIT (PRODUCT)",
        "Dri-FIT (PRODUCT) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7317,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2468,
        "completion_tokens": 191,
        "total_tokens": 2659
      }
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "Mondelez International has significantly enhanced its investment in backup and disaster recovery from 2022 to 2024 in response to increasing cybersecurity threats. In 2022, the company highlighted its focus on network security, backup and disaster recovery, and workforce training to address rising global cybersecurity risks, particularly with more employees working remotely. By 2024, Mondelez had augmented its cybersecurity program with advanced measures, including enhanced identity and access management, multi-factor authentication, privileged access management, and 24/7 security operations to monitor and detect threats. These investments reflect a strategic evolution aimed at reducing the attack surface and improving resilience against sophisticated cyber threats, including those from state-sponsored actors, while acknowledging the ongoing challenge of ensuring absolute protection in an increasingly complex threat landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enhances]-> RISK_FACTOR <-[Invests_In]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Backup and Disaster Recovery (RISK_FACTOR)",
        "Backup and Disaster Recovery (RISK_FACTOR) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8590,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2797,
        "completion_tokens": 235,
        "total_tokens": 3032
      }
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "Microsoft's financial commitment and engagement with Black and African American-owned suppliers significantly advanced from fiscal year 2022 to 2024. In 2022, Microsoft reported reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, the company achieved its full $500 million spending goal with double the number of such suppliers, demonstrating measurable progress. Additionally, Microsoft provided 162 low- or no-interest loans to small and medium-sized partners through its Partner Capital Fund in 2024, further supporting Black and African American-owned businesses. These efforts reflect Microsoft's ongoing commitment to leveraging its resources to foster economic inclusion and drive societal change within its supplier ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Black and African American-Owned Suppliers (COMP)",
        "Black and African American-Owned Suppliers (COMP) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9989,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3147,
        "completion_tokens": 207,
        "total_tokens": 3354
      }
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "From 2022 to 2023, the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees decreased from 10,638,639 shares as of December 31, 2021 (reported in the 2022 filing) to 8,565,087 shares as of December 31, 2023 (reported in the 2023 filing). This decline indicates that Abbott has been utilizing shares from the plan for employee purchases during the six-month purchase cycles, which typically begin on August 1 and February 1. The continued operation of the plan, along with the availability of shares from treasury or open-market purchases, reflects Abbott’s ongoing commitment to offering stock-based incentives to non-U.S. employees, aligning their interests with shareholders while managing share issuance within the constraints of the 2017 Program.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Reacquired Shares (FIN_INST)",
        "Reacquired Shares (FIN_INST) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2022.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9557,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3050,
        "completion_tokens": 207,
        "total_tokens": 3258
      }
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "Between fiscal years 2023 and 2024, Nike's treatment of Nike Air technology has remained a core component of its product development strategy, as both the 2023 and 2024 10-K filings emphasize the continued proliferation and integration of Nike Air, alongside other technologies like Zoom, Air Max, and React, across its product categories. The company continues to leverage Nike Air in innovative product designs, driven by research and market insights to meet evolving consumer preferences. The knowledge graph confirms Nike (NKE) as the organization that both produces and expands the Nike Air product, reinforcing its strategic importance in Nike's ongoing commitment to technical innovation and performance enhancement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Expands]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Nike Air (PRODUCT)",
        "Nike Air (PRODUCT) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7317,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2455,
        "completion_tokens": 180,
        "total_tokens": 2636
      }
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "Between 2022 and 2023, Abbott has maintained Osmolite as a key component of its Nutritional Products segment, specifically within its enteral feeding portfolio. In both years, Osmolite is listed among the principal products used in enteral feeding in healthcare institutions, alongside Jevity, Glucerna, Oxepa, and others. While the product lineup and positioning of Osmolite remain consistent in both years, the 2023 filing emphasizes Abbott’s continued focus on securing physician and healthcare professional recommendations, as well as consumer marketing, to drive adoption of its enteral feeding solutions. This suggests a stable yet targeted strategy to reinforce Osmolite’s role in Abbott’s broader nutritional care offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Osmolite (PRODUCT)",
        "Osmolite (PRODUCT) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2022.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10645,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3307,
        "completion_tokens": 183,
        "total_tokens": 3490
      }
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "Between 2022 and 2024, 3M's regulatory engagement and remediation obligations related to PFAS discharge have evolved significantly in Minnesota and Alabama. In Minnesota, 3M continued its obligations under the 2007 Settlement Agreement with the MPCA to address PFAS contamination at multiple sites, including Cottage Grove, Oakdale, and Woodbury. In 2022, the company was already engaged in operational and maintenance activities at these sites, with substantial remediation completed. By 2024, 3M faced increased regulatory scrutiny, including a Notice of Violation in 2021 for PFAS in wastewater, a 2022 directive to address PFAS in stormwater, and a 2024 revised draft Clean Water Act permit with significantly stricter effluent limits. Additionally, in Hutchinson, Minnesota, a 2023 Notice of Violation alleged PFAS discharge in stormwater. In Alabama, 3M had entered into an interim Consent Order with ADEM in 2020, requiring ongoing operational reporting, capital improvements, and remediation activities. By 2024, the company continued to comply with the Consent Order and manage its NPDES permit obligations, including addressing previously incorrect PFAS discharge data and implementing wastewater treatment controls. These developments reflect an intensifying regulatory environment and expanding remediation commitments for 3M in both states.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discovers]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "MMM (ORG) -> PFAS Discharge (RISK_FACTOR)",
        "PFAS Discharge (RISK_FACTOR) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12050,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3653,
        "completion_tokens": 338,
        "total_tokens": 3991
      }
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved from 2022 to 2024 in terms of investment classification and stake percentage. In 2022, Coca-Cola HBC AG was classified as an equity method investment, as indicated by the inclusion of equity method investees in the 2024 10-K, where The Coca-Cola Company owned a 22% stake as of December 31, 2024. While the 2022 10-K does not explicitly state the stake percentage, the 2024 10-K confirms the continued use of the equity method for Coca-Cola HBC AG, with a slightly adjusted stake of 22%, reflecting a stable but non-controlling investment position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Coca-Cola HBC AG (COMP)",
        "Coca-Cola HBC AG (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_118",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5451,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2005,
        "completion_tokens": 156,
        "total_tokens": 2161
      }
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "Oracle's strategic emphasis on hybrid deployments has evolved significantly between fiscal 2022 and fiscal 2024, with a stronger focus on integration and investment in product development. In fiscal 2022, Oracle highlighted its commitment to providing flexible deployment models, including hybrid options like Oracle Cloud@Customer, and reported $7.2 billion in R&D investments aimed at enhancing existing products and developing new technologies to improve performance, integration, and cost-effectiveness. By fiscal 2024, Oracle continued to emphasize hybrid deployments as a core part of its offerings, reinforcing the interoperability between on-premise, cloud-based, and hybrid environments. The company further integrated Oracle Cloud Services (SaaS and OCI) with its hybrid solutions, enabling customers to seamlessly transition and operate across deployment models. This evolution reflects Oracle's ongoing strategy to deliver comprehensive, flexible IT solutions that align with customer needs and competitive market demands.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Hybrid Deployments (PRODUCT)",
        "Hybrid Deployments (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9682,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3069,
        "completion_tokens": 258,
        "total_tokens": 3328
      }
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "The filing status of the Mandatory Clawback Policy for Wells Fargo & Company remained consistent between the 2023 and 2024 SEC 10-K disclosures, as both filings reference the policy as effective as of October 2, 2023. In the 2023 10-K (Chunk 1), the policy was filed herewith under Exhibit 97, while in the 2024 10-K (Chunk 2), it was incorporated by reference to the 2023 10-K, indicating no substantive change in the policy’s status or content during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Files]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "WFC (ORG) -> Mandatory Clawback Policy (ACCOUNTING_POLICY)",
        "Mandatory Clawback Policy (ACCOUNTING_POLICY) -> WFC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WFC_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WFC_10k_2024.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12150,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3683,
        "completion_tokens": 116,
        "total_tokens": 3799
      }
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "Thermo Fisher Scientific (TMO) acquired CorEvitas, LLC on August 14, 2023, for $0.91 billion as part of its investing activities, enhancing its Laboratory Products and Biopharma Services segment with real-world evidence solutions. By 2024, the definite-lived intangible assets from this acquisition were being amortized over a weighted-average period of 18 years, indicating the long-term value and integration of CorEvitas into TMO’s operations. This acquisition had significant financial implications, including a cash outflow of $0.91 billion in 2023 and the addition of non-tax-deductible goodwill, which affects future earnings and balance sheet composition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Acquires]- ORG",
      "triplets_used": [
        "TMO (ORG) -> CorEvitas, LLC (COMP)",
        "CorEvitas, LLC (COMP) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TMO_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6525,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2267,
        "completion_tokens": 165,
        "total_tokens": 2433
      }
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "Between 2022 and 2023, RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce remained contingent on the number of flight hours flown by V2500-powered aircraft through June 2027. These payments are due for each hour flown by aircraft in service as of the acquisition date. In both years, the payments are classified under \"Other commercial aerospace commitments\" and are capitalized as collaboration intangible assets as they are made, with amortization over the term of the underlying economic benefit. The timing of these payments continues to be tied to actual flight activity rather than fixed schedules, and the capitalization treatment has remained consistent across both periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Reflects]-> FIN_INST <-[Pays]- ORG",
      "triplets_used": [
        "RTX (ORG) -> Flight Hour Payments (FIN_INST)",
        "Flight Hour Payments (FIN_INST) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5296,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1975,
        "completion_tokens": 177,
        "total_tokens": 2152
      }
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "The Coca-Cola Company's financial relationship with fairlife has evolved from 2022 to 2024 through contingent payments tied to performance milestones. In 2020, KO acquired the remaining ownership interest in fairlife, as noted in Chunk 1. By 2024, as detailed in Chunk 2, a remaining milestone payment related to this acquisition remains contingent on fairlife achieving certain financial targets through 2024, with the payment due in 2025. This contingent payment is based on agreed-upon formulas, reflecting an ongoing financial commitment from KO tied to fairlife's performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> fairlife (COMP)",
        "fairlife (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6724,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2316,
        "completion_tokens": 145,
        "total_tokens": 2462
      }
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "Between 2022 and 2024, Oracle's strategic positioning of Oracle Cloud Services evolved by emphasizing deeper integration with enterprise applications and infrastructure technologies, enabling customers to deploy, manage, and maintain cloud-based solutions with greater flexibility and interoperability. In 2022, Oracle highlighted its focus on leveraging emerging technologies like machine learning in offerings such as the Oracle Autonomous Database, while also expanding through strategic acquisitions, including Cerner Corporation, to enhance its cloud and license business. By 2024, Oracle further solidified its position by offering a comprehensive and integrated suite of Oracle Cloud Software-as-a-Service (SaaS) and Oracle Cloud Infrastructure (OCI), allowing customers to choose deployment models that best fit their needs—on-premise, cloud-based, or hybrid. This evolution reflects Oracle's commitment to providing scalable, secure, and enterprise-grade solutions that support modern IT environments and customer digital transformation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Cloud Services (PRODUCT)",
        "Oracle Cloud Services (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9708,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3077,
        "completion_tokens": 261,
        "total_tokens": 3339
      }
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "The Key/Specified Employee Policy was incorporated by reference in both the 2023 and 2024 SEC filings, specifically under Exhibit 10(r) and linked to the Company's Annual Report on Form 10-K for the year ended December 31, 2018, indicating no change in its documentation or incorporation by reference between the two years. This consistency suggests that the policy remained unchanged in terms of its formal reference within the filings during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Announces]- ORG",
      "triplets_used": [
        "WFC (ORG) -> Key/Specified Employee Policy (ACCOUNTING_POLICY)",
        "Key/Specified Employee Policy (ACCOUNTING_POLICY) -> WFC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WFC_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WFC_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15378,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4505,
        "completion_tokens": 114,
        "total_tokens": 4619
      }
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "The aggregate principal balance of RTX's 6.700% notes due 2028 remained unchanged at $285 million between 2022 and 2023, as shown in both the 2022 and 2023 disclosures. This stability suggests that RTX did not refinance or retire these notes during the period, indicating a strategy of maintaining existing long-term debt obligations without immediate restructuring. The consistency in the balance reflects a disciplined approach to debt management, preserving liquidity and avoiding near-term refinancing risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "RTX (ORG) -> 6.700% notes due 2028 (FIN_INST)",
        "6.700% notes due 2028 (FIN_INST) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3585,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 128,
        "total_tokens": 1668
      }
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "The carrying value of TMO's 1.95% 12-Year Senior Notes decreased from $773 million in 2023 to $725 million in 2024, while the effective interest rate remained relatively stable, increasing slightly from 2.08% in 2023 to 2.07% in 2024. This evolution reflects a reduction in the carrying value of the notes and a marginal decrease in the effective interest rate over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG",
      "triplets_used": [
        "TMO (ORG) -> 1.95% 12-Year Senior Notes (FIN_INST)",
        "1.95% 12-Year Senior Notes (FIN_INST) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2023.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TMO_10k_2024.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14990,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4382,
        "completion_tokens": 94,
        "total_tokens": 4477
      }
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "The change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings reflects a shift in corporate governance transparency and accessibility. In 2022, the Directors' Code of Conduct was disclosed in the 10-K under the \"Code of Ethics\" section, with a reference to its availability on the company’s website. By 2024, the Directors' Code of Conduct is explicitly listed among other corporate governance materials made available on the website in the \"Available Information\" section of the 10-K. This change implies a more structured and centralized approach to governance disclosure, enhancing stakeholder access to and awareness of director conduct standards, thereby reinforcing accountability and alignment with regulatory expectations under the SEC’s disclosure requirements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "BK (ORG) -> Directors' Code of Conduct (ACCOUNTING_POLICY)",
        "Directors' Code of Conduct (ACCOUNTING_POLICY) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6959,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2390,
        "completion_tokens": 203,
        "total_tokens": 2594
      }
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "Amazon's Short-Term Credit Agreement evolved between 2023 and 2024 with a consistent facility size of $5.0 billion. In November 2023, the agreement was established with a maturity date of October 2024, replacing the prior agreement from November 2022. By October 2024, Amazon entered into a new $5.0 billion unsecured 364-day revolving credit facility, extending the maturity date to October 2025. Thus, while the facility size remained unchanged, the maturity date was extended by one year, and the agreement was renewed in October 2024 to replace the prior November 2023 agreement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Short-Term Credit Agreement (FIN_INST)",
        "Short-Term Credit Agreement (FIN_INST) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4741,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1834,
        "completion_tokens": 145,
        "total_tokens": 1979
      }
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "From 2022 to 2024, AMD's APU strategy has evolved from focusing on integrated computing solutions for servers, embedded systems, and semi-custom markets to a more targeted integration of AI-specific capabilities, particularly in the AI PC segment. In 2022, APUs were part of a broader portfolio addressing enterprise, embedded, and semi-custom markets, emphasizing performance and adaptability for visual and computational tasks. By 2024, AMD introduced APUs with a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU, directly targeting AI PCs and embedding AI processing at the edge. This shift, supported by the acquisition of Silo AI and the expansion of the AMD Instinct GPU roadmap, positions AMD to capture a growing market for AI-enhanced consumer and enterprise PCs, thereby significantly enhancing its revenue potential in this emerging segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AMD (ORG) -> APUs (PRODUCT)",
        "APUs (PRODUCT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10939,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3376,
        "completion_tokens": 218,
        "total_tokens": 3594
      }
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "Between 2023 and 2024, the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic has remained consistent in key aspects. In both years, dividends paid by Medtronic are generally subject to a 25% Irish dividend withholding tax unless an exemption applies, such as providing a valid U.S. Certification of Residence (Form 6166) or meeting DTC requirements. U.S. residents who qualify for these exemptions typically do not incur Irish income tax liability, and if withholding tax is applied, it generally discharges any Irish income tax obligation, provided the shareholder reports the withholding to Irish Revenue. No substantive changes in the tax treatment or regulatory framework were disclosed in the 2023 and 2024 filings, indicating continuity in the application of Irish tax rules for U.S. shareholders.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Irish Income Tax (REGULATORY_REQUIREMENT)",
        "Irish Income Tax (REGULATORY_REQUIREMENT) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6744,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2347,
        "completion_tokens": 212,
        "total_tokens": 2560
      }
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "Between 2022 and 2024, BNY Mellon's risk disclosure around new products and services has evolved to include a specific reference to the company's transition to a **platforms operating model**, which was not explicitly mentioned in 2022. In both years, the company highlighted that new lines of business and strategic initiatives introduce new or additional risks, and failure to implement them could affect results of operations. However, in the 2024 10-K, BNY Mellon added a **new risk factor** stating that it may not realize some or all of the expected benefits of its transition to a platforms operating model, indicating a more detailed and specific acknowledgment of the associated uncertainties and risks tied to this strategic initiative.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Subject_To]- ORG",
      "triplets_used": [
        "BK (ORG) -> New Products and Services (PRODUCT)",
        "New Products and Services (PRODUCT) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2022.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6618,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2300,
        "completion_tokens": 186,
        "total_tokens": 2486
      }
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "Between 2023 and 2024, Amazon's relationship with the 3.600% Note due 2032 remained consistent in terms of its debt instrument disclosures, as both the 2023 and 2024 10-K filings reference the same Supplemental Indenture dated April 13, 2022 (Exhibit 4.2), which includes the form of the 3.600% Note due 2032. This indicates that there were no material changes to the terms or structure of the note during this period, and Amazon continued to disclose the note under the same indenture agreement with Computershare Trust Company, National Association, as trustee. The absence of new or amended terms in the 2024 filing suggests stability in Amazon's debt obligations related to this instrument.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> 3.600% Note due 2032 (FIN_INST)",
        "3.600% Note due 2032 (FIN_INST) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9540,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3024,
        "completion_tokens": 173,
        "total_tokens": 3197
      }
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "From 2023 to 2024, MDLZ continued to use net investment hedge derivative contracts, including cross-currency interest rate swaps and forward contracts, to hedge its net investments in non-U.S. operations. In 2023, the company disclosed fair values of derivative assets and liabilities on its consolidated balance sheets, with $1,347 million in derivative assets and $1,209 million in derivative liabilities as of December 31, 2023. By 2024, MDLZ shifted its presentation by incorporating the financial impact of these hedges into \"Other income, net,\" which includes amounts excluded from hedge effectiveness assessments and foreign currency movements on related economic hedges, as detailed in Note 10, Financial Instruments. This evolution reflects a change in how the financial effects of these hedges are presented within the income statement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Net Investment Hedge Derivative Contracts (FIN_INST)",
        "Net Investment Hedge Derivative Contracts (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2183,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 211,
        "total_tokens": 1421
      }
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "From 2023 to 2024, the Abrams Main Battle Tank's modernization strategy has evolved to focus on both technological advancement and expanding international demand. In 2023, General Dynamics (GD) announced the development of the M1E3 Abrams, a significant engineering upgrade that introduces next-generation systems architecture for improved technology integration, reduced sustainment needs, and enhanced mobility. This followed continued delivery of the SEPv3 configuration, which enhanced communications, power generation, and armor. By 2024, international demand for Abrams tanks had grown, with strong procurement and upgrade interest from NATO members and allies in Europe, the Middle East, North Africa, and the Indo-Pacific. This global demand reflects the tank's strategic importance and modernization efforts to maintain battlefield superiority against emerging threats.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Upgrades]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GD (ORG) -> Abrams Main Battle Tank (PRODUCT)",
        "Abrams Main Battle Tank (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7267,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2459,
        "completion_tokens": 219,
        "total_tokens": 2679
      }
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "Between 2022 and 2024, AMD's role in the development and positioning of APUs has evolved significantly in terms of market segmentation and strategic emphasis. In 2022, APUs were part of AMD's broader product portfolio addressing the Enterprise, Embedded, and Semi-Custom markets, with a focus on computational and visual data processing needs in servers and embedded systems. By 2024, APUs were explicitly integrated into AMD's four reportable segments—Data Center, Client, Gaming, and Embedded—highlighting a more strategic and segmented approach. This evolution reflects AMD's emphasis on tailoring APUs to specific market demands, such as high-performance computing in the Data Center segment and consumer-focused computing in the Client segment, thereby strengthening their competitive positioning across diverse applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AMD (ORG) -> APUs (PRODUCT)",
        "APUs (PRODUCT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7298,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2459,
        "completion_tokens": 207,
        "total_tokens": 2666
      }
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries remained consistent from 2023 to 2024. In both years, the 10-K filings stated that the Irish Minister for Finance has the authority to restrict financial transfers under the Act and has imposed such restrictions on a number of third countries, with the list subject to ongoing change. Additionally, both disclosures highlighted that transfers involving entities or governments under United Nations or EU sanctions may also be restricted under Irish law. No substantive changes in the nature or scope of these disclosures were observed between the two periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Financial Transfers Act 1992 (REGULATORY_REQUIREMENT)",
        "Financial Transfers Act 1992 (REGULATORY_REQUIREMENT) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6744,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2347,
        "completion_tokens": 176,
        "total_tokens": 2523
      }
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "From 2023 to 2024, the G700 aircraft transitioned from an upcoming model to one in active production and delivery. In 2023, Gulfstream (GD) disclosed that the G700 was expected to enter service following FAA certification in early 2024. By 2024, GD reported that the G700 had begun deliveries in the second quarter, contributing to a ramp-up in production of new Gulfstream models and an increase in total inventories. This evolution reflects the successful certification and initial commercial rollout of the G700, marking a key milestone in its production outlook.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GD (ORG) -> G700 (PRODUCT)",
        "G700 (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4704,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1797,
        "completion_tokens": 141,
        "total_tokens": 1939
      }
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "From 2023 to 2024, PMI's relationship with KT&G has evolved from a long-term commercialization partnership to a more integrated strategic collaboration, particularly in the commercialization of smoke-free products. In 2023, PMI entered a 15-year agreement with KT&G to exclusively commercialize KT&G’s smoke-free devices and consumables worldwide (excluding South Korea), granting PMI access to KT&G’s innovation pipeline and enhancing its smoke-free product portfolio. By 2024, this partnership is reflected in PMI’s financial reporting, as KT&G’s heat-not-burn products are explicitly included in PMI’s smoke-free net revenues, indicating a deepened dependency on KT&G for product offerings and a shared commitment to regulatory compliance and market expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "PM (ORG) -> KT&G (COMP)",
        "KT&G (COMP) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6338,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2215,
        "completion_tokens": 190,
        "total_tokens": 2405
      }
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "From 2022 to 2024, AMD's approach to semi-custom SoC products has evolved from being primarily revenue-dependent on third-party product success to a more strategic and integrated positioning within a broader AI and adaptive computing ecosystem. In 2022, AMD emphasized that its semi-custom SoC revenue was tied to the success of customer products, with no control over their marketing or market performance. By 2024, AMD repositioned itself as a leader in high-performance and adaptive computing, integrating semi-custom SoCs into a broader portfolio that includes AI accelerators, CPUs, GPUs, and embedded solutions. This shift is supported by AMD’s investment in custom-ready chiplet platforms, Infinity Architecture, and strategic acquisitions like Silo AI, which enhance its ability to deliver end-to-end AI solutions and strengthen its role as a custom-design silicon provider of choice.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Semi-Custom SoC Products (PRODUCT)",
        "Semi-Custom SoC Products (PRODUCT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10912,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3376,
        "completion_tokens": 223,
        "total_tokens": 3599
      }
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "Between 2023 and 2024, the treatment of Irish income tax on dividends paid to U.S. residents has remained largely consistent in terms of exemptions and withholding tax obligations. In both years, U.S. residents are generally exempt from Irish dividend withholding tax (currently at 25%) if they hold shares through DTC with a U.S. address recorded by their broker or provide a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. Shareholders who qualify for these exemptions are also typically not subject to Irish income tax on the dividends, unless they have a connection to Ireland beyond their shareholding. Additionally, withholding tax payments satisfy any potential Irish income tax liability, provided the shareholder submits the required documentation to Irish Revenue. The 2024 filing reaffirms these rules and notes that the U.S./Ireland Double Tax Treaty is generally unnecessary due to the broad exemptions under Irish domestic law.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Irish Income Tax (REGULATORY_REQUIREMENT)",
        "Irish Income Tax (REGULATORY_REQUIREMENT) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2023.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8700,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2829,
        "completion_tokens": 243,
        "total_tokens": 3073
      }
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "From 2023 to 2024, General Dynamics' Marine Systems segment experienced increased revenue in 2023 driven by the Columbia-class submarine program, although its operating margin declined due to cost pressures on the Virginia-class and DDG-51 programs. In 2024, the company expects revenue to rise to approximately $12.8–12.9 billion with an operating margin of about 7.6%, reflecting ongoing challenges in ship construction. The 2024 10-K also highlights General Dynamics' continued involvement in ship construction and repair as a core business area, emphasizing the strategic and financial significance of this segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GD (ORG) -> Ship Construction (PRODUCT)",
        "Ship Construction (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3939,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1650,
        "completion_tokens": 154,
        "total_tokens": 1805
      }
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "BKNG's financial dependency on Booking.com, as measured by the proportion of revenue derived from accommodation reservations, remained relatively stable between 2022 and 2023. In 2022, approximately 89% of BKNG's revenue came from online accommodation reservation services, and this proportion remained nearly unchanged at 89% in 2023. Additionally, the 10-K filing notes that the majority of the Company's merchant revenues and substantially all of its agency revenues are from Booking.com's accommodation reservations, reinforcing the central role of Booking.com in BKNG's revenue structure. The consistency in these percentages indicates that BKNG's financial dependency on Booking.com did not significantly shift during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "BKNG (ORG) -> Booking.com (COMP)",
        "Booking.com (COMP) -> BKNG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BKNG_10k_2022.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BKNG_10k_2023.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7859,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2600,
        "completion_tokens": 183,
        "total_tokens": 2783
      }
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "Between 2023 and 2024, the company's Swiss Franc note, which had a carrying value of $299 million as of December 31, 2023, was fully repaid by December 31, 2024, as it was no longer listed in the 2024 disclosures. This indicates that the company settled its foreign currency obligation related to the Swiss Franc note, which was due in 2024. The repayment reflects a reduction in the company's foreign currency exposure and aligns with the broader trend of decreasing foreign currency obligations, as seen in the reductions of Euro notes and other foreign currency debt during the same period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "PM (ORG) -> Swiss Franc Note (FIN_INST)",
        "Swiss Franc Note (FIN_INST) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4239,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1701,
        "completion_tokens": 148,
        "total_tokens": 1849
      }
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "Between the 2023 and 2024 10-K filings, Goldman Sachs continued to reference the pre-2015 **Form of Non-Employee Director RSU Award Agreement** in both filings (Chunk 1 and Chunk 2), indicating no material change to this specific agreement during the period. However, in the 2024 filing, a new entry titled **\"Amendments to Certain Non-Employee Director Equity Award Agreements\"** was included (Chunk 2), which suggests that modifications were introduced or documented in 2024, likely affecting the terms or administration of these agreements. Thus, while the core RSU award agreement remained unchanged, the 2024 filing reflects an updated acknowledgment or formalization of amendments to these agreements, signaling a procedural or substantive evolution in their treatment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Adopts]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "GS (ORG) -> Non-Employee Director RSU Award Agreement (ACCOUNTING_POLICY)",
        "Non-Employee Director RSU Award Agreement (ACCOUNTING_POLICY) -> GS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_246",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10010,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3167,
        "completion_tokens": 193,
        "total_tokens": 3361
      }
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "Between 2023 and 2024, PM's financial relationship with Swedish Match AB, particularly in terms of long-term debt obligations tied to the acquisition, evolved as reflected in the debt structure. In 2023, PM had significant long-term debt obligations related to the Swedish Match acquisition, including $6,121 million in euro credit facility borrowings due through 2027. By 2024, this amount had decreased to $2,610 million, indicating a reduction in debt specifically tied to the acquisition. This reduction, combined with the earlier goodwill adjustments in 2023 due to the final purchase price allocation for Swedish Match, reflects PM's ongoing financial integration and restructuring following the acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "PM (ORG) -> Swedish Match AB (COMP)",
        "Swedish Match AB (COMP) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3574,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 178,
        "total_tokens": 1710
      }
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "From 2023 to 2024, BMY significantly advanced its strategic positioning around KRAS inhibition through the acquisition of Mirati in January 2024, which added the FDA-approved KRAS G12C inhibitor Krazati to its portfolio. In 2023, BMY's focus on oncology was evident through collaborations with BridgeBio and 2seventy bio, but it was the 2024 acquisition of Mirati that marked a pivotal shift, securing Krazati as a key asset for treating non-small cell lung cancer (NSCLC) in second-line therapy and in combination with a PD-1 inhibitor for first-line therapy. Additionally, the acquisition provided access to clinical-stage assets like MRTX1719, a PRMT5 inhibitor, further strengthening BMY's pipeline in targeted oncology. This strategic move underscores BMY's commitment to expanding its presence in KRAS inhibition and enhancing its therapeutic offerings in lung cancer.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Adds]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Krazati (PRODUCT)",
        "Krazati (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6451,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2252,
        "completion_tokens": 218,
        "total_tokens": 2470
      }
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "Goldman Sachs disclosed the Amended and Restated Restricted Partner Compensation Plan in both its 2023 and 2024 10-K filings, indicating continuity in its adoption of this accounting policy. However, in 2024, the firm introduced a new governance policy—the Amended and Restated Clawback Policy, effective December 1, 2023—which was not present in the 2023 filing. This evolution reflects a broader enhancement of compensation governance, with the Clawback Policy likely reinforcing accountability and aligning with regulatory expectations by enabling the recovery of compensation under certain conditions. Thus, while the Restricted Partner Compensation Plan remained consistent, the introduction of the Clawback Policy in 2024 marked a significant addition to Goldman Sachs’ compensation governance framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Adopts]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "GS (ORG) -> Restricted Partner Compensation Plan (ACCOUNTING_POLICY)",
        "Restricted Partner Compensation Plan (ACCOUNTING_POLICY) -> GS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_246",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10010,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3174,
        "completion_tokens": 202,
        "total_tokens": 3376
      }
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "From 2022 to 2023, Philip Morris International (PMI) evolved its approach to heat-not-burn products by integrating them more explicitly into its broader smoke-free product portfolio and reiterating their categorization as reduced-risk products (RRPs). In 2022, PMI described heat-not-burn products, such as HEETS and the IQOS Platform 1, as part of its RRPs, emphasizing their potential to reduce harm compared to traditional cigarettes. By 2023, PMI further clarified the categorization of heat-not-burn products as smoke-free products, placing them alongside e-vapor and oral nicotine products under the broader smoke-free revenue category, distinct from combustible tobacco. Additionally, the 2023 filing highlighted the inclusion of licensed KT&G heat-not-burn products, reflecting a more integrated and expanded business approach to heat-not-burn offerings across markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "PM (ORG) -> Heat-Not-Burn Products (PRODUCT)",
        "Heat-Not-Burn Products (PRODUCT) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6979,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2390,
        "completion_tokens": 219,
        "total_tokens": 2609
      }
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "Between 2023 and 2024, Bristol-Myers Squibb (BMY) reinforced its business risk governance framework in alignment with its SEC Consent Order compliance, particularly through the continued role of the business risk and disclosure group. In 2023, BMY explicitly outlined the establishment of this group as part of the Consent Order measures, emphasizing its role in enhancing internal controls and ensuring transparency in financial reporting and sales practices. By 2024, BMY reiterated the same governance procedures and compliance mechanisms, including the business risk and disclosure group, indicating a sustained commitment to these practices without introducing new structural changes. This consistency suggests that the group remained a central component of BMY’s risk management and disclosure processes throughout both years, supporting adherence to the Consent Order and broader regulatory expectations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Establishes]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Business Risk Group (ACCOUNTING_POLICY)",
        "Business Risk Group (ACCOUNTING_POLICY) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10899,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3388,
        "completion_tokens": 227,
        "total_tokens": 3615
      }
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "Between 2023 and 2024, UNP has consistently based the expected return on its pension plan assets on the asset allocation mix and historical returns, adjusted for market conditions, as noted in both the 2023 and 2024 10-K filings. However, the 2023 filing provides specific actual return figures (6% in 2023), while the 2024 filing omits such details, suggesting a shift toward emphasizing the methodology over recent performance in its disclosure. This evolution reflects a continued reliance on asset allocation as a key determinant of expected returns, with a more generalized presentation in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Considers]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Asset Allocation Mix (ACCOUNTING_POLICY)",
        "Asset Allocation Mix (ACCOUNTING_POLICY) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_9",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_9",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1082,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 916,
        "completion_tokens": 150,
        "total_tokens": 1066
      }
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon enhanced the accessibility and integration of its Directors' Code of Conduct within corporate governance reporting. In 2022, the Code was disclosed as part of the Proxy Statement and referenced in the 10-K under Item 10, with a commitment to post it on the company’s website for public access and to disclose amendments or waivers there. By 2023, the Directors' Code of Conduct was explicitly listed among the materials made freely available on the company’s website, alongside other key governance documents such as the Corporate Governance Guidelines and Committee Charters, indicating a more centralized and proactive integration into broader corporate governance disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "BK (ORG) -> Directors' Code of Conduct (ACCOUNTING_POLICY)",
        "Directors' Code of Conduct (ACCOUNTING_POLICY) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6873,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2380,
        "completion_tokens": 178,
        "total_tokens": 2558
      }
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "Between 2023 and 2024, Oracle has enhanced the strategic positioning of Oracle Database by expanding its deployment flexibility through offerings like Oracle Exadata Cloud@Customer, OCI Dedicated Region, and Oracle Roving Edge Infrastructure, enabling secure, on-premise execution of cloud services and supporting hybrid and multicloud environments. The 2024 filing highlights deeper integration with Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, and hardware for optimized performance and scalability across on-premise and cloud deployments. These developments indicate Oracle’s continued focus on facilitating cloud migration and supporting hybrid IT environments by providing customers with seamless, secure, and flexible options to run workloads across diverse infrastructures, aligning with the evolving demand for hybrid and multicloud solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Utilizes]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Database (PRODUCT)",
        "Oracle Database (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8463,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2782,
        "completion_tokens": 228,
        "total_tokens": 3010
      }
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "Between 2023 and 2024, Bristol-Myers Squibb (BMY) continued to enforce and refine its formal review and certification process for annual and quarterly SEC reports, as mandated by the 2004 SEC Consent Order. In 2023, BMY emphasized the establishment of governance procedures to escalate compliance concerns and ensure timely resolution, along with regular monitoring of compliance with its company-wide policy on sales to direct customers. By 2024, these procedures remained in place, with a continued focus on compliance monitoring and governance, particularly in relation to limiting sales based on expected demand and avoiding excessive inventory accumulation. The formal review process was integrated into broader financial reporting controls, including the oversight of GTN sales adjustments and revenue recognition, reflecting an ongoing commitment to strengthen internal controls and transparency in SEC filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Establishes]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Formal Review Process (ACCOUNTING_POLICY)",
        "Formal Review Process (ACCOUNTING_POLICY) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10899,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3388,
        "completion_tokens": 229,
        "total_tokens": 3618
      }
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "From 2022 to 2023, Philip Morris International (PMI) has evolved its approach to heat-not-burn products by more clearly positioning them within its broader smoke-free product portfolio and refining their categorization in financial reporting. In 2022, PMI described heat-not-burn products as part of its reduced-risk products (RRPs), emphasizing their potential to present less risk to smokers who switch from combustible products. By 2023, PMI explicitly categorized heat-not-burn products under its \"smoke-free products\" in revenue reporting, aligning them with e-vapor and oral nicotine products and reflecting a strategic shift toward a smoke-free market positioning. Additionally, the 2023 filing noted that PMI's heat-not-burn products include licensed KT&G products, indicating an expanded commercialization strategy through partnerships.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "PM (ORG) -> Heat-Not-Burn Products (PRODUCT)",
        "Heat-Not-Burn Products (PRODUCT) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5645,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2057,
        "completion_tokens": 211,
        "total_tokens": 2268
      }
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "Oracle's strategic positioning of Oracle Database between 2023 and 2024 has evolved to emphasize greater deployment flexibility and deeper integration with other Oracle technologies. In 2023, Oracle highlighted increased customer demand for cloud-based deployments, with cloud services revenues rising to 37% of total revenues in fiscal 2024 from 32% in 2023, reflecting a strategic shift toward enabling customers to pivot licenses and workloads to Oracle Cloud Infrastructure (OCI). By 2024, Oracle further reinforced this strategy by offering Oracle Engineered Systems, such as the Oracle Exadata Database Machine, through flexible deployment options—on-premise, as a cloud service in OCI, or as a hybrid solution. These systems integrate Oracle Database with storage, operating system software, and hardware, enhancing performance and simplifying maintenance. Additionally, Oracle Middleware and Java technologies continue to support Oracle Database by enabling seamless integration across Oracle and non-Oracle environments, facilitating application development and deployment across diverse IT ecosystems. This evolution underscores Oracle’s commitment to providing a cohesive, flexible, and interoperable technology stack.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Database (PRODUCT)",
        "Oracle Database (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9312,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2970,
        "completion_tokens": 307,
        "total_tokens": 3277
      }
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "BMY's strategic relationship with Krazati evolved significantly from 2023 to 2024, transitioning from portfolio integration to full acquisition. In 2023, Krazati was highlighted as a key addition to BMY’s oncology portfolio following its acquisition of Mirati, with the drug already approved for second-line NSCLC and in development for first-line use in combination with a PD-1 inhibitor. By 2024, BMY completed the full acquisition of Mirati for $4.8 billion (net $4.1 billion), securing commercial rights to Krazati and other clinical assets like the PRMT5 Inhibitor. The transaction also included a contingent value right (CVR) of up to $1.0 billion tied to the FDA acceptance of an NDA for the PRMT5 Inhibitor within seven years, underscoring BMY’s long-term commitment to advancing Krazati and related therapies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Krazati (PRODUCT)",
        "Krazati (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9016,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2890,
        "completion_tokens": 204,
        "total_tokens": 3094
      }
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "Based on BK's SEC filings in both 2022 and 2023, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV remained registered under Section 12(b) of the Exchange Act and continued to trade on the New York Stock Exchange under the symbol \"BK/P.\" The status of these securities as being \"fully and unconditionally guaranteed by The Bank of New York Mellon Corporation\" (BK) was consistent between the two years, indicating no material change in BK's obligation or the securities' treatment during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "BK (ORG) -> 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV (FIN_INST)",
        "6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV (FIN_INST) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2022.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2314,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 135,
        "total_tokens": 1395
      }
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "From 2022 to 2023, PMI's short-term credit arrangements increased from approximately $1.9 billion at December 31, 2022, to $2.7 billion at December 31, 2023, while borrowings under these arrangements slightly decreased from $295 million to $283 million. This increase in available credit capacity, combined with low utilization (less than 10% in both years), suggests that PMI maintains a strong near-term liquidity posture, with ample access to short-term financing to meet working capital needs and manage operational flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Maintains]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "PM (ORG) -> Short-Term Credit Arrangements (FIN_INST)",
        "Short-Term Credit Arrangements (FIN_INST) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3147,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 133,
        "total_tokens": 1571
      }
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "Between 2023 and 2024, Oracle has enhanced the positioning of its Autonomous Database by emphasizing deeper integration with other Oracle Cloud services and expanding automation capabilities. In 2023, the Autonomous Database was described as part of Oracle's broader infrastructure technologies, marketed through cloud and license offerings, with a focus on performance, scalability, and deployment flexibility across cloud, on-premise, and hybrid environments. By 2024, the Autonomous Database was highlighted as a self-driving solution that automates routine database tasks such as maintenance, tuning, and security, while integrating with services like Java Cloud, Oracle APEX, and Oracle Analytics Cloud to provide a modern, open platform for cloud-native application development. Additionally, Oracle emphasized consumption-based pricing, automatic scaling, and enhanced machine learning-driven diagnostics, reflecting a stronger focus on cost efficiency and operational agility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Autonomous Database (PRODUCT)",
        "Oracle Autonomous Database (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9307,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2976,
        "completion_tokens": 246,
        "total_tokens": 3222
      }
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "Between 2023 and 2024, GM's financial relationship with Ultium Cells Holdings LLC evolved in terms of capital involvement and strategic positioning, as reflected in its investment and exposure levels. In 2023, GM had committed capital contributions of $0.8 billion to Ultium Cells Holdings LLC, with a maximum exposure to loss of $3.5 billion. By 2024, GM's investment in Ultium Cells Holdings LLC remained significant, with $0.7 billion in contributions for both 2024 and 2023, indicating continued strategic alignment with the venture. However, GM maintained that it lacked the power to directly influence the activities of Ultium Cells Holdings LLC, highlighting a non-controlling, yet financially committed, partnership.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "GM (ORG) -> Ultium Cells Holdings LLC (COMP)",
        "Ultium Cells Holdings LLC (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2282,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 181,
        "total_tokens": 1396
      }
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "Between 2022 and 2024, the financial impact of the Litigation Management Deed evolved as follows: on June 21, 2022 (sixth anniversary of the Visa Europe acquisition), Visa released $3.5 billion of as-converted value and issued 176,655 series A preferred shares (Sixth Anniversary Release). By June 21, 2024 (eighth anniversary), the as-converted value released had decreased to $2.7 billion, with 99,264 series A preferred shares issued (Eighth Anniversary Release). These releases reflect adjustments to the conversion rates of series B and C preferred stock in response to recorded VE territory covered losses, with the amount of value released and shares issued declining over the two-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "V (ORG) -> Litigation Management Deed (ACCOUNTING_POLICY)",
        "Litigation Management Deed (ACCOUNTING_POLICY) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10738,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3356,
        "completion_tokens": 175,
        "total_tokens": 3531
      }
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "Between 2023 and 2024, the financial and strategic relationship between 3M and the Aearo Entities evolved significantly due to litigation and business segment adjustments. In 2022, 3M deconsolidated the Aearo Entities as part of bankruptcy proceedings, committing $1.2 billion to fund a trust for litigation claims related to Combat Arms Earplugs and respirator mask/asbestos cases. However, in June 2023, the bankruptcy was dismissed, prompting 3M to reconsolidate the Aearo Entities in Q2 2023. This reconsolidation had an immaterial impact on 3M’s income statement. By 2024, the Aearo Entities were reflected in 3M’s Transportation and Electronics segment, with their divestiture and reconsolidation impacts treated as separate adjustments in sales and operating income. Litigation continued to influence the relationship, culminating in the August 2023 CAE Settlement, which aimed to resolve all Combat Arms Earplug claims. The reconsolidation also affected segment reporting, with the Aearo Entities contributing to the Transportation and Electronics segment’s sales and margin dynamics, particularly amid broader challenges like PFAS product exits and market headwinds.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Reconsolidates]-> COMP <-[Involved_In]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Aearo Entities (COMP)",
        "Aearo Entities (COMP) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8365,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2736,
        "completion_tokens": 293,
        "total_tokens": 3030
      }
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "Between 2022 and 2024, the financial treatment of Class C Common Stock has shown a notable evolution in earnings per share (EPS) performance, while its structural relationship with other stock classes has remained largely consistent. In 2022, disclosures highlighted that Class C Common Stock, along with Class B Common Stock and preferred stock, retains limited voting rights but can influence significant corporate actions, such as mergers or changes in control. By 2024, the EPS for Class C Common Stock was $33.17 for basic earnings and $33.13 for diluted earnings, significantly outpacing both Class A ($8.29 basic, $8.28 diluted) and Class B-1 ($13.26 basic, $13.24 diluted) common stock. This disparity in EPS performance underscores a growing financial distinction between the classes, despite their shared structural role in corporate governance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Class C Common Stock (FIN_INST)",
        "Class C Common Stock (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7025,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2409,
        "completion_tokens": 213,
        "total_tokens": 2623
      }
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "From fiscal 2022 to fiscal 2024, Qualcomm's involvement in the development and commercialization of ADAS/AD technology has evolved from strategic investment and R&D focus to explicit revenue generation through product sales. In fiscal 2022, Qualcomm's engagement in ADAS/AD was primarily through its QSI segment, which made strategic investments in early-stage companies and supported the design and introduction of new technologies, including ADAS/AD, as part of its broader R&D and innovation efforts. The 10-K also highlighted Qualcomm's continued investment in technologies beyond mobile handsets, including ADAS/AD, through its engineering resources and acquisitions. By fiscal 2024, ADAS/AD had transitioned into a revenue-generating category under QCT's product offerings, with specific revenue recognition from products sold for use in automobiles, including ADAS/AD, indicating a shift from investment and development to commercialization. This evolution reflects Qualcomm's strategic move to expand its technology footprint into automotive applications and monetize its ADAS/AD innovations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Develops]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> ADAS/AD (PRODUCT)",
        "ADAS/AD (PRODUCT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7353,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2488,
        "completion_tokens": 275,
        "total_tokens": 2763
      }
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "Between 2022 and 2024, Visa's U.S. Retrospective Responsibility Plan evolved from a mechanism primarily involving a U.S. litigation escrow account to a more comprehensive framework that includes a U.S. litigation escrow agreement, the conversion feature of class B common stock, makewhole agreements, indemnification obligations of Visa U.S.A. Inc. members, interchange judgment sharing, loss sharing, and an omnibus agreement. This expansion reflects a more structured and diversified approach to managing litigation risk, particularly in addressing monetary liabilities from settlements or judgments in U.S. covered litigation. The evolution suggests that Visa is enhancing its risk mitigation strategies by incorporating multiple financial and contractual safeguards, indicating a proactive stance in managing potential legal exposures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "V (ORG) -> Retrospective Responsibility Plan (ACCOUNTING_POLICY)",
        "Retrospective Responsibility Plan (ACCOUNTING_POLICY) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7201,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2482,
        "completion_tokens": 209,
        "total_tokens": 2691
      }
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "Merck's financial stake in Lynparza, as of December 31, 2023, was valued at $1.5 billion, reflecting its collaboration with AstraZeneca. By 2024, while no updated valuation of the stake is explicitly provided, indicators suggest increased strategic importance and performance: alliance revenue from Lynparza grew by 9%, driven by higher demand in international markets, and in January 2025, it received approval in China for a new indication in early breast cancer, further expanding its market potential. These developments highlight both the growing commercial success and regulatory progress of Lynparza during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Lynparza (PRODUCT)",
        "Lynparza (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5218,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1946,
        "completion_tokens": 156,
        "total_tokens": 2103
      }
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "Between 2022 and 2024, Skoal's market position within Altria's oral tobacco products segment declined, as evidenced by its retail share dropping from 9.3% in 2023 to 7.6% in 2024. This decline contrasts with the performance of Copenhagen, which also saw a decrease in retail share (from 23.5% to 19.1%), and on! oral nicotine pouches, which experienced a modest increase (from 6.8% to 8.3%). Despite Skoal's continued inclusion in the segment alongside premium and value brands like Copenhagen and Red Seal, its relative competitive position weakened over the period, as it lost market share to both its traditional MST competitors and newer nicotine pouch offerings. The overall oral tobacco segment's total retail share also declined from 42.5% in 2023 to 37.5% in 2024, reflecting broader industry and regulatory pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Skoal (PRODUCT)",
        "Skoal (PRODUCT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6651,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2303,
        "completion_tokens": 206,
        "total_tokens": 2510
      }
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "Between fiscal years 2022 and 2023, the revenue contribution from Dynamics 365 within Microsoft Cloud increased significantly. In fiscal year 2022, Microsoft Cloud revenue was $91.2 billion, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, Microsoft Cloud revenue rose to $111.6 billion, and while the exact growth rate for Dynamics 365 is not specified, its inclusion in the broader Microsoft Cloud portfolio indicates it contributed to the overall 22.3% year-over-year increase in Microsoft Cloud revenue. This growth reflects the continued strength and adoption of Dynamics 365 as a core component of Microsoft's cloud offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Dynamics 365 (PRODUCT)",
        "Dynamics 365 (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5436,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1986,
        "completion_tokens": 177,
        "total_tokens": 2163
      }
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "From 2023 to 2024, Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program has evolved by expanding the scope of hedging activities and diversifying the instruments used. In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange rate volatility on monetary assets and liabilities, with a focus on major currencies like the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. In 2024, the Company introduced a more comprehensive foreign currency risk management framework, which includes revenue hedging, balance sheet risk management, and net investment hedging programs. To hedge forecasted foreign currency denominated sales, Merck now employs a mix of purchased local currency put options, forward contracts, and purchased collar options, with a planning horizon of up to two years. Additionally, the Company continues to use forward contracts for balance sheet risk management, but now explicitly emphasizes layering in hedges over time and applying cost-benefit analyses to determine the portion of forecasted sales to hedge.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Balance Sheet Risk Management Program (ACCOUNTING_POLICY)",
        "Balance Sheet Risk Management Program (ACCOUNTING_POLICY) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7383,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2520,
        "completion_tokens": 306,
        "total_tokens": 2826
      }
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "PayPal's involvement with merchant receivables grew significantly between 2022 and 2024, as reflected in both its direct investment and credit loss provisions. In 2022, PayPal established an allowance for credit losses on merchant receivables based on historical loss data and macroeconomic forecasts, with a principal and interest coverage ratio of 9% by year-end. By 2024, PayPal had expanded its merchant financing offerings through its PPWC and PPBL products, purchasing $1.8 billion in merchant receivables, up from $1.7 billion in 2023, with the total outstanding balance rising to $1.5 billion (net of $53 million participation interest sold). The allowance for credit losses on the consumer receivables portfolio decreased to $348 million in 2024 from $380 million in 2023, reflecting improved credit quality in certain markets, though merchant receivables are serviced and managed directly by PayPal, indicating a deeper financial commitment compared to 2022 when the focus was more on external macroeconomic modeling.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Merchant Receivables (FIN_INST)",
        "Merchant Receivables (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9804,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3101,
        "completion_tokens": 256,
        "total_tokens": 3358
      }
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "From 2022 to 2024, smokeable products have remained a significant part of MO's operations, both in terms of goodwill allocation and operating income performance. In 2022, smokeable products had $99 million in goodwill, with $3,017 million in other intangible assets, indicating a stable asset base. By 2024, smokeable products generated $10,821 million in operating income, a slight increase from $10,670 million in 2023, despite a decline in net revenues from $21,756 million in 2023 to $21,204 million in 2024. This suggests that while revenue for smokeable products has decreased slightly, their profitability has remained robust, highlighting their continued financial significance to MO.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Smokeable products (PRODUCT)",
        "Smokeable products (PRODUCT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3114,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 173,
        "total_tokens": 1592
      }
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "The revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud was $91.2 billion in fiscal year 2022 and remained part of the $137.4 billion Microsoft Cloud revenue in fiscal year 2023. While the exact LinkedIn contribution for 2023 is not specified, it is included in the overall Microsoft Cloud growth from $91.2 billion in 2022 to $137.4 billion in 2023, indicating a positive contribution to the overall increase.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> LinkedIn Commercial (PRODUCT)",
        "LinkedIn Commercial (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2435,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 110,
        "total_tokens": 1355
      }
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "Between 2023 and 2024, the commercialization and market expansion of Lynparza evolved significantly, with key geographic approvals and notable revenue growth. In May 2023, Lynparza received FDA approval for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC), and by August 2023, it was approved in Japan for the same indication. In 2024, alliance revenue related to Lynparza grew by 9%, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, further expanding its global footprint and reinforcing its commercial momentum.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Lynparza (PRODUCT)",
        "Lynparza (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10827,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3342,
        "completion_tokens": 180,
        "total_tokens": 3522
      }
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "Between 2023 and 2024, RTX's financial treatment of the Powder Metal Matter, as reflected in its future income tax benefits, decreased from $644 million in 2023 to $455 million in 2024. This reduction indicates a decline in the anticipated tax benefits associated with this matter, which is disclosed by RTX as a risk factor. The change suggests a potential adverse impact on future tax benefits, aligning with the risk-related nature of the Powder Metal Matter and its influence on RTX's financial reporting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "RTX (ORG) -> Powder Metal Matter (RISK_FACTOR)",
        "Powder Metal Matter (RISK_FACTOR) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2024.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1772,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1086,
        "completion_tokens": 127,
        "total_tokens": 1213
      }
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "From 2022 to 2024, the borrowing capacity and terms of the Paidy Credit Agreement evolved significantly. In October 2021, PayPal assumed the Paidy Credit Agreement, which initially provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding and $100 million in available borrowing capacity. By February 2022, the agreement was restructured as an unsecured facility, and in September 2022, it was expanded by ¥30.0 billion (approximately $287 million), increasing the total borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024). The terms also shifted to an unsecured basis, with interest rates based on the Tokyo Interbank Offered Rate plus a margin of 0.40% to 0.60%, and the facility is set to mature in February 2027. This evolution reflects PayPal's strategic enhancement of Paidy's credit flexibility and alignment with broader financial objectives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Assumes]-> FIN_INST <-[Announces]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Paidy Credit Agreement (FIN_INST)",
        "Paidy Credit Agreement (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10551,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3265,
        "completion_tokens": 233,
        "total_tokens": 3498
      }
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "Altria's reliance on long-term senior unsecured notes as part of its capital resources remained consistent between 2022 and 2024, as both filings mention access to credit markets through the issuance of these notes. In 2022, Altria had $4.5 billion in cash and cash equivalents and referenced its ability to issue long-term senior unsecured notes as part of its capital resources. By 2024, cash and cash equivalents had decreased to $3.1 billion, but the company still maintained access to long-term senior unsecured notes as a key component of its capital structure, alongside its $3.0 billion senior unsecured credit agreement. Thus, while cash reserves declined, Altria continued to rely on long-term senior unsecured notes as a stable source of liquidity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Long-Term Senior Unsecured Notes (FIN_INST)",
        "Long-Term Senior Unsecured Notes (FIN_INST) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7357,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2478,
        "completion_tokens": 189,
        "total_tokens": 2668
      }
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "RTX's financial treatment of the Powder Metal Matter showed a decrease in future income tax benefits from $644 million in 2023 to $455 million in 2024, as detailed in the 2024 10-K. This decline suggests a reduced impact of the matter on tax benefits, potentially due to changes in the related liabilities or adjustments in tax accounting. The Powder Metal Matter, disclosed as a risk factor by RTX, thus appears to have a diminishing influence on future tax positions, indicating a possible resolution or reclassification of the associated financial exposure over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "RTX (ORG) -> Powder Metal Matter (RISK_FACTOR)",
        "Powder Metal Matter (RISK_FACTOR) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2024.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2961,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 144,
        "total_tokens": 1529
      }
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "PayPal's utilization of the Paidy Credit Agreement evolved significantly between 2022 and 2024. In 2022, the facility had a borrowing capacity of approximately $198 million, with $98 million outstanding, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion) following a modification in September 2022. During 2024, the full $574 million was drawn down, leaving no available borrowing capacity. This reflects a substantial increase in both capacity and utilization, indicating a more aggressive use of the facility to fund loan receivables over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Paidy Credit Agreement (FIN_INST)",
        "Paidy Credit Agreement (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7423,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2498,
        "completion_tokens": 157,
        "total_tokens": 2656
      }
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "From 2023 to 2024, the ownership structure between Accenture plc and Accenture Canada Holdings Inc. remained closely interlinked, with Accenture plc maintaining control over Accenture Canada Holdings Inc., and the latter's equity structure involving exchangeable shares tied to Accenture plc's Class A ordinary shares. As of August 31, 2024, noncontrolling interests in Accenture Canada Holdings Inc. held by current and former members of Accenture Leadership were less than 1%, reflecting continued consolidation of ownership under Accenture plc. Additionally, Accenture Canada Holdings Inc. exchangeable shares, held primarily by pre-incorporation partners in Canada and New Zealand, remained redeemable or exchangeable for Accenture plc Class A ordinary shares on a one-for-one basis, with Accenture plc retaining the option to redeem Class X ordinary shares to align with outstanding exchangeable shares. This structure ensures that the equity relationship remains dynamic and subject to ongoing management and leadership transitions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Accenture Canada Holdings Inc. (COMP)",
        "Accenture Canada Holdings Inc. (COMP) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4987,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1905,
        "completion_tokens": 259,
        "total_tokens": 2164
      }
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "Between 2022 and 2024, Merck's approach to managing balance sheet risk through forward exchange contracts has remained consistent in its core strategy but has evolved in terms of currency scope and cost-benefit considerations. In both years, Merck primarily uses forward exchange contracts to hedge net monetary assets denominated in currencies other than a subsidiary's functional currency, focusing on developed market currencies such as the euro, Japanese yen, British pound, Canadian dollar, and Swiss franc. However, in 2024, the company expanded its hedging rationale for developing country currencies like the Chinese renminbi, entering forward contracts when deemed economical based on a more refined cost-benefit analysis that considers exposure magnitude, exchange rate volatility, and hedging costs. Additionally, Merck continued to layer hedges over time, increasing coverage as forecasted sales approach, with decisions influenced by updated assessments of natural offsetting exposures and market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Establishes]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Balance Sheet Risk Management Program (ACCOUNTING_POLICY)",
        "Balance Sheet Risk Management Program (ACCOUNTING_POLICY) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9251,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2979,
        "completion_tokens": 255,
        "total_tokens": 3234
      }
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "The change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024, as reflected in the future income tax benefits, suggests a reduction in its ongoing financial impact. In 2023, the Powder Metal Matter contributed $644 million to future income tax benefits, but this decreased to $455 million in 2024, indicating a decline in the associated tax benefit. This reduction implies that the financial impact of the Powder Metal Matter on future tax benefits is diminishing over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "RTX (ORG) -> Powder Metal Matter (RISK_FACTOR)",
        "Powder Metal Matter (RISK_FACTOR) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2024.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3160,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 123,
        "total_tokens": 1561
      }
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "PayPal's involvement in the merchant receivables space has expanded between 2022 and 2024, both in terms of scale and partnership structure. In 2022, PayPal originated and serviced merchant receivables through its PayPal Working Capital (PPWC) and PayPal Business Loan (PPBL) products, with U.S. offerings facilitated by WebBank, a partner institution that extended credit and allowed PayPal to purchase the related receivables. By 2024, PayPal continued this partnership model, purchasing $1.8 billion in merchant receivables, up from $1.7 billion in 2023, with the total outstanding balance rising to $1.5 billion (net of $53 million in participation interests sold to the partner institution) from $1.2 billion in 2023 (net of $44 million). This growth reflects PayPal's increasing scale in merchant finance, supported by its continued collaboration with partner institutions to manage credit risk and expand access to small and medium-sized businesses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Merchant Receivables (FIN_INST)",
        "Merchant Receivables (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9471,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3022,
        "completion_tokens": 239,
        "total_tokens": 3261
      }
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "Merck's alliance revenue from Lynparza grew by 9% in 2024, as noted in Chunk 2, primarily due to higher demand in most international markets. Referring to Chunk 1, the alliance revenue from Lynparza was $989 million in 2022 (total U.S. and international). This growth was further supported by the approval of Lynparza in China in January 2025 for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, which is expected to drive additional demand. Thus, the increase in 2024 was driven by both international demand and regulatory approvals expanding the drug's market reach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Lynparza (PRODUCT)",
        "Lynparza (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_141",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10544,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3261,
        "completion_tokens": 159,
        "total_tokens": 3420
      }
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "PayPal's involvement in merchant receivables has grown significantly between 2022 and 2024, both in terms of financial exposure and operational role. In 2022, the company disclosed credit risk management practices for merchant receivables, including net charge-offs and reserve adjustments under the CECL accounting standard. By 2024, PayPal had expanded its merchant finance offerings, purchasing $1.8 billion in merchant receivables, up from $1.7 billion in 2023, with an outstanding balance of $1.5 billion as of December 31, 2024, compared to $1.2 billion in 2023. Operationally, PayPal not only purchases these receivables but also assumes servicing responsibilities, structuring repayment through fixed percentages of future payment volumes for PPWC and fixed periodic payments for PPBL, thereby deepening its role in merchant financial solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Merchant Receivables (FIN_INST)",
        "Merchant Receivables (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4152,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1679,
        "completion_tokens": 213,
        "total_tokens": 1892
      }
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "From 2022 to 2024, Merck’s involvement in the development and commercialization of Lynparza has evolved significantly in terms of regulatory progress and revenue growth. In 2022, the FDA accepted for priority review a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk, early-stage breast cancer, with a PDUFA date in early 2022. By 2024, alliance revenue related to Lynparza grew by 9%, driven by higher demand in international markets. Additionally, in January 2025, Lynparza received approval in China for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, marking a key regulatory expansion. These developments reflect both regulatory advancements and revenue growth in Lynparza’s commercialization under Merck’s collaboration with AstraZeneca.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Lynparza (PRODUCT)",
        "Lynparza (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8863,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2854,
        "completion_tokens": 215,
        "total_tokens": 3069
      }
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "Between 2022 and 2024, Boeing's strategy with commodity purchase contracts has evolved to extend the risk management horizon and enhance financial exposure control. In 2022, Boeing used commodity purchase contracts and swaps to hedge against price fluctuations, with a 10% market price change impacting unrealized losses by $46 million. By 2024, Boeing expanded the use of these contracts as part of its cash flow hedges, extending foreign currency forward contracts to manage risk through 2031 and incorporating commodity derivatives to hedge expected commodity costs over a longer timeframe. This shift indicates a more forward-looking approach to risk management, aiming to stabilize financial exposure by locking in prices for longer periods and reducing the volatility of commodity costs on its production activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "BA (ORG) -> Commodity Purchase Contracts (FIN_INST)",
        "Commodity Purchase Contracts (FIN_INST) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4624,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1801,
        "completion_tokens": 205,
        "total_tokens": 2007
      }
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "Schwab's exposure to PALs and the associated credit risk evolved between 2021 and 2024, with PALs being fully collateralized by securities in 2021, resulting in no allowance for credit losses being required at that time. By 2024, while there was a slight decrease in PALs in 2023, the overall growth in Schwab's loan portfolio, including PALs, continued due to an expanding client base and assets. The credit risk decreased over this period, as evidenced by a reduction in the allowance for credit losses, driven by lower projected loss rates and improved credit quality metrics in the bank loans portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> PALs (FIN_INST)",
        "PALs (FIN_INST) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_142",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1776,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1081,
        "completion_tokens": 151,
        "total_tokens": 1233
      }
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "Between 2022 and 2024, Boeing's financial treatment and strategic positioning of the 777X program evolved with increasing R&D investments and ongoing cost impacts. In 2022, the 777X program contributed to higher research and development expenses, which rose by $525 million in 2023 compared to 2022, driven by continued expenditures on the program. This trend continued in 2024, with R&D expenses increasing by an additional $435 million compared to 2023, primarily due to ongoing development efforts for the 777X at BCA and broader enterprise investments. These escalating R&D costs reflect Boeing's sustained strategic focus on advancing the 777X program despite earlier cost challenges, such as the reach-forward loss and other charges noted in 2020, which had negatively impacted financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "BA (ORG) -> 777X Program (PRODUCT)",
        "777X Program (PRODUCT) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1610,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1048,
        "completion_tokens": 201,
        "total_tokens": 1250
      }
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "Between 2022 and 2024, Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved with a focus on maintaining limited credit risk through collateral management and refining credit loss allowance methodologies. In 2022, Schwab applied a practical expedient for estimating credit losses on PALs due to their over-collateralized nature, with collateral monitored daily and adjusted as needed. By 2024, while there was a slight decrease in PALs in 2023, the overall loan portfolio growth—driven by client and asset growth—continued, and Schwab reported a decrease in the allowance for credit losses due to improved credit quality and lower projected loss rates. This reflects an ongoing risk management strategy that leverages collateral controls and adapts credit loss models to current economic conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> PALs (FIN_INST)",
        "PALs (FIN_INST) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_142",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6566,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2285,
        "completion_tokens": 207,
        "total_tokens": 2492
      }
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "From 2022 to 2023, the value of MDLZ's British pound sterling notes increased from $3 million to $45 million, as shown in the respective 10-K filings. This shift suggests that MDLZ may have adopted a more proactive approach to managing its foreign exchange risk, potentially through hedging or issuing debt in British pounds to align with its exposure in that currency, thereby reducing potential volatility from currency fluctuations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> British pound sterling notes (FIN_INST)",
        "British pound sterling notes (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2398,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 108,
        "total_tokens": 1358
      }
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for its 2025 Notes, indicating a traditional fixed-rate debt instrument. However, in the 2024 filing, the interest rate for the same 2025 Notes was disclosed as SOFR+2.1%, reflecting a shift to a floating rate structure tied to the Secured Overnight Financing Rate (SOFR). This change suggests that Amgen has restructured or refinanced the debt to incorporate floating-rate terms, likely to better manage interest rate risk in a rising rate environment and align with market practices favoring variable-rate instruments. The shift from fixed to floating rates reveals a more adaptive approach to debt financing, aiming for cost efficiency and flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 3.125% 2025 Notes (FIN_INST)",
        "3.125% 2025 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_149",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6054,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2164,
        "completion_tokens": 180,
        "total_tokens": 2345
      }
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "Schwab's reliance on its Commercial Paper Issuance Program has increased between 2022 and 2024 in response to market disruptions and rising interest rates. In 2022, Schwab acknowledged the potential limitations on external financing during credit market disruptions and highlighted the importance of its commercial paper program as a liquidity source. By 2024, the company noted that rapid increases in short-term interest rates led to higher client outflows of cash balances into higher-yielding alternatives, necessitating the use of supplemental funding sources, including its commercial paper issuance program, to meet liquidity needs. The program remains a critical tool for Schwab to access capital amid tighter market conditions and elevated borrowing costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> Commercial Paper Issuance Program (ACCOUNTING_POLICY)",
        "Commercial Paper Issuance Program (ACCOUNTING_POLICY) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10980,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3400,
        "completion_tokens": 191,
        "total_tokens": 3592
      }
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "The 3.625% Notes due 2024 had a notional amount of $1,400 million in 2022, with a fixed interest rate of 3.625%. By 2024, these notes were fully repaid, as indicated by a notional amount of $0 and an interest rate marked as N/A, reflecting their maturity. This repayment demonstrates the company's disciplined debt management strategy, proactively retiring fixed-rate debt as it matures. The shift to SOFR-based floating rates in newer issuances, such as the 3.125% 2025 Notes and others, suggests a strategic move to better align with current market conditions and potentially reduce long-term interest rate risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 3.625% 2024 Notes (FIN_INST)",
        "3.625% 2024 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_149",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6054,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2157,
        "completion_tokens": 153,
        "total_tokens": 2310
      }
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "Between 2022 and 2024, Schwab's approach to providing financial or other support to variable interest entities (VIEs) has shown a shift in intent and conditions for funding commitments. In 2022, Schwab stated it did not provide or intend to provide financial or other support to VIEs beyond what was contractually required, with funding of commitments conditional upon certain events and expected to be fulfilled between 2022 and 2025. By 2024, Schwab acknowledged the potential for providing credit, liquidity, or other support to its proprietary funds in response to significant valuation declines or redemption pressures, even though such support was not contractually required. This reflects a more flexible and situational approach, acknowledging that such support could impact financial statements and liquidity, while also recognizing the reputational and operational risks of not providing it.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Did_Not_Supply]-> FIN_INST <-[Provides]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> Other Support (FIN_INST)",
        "Other Support (FIN_INST) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6528,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2283,
        "completion_tokens": 225,
        "total_tokens": 2508
      }
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "Between 2022 and 2023, MDLZ's financial relationship with JDE Peet's has evolved as the investment has increasingly been recognized as a strategic component of MDLZ's liquidity and capital structure. In 2022, MDLZ's equity method investment in JDE Peet's included mark-to-market gains and losses that impacted operating income and interest expense, as well as the consolidated statement of earnings through gains on equity method investment transactions. By 2023, MDLZ explicitly highlighted that its investment in JDE Peet's provides additional financial flexibility, contributing to its overall liquidity and supporting its ability to meet short- and long-term funding needs without relying on equity financing. This indicates a shift from a primarily earnings-impacting investment in 2022 to a more integral part of MDLZ's liquidity strategy in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> JDE Peet's (COMP)",
        "JDE Peet's (COMP) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4478,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1759,
        "completion_tokens": 213,
        "total_tokens": 1972
      }
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "Between 2022 and 2024, Amgen's interest rate hedging strategy for the 3.125% 2025 Notes evolved as part of broader adjustments to its interest rate swap agreements. In 2022, Amgen terminated existing swaps hedging the 3.125% 2025 Notes along with other notes due to historically low interest rates, receiving $576 million in cash, and subsequently entered into new swap agreements at then-current rates. By 2024, the interest rate applied under the swap agreements for the 3.125% 2025 Notes was SOFR + 2.1%, and this rate remained unchanged from the prior year, indicating stability in the hedging cost for this specific note.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 3.125% 2025 Notes (FIN_INST)",
        "3.125% 2025 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_149",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2371,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 156,
        "total_tokens": 1394
      }
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million as of January 31, 2022, to $4,414 million as of January 31, 2023, representing a decline of $1,405 million. This reduction reflects a significant decrease in the value of these investments over the fiscal year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Equity Investments Level 2 (FIN_INST)",
        "Equity Investments Level 2 (FIN_INST) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_8",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1382,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 994,
        "completion_tokens": 78,
        "total_tokens": 1072
      }
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "Apple's characterization of its reliance on marketing abilities remained consistent between its 2023 and 2024 10-K filings, as both explicitly state that the Company relies primarily on the innovative skills, technical competence, and marketing abilities of its personnel for success. Neither filing introduced a new or altered emphasis on marketing abilities compared to the prior year, maintaining marketing as a key component among other factors such as product innovation, design, and intellectual property. The 2023 and 2024 filings both underscore the importance of marketing in the broader context of Apple's competitive strategy and business differentiation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Relies_On]-> CONCEPT <-[Depends_On]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> Marketing Abilities (CONCEPT)",
        "Marketing Abilities (CONCEPT) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11793,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3579,
        "completion_tokens": 166,
        "total_tokens": 3746
      }
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "Between 2022 and 2024, the notional amount for the 3.625% 2024 Notes decreased from $1,400 million (as noted in 2023 in Chunk 2) to $0 by December 31, 2024, indicating the full redemption or payoff of these notes. In 2022, Amgen had interest rate swaps hedging these notes, with an aggregate notional amount of $5.2 billion, which were terminated due to historically low interest rates and then replaced with new swaps at current rates. By 2024, the interest rate structure for the remaining notes shifted to SOFR-based rates, but the 3.625% 2024 Notes were no longer hedged, as their notional amount was fully extinguished. This change suggests that Amgen actively managed its interest rate risk by adjusting its hedging strategy in response to market conditions, particularly by terminating and replacing swaps when advantageous and redeeming debt as it matured.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 3.625% 2024 Notes (FIN_INST)",
        "3.625% 2024 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_149",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2371,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 216,
        "total_tokens": 1452
      }
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "Schwab's integration of the iRebal portfolio rebalancing solution from 2022 to 2023 evolved from its initial retention of the product post-TD Ameritrade acquisition in 2020 to its full incorporation into Schwab's offerings for independent advisor clients by 2023. In 2022, Schwab highlighted the retention of iRebal as part of its integration strategy to enhance its RIA services, leveraging TD Ameritrade Institutional's customizable solution. By 2023, Schwab had fully integrated iRebal into its platform, demonstrating a strategic focus on expanding its capabilities for RIAs. This evolution underscores Schwab's competitive positioning in the RIA market by enhancing its service offerings through technology and customization, reinforcing its scale and operating efficiency as key competitive advantages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Retains]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> iRebal (PRODUCT)",
        "iRebal (PRODUCT) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9938,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3124,
        "completion_tokens": 202,
        "total_tokens": 3326
      }
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "Between 2023 and 2024, Apple's approach to the iMac product line evolved as reflected in its 10-K filings. In 2023, the iMac was listed as part of the Mac product line in the Company's business description, indicating its ongoing role in Apple’s personal computing strategy. In 2024, Apple explicitly announced the iMac in the first quarter under its product announcements, signaling a renewed focus or update to the product line. This suggests that Apple has continued to position the iMac as a key component of its Mac offerings while actively refreshing it in 2024 to align with broader product innovation efforts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> iMac (PRODUCT)",
        "iMac (PRODUCT) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2024.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5961,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2118,
        "completion_tokens": 154,
        "total_tokens": 2272
      }
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "RTX's relationship with the 2.820% Notes Due 2051 has remained consistent between 2022 and 2024, with the aggregate principal balance remaining at $1,000 million in both periods. This indicates that RTX has not issued additional amounts or retired any portion of these notes during this time, suggesting a stable component of its long-term debt structure. The continued presence of these notes, alongside other long-dated debt instruments, reflects RTX’s strategy of maintaining a diversified and extended maturity profile to manage interest rate risk and ensure long-term financial flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "RTX (ORG) -> 2.820% Notes Due 2051 (FIN_INST)",
        "2.820% Notes Due 2051 (FIN_INST) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4701,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1819,
        "completion_tokens": 148,
        "total_tokens": 1968
      }
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "Between 2022 and 2023, Schwab's IDA agreement underwent notable changes. In 2022, the amended IDA agreement reduced the service fee on client cash deposits held at the TD Depository Institutions from 25 basis points to 15 basis points. By 2023, Schwab completed the transition of its IDA agreement—and other financial agreements—from LIBOR to alternative reference rates, as part of its broader effort to address the phase-out of LIBOR. This transition was part of a company-wide initiative affecting financial models, systems, and intercompany lending agreements, and it is now considered substantially complete, with no expected material impact going forward.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> IDA Agreement (ACCOUNTING_POLICY)",
        "IDA Agreement (ACCOUNTING_POLICY) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7540,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2526,
        "completion_tokens": 165,
        "total_tokens": 2691
      }
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "The change in Filorga's financial treatment—from being a standalone reporting unit with $221 million in goodwill in 2023 to being listed among other trademarks within broader segments in 2024—suggests a strategic reevaluation of its role within Colgate-Palmolive’s portfolio. In 2023, Filorga was treated as a distinct reporting unit, indicating it was considered a significant, standalone contributor to value, with its goodwill reflecting its acquired value and performance. However, by 2024, its inclusion among other trademarks implies a shift in valuation approach, likely integrating it into a broader brand portfolio assessment rather than as a separate entity. This could indicate either a reduced strategic emphasis or a more streamlined reporting structure, aligning Filorga with other trademarks under a unified valuation methodology.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "CL (ORG) -> Filorga (PRODUCT)",
        "Filorga (PRODUCT) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2023.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6015,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2169,
        "completion_tokens": 211,
        "total_tokens": 2381
      }
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "Apple's 2023 10-K filing mentions the iPhone 16 Pro only in the context of product announcements in the fourth quarter of 2024, suggesting a forward-looking disclosure typical of prior years. However, in the 2024 10-K, the iPhone 16 Pro is explicitly listed as part of the iPhone product line, indicating a shift toward more immediate and integrated reporting of new products within its core offerings. This evolution reflects a more transparent and strategic approach to product development and disclosure, aligning with Apple's broader emphasis on forward-looking statements and the importance of new product introductions in its business model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> iPhone 16 Pro (PRODUCT)",
        "iPhone 16 Pro (PRODUCT) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5958,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2132,
        "completion_tokens": 161,
        "total_tokens": 2294
      }
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "Between 2022 and 2023, the company enhanced its use of Economic Value of Equity (EVE) simulations to assess interest rate risk by refining modeling assumptions and incorporating more dynamic balance sheet behaviors. In 2022, EVE simulations focused on long-term impacts of interest rate changes using assumptions such as rate floors, prepayment speeds, term structure models, and non-maturity deposit behavior, while assuming non-negative investment yields. By 2023, the company expanded its modeling to include updated deposit beta assumptions in a declining rate environment and explicitly used EVE simulations to capture the impact of client cash allocation changes on the balance sheet, reflecting a more active approach to managing interest rate exposure in response to evolving market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> EVE Simulations (ACCOUNTING_POLICY)",
        "EVE Simulations (ACCOUNTING_POLICY) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9293,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2982,
        "completion_tokens": 200,
        "total_tokens": 3183
      }
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 significantly enhanced its competitive positioning in the broader networking market by expanding its product portfolio breadth and deepening its integration across the value chain. In 2022, Qualcomm primarily enabled wireless access points through its foundational technologies and intellectual property, as highlighted in its 10-K, which supported the development of edge networking products like Wi-Fi 6 and 6E access points. By 2023, Qualcomm had moved beyond enabling to directly producing wireless access points and routers as part of its broader networking product line, which now includes Wi-Fi, Ethernet, and PON chips, as well as broadband gateway equipment. This shift allowed Qualcomm to offer end-to-end solutions—from modem to antenna—thereby strengthening its leadership in intelligent computing and enhancing its ability to deliver optimized performance and efficiency for home and business networks, directly supporting its Snapdragon brand's expansion into premium experiences across IoT and automotive markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> Wireless Access Points (PRODUCT)",
        "Wireless Access Points (PRODUCT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12952,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3897,
        "completion_tokens": 286,
        "total_tokens": 4184
      }
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "From 2022 to 2023, Schwab's HELOC product interest-only payment structure showed a slight decline in the percentage of adjustable-rate mortgages with interest-only terms, from 28% to 27%. Additionally, the portion of interest-only loans not scheduled to reset for three or more years decreased from 89% to 86%. These changes suggest a modest shift in the composition of Schwab's mortgage portfolio, with fewer interest-only loans having extended reset periods in 2023 compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> HELOC Product (PRODUCT)",
        "HELOC Product (PRODUCT) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2818,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 121,
        "total_tokens": 1484
      }
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "Qualcomm's involvement in the XR market evolved from 2022 to 2023 through both strategic investments and product development. In 2022, Qualcomm's QSI segment highlighted investments in XR through Qualcomm Ventures, focusing on early-stage companies to support new product introductions and enhance existing technologies. Additionally, Qualcomm's R&D efforts included the development of technologies for XR devices, reflecting a strategic push into this market. By 2023, XR was explicitly included in the revenue breakdown under the consumer segment, indicating that Qualcomm had not only invested in the ecosystem but also generated product revenue from XR devices, demonstrating a transition from investment to commercialization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> XR (PRODUCT)",
        "XR (PRODUCT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7343,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2464,
        "completion_tokens": 182,
        "total_tokens": 2647
      }
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained constant at $1,100 million between 2022 and 2024, as shown in both the 2022 and 2024 10-K filings. This consistency indicates that RTX has not refinanced or redeemed this long-term debt issue during this period, reflecting a stable component of its long-term debt structure. The unchanged balance also suggests that RTX is maintaining its existing long-term obligations, which contributes to the predictability of its debt servicing requirements well into the future.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "RTX (ORG) -> 3.030% Notes Due 2052 (FIN_INST)",
        "3.030% Notes Due 2052 (FIN_INST) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4701,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1820,
        "completion_tokens": 134,
        "total_tokens": 1954
      }
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "AXP's focus on Corporate Card solutions has remained consistent between 2023 and 2024, with an emphasis on evolving card value propositions, differentiating corporate card and accounts payable expense management solutions, and designing innovative products and features for business customers. This continuity suggests that AXP views its Corporate Card offerings as a core component of its broader commercial payments strategy, aiming to strengthen its leadership in this space through enhanced functionality and tailored solutions. The mutual relationship between AXP and the Corporate Card product underscores a strategic commitment to leveraging this product as a key driver of growth and differentiation in commercial payments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enhances]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Corporate Card (PRODUCT)",
        "Corporate Card (PRODUCT) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2023.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3629,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 182,
        "total_tokens": 1728
      }
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "Between 2023 and 2024, PCA SKIN's strategic positioning within Colgate-Palmolive's Oral, Personal, and Home Care segment has evolved to emphasize a broader distribution strategy, particularly in terms of channel diversification. In 2023, PCA SKIN products were primarily sold to traditional and e-commerce retailers, wholesalers, distributors, and in some segments, skin health professionals. By 2024, the distribution strategy expanded to include a more explicit focus on authorized retailers and skin health professionals in specific geographies, while also maintaining a presence in direct-to-consumer channels. This shift reflects a more targeted approach to leveraging PCA SKIN's brand within professional and retail markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "CL (ORG) -> PCA SKIN (PRODUCT)",
        "PCA SKIN (PRODUCT) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2023.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3206,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 182,
        "total_tokens": 1626
      }
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "Between 2022 and 2023, Opdivo's strategic focus and commercial positioning evolved to emphasize earlier lines of therapy, expansion into new tumor types, and the acceleration of next-wave oncology mechanisms, including combination therapies with Yervoy and other anti-cancer agents. In 2022, Opdivo was already approved for multiple indications and demonstrated strong revenue performance, particularly in the U.S. and internationally, driven by demand for Opdivo + Yervoy combinations in NSCLC and other cancers. By 2023, BMY further broadened Opdivo’s commercial strategy, aiming to expand its use into earlier-stage treatment and additional tumor types, supported by positive data from its investigational subcutaneous formulation and the development of Opdualag for melanoma and potential other indications. These strategic advancements, combined with a growing differentiated NSCLC portfolio and the integration of new assets like Krazati, are expected to enhance Opdivo’s revenue growth trajectory by expanding its market reach and therapeutic relevance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Opdivo (PRODUCT)",
        "Opdivo (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11274,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3473,
        "completion_tokens": 265,
        "total_tokens": 3738
      }
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "Between 2023 and 2024, American Express's investment in foreign government bonds and obligations showed a significant increase in fair value, from $549 million in 2023 to $765 million in 2024. In 2023, these obligations were entirely classified as having a maturity of 12 months or more, with no unrealized losses reported. In 2024, the entire $764 million was due within one year, indicating a shift in the maturity distribution toward shorter-term holdings. This evolution reflects both a growth in the investment and a change in the timing of expected returns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Foreign government bonds and obligations (FIN_INST)",
        "Foreign government bonds and obligations (FIN_INST) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2023.pdf",
          "page_id": "page_120",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4254,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1716,
        "completion_tokens": 140,
        "total_tokens": 1856
      }
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "Between 2022 and 2024, Walmart's use of intercompany financing arrangements has remained a key strategy to efficiently allocate cash across its global operations, particularly in countries where cash is needed with minimal cost. In 2022, approximately $4.3 billion of Walmart’s cash and cash equivalents were not freely transferable to the U.S., with $2.2 billion requiring approval from Flipkart’s minority shareholders for access via dividends or intercompany financing. By 2024, this amount had decreased to $3.5 billion, and by 2025, it further declined to $3.3 billion, indicating a reduction in the volume of restricted cash over the period. Transfers of such cash remain subject to local laws, regulatory restrictions, or noncontrolling interest approvals, though Walmart does not expect these limitations to materially impact its liquidity or operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Intercompany Financing Arrangements (ACCOUNTING_POLICY)",
        "Intercompany Financing Arrangements (ACCOUNTING_POLICY) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2022.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7386,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2519,
        "completion_tokens": 215,
        "total_tokens": 2734
      }
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "Between 2023 and 2024, the composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained unchanged in terms of fixed income securities and cash equivalents, which totaled $210, and equity securities, which totaled $54. Both the 2023 and 2024 filings show the same allocation, indicating no material shift in the plan's asset mix during this period. This consistency is reflected in the data provided in both chunks, which align with the disclosed financial instruments and their relationships through the knowledge graph.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "TXN (ORG) -> U.S. Retiree Health Care Plan (FIN_INST)",
        "U.S. Retiree Health Care Plan (FIN_INST) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2024.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4217,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1713,
        "completion_tokens": 134,
        "total_tokens": 1848
      }
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "Between 2022 and 2024, Honeywell's 2006 Stock Plan for Non-Employee Directors evolved by introducing new forms of award agreements, particularly under the 2016 Stock Plan for Non-Employee Directors. In 2024, the company filed new forms such as the \"Form of Restricted Stock Unit Agreement, Form 1,\" \"Form of Restricted Stock Unit Agreement, Form 2,\" \"Form of Stock Option Award Agreement,\" and \"Form of Performance Plan Grant Agreement.\" This suggests a shift in the company's non-employee director compensation structure toward more diversified and performance-linked equity incentives, reflecting a broader trend of aligning director compensation with long-term performance and shareholder value creation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Amends]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "HON (ORG) -> 2006 Stock Plan for Non-Employee Directors (ACCOUNTING_POLICY)",
        "2006 Stock Plan for Non-Employee Directors (ACCOUNTING_POLICY) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2024.pdf",
          "page_id": "page_123",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 20707,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5860,
        "completion_tokens": 176,
        "total_tokens": 6037
      }
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "Between 2022 and 2024, Walmart's strategic position regarding its ownership stake in Flipkart evolved from holding approximately 83% ownership in 2021 to 75% in 2022, following a new equity funding round in Flipkart. This reduction in ownership, as disclosed in the 2022 10-K, reflects a dilution of Walmart's stake, potentially affecting its control and financial returns from the investment. By 2024, Flipkart faced regulatory scrutiny in India under the Directorate of Enforcement, which raised concerns about potential violations of India's Foreign Direct Investment rules from 2009 to 2015, prior to Walmart's 2018 acquisition. These proceedings could result in monetary penalties, share ownership restrictions, or other regulatory actions, exposing Walmart to material adverse financial and operational risks, as noted in the 2024 10-K. Walmart and Flipkart have been actively responding to these regulatory inquiries, with Flipkart intending to vigorously defend itself if the matter progresses to a hearing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Flipkart (COMP)",
        "Flipkart (COMP) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7384,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2490,
        "completion_tokens": 253,
        "total_tokens": 2743
      }
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "Between 2022 and 2024, HON's U.S. cash balances decreased from $11.5 billion (as of December 31, 2021) to $8.1 billion (as of December 31, 2023), with a further decline to $11.0 billion by December 31, 2024. This reflects a shift in the geographic distribution of funds, as HON held $8.0 billion in non-U.S. subsidiaries by 2024, indicating a strategic emphasis on diversifying liquidity sources and leveraging global cash holdings while maintaining a focus on safety of principal and minimizing counterparty exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "HON (ORG) -> U.S. Cash Balances (FIN_INST)",
        "U.S. Cash Balances (FIN_INST) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2024.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3221,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 129,
        "total_tokens": 1583
      }
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "From 2023 to 2024, the financial treatment and liability estimation methodology for the Membership Rewards program evolved to incorporate more detailed modeling of deferred fees and assumptions for liability estimation. In 2023, deferred fees for the Membership Rewards program were explicitly included in the financial reporting. By 2024, the liability estimation process became more sophisticated, relying on two key assumptions: the Ultimate Redemption Rate (URR), which estimates the proportion of points expected to be redeemed, and the Weighted Average Cost (WAC) per point, which estimates future redemption costs. These assumptions are derived from statistical and actuarial models based on redemption trends, card usage, and partner arrangements, and are periodically reviewed for accuracy. The 2024 methodology also quantified the sensitivity of the liability to changes in these assumptions, with a 25 basis point increase in URR raising the liability by approximately $197 million and a 1 basis point increase in WAC per point increasing it by about $220 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Membership Rewards (PRODUCT)",
        "Membership Rewards (PRODUCT) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2023.pdf",
          "page_id": "page_128",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4993,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1900,
        "completion_tokens": 268,
        "total_tokens": 2169
      }
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "Adobe's strategic positioning and integration of Frame.io between 2022 and 2024 have evolved to more deeply align with Adobe's broader product ecosystem. Initially acquired in late fiscal 2021 for $1.18 billion and integrated into the Digital Media segment, Frame.io was positioned to enhance Adobe's video collaboration capabilities. By 2024, Frame.io is described as a cloud-native creative collaboration platform that is directly integrated with key Adobe applications such as Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, enabling seamless workflows for video creators. Additionally, Frame.io is part of Adobe GenStudio, which, along with Adobe Express and Firefly Services, supports large-scale content production, reflecting Adobe's broader strategy to unify creative tools and generative AI capabilities across its ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Integrates]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Frame.io (COMP)",
        "Frame.io (COMP) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8871,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2855,
        "completion_tokens": 214,
        "total_tokens": 3070
      }
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "Between 2022 and 2023, the fair value of equity-like funds under private alternative investments using significant unobservable inputs (Level 3) increased for both Defined Benefit Pension Plans and Retiree Health Benefit Plans. In 2022, the Level 3 fair value for equity-like funds in Defined Benefit Pension Plans was $5.5 million, rising to $25.4 million in 2023. For Retiree Health Benefit Plans, the Level 3 fair value increased from $0.5 million in 2022 to $2.4 million in 2023. This indicates a significant upward shift in the valuation of these funds based on unobservable inputs over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Private Alternative Investments (FIN_INST)",
        "Private Alternative Investments (FIN_INST) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16009,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4661,
        "completion_tokens": 150,
        "total_tokens": 4812
      }
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "Between 2022 and 2024, Adobe has significantly evolved the integration and positioning of Frame.io within its Digital Media offerings. In 2022, Adobe acquired Frame.io and began integrating it into the Digital Media segment, positioning it as a cloud-based video collaboration platform. By 2024, Frame.io had evolved into a more deeply integrated and feature-rich component of Adobe's creative ecosystem, offering real-time upload, review, and approval capabilities, and supporting workflows beyond post-production, such as casting and location scouting. It was directly integrated with Adobe Premiere Pro, After Effects, and other key apps, and was included in Adobe GenStudio to enable scalable content production. This evolution reflects Adobe's strategy to enhance cross-product collaboration and streamline creative workflows for professionals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Frame.io (COMP)",
        "Frame.io (COMP) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9998,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3124,
        "completion_tokens": 212,
        "total_tokens": 3336
      }
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "Between 2022 and 2024, CVS has significantly evolved its approach to Medication Management by enhancing clinical programs and expanding digital tools to improve medication adherence and cost efficiency. In 2022, the company focused on formulary management, retail and mail-order pharmacy services, and clinical programs aimed at reducing inappropriate medication use and promoting adherence through utilization management and drug reviews. By 2024, CVS introduced more integrated digital solutions such as Pharmacy Advisor and Drug Savings Review, which provide outreach to help members with chronic diseases manage their medications more effectively. Additionally, the company expanded its clinical offerings with the CVS Weight Management program, optimized GLP-1 medication use, and enhanced digital connectivity to identify lower-cost alternatives. These advancements reflect a stronger emphasis on leveraging technology and data analytics to support both cost efficiency and improved health outcomes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Medication Management (PRODUCT)",
        "Medication Management (PRODUCT) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11054,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3415,
        "completion_tokens": 251,
        "total_tokens": 3667
      }
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "Adobe acquired Frame.io in October 2021 and, by 2022, began integrating it into the Creative Cloud ecosystem to enhance collaboration and streamline creative workflows. In 2022, Adobe focused on deepening Frame.io's integration with Creative Cloud applications like Premiere Pro and After Effects, enabling native collaboration features such as review and approval workflows. By 2024, Frame.io had evolved into a fully integrated cloud-native platform, offering real-time upload, frame-accurate commenting, and support for video pre-production workflows like casting and location scouting. Additionally, Frame.io was integrated with Adobe Workfront and enabled Camera to Cloud functionality, allowing automatic footage uploads from on-set devices. These enhancements significantly improved cross-platform collaboration and positioned Frame.io as a central tool within Adobe’s creative ecosystem for managing and refining content at scale.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Frame.io (COMP)",
        "Frame.io (COMP) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11569,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3539,
        "completion_tokens": 234,
        "total_tokens": 3774
      }
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "From 2023 to 2024, the use of recently executed transactions in the valuation of loans and other assets has remained a key component in fair value determination, particularly for corporate loans, mortgage loans, and corporate bonds. In 2023, recently executed transactions were used alongside market price quotations, CDS spreads, and benchmarking to comparable instruments when position-specific data were not observable. By 2024, the continued reliance on recently executed transactions is evident, especially for held-for-sale loans and other investments, where they are explicitly used in conjunction with market price quotations and valuation models incorporating market observable inputs. This evolution reflects a consistent approach to leveraging transaction data for fair value, with an increased emphasis in 2024 on integrating these transactions into broader valuation methodologies that include discounted cash flow models and comparable company multiples.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MS (ORG) -> Recently Executed Transactions (FIN_INST)",
        "Recently Executed Transactions (FIN_INST) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_9",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7676,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2570,
        "completion_tokens": 242,
        "total_tokens": 2812
      }
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "Between 2022 and 2024, Adobe's approach to Substance 3D Stager has evolved by more clearly positioning it as a core component of the broader Substance 3D ecosystem. In 2022, Substance 3D Stager was listed among Adobe's key products in its trademark summary, indicating its recognition as a distinct offering. By 2024, Adobe provided a more detailed description of Substance 3D Stager as part of the Substance 3D Collection, emphasizing its role in enabling users to build and assemble 3D scenes, while integrating with other Substance 3D tools like Painter, Sampler, Designer, and Modeler. This evolution reflects Adobe's strategy to enhance the cohesion and functionality of the Substance 3D ecosystem, supporting a more comprehensive workflow for 3D content creation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Substance 3D Stager (PRODUCT)",
        "Substance 3D Stager (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5921,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2125,
        "completion_tokens": 192,
        "total_tokens": 2317
      }
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "From 2022 to 2023, GE's strategic positioning regarding grid-scale batteries evolved as part of its broader energy transition strategy, with an increased emphasis on their role in enabling deep decarbonization of the power sector. In 2022, GE acknowledged grid-scale batteries as one of several emerging technologies critical for future decarbonization but noted the uncertainty and complexity involved in developing and commercializing such technologies. By 2023, GE more explicitly highlighted grid-scale batteries as a key enabler for integrating higher shares of renewable energy into power grids, underscoring the need for significant investments in infrastructure and R&D. This shift reflects a growing strategic reliance on grid-scale batteries as a core component of GE’s energy transition efforts, particularly in response to evolving market dynamics, regulatory expectations, and the need to modernize power systems for reliability and sustainability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GE (ORG) -> Grid-Scale Batteries (PRODUCT)",
        "Grid-Scale Batteries (PRODUCT) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2022.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12501,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3777,
        "completion_tokens": 240,
        "total_tokens": 4018
      }
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "CVS's disclosure regarding the use of broker-quoted debt securities in its fair value measurements indicates no presence of such securities in both 2022 and 2024. Specifically, in 2022, the company explicitly stated it had no broker-quoted debt securities for the years ended December 31, 2021 and 2020, and in 2024, it similarly reported no broker-quoted debt securities for the years ended December 31, 2024 and 2023. This consistent absence suggests that broker-quoted debt securities have not impacted CVS's financial reporting during this period, as the company continues to rely on Level 2 and Level 3 inputs for its debt securities valuation without the influence of broker-quoted prices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Broker Quoted Debt Securities (FIN_INST)",
        "Broker Quoted Debt Securities (FIN_INST) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_148",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_146",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5027,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1918,
        "completion_tokens": 173,
        "total_tokens": 2091
      }
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "Between 2023 and 2024, the composition of BlackRock's Equity Securities at FVTNI changed significantly. In 2023, \"Equity securities/mutual funds\" totaled $1,211 million, while \"Equity method\" investments amounted to $1,895 million, including $181 million in equity, fixed income, and multi-asset mutual funds. By 2024, \"Equity securities/mutual funds\" increased to $1,950 million, and \"Equity method\" investments rose to $2,783 million, driven by higher contributions from equity, fixed income, and multi-asset mutual funds ($478 million) and other categories like private equity and real assets funds. This reflects a substantial growth in both categories, with equity method investments expanding more significantly.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BLK (ORG) -> Equity Securities at FVTNI (FIN_INST)",
        "Equity Securities at FVTNI (FIN_INST) -> BLK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BLK_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BLK_10k_2024.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 21674,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6070,
        "completion_tokens": 179,
        "total_tokens": 6249
      }
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "From 2022 to 2024, UnitedHealth Group (UNH) maintained a consistent approach to evaluating credit-related impairments for available-for-sale debt securities, emphasizing that unrealized losses were primarily driven by interest rate changes rather than credit deterioration. In 2022, the Company noted unrealized losses from approximately 13,000 positions out of 39,000, with no significant credit deterioration observed and no material allowance for credit losses. By 2024, the Company continued to assess impairments by evaluating expected cash flows, issuer credit quality, and fair value relative to amortized cost, with credit-related impairments recorded as an allowance and non-credit impairments affecting other comprehensive income. The Company reaffirmed its intent not to sell impaired securities and maintained its investment strategy to limit exposure to any one issuer or market sector, consistent with its 2022 disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Evaluates]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Credit-Related Impairment (RISK_FACTOR)",
        "Credit-Related Impairment (RISK_FACTOR) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7394,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2512,
        "completion_tokens": 234,
        "total_tokens": 2746
      }
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "Between 2022 and 2023, AMD's financial relationship with the ATMP JV evolved with an increase in both investment value and equity income. The carrying value of AMD's investment in the ATMP JV rose from approximately $69 million in 2022 to $99 million in 2023, reflecting a $30 million increase. Additionally, AMD's equity income from the ATMP JV grew from $14 million in 2022 to $16 million in 2023, indicating improved performance of the joint venture. These figures, combined with AMD's significant role in managing inventory and conducting substantial purchases from the ATMP JV, highlight a strengthening financial and operational relationship during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "AMD (ORG) -> ATMP JV (COMP)",
        "ATMP JV (COMP) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6510,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2257,
        "completion_tokens": 166,
        "total_tokens": 2424
      }
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "UnitedHealth Group's exposure to tort claims, particularly those related to the delivery of health care services such as medical malpractice, has remained a significant risk factor between 2022 and 2024, as highlighted in both the 2022 and 2024 10-K filings. In 2022, the company noted that it is largely self-insured for litigation risks, including tort claims, and emphasized the increasing frequency of legal actions against healthcare providers, even in states with damage caps, as litigants pursue new theories of liability. By 2024, the nature of these claims has not fundamentally changed, but the potential financial impact remains high due to the large claims and significant defense costs associated with tort litigation. The 2024 filing reiterates the company's exposure to tort claims, including those arising from failures to meet clinical and patient safety standards, and underscores the potential for substantial monetary damages or reputational harm if such claims are resolved unfavorably.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> RISK_FACTOR <-[Faces]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Tort Claims (RISK_FACTOR)",
        "Tort Claims (RISK_FACTOR) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12689,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3813,
        "completion_tokens": 251,
        "total_tokens": 4065
      }
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "Between 2023 and 2024, Boeing’s three-year revolving credit agreement, which had a $3.0 billion capacity and was set to expire in August 2025 as of 2023, remained in effect in 2024 with the same $3.0 billion capacity. However, in 2024, Boeing entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029, replacing the terminated $0.8 billion 364-day credit facility and $3.2 billion five-year facility. This shift to a larger, longer-term credit facility suggests Boeing is enhancing its liquidity strategy by securing more extended, stable backup financing, likely to reduce reliance on short-term borrowing and support its ongoing operations and debt management needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BA (ORG) -> Three-Year Revolving Credit Agreement (FIN_INST)",
        "Three-Year Revolving Credit Agreement (FIN_INST) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7711,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2584,
        "completion_tokens": 175,
        "total_tokens": 2759
      }
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "The financial impact of the 2017 Performance-based Options evolved significantly between 2023 and 2024. In 2023, the total fair value of options vested was $56 million, with an aggregate intrinsic value of exercised options at $44 million. By 2024, the fair value of options vested slightly decreased to $52 million, while the intrinsic value of exercised options surged to $373 million, reflecting a substantial increase in the value realized by employees upon exercise.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BLK (ORG) -> 2017 Performance-based Options (FIN_INST)",
        "2017 Performance-based Options (FIN_INST) -> BLK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BLK_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BLK_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2813,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 117,
        "total_tokens": 1478
      }
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "Between 2022 and 2023, AMD's approach to estimating adjustments for product return rights remained largely consistent in its reliance on actual historical return rates and adjustments for known events or market conditions. In 2022, AMD stated that it utilized trended actual historical product return rate information, adjusted for actual known information or events. In 2023, the methodology was reiterated with a similar emphasis on historical returns, rebates, and credits, adjusted for known events or current economic conditions. A specific evolution noted in 2023 was the inclusion of a more explicit reference to the application of ASC 606-10-32-8 through 14 in determining the net amount of consideration to be recognized, highlighting a formalized alignment with updated accounting standards. This reflects a refinement in the documentation and application of the methodology without a fundamental shift in the estimation approach itself.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Provides]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Product Return Rights (ACCOUNTING_POLICY)",
        "Product Return Rights (ACCOUNTING_POLICY) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10399,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3255,
        "completion_tokens": 236,
        "total_tokens": 3492
      }
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "The number of shares under option for the 2017 Performance-based Options decreased from 1,549,080 at the end of 2023 to 625,825 at the end of 2024, a reduction of 923,255 shares. This decline was driven by 905,219 shares being exercised and 18,036 shares forfeited during 2024, reflecting significant exercise activity and limited forfeiture. The substantial exercise volume suggests that many employees chose to exercise their vested options, likely due to the intrinsic value of the options given the strike price of $513.50 and the Company’s stock performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BLK (ORG) -> 2017 Performance-based Options (FIN_INST)",
        "2017 Performance-based Options (FIN_INST) -> BLK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BLK_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BLK_10k_2024.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3138,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 140,
        "total_tokens": 1580
      }
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "Between 2022 and 2024, Optum Rx's Pharmacy Care Services has evolved to play a more integrated and strategic role within UnitedHealth Group's broader health care ecosystem, emphasizing data-driven clinical programs, expanded service offerings, and a stronger focus on affordability and outcomes. In 2022, Optum Rx managed $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceuticals, and offered a range of clinical and digital tools to help clients manage costs and improve health outcomes. By 2024, Optum Rx is positioned as a key component of UnitedHealth Group's value-oriented, connected health care approach, leveraging its pharmacy care services to support whole-person health, streamline care delivery, and integrate medical and pharmaceutical management. This strategic positioning reflects UnitedHealth Group's broader mission to build a high-performing health system through innovative, end-to-end solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Controls]-> PRODUCT <-[Supplies]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Pharmacy Care Services (PRODUCT)",
        "Pharmacy Care Services (PRODUCT) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9133,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2941,
        "completion_tokens": 237,
        "total_tokens": 3179
      }
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "Between 2023 and 2024, the valuation of BlackRock's Equity Securities at FVTNI increased, with investments related to deferred cash compensation plans rising from $9 million in 2023 to $173 million in 2024. In 2023, these investments were included within equity securities at FVTNI, while in 2024, they were explicitly categorized under \"investments related to deferred cash compensation plans\" within the equity method section of the investment breakdown. This indicates a significant increase in the allocation of assets tied to these compensation plans, reflecting a shift in the composition of Equity Securities at FVTNI.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BLK (ORG) -> Equity Securities at FVTNI (FIN_INST)",
        "Equity Securities at FVTNI (FIN_INST) -> BLK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BLK_10k_2023.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BLK_10k_2024.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12807,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3854,
        "completion_tokens": 156,
        "total_tokens": 4010
      }
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 as of August 31, 2022, to $2,694,281 as of August 31, 2024. This reduction indicates that the company has utilized a portion of its authorization for share repurchases and redemptions, reflecting an active capital allocation strategy focused on returning value to shareholders through buybacks and managing equity levels, particularly for Class A ordinary shares and exchangeable shares held by leadership and transferees.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Announces]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Share Purchase Program (FIN_INST)",
        "Share Purchase Program (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8442,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2764,
        "completion_tokens": 134,
        "total_tokens": 2899
      }
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "Between 2022 and 2024, the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved to reflect more detailed shareholder rights and repurchase activity. In 2022, the 10-K noted that repurchases included Accenture Canada Holdings Inc. exchangeable shares and highlighted the company's intent to use cash for share repurchases, though the exact amounts were subject to market and operational factors. By 2024, the 10-K provided clearer details on the rights of holders of these exchangeable shares, including their ability to exchange them for Accenture plc Class A ordinary shares on a one-for-one basis and the company's redemption rights. Additionally, the 2024 filing specified that the share repurchase program explicitly included both Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares, with a remaining authorization of $2,694,281 as of August 31, 2024, indicating an ongoing commitment to repurchase activity involving these shares.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Accenture Canada Holdings Inc. Exchangeable Shares (FIN_INST)",
        "Accenture Canada Holdings Inc. Exchangeable Shares (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7446,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2529,
        "completion_tokens": 253,
        "total_tokens": 2783
      }
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "The global revenue from Electrophysiology Devices increased from $2,195 million in 2023 to $2,467 million in 2024, representing a total growth of 12.3%. Excluding the impact of foreign exchange fluctuations, the percentage change in revenue was 14.4%. This growth reflects strong performance in the Electrophysiology segment, as highlighted in the 2024 10-K report.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Increases]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Electrophysiology Devices (PRODUCT)",
        "Electrophysiology Devices (PRODUCT) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2024.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7231,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2460,
        "completion_tokens": 91,
        "total_tokens": 2551
      }
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024, Accenture's financial relationship with Duck Creek Technologies evolved in terms of investment valuation and its impact on financial performance. As of August 31, 2022, Accenture's investment in Duck Creek Technologies had a carrying amount of $138,902 and an estimated fair value of $223,166 for its approximately 16% ownership stake. By fiscal 2024, the investment generated a $253 million gain, which positively impacted diluted earnings per share and the effective tax rate, as noted in the adjusted financial metrics. This gain, recorded in fiscal 2023, reflects an increase in the investment's valuation and highlights the strategic and financial significance of Accenture's stake in Duck Creek Technologies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Duck Creek Technologies (COMP)",
        "Duck Creek Technologies (COMP) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5880,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2122,
        "completion_tokens": 187,
        "total_tokens": 2310
      }
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "Between 2022 and 2023, Union Pacific's retention share and unit awards show a shift in composition and scale, reflecting a strategic focus on long-term retention and alignment with executive performance. In 2022, the 2013 Plan reported 1,218,397 retention shares and stock units outstanding, while the 2021 Plan had 389,207 retention shares outstanding. By 2023, the 2021 Plan retained a significant portion of these awards, with 366,046 retention units and 954,405 retention shares issued and outstanding. The elimination of new grants under older plans (2004 and 2013) and the continued use of the 2021 Plan indicate a deliberate strategy to consolidate and streamline executive compensation through newer, performance-aligned mechanisms, emphasizing retention and long-term value creation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Retention Shares (FIN_INST)",
        "Retention Shares (FIN_INST) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7158,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2438,
        "completion_tokens": 198,
        "total_tokens": 2636
      }
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "MetLife's application of GAAP guidance for adjusted earnings in 2023 included exclusions related to market volatility and asymmetrical accounting adjustments, such as excluding changes in fair value associated with MRBs, discount rates on annuitization guarantees, and non-economic losses at contract inception. By 2024, these exclusions remained consistent, with continued emphasis on excluding market volatility impacts like net investment and derivative gains/losses, as well as ongoing adjustments for asymmetrical accounting, including those related to in-force reinsurance and inflation-indexed benefits. The evolution reflects a sustained alignment with GAAP and a focus on presenting earnings that highlight core operational performance by mitigating distortions from market and accounting anomalies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "MET (ORG) -> GAAP Guidance (REGULATORY_REQUIREMENT)",
        "GAAP Guidance (REGULATORY_REQUIREMENT) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_170",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_150",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9135,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2946,
        "completion_tokens": 202,
        "total_tokens": 3148
      }
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "From 2022 to 2024, Accenture's approach to achieving compressed transformations has evolved by expanding the technologies leveraged and broadening the scope of transformation services. In 2022, Accenture emphasized transformative technologies such as digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients reimagine products and operations, focusing on resilience, productivity, and sustainability. By 2024, the firm introduced generative AI as a key enabler, alongside AI, and expanded its use of technologies like artificial reality/virtual reality and advanced automation equipment. Additionally, the scope of services grew to include digitally transforming capital projects, such as plant and asset construction, and assembling specialized commercial hardware to support client operations. These advancements reflect a more integrated and accelerated approach to enterprise reinvention, underpinned by a broader ecosystem of technology partners and innovation through Accenture Labs and Ventures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Achieves]-> CONCEPT <-[Announces]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Compressed Transformations (CONCEPT)",
        "Compressed Transformations (CONCEPT) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10579,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3298,
        "completion_tokens": 258,
        "total_tokens": 3556
      }
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "Between 2023 and 2024, Abbott maintained a consistent use of interest rate hedge contracts to manage its exposure to changes in the fair value of fixed-rate debt, with notional values totaling $2.2 billion in both years. These contracts are designated as fair value hedges, effectively converting a portion of fixed-rate debt to variable-rate obligations. In 2023, the contracts were discussed in the context of managing interest rate risk on a significant amount of fixed-rate debt, while in 2024, the disclosure reiterated the same notional value and purpose, emphasizing that Abbott does not use such instruments for investment securities. This continuity indicates a stable hedging strategy to mitigate interest rate risk over the two-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Interest Rate Hedge Contracts (FIN_INST)",
        "Interest Rate Hedge Contracts (FIN_INST) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8740,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2830,
        "completion_tokens": 187,
        "total_tokens": 3018
      }
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "Between 2023 and 2024, MetLife's treatment and definition of Adjusted Earnings evolved in response to GAAP guidance and segment performance measurement requirements. In 2023, the adoption of the Long-Duration Targeted Improvements (LDTI) led to a simplified measurement model for Deferred Acquisition Costs (DAC) and Value of Business Acquired (VOBA), resulting in the removal of certain adjustments related to their amortization and changes in the measurement of guarantees. Adjusted Earnings was updated to exclude changes in fair value associated with Measurement Rebaselining (MRB), changes in discount rates on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. In 2024, MetLife continued to align its Adjusted Earnings with GAAP guidance for segment reporting, emphasizing its use as the primary GAAP measure of segment performance. The 2024 definition further clarified that Adjusted Earnings excludes market volatility impacts, asymmetrical and non-economic accounting, and results from divested or discontinued operations, reinforcing its role in evaluating management performance and business plan execution.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "MET (ORG) -> GAAP Guidance (REGULATORY_REQUIREMENT)",
        "GAAP Guidance (REGULATORY_REQUIREMENT) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_119",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_150",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7318,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2483,
        "completion_tokens": 287,
        "total_tokens": 2770
      }
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "From 2022 to 2024, Accenture's share purchase program has seen a shift in both available authorization and share acquisition methods. As of August 31, 2022, the available authorization under the publicly announced open-market share purchase program was $3,129,296. By fiscal 2024, the program continued to operate, with shares acquired primarily through share withholding for payroll tax obligations related to employee equity plans, rather than open-market purchases. These acquisitions under employee plans did not impact the overall available authorization, indicating a strategic reallocation of share repurchase activity toward operational and employee-related obligations, while maintaining the existing funding authorization for broader share repurchase initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Announces]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Share Purchase Program (FIN_INST)",
        "Share Purchase Program (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5186,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1944,
        "completion_tokens": 193,
        "total_tokens": 2138
      }
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "From 2023 to 2024, MetLife's treatment and valuation methodology for Unit-linked Securities evolved in terms of cost basis and fair value sensitivity as follows: In 2023, the cost basis for Unit-linked Securities was primarily based on original cost, adjusted for amortization of premiums or accretion of discounts for fixed maturity securities, while equity securities were valued at original cost. By 2024, the valuation methodology for Unit-linked Securities, particularly those classified within Level 3, incorporated more nuanced sensitivity to unobservable inputs such as mortality rates, lapse rates, utilization rates, withdrawal rates, and long-term equity volatilities. These inputs directly influenced the estimated fair value of guarantees and benefits, with specific inverse or direct relationships depending on the type of guarantee (e.g., GMDB, GMIB, GMWB). This evolution reflects a more dynamic and assumption-driven approach to fair value measurement, emphasizing the sensitivity of fair value to changes in key actuarial and market assumptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> Unit-linked Securities (FIN_INST)",
        "Unit-linked Securities (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_320",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_250",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5318,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1976,
        "completion_tokens": 265,
        "total_tokens": 2242
      }
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "Between fiscal years 2022 and 2023, the structure and vesting timeline of market-based RSUs evolved as follows: In 2022, market-based RSUs generally vested over four years, with grantees potentially receiving 0% to 300% of the original grant based on total stockholder return (TSR) relative to an index. In 2023, while the four-year vesting structure remained for some RSUs, the company also introduced market-based RSUs with a five-year vesting timeline, contingent on stock price performance milestones. This indicates a diversification in vesting periods and performance metrics for market-based RSUs in 2023 compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Vests]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> Market-Based RSUs (FIN_INST)",
        "Market-Based RSUs (FIN_INST) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2022.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7894,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2599,
        "completion_tokens": 157,
        "total_tokens": 2757
      }
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "Between 2023 and 2024, the phase-in treatment of the CECL standard's ongoing impact on regulatory capital continued under the CECL Transition Election, which COF adopted in early 2020. Pursuant to the CECL Transition Rule, COF delayed the capital impact of CECL through December 31, 2021, and then phased in the cumulative impact from January 1, 2022, through December 31, 2024, at 25% per year. During the phase-in period, the after-tax \"day 1\" CECL adoption impact and the cumulative \"day 2\" ongoing impact were added back to regulatory capital at 25% annually, allowing COF to manage the capital effects of the CECL standard over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "COF (ORG) -> CECL Transition Election (ACCOUNTING_POLICY)",
        "CECL Transition Election (ACCOUNTING_POLICY) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7608,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2565,
        "completion_tokens": 159,
        "total_tokens": 2724
      }
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "Between 2022 and 2023, Broadcom's relationship with Wilmington Trust, National Association as trustee evolved with the issuance of new senior notes under updated indentures. In 2022, Broadcom entered into an indenture dated April 18, 2022, with Wilmington Trust for the issuance of 4.926% Senior Notes due 2037. By 2023, this relationship expanded significantly through multiple supplemental indentures dated July 12, 2024, and October 2, 2024, under which Broadcom issued additional senior notes with varying maturities and coupon rates, including 5.050% Senior Notes due 2027, 2029, and 2031, as well as 4.150%, 4.350%, 4.550%, and 4.800% Senior Notes due 2028 through 2034. These developments reflect a deepening and more complex partnership in managing Broadcom's debt structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Enters_Agreement_With]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> Wilmington Trust, National Association (COMP)",
        "Wilmington Trust, National Association (COMP) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2022.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14542,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4294,
        "completion_tokens": 195,
        "total_tokens": 4490
      }
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "Capital One's regulatory capital add-back under the CECL Transition Rule evolved from 2023 to 2024 as part of a structured phase-in process. From January 1, 2022, through December 31, 2024, Capital One phased in 25% of the after-tax \"day 1\" CECL adoption impact and the cumulative \"day 2\" ongoing impact each year. By January 1, 2024, 75% of the $2.4 billion add-back, which was initially added as of December 31, 2021, had been phased in, with the remaining 25% to be fully phased in by the end of 2024. This progression reflects the mandated three-year phase-in period under the CECL Transition Rule.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "COF (ORG) -> CECL Transition Rule (REGULATORY_REQUIREMENT)",
        "CECL Transition Rule (REGULATORY_REQUIREMENT) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5290,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1979,
        "completion_tokens": 150,
        "total_tokens": 2130
      }
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "Following the Broadcom acquisition, the treatment of VMware stock options for non-employee directors evolved between 2022 and 2023 as outlined in the VMware Merger Agreement. As of May 2022, all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors were accelerated and converted into the right to receive equal parts cash and shares of Broadcom common stock. This conversion was reiterated in 2023, confirming that the treatment remained consistent post-merger, with the awards no longer denominated in VMware stock but instead converted into Broadcom equity and cash. The conversion aligns with the broader assumption and restructuring of VMware equity awards under the terms of the Broadcom acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Converts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> VMware Stock Options (FIN_INST)",
        "VMware Stock Options (FIN_INST) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2022.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5283,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1957,
        "completion_tokens": 186,
        "total_tokens": 2143
      }
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "Based on AbbVie's disclosures, the therapeutic positioning of Vraylar has evolved from 2022 to 2024 by expanding its role in treating major depressive disorder (MDD) as an adjunctive therapy, as highlighted in 2021 clinical trial results. By 2024, Vraylar is formally indicated for the acute treatment of depressive episodes associated with bipolar I disorder in adults and as an adjunctive treatment in MDD, reflecting a broader and more defined therapeutic application within AbbVie's neuroscience portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Vraylar (PRODUCT)",
        "Vraylar (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7572,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2514,
        "completion_tokens": 127,
        "total_tokens": 2641
      }
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "From 2022 to 2024, GE's accounting policy for long-term services agreements has evolved from recognizing revenue on a straight-line basis to using the percentage of completion method. In 2022, revenue was recognized consistently with the timing of services provided, primarily for routine maintenance and equipment repairs, with invoicing occurring periodically as services were delivered. By 2024, revenue recognition is based on costs incurred relative to total estimated costs, requiring significant estimates of customer payments and maintenance costs over the contract term. Additionally, billing estimates now incorporate forward-looking factors such as asset utilization, market conditions, and asset retirements, with adjustments made to revenue on a cumulative catch-up basis as estimates are revised.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Announces]- ORG",
      "triplets_used": [
        "GE (ORG) -> Long-Term Services Agreements (ACCOUNTING_POLICY)",
        "Long-Term Services Agreements (ACCOUNTING_POLICY) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2022.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13144,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3943,
        "completion_tokens": 202,
        "total_tokens": 4145
      }
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as being part of the instruments filed under Form 8-K on January 30, 2019 (Exhibit 4.3). By the 2023 10-K filing, the 1.250% Notes due 2027 were explicitly listed as a registered security traded on the New York Stock Exchange under the trading symbol IBM 27B, indicating a formal registration and public trading status that was not explicitly highlighted in the prior year’s filing. This evolution reflects IBM's updated disclosure and registration of the notes for public trading.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 1.250% Notes due 2027 (FIN_INST)",
        "1.250% Notes due 2027 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8934,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2861,
        "completion_tokens": 136,
        "total_tokens": 2998
      }
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "Between 2022 and 2024, the structure of AbbVie's performance-vested RSUs has remained consistent in terms of vesting increments, with awards continuing to vest in one-third increments over a three-year performance period. However, the performance metric has evolved: in 2022, the focus was on return on invested capital (ROIC) relative to a defined peer group, as noted in the 2022 filing. By 2024, the 10-K filing explicitly confirms that the performance-vested RSUs may be earned based on ROIC performance relative to the same peer group, indicating continuity in the metric but with potential refinements in its application or peer group definition over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Vests]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Performance-Vested RSUs (FIN_INST)",
        "Performance-Vested RSUs (FIN_INST) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_123",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2790,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 165,
        "total_tokens": 1512
      }
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "From 2022 to 2024, GE's financial relationship with AerCap evolved significantly, as reflected in the realized and unrealized gains or losses associated with its investment. In 2022, GE recorded a realized and unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation shift. By 2023, this loss had decreased to $129 million, suggesting some improvement in the investment's value. In 2024, GE reported a modest gain of $38 million, reflecting a further positive shift in the valuation of its AerCap investment. This progression aligns with GE's broader strategy to exit its equity ownership positions, as mentioned in the 2022 10-K, and indicates a gradual improvement in the financial position of its stake in AerCap over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Disposes]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "GE (ORG) -> AerCap (COMP)",
        "AerCap (COMP) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2022.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7976,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2625,
        "completion_tokens": 197,
        "total_tokens": 2822
      }
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "Between 2022 and 2023, IBM's treatment of the 0.300% Notes due 2026 evolved in terms of disclosure and visibility. In the 2022 filing (Chunk 1), the notes were disclosed as Exhibit 4 to Form 8-K filed on November 1, 2016, indicating they were incorporated by reference. By the 2023 filing (Chunk 2), the 0.300% Notes due 2026 were explicitly listed in the table of registered securities with the trading symbol \"IBM 26B\" and registered on the New York Stock Exchange, reflecting increased visibility and direct inclusion in the financial instruments section. This transition suggests a shift from reference-based disclosure to a more prominent, standalone listing in the 2023 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 0.300% Notes due 2026 (FIN_INST)",
        "0.300% Notes due 2026 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8934,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2883,
        "completion_tokens": 170,
        "total_tokens": 3054
      }
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "Between 2022 and 2024, GE's approach to the RISE Program has evolved from an initial announcement and technology development focus to a more strategic and investment-driven emphasis on sustainable aviation solutions. In 2022, GE Aviation, in collaboration with Safran, launched the RISE Program in June 2021, targeting more than 20% lower fuel consumption and CO2 emissions compared to current engines, reflecting a commitment to sustainability amid a recovering aviation market. By 2024, the RISE Program had transitioned into a core component of GE's broader R&D strategy, with the company making significant investments in the program suite of technologies to enable a more sustainable future of flight, as highlighted in its 10-K. This shift underscores a stronger strategic emphasis on innovation and environmental performance, aligning with long-term market recovery and regulatory trends in aviation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "GE (ORG) -> RISE Program (PRODUCT)",
        "RISE Program (PRODUCT) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2022.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5482,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2003,
        "completion_tokens": 226,
        "total_tokens": 2230
      }
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "From 2022 to 2023, American Express (AXP) has placed a growing emphasis on asset securitizations as a key component of its funding strategy. In 2022, the 10-K filing described asset securitizations as a process where loans or receivables are transferred to a special-purpose entity, which issues asset-backed securities to fund the purchase of these assets, with the securitized loans and receivables reported on AXP’s balance sheet. By 2023, the 10-K filing explicitly highlighted asset securitizations as one of the core funding sources, alongside deposits and unsecured debt, within a diversified funding strategy aimed at maintaining liquidity and cost efficiency. This evolution reflects a strategic shift toward leveraging asset-backed structures to finance the company’s proprietary card-issuing operations and manage liquidity needs more effectively.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Asset Securitizations (FIN_INST)",
        "Asset Securitizations (FIN_INST) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2022.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7153,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2438,
        "completion_tokens": 214,
        "total_tokens": 2653
      }
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "From 2022 to 2023, Emerson's financial and strategic relationship with AspenTech evolved significantly through increased investment returns and deeper operational integration. In 2022, Emerson's investment in AspenTech yielded mixed results, with AspenTech reporting sales of $656 million and earnings of $12 million, reflecting a modest return. However, by 2023, Emerson completed its acquisition of Heritage AspenTech, gaining 55% ownership, which led to operational integration under the 'Aspen Technology, Inc.' brand. This acquisition positively impacted Emerson's gross margin by 0.6 percentage points and contributed to higher sales and SG&A expenses, indicating deeper integration. Additionally, Emerson's investment in AspenTech shifted from a minority stake with variable returns to a controlling interest, enhancing strategic alignment and financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8053,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2649,
        "completion_tokens": 218,
        "total_tokens": 2867
      }
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech evolved significantly due to the business combination that created \"New AspenTech.\" In 2022, Emerson contributed its industrial software businesses and $6.0 billion in cash to Heritage AspenTech, acquiring 55% of the new entity and recording a $5.9 billion noncontrolling interest for the remaining 45% owned by former Heritage AspenTech stockholders. This noncontrolling interest was valued using the market price of Heritage AspenTech shares and impacted Emerson’s equity by reducing additional paid-in-capital by $550. In 2023, the Heritage AspenTech acquisition positively impacted Emerson’s gross margins by 0.6 percentage points and increased SG&A expenses, partly due to higher stock compensation costs, including $50 related to AspenTech stock plans. These impacts reflect the ongoing financial integration and operational effects of the acquisition on Emerson’s expenses and equity structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7387,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2491,
        "completion_tokens": 243,
        "total_tokens": 2734
      }
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "Between 2022 and 2023, IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved from being referenced as an exhibit incorporated by reference in the 2022 10-K to being explicitly listed as a registered security on the New York Stock Exchange in the 2023 10-K under the title of each class with the trading symbol \"IBM 27.\" This change reflects a shift in how the debentures are disclosed, moving from a document reference to a direct listing of the security's registration and trading details, indicating a more prominent and current presentation in the 2023 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 6.22% Debentures due 2027 (FIN_INST)",
        "6.22% Debentures due 2027 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6112,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2162,
        "completion_tokens": 145,
        "total_tokens": 2307
      }
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers has increased from 2023 to 2024, as these arrangements involve the Company assuming the economic risk of funding healthcare costs while relying on providers' financial and operational capabilities. In 2023, the Company's risk-based arrangements were primarily tied to premium revenues from fixed-rate contracts, where it estimated medical costs and rebates based on historical and projected data, including CMS risk adjustment models. By 2024, the Company faces heightened exposure due to potential financial difficulties or disputes among providers, which could result in unpaid claims or disruptions in service delivery. This evolution increases the complexity of cost estimation and service delivery responsibilities, as the Company must now navigate not only its own operational risks but also the financial solvency and performance of its provider partners, potentially impacting its profitability and regulatory compliance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY <-[Impacted_By]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Risk-Based Arrangements (ACCOUNTING_POLICY)",
        "Risk-Based Arrangements (ACCOUNTING_POLICY) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2023.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11690,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3593,
        "completion_tokens": 258,
        "total_tokens": 3852
      }
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech evolved significantly, both in terms of investment magnitude and strategic involvement. In 2022, Emerson's investment in AspenTech was reflected in financial data showing revenue contributions from Emerson's Automation Solutions and AspenTech's regional operations, with total AspenTech revenue reaching $656 million. By 2023, Emerson's strategic involvement deepened through a major acquisition, in which Emerson contributed its Industrial Software business and approximately $6.0 billion in cash to Heritage AspenTech stockholders, acquiring 55% ownership of AspenTech on a fully diluted basis. This acquisition had a measurable impact on Emerson's financials, positively affecting gross margins by 0.6 percentage points and increasing SG&A expenses due to the inclusion of AspenTech's operations. Thus, Emerson's relationship with AspenTech transitioned from a financial partnership to a controlling stake, significantly altering the scale and strategic integration of their business operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6033,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2142,
        "completion_tokens": 267,
        "total_tokens": 2409
      }
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "From fiscal 2022 to fiscal 2023, Adobe Target's role within Adobe's customer journey solutions evolved from being a key personalization tool to a central component of Adobe's AI-driven personalization strategy. In fiscal 2022, Adobe Target was positioned as part of the broader Customer Journeys solutions under the Digital Experience segment, enabling customers to test, target, and optimize content across channels. By fiscal 2023, Adobe Target was highlighted as an AI- and machine learning-driven personalization engine, emphasizing its ability to deliver omnichannel experiences at scale through automation and A/B testing. This evolution aligns with Adobe's strategic direction of leveraging AI and predictive intelligence to enhance customer engagement, as seen in the integration of Adobe Target with other AI-powered tools like Adobe Campaign, Journey Optimizer, and Adobe Sensei. The shift underscores Adobe's commitment to embedding AI-driven personalization across its customer journey solutions to deliver real-time, data-driven experiences.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Adobe Target (PRODUCT)",
        "Adobe Target (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8378,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2745,
        "completion_tokens": 263,
        "total_tokens": 3009
      }
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "Emerson's relationship with AspenTech evolved significantly from 2022 to 2023, beginning with the acquisition of Heritage AspenTech in the third quarter of 2022, which increased Emerson’s financial stake to $8,326 million by September 30, 2022, as shown in the consolidated balance sheet. Post-acquisition, Emerson integrated AspenTech by converting all outstanding Heritage AspenTech stock-based compensation awards into equivalent AspenTech awards, maintaining the original terms and conditions. In 2023, Emerson continued this integration by granting performance stock units tied to annual contract value and free cash flow goals, and by recognizing stock-based compensation expenses for post-combination service periods, reflecting a strategic alignment of financial and operational integration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5390,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1982,
        "completion_tokens": 199,
        "total_tokens": 2182
      }
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "From 2022 to 2023, Adobe Experience Platform has evolved as a central infrastructure for Adobe's customer journey solutions, enhancing integration with AI-powered tools and enabling more sophisticated cross-channel campaign orchestration. In 2022, it was positioned as a foundational platform that connects Adobe's comprehensive solutions, enabling standardized data formats for AI-driven services like Adobe Sensei, which provide domain-specific intelligence across customer journeys. By 2023, Adobe Experience Platform underpins newer tools such as Adobe Journey Optimizer, which leverages real-time data and AI to orchestrate personalized, cross-channel customer journeys across multiple touchpoints. This evolution reflects Adobe's strategy to strengthen its competitive differentiation by delivering scalable, intelligent, and integrated customer experience management solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Adobe Experience Platform (PRODUCT)",
        "Adobe Experience Platform (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10144,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3194,
        "completion_tokens": 221,
        "total_tokens": 3415
      }
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "In response to Medicare Advantage funding pressures from 2023 to 2024, UnitedHealth Group evolved its care delivery models by accelerating the transition from fee-for-service to fully accountable value-based care, as outlined in Chunk 1. This included integrating in-clinic, in-home, behavioral, and virtual care models, supported by data and analytics to enhance clinical decision-making and cost efficiency. As noted in Chunk 2, these strategies were part of broader efforts to mitigate funding pressures, which also involved adjusting member benefits, premiums, and network compositions. The shift toward value-based care aims to improve health outcomes and reduce long-term system costs, aligning with regulatory and market demands for more efficient and high-quality care delivery.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Impacted_By]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Care Delivery Models (PRODUCT)",
        "Care Delivery Models (PRODUCT) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2023.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11367,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3478,
        "completion_tokens": 196,
        "total_tokens": 3675
      }
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "Between 2022 and 2023, TMO's debt instrument composition remained largely consistent, with the 1.950% Notes due 2029 continuing to be a part of its registered debt offerings, listed under the trading symbol TMO 29 on the New York Stock Exchange in both years. However, TMO introduced new debt instruments in 2023, including the 3.200% Notes due 2026 (TMO 26B) and the 3.650% Notes due 2034 (TMO 34), indicating a shift toward issuing higher-yielding long-term debt. The 1.950% Notes due 2029 remained unchanged in both structure and exchange listing, reflecting stability in this specific component of TMO's debt portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "TMO (ORG) -> 1.950% Notes due 2029 (FIN_INST)",
        "1.950% Notes due 2029 (FIN_INST) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2022.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TMO_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3762,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1576,
        "completion_tokens": 155,
        "total_tokens": 1732
      }
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "Between 2022 and 2023, TMO's debt instrument composition remained largely consistent, with the 0.500% Notes due 2028 (TMO 28A) continuing to be part of its registered debt offerings. However, a notable change was the introduction of the 3.650% Notes due 2034 (TMO 34) in 2023, which did not appear in the 2022 filing. Additionally, the 2.000% Notes due 2025 (TMO 25) and the 1.400% Notes due 2026 (TMO 26A) remained consistent, while the 3.200% Notes due 2026 (TMO 26B) were newly listed in 2023, reflecting a shift in TMO's debt structure toward higher-yielding instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "TMO (ORG) -> 0.500% Notes due 2028 (FIN_INST)",
        "0.500% Notes due 2028 (FIN_INST) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2022.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TMO_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3762,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1587,
        "completion_tokens": 143,
        "total_tokens": 1731
      }
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "The range of excess fair value over carrying value for DHR's reporting units in the 2023 annual goodwill impairment analysis ranged from approximately 140% to 495%, while in 2024, the range narrowed to approximately 70% to 450%. This indicates a decrease in the lowest end of the excess range by 70 percentage points, although the highest end remained relatively stable. In both years, all reporting units passed the impairment test, with fair values exceeding carrying values.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Conducts]-> ACCOUNTING_POLICY <-[Performs]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Annual Goodwill Impairment Analysis (ACCOUNTING_POLICY)",
        "Annual Goodwill Impairment Analysis (ACCOUNTING_POLICY) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2024.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12298,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3729,
        "completion_tokens": 119,
        "total_tokens": 3848
      }
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "From 2022 to 2023, the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan remained consistent in its impact on the available share pool. In 2022, it was stated that RSUs canceled and shares withheld to satisfy tax withholding obligations increased the number of shares available for grant under the 2022 Plan by a factor of two times the number of RSUs canceled or shares withheld. The 2023 filing reiterated the structure of the 2022 Plan, including the treatment of these shares, confirming that the same two-times reversion factor continued to apply, thereby maintaining the same positive impact on the available share pool in 2023 as in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> 2022 Employee Stock Plan (ACCOUNTING_POLICY)",
        "2022 Employee Stock Plan (ACCOUNTING_POLICY) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3458,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 170,
        "total_tokens": 1690
      }
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "Between 2023 and 2024, Danaher's strategic relationship with Aldevron has evolved as Aldevron has been fully integrated into Danaher's Life Sciences segment, as noted in the 2024 10-K. Aldevron, acquired in 2021, is now part of the segment's bioprocessing business, contributing to Danaher's offerings in cell and gene therapy manufacturing. Financially, as shown in the 2023 10-K, Danaher's acquisition of Aldevron involved significant assets, including $6.15 billion in goodwill and $3.48 billion in other intangible assets, with a net cash consideration of $9.56 billion, reflecting a substantial and strategic financial stake in the company.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Aldevron (COMP)",
        "Aldevron (COMP) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7881,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2609,
        "completion_tokens": 161,
        "total_tokens": 2770
      }
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "Between 2023 and 2024, Microsoft's strategic positioning of Microsoft 365 evolved significantly, with a stronger emphasis on AI integration and a more prominent role in the company's commercial business metrics. In 2023, Microsoft 365 was already positioned as an \"AI-first platform,\" incorporating AI through Copilot, Microsoft Graph, and role-specific AI tools like Copilot for Sales and Service. By 2024, this integration deepened, with Microsoft expanding its Microsoft Cloud revenue metric to include revenue growth and broadening the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, reflecting the product's growing importance in both revenue and user metrics. This evolution underscores Microsoft 365's central role in driving the company’s commercial performance and its alignment with Microsoft’s broader AI and cloud ambitions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Microsoft 365 (PRODUCT)",
        "Microsoft 365 (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6453,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2265,
        "completion_tokens": 218,
        "total_tokens": 2483
      }
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "Between 2023 and 2024, Microsoft has consistently emphasized Copilot Pro as a consumer subscription service that delivers faster and more powerful AI assistance within Microsoft 365 apps and on the web, as highlighted in both the 2023 and 2024 10-K filings. In 2023, Copilot Pro was positioned as part of Microsoft’s broader AI-first strategy, integrated with Microsoft 365 and the Microsoft Graph to enhance productivity and business processes. By 2024, the emphasis remained strong, with Copilot Pro continuing to be described in the same context, underscoring its role in empowering users with AI assistance across Microsoft’s ecosystem. This consistency reflects Microsoft’s ongoing commitment to embedding AI deeply into its productivity tools and expanding its reach beyond enterprise to individual consumers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Copilot Pro (PRODUCT)",
        "Copilot Pro (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8702,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2818,
        "completion_tokens": 203,
        "total_tokens": 3022
      }
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "Between 2023 and 2024, the 2007 Omnibus Incentive Plan remained a key vehicle for DHR's stock-based compensation, with a total of approximately 135 million shares authorized for issuance since its inception. As of December 31, 2024, approximately 47 million shares remained available for issuance under the plan, excluding shares underlying outstanding awards. This indicates a reduction in available shares from prior years, as the plan continues to be utilized for granting stock options, RSUs, and PSUs to directors, officers, and employees. The structure of the plan also evolved slightly, with stock options granted after December 31, 2021 vesting over a four-year period instead of the prior five-year vesting schedule.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> 2007 Omnibus Incentive Plan (ACCOUNTING_POLICY)",
        "2007 Omnibus Incentive Plan (ACCOUNTING_POLICY) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5488,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2028,
        "completion_tokens": 181,
        "total_tokens": 2209
      }
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "Between fiscal years 2023 and 2024, Microsoft did not change its accounting policy regarding the estimated useful lives of server and network equipment, as the change from four years to six years was already effective beginning in fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. The policy remains consistent in 2024, reflecting Microsoft’s ongoing adaptation to evolving industry trends and infrastructure demands.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Useful Lives of Server Equipment (ACCOUNTING_POLICY)",
        "Useful Lives of Server Equipment (ACCOUNTING_POLICY) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8161,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2703,
        "completion_tokens": 125,
        "total_tokens": 2829
      }
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "MDT's exposure to auction rate securities decreased slightly in fair value from $33 million as of April 29, 2022, to $33 million as of April 28, 2023. In 2022, these securities were classified under \"More than 12 months\" with a small unrealized loss of $3 million, while in 2023, they were categorized under Level 3 fair value measurements and reported as part of \"Other Assets\" on the balance sheet with a fair value of $33 million and an unrealized loss of $3 million. This indicates that the classification shifted from long-term available-for-sale debt securities to a separate \"Other Assets\" category in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Auction rate securities (FIN_INST)",
        "Auction rate securities (FIN_INST) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4537,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1774,
        "completion_tokens": 153,
        "total_tokens": 1927
      }
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "Between fiscal years 2023 and 2024, Cisco's net losses from available-for-sale debt investments increased from $21 million to $67 million, as shown in Chunk 2. This indicates a significant decline in investment performance within this category. Additionally, Chunk 1 reveals that the fair value of these investments decreased from $15,592 million in 2023 to $9,865 million in 2024, further reflecting a negative impact due to interest rate increases and a corresponding drop in valuation. Together, these data points suggest a deterioration in the performance of Cisco's available-for-sale debt investments in fiscal 2024 compared to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Available-for-sale debt investments (FIN_INST)",
        "Available-for-sale debt investments (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4960,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1903,
        "completion_tokens": 159,
        "total_tokens": 2063
      }
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "Between 2023 and 2024, Cisco’s approach to the APJC region evolved from a primarily operational focus on geographic segmentation and infrastructure modernization to a more financially integrated model, as evidenced by the inclusion of APJC in consolidated financial reporting and the management of investments under the voting interest model. In 2023, Cisco emphasized operational strategies in APJC, aligning with global priorities such as modern infrastructure, cybersecurity, and AI-driven insights. By 2024, the company expanded its financial integration, consolidating APJC operations and investments, which reflects a shift toward deeper financial oversight and control. This evolution suggests a more centralized revenue model for APJC, where financial performance is closely tied to Cisco’s global financial statements, potentially enhancing transparency and strategic decision-making but also increasing exposure to regional financial risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> APJC (GPE)",
        "APJC (GPE) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10561,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3285,
        "completion_tokens": 237,
        "total_tokens": 3522
      }
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "Between 2022 and 2024, Apple has adapted its App Store commission structure and regulatory compliance in response to legal and market pressures. In 2022, Apple acknowledged that litigation, investigations, and new legislation like the EU Digital Markets Act (DMA) could lead to changes in how it charges developers and manages app distribution, potentially reducing commission rates and affecting revenue. By 2024, Apple had implemented specific changes, particularly in the U.S. and EU, including new communication rules for alternative purchasing mechanisms and compliance with the DMA through alternative fee structures, app distribution methods, and payment processing. These adjustments reflect Apple’s evolving approach to balancing regulatory demands, competitive pressures, and the need to maintain developer and consumer trust while mitigating financial risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> App Store (PRODUCT)",
        "App Store (PRODUCT) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11812,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3589,
        "completion_tokens": 217,
        "total_tokens": 3806
      }
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "Between 2022 and 2024, the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan shifted significantly from equity securities to fixed income securities. In 2022, the plan held $137 in equity securities and $238 in fixed income securities and cash equivalents (Chunk 1). By 2024, the allocation had changed to 20% in equity securities and 80% in fixed income securities and cash equivalents (Chunk 2), indicating a more conservative investment approach over the two-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "TXN (ORG) -> U.S. Retiree Health Care Plan (FIN_INST)",
        "U.S. Retiree Health Care Plan (FIN_INST) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3227,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 124,
        "total_tokens": 1579
      }
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "Texas Instruments has increasingly emphasized its Embedded Processing Products as a core strategic pillar from 2022 to 2024, reflecting their critical role in the company’s competitive advantages and segment structure. In 2022, Embedded Processing was highlighted as a foundational component of TI’s business model, contributing to four sustainable competitive advantages: cost-effective manufacturing, a broad product portfolio, strong market reach, and product diversity. By 2024, this emphasis evolved into a formal segment structure, with Embedded Processing becoming one of TI’s two reportable segments, alongside Analog, reflecting its strategic and operational significance. This shift underscores TI’s focus on leveraging Embedded Processing to drive revenue growth, gross margin performance, and long-term value creation, as evaluated by the chief operating decision maker in resource allocation and performance assessment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "TXN (ORG) -> Embedded Processing Products (PRODUCT)",
        "Embedded Processing Products (PRODUCT) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2022.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7144,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2446,
        "completion_tokens": 233,
        "total_tokens": 2679
      }
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "TMO issued its 2.00% 10-Year Senior Notes in 2022 with a par value of $1,200 million, maturing on October 15, 2031, and an effective interest rate of 2.23%. By 2024, the carrying value of these notes remained unchanged at $1,200 million, as shown in the 2024 10-K, indicating no material changes in valuation or issuance activity for this specific debt instrument between 2022 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG",
      "triplets_used": [
        "TMO (ORG) -> 2.00% 10-Year Senior Notes (FIN_INST)",
        "2.00% 10-Year Senior Notes (FIN_INST) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2022.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TMO_10k_2024.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9649,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3042,
        "completion_tokens": 96,
        "total_tokens": 3139
      }
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "Between 2022 and 2024, REMICADE's financial performance declined significantly, with sales dropping from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% total decline. The decrease was primarily driven by a 11.4% operational decline, likely due to market competition and maturity of the product, along with a 1.4% negative impact from currency fluctuations. This decline indicates that REMICADE's role within Johnson & Johnson's Pharmaceutical segment has diminished, as newer therapies like STELARA and TREMFYA have gained traction in the immunology space. Despite its historical importance, REMICADE's performance suggests it is no longer a primary growth driver for the segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> REMICADE (PRODUCT)",
        "REMICADE (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10194,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3185,
        "completion_tokens": 176,
        "total_tokens": 3361
      }
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "From 2022 to 2024, REMICADE's sales declined from $3,190 million to $1,605 million, representing a significant drop of 12.8% in 2024 compared to 2023 and a cumulative decline of 46.5% from 2022 to 2024. This steep decline indicates a weakening market position for REMICADE within JNJ's Immunology portfolio, as newer products like STELARA and TREMFYA have seen growth and are gaining traction, highlighting a shift in market dynamics and therapeutic preferences.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> REMICADE (PRODUCT)",
        "REMICADE (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7980,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2629,
        "completion_tokens": 115,
        "total_tokens": 2744
      }
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "The sales performance of REMICADE declined from 2021 to 2024, with sales dropping from $16.8 billion in 2021 (as part of the Immunology segment) to $1,605 million in 2024. This significant decrease was primarily driven by biosimilar competition, as noted in 2022, with continued infliximab biosimilar competition leading to a further reduction in sales. The 2024 results reflect a 12.8% decline compared to 2023, underscoring the ongoing impact of biosimilars and market pressures on REMICADE's performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> REMICADE (PRODUCT)",
        "REMICADE (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7429,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2481,
        "completion_tokens": 126,
        "total_tokens": 2608
      }
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "Between 2022 and 2024, STELARA (ustekinumab) maintained a significant commercial presence, with 2024 sales reaching $10,361 million, representing a 4.6% decline compared to $10,858 million in 2023. In 2022, STELARA was in the process of filing for approval in the U.S. for the treatment of pediatric patients with juvenile psoriatic arthritis, as disclosed in the 2022 10-K filing by JNJ. By 2024, while no new approvals for STELARA were listed in the filing, its sales performance remained stable within the Immunology segment, reflecting its continued role as a key product for JNJ.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> STELARA (PRODUCT)",
        "STELARA (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11031,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3378,
        "completion_tokens": 146,
        "total_tokens": 3524
      }
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "The total net revenue from Restasis in the United States decreased from $382 million in 2023 to $172 million in 2024, representing a 55.2% decrease in 2024. In 2023, the revenue decreased from $621 million in 2022 to $382 million, reflecting a 38.5% decrease. These figures highlight a significant decline in U.S. Restasis revenue over the two-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Restasis (PRODUCT)",
        "Restasis (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14548,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4269,
        "completion_tokens": 89,
        "total_tokens": 4358
      }
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "Between 2022 and 2023, the role and strategic importance of AMT’s Master Lease Agreements evolved to further support its international growth and strengthen tenant relationships. In 2022, these agreements were highlighted as tools to provide consistent, long-term revenue and reduce non-contractual churn, while also enabling rapid and efficient deployment of equipment on AMT’s sites, which is critical as carriers expand and densify their networks. By 2023, the agreements were emphasized as foundational to building and augmenting strong strategic partnerships with tenants, particularly as AMT expanded its international portfolio to approximately 182,000 communications sites. This growth, supported by the comprehensive nature of the agreements, allowed AMT to capitalize on increasing network investments in international markets and drive sustainable, long-term revenue, especially as carriers continued to deploy 4G and 5G technologies globally.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Master Lease Agreements (ACCOUNTING_POLICY)",
        "Master Lease Agreements (ACCOUNTING_POLICY) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9172,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2945,
        "completion_tokens": 238,
        "total_tokens": 3184
      }
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "Between 2023 and 2024, the Google Marketing Platform has remained a key channel through which advertising revenues are generated and managed across Google Network properties, as both chunks highlight its role in enabling customer purchases of advertising inventory. In 2023, the platform was explicitly mentioned as one of the tools used by customers to purchase advertising, with revenues from Google Network properties generally recognized on a gross basis, where Google acts as the principal. In 2024, this structure was reaffirmed, with no material changes noted in the platform’s role or the revenue recognition methodology for ads placed on Google Network properties. Thus, the Google Marketing Platform continued to support advertising revenue generation in alignment with consistent revenue recognition practices across both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Marketing Platform (PRODUCT)",
        "Google Marketing Platform (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8532,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2797,
        "completion_tokens": 209,
        "total_tokens": 3007
      }
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "Between 2023 and 2024, the volume of Federal Funds Purchased & Sec Loaned increased from $1,662 million to $570,236 million, while the fair value rose from $144,501 million to $192,859 million. This significant increase in both volume and fair value indicates that Bank of America (BAC) substantially expanded its short-term funding through these instruments in 2024, suggesting a shift toward more aggressive short-term liquidity management or increased reliance on secured funding sources amid changing market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Fed Funds Purchased & Sec Loaned (FIN_INST)",
        "Fed Funds Purchased & Sec Loaned (FIN_INST) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BAC_10k_2024.pdf",
          "page_id": "page_155",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 24383,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6747,
        "completion_tokens": 130,
        "total_tokens": 6878
      }
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations has evolved to include a broader context of market risks, such as inflationary, deflationary, and recessionary conditions. In 2022, the sensitivity of these liabilities was mentioned in the context of market fluctuations, with a reference to \"Our Critical Accounting Policies and Estimates.\" By 2024, the disclosure explicitly links these liabilities to a wider range of market risks, including interest rates and macroeconomic conditions, indicating a more comprehensive risk assessment approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Pension and Retiree Medical Plan Liabilities (FIN_INST)",
        "Pension and Retiree Medical Plan Liabilities (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7352,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2492,
        "completion_tokens": 159,
        "total_tokens": 2651
      }
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "Between 2023 and 2024, Adobe has enhanced Adobe Scan's positioning within its broader document management ecosystem by integrating it more deeply into Adobe Document Cloud. In 2023, Adobe Scan was described as a free mobile tool that captures paper documents and converts them into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its role in enabling instant sharing and cloud storage. By 2024, Adobe Scan is explicitly listed as part of Adobe Document Cloud, which now includes Acrobat, Acrobat Sign, and other apps, highlighting its role in enabling automated digital document workflows across platforms. This evolution underscores Adobe's strategy to position Adobe Scan as a foundational tool for document capture, seamlessly connecting with Acrobat and Acrobat Sign to streamline end-to-end document management and productivity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Adobe Scan (PRODUCT)",
        "Adobe Scan (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10047,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3149,
        "completion_tokens": 214,
        "total_tokens": 3364
      }
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "Gemini's role and integration across Google's products evolved significantly from its initial launch in December 2023 to 2024, with the release of Gemini 2.0, which marked a major advancement in its capabilities. Initially introduced as a multimodal model capable of understanding and combining text, code, audio, images, and video, Gemini was leveraged across Alphabet teams to enhance product and service experiences. By 2024, Gemini had been integrated into all seven of Google's two-billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—demonstrating its expanded role in powering AI features for everyday users. Additionally, Gemini's multimodal capabilities advanced further, enabling new experimental features like Project Astra and Project Mariner, and supporting generative AI applications in Google Workspace, YouTube, and Google Cloud, where it assists developers and improves productivity and creativity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Gemini (PRODUCT)",
        "Gemini (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11081,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3411,
        "completion_tokens": 236,
        "total_tokens": 3648
      }
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "Between 2022 and 2024, Linde's relationship with helium has had a mixed impact on its financial performance. In 2024, lower global helium volumes contributed to a 2% decrease in sales for Linde's \"Other\" segment compared to 2023. However, operating profit in the same segment increased by 44%, driven by insurance recovery for Linde Advanced Materials Technology (LAMT), despite higher costs associated with helium. This highlights a negative impact of helium on profitability, as indicated by the KG triplet, where helium negatively impacts Linde, even as Linde supplies helium as a raw material. Currency translation effects remained relatively flat during this period, not significantly influencing the helium-related financial outcomes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> RAW_MATERIAL <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Helium (RAW_MATERIAL)",
        "Helium (RAW_MATERIAL) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2022.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1310,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 962,
        "completion_tokens": 185,
        "total_tokens": 1147
      }
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "The net value of acquired franchise rights decreased from $789 million in 2022 to $598 million in 2024, representing a decline of $191 million over the two-year period. This reduction was driven by continued amortization, as reflected in the accumulated amortization increasing from $187 million in 2022 to $223 million in 2024, while the gross value of acquired franchise rights also declined from $976 million to $821 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Acquired Franchise Rights (FIN_INST)",
        "Acquired Franchise Rights (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3124,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 107,
        "total_tokens": 1523
      }
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolved from 2023 to 2024 as follows: In 2023, Chevron reported total \"as sold\" natural gas volumes of 7,148 million cubic feet per day, with Tengizchevroil being one of the key affiliates contributing to these volumes. By 2024, these volumes increased to 7,569 million cubic feet per day, reflecting a rise in production or delivery. Additionally, Chevron remained contractually committed to delivering natural gas under various obligations, with a portion of these commitments tied to production from affiliates like Tengizchevroil, which continues to be a significant operational stake for Chevron.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Tengizchevroil (COMP)",
        "Tengizchevroil (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2446,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 173,
        "total_tokens": 1413
      }
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "Between 2023 and 2024, the role of Google Network partners in Google's advertising revenue model has evolved from being primarily a cost center—where payments to these partners were described as part of operating expenses in the 2023 10-K—to being more explicitly tied to the generation of advertising revenue, as detailed in the 2024 10-K. In 2023, payments to Google Network partners were listed as a primary use of cash from operating activities, indicating their role in supporting Google's advertising distribution. By 2024, the description of TAC (Traffic Acquisition Costs) clarifies that these payments are directly linked to ads displayed on partners' properties, emphasizing their integral role in the monetization of advertising inventory. This shift in description reflects a more nuanced recognition of how these partners contribute to the advertising revenue ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Network Partners (COMP)",
        "Google Network Partners (COMP) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7767,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2589,
        "completion_tokens": 220,
        "total_tokens": 2809
      }
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "From 2023 to 2024, the impact of public policies on Bank of America’s (BAC) climate-related regulatory requirements has intensified, particularly due to increasing global regulatory focus and jurisdictional divergence. In 2023, BAC noted that regulatory requirements were expanding across state, federal, and non-U.S. jurisdictions, leading to higher legal, compliance, and public disclosure risks and costs. By 2024, this trend had evolved, with the company emphasizing that existing and pending climate-related disclosure requirements in various jurisdictions—marked by jurisdictional divergence—were expected to further impact its compliance and legal risks. This divergence complicates BAC’s ability to maintain consistent compliance strategies, amplifying regulatory and reputational risks as it navigates a fragmented and evolving policy landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Public Policies (REGULATORY_REQUIREMENT)",
        "Public Policies (REGULATORY_REQUIREMENT) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BAC_10k_2024.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15557,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4551,
        "completion_tokens": 213,
        "total_tokens": 4765
      }
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "General Motors has increasingly emphasized its full-size pickup trucks from 2022 to 2024, as highlighted by their continued mention as a key product line in 2022 risk factors and a significant contributor to 2024 sales and profitability. In 2024, quantitative indicators such as increased net wholesale volumes, a favorable product mix, and higher pricing due to strong demand demonstrate a strategic shift toward stronger performance and improved market positioning for this product line. Additionally, the higher profitability margin of trucks compared to crossovers and cars further underscores the financial rationale for this strategic focus.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GM (ORG) -> Full-Size Pickup Trucks (PRODUCT)",
        "Full-Size Pickup Trucks (PRODUCT) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8526,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2790,
        "completion_tokens": 161,
        "total_tokens": 2952
      }
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "The allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts for Alabama Power decreased from $21 million in 2022 to $20 million in 2024, while for Georgia Power, it increased from $293 million in 2022 to $349 million in 2024. This shift indicates a strategic reallocation of investments, with Georgia Power emphasizing safer, government-backed securities, likely to enhance liquidity and reduce risk, while Alabama Power slightly reduced its holdings, possibly reallocating capital to other investment vehicles.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> U.S. Treasury and government agency securities (FIN_INST)",
        "U.S. Treasury and government agency securities (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_311",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_277",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 21580,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6064,
        "completion_tokens": 139,
        "total_tokens": 6203
      }
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "From 2022 to 2024, PepsiCo's relationship with independent bottlers has evolved to include more structured and negotiated annual financial incentives, such as bottler funding, aimed at supporting trade and consumer programs, advertising, new product launches, and equipment placement. In 2022, PepsiCo emphasized its ongoing commitment to providing incentives based on annual targets, including payments for advertising and marketing activities, with accruals established during the year. By 2024, these incentives had become more formalized and strategic, with specific programs tailored to support bottler performance and market expansion. Additionally, PepsiCo's strategic dependency on independent bottlers remains strong, as evidenced by exclusive geographic contracts and the importance of bottler performance in achieving broader distribution and sales objectives, including those tied to major customers like Walmart.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Independent Bottlers (COMP)",
        "Independent Bottlers (COMP) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8764,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2826,
        "completion_tokens": 231,
        "total_tokens": 3058
      }
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "From 2023 to 2024, Adobe Firefly's role within Adobe's product innovation strategy has evolved from being a listed trademark in Adobe's portfolio to a central example of the company's focus on generative AI innovation. In 2023, Adobe Firefly was included in the company's trademark listing, signaling its recognition as a key product. By 2024, Adobe Firefly was highlighted in risk disclosures as a flagship generative AI offering, reflecting its strategic importance in Adobe's efforts to integrate AI across its product suite and adapt to rapid technological changes. This evolution underscores Adobe's increasing emphasis on AI-driven solutions and the associated regulatory and operational challenges tied to its deployment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Adobe Firefly (PRODUCT)",
        "Adobe Firefly (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7180,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2438,
        "completion_tokens": 182,
        "total_tokens": 2620
      }
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "Between 2022 and 2023, the role of contractual rent escalations in driving tenant billing growth remained a key factor, but their impact was partially offset by increased churn and lease cancellations in 2023. In 2022, contractual rent escalations were explicitly listed as a primary driver of tenant billing growth, net of churn, alongside colocations and new leases on acquired sites. By 2023, while contractual rent escalations were still a component of tenant billing growth, churn had risen to approximately 3% of tenant billings, primarily in the U.S. & Canada segment, driven by lease cancellations and non-renewals, including those by T-Mobile under the terms of its 2020 MLA. This elevated churn rate suggests that the positive impact of contractual rent escalations on tenant billing growth was somewhat diminished in 2023 compared to 2022 due to the increased lease terminations and renegotiations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Contractual Rent Escalations (ACCOUNTING_POLICY)",
        "Contractual Rent Escalations (ACCOUNTING_POLICY) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11425,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3517,
        "completion_tokens": 227,
        "total_tokens": 3744
      }
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "Between 2023 and 2024, Chevron's (CVX) relationship with Tengizchevroil remained significant in terms of capital expenditure and production involvement. In 2023, Chevron allocated $3.5 billion in Affiliate Capex, with nearly half ($1.75 billion) directed to Tengizchevroil's FGP/WPMP Project in Kazakhstan. For 2024, Affiliate Capex is projected at $3 billion, with a similar emphasis on Tengizchevroil, indicating continued investment in the project. Additionally, Tengizchevroil remains a key production affiliate, as Chevron's 2024 production volumes explicitly include its share from Tengizchevroil in Kazakhstan, highlighting its ongoing operational and financial involvement in the joint venture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Tengizchevroil (COMP)",
        "Tengizchevroil (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3322,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 175,
        "total_tokens": 1642
      }
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "Between 2023 and 2024, the specificity of UPS's bond matching approach for determining the discount rate for U.S. pension and postretirement benefit plans remained consistent in its methodology, as both the 2023 and 2024 10-K filings describe the same process of selecting specific bonds to match projected benefit payments. However, the evolution lies in the updated application of this approach as of December 31, 2024, where the discount rate assumptions were recalibrated based on the yield curve of long-term, high-quality fixed income debt instruments available at the new measurement date, reflecting changes in market conditions and the updated impact of each basis point change on the projected benefit obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Guides_On]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Bond Matching Approach (ACCOUNTING_POLICY)",
        "Bond Matching Approach (ACCOUNTING_POLICY) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2088,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 181,
        "total_tokens": 1355
      }
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "From 2022 to 2024, Linde's relationship with helium evolved from being a supplier of the raw material to experiencing a negative impact due to higher costs and lower volumes in its global helium wholesale operations. In 2024, sales in the \"Other\" segment, which includes global helium wholesale, decreased by $32 million (2%) compared to 2023, driven by lower helium volumes. Despite this, operating profit in the \"Other\" segment increased by $19 million (44%) in 2024, primarily due to insurance recovery for Linde Advanced Materials Technology (LAMT), although higher helium costs partially offset this gain. This highlights a shift from helium as a core contributor to a source of financial pressure during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> RAW_MATERIAL <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Helium (RAW_MATERIAL)",
        "Helium (RAW_MATERIAL) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2022.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1300,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 969,
        "completion_tokens": 180,
        "total_tokens": 1150
      }
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "Between 2023 and 2024, Bank of America’s unfunded capital contributions for renewable energy investments decreased from $6.2 billion to $4.6 billion. Correspondingly, the recognized tax credits related to these investments declined slightly from $4.0 billion in 2023 to $3.9 billion in 2024. This indicates a reduction in both the contingent funding commitments and the associated tax benefits derived from renewable energy equity investments during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Unfunded Capital Contributions (FIN_INST)",
        "Unfunded Capital Contributions (FIN_INST) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BAC_10k_2024.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4329,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1743,
        "completion_tokens": 115,
        "total_tokens": 1858
      }
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "General Motors' approach to fleet sales involving commercial fleet customers from 2022 to 2024 has shown a continued reliance on both direct and dealer-based sales channels, with a focus on managing profitability. In 2022, GM noted that fleet sales, particularly to daily rental car companies, were generally less profitable than retail sales, and these sales were conducted directly or through the dealer network. By 2024, GM maintained this dual-channel approach, selling to commercial fleet customers both through the dealer network and, in some cases, directly. Additionally, GM emphasized vehicle-level profitability metrics during planning and program life cycles, indicating a strategic effort to enhance the profitability of fleet sales, including those to commercial customers, while maintaining a consolidated and efficient operational structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Sells_To]- ORG",
      "triplets_used": [
        "GM (ORG) -> Commercial Fleet Customers (COMP)",
        "Commercial Fleet Customers (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4439,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1757,
        "completion_tokens": 214,
        "total_tokens": 1971
      }
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's relationship with Sabra evolved from a joint venture ownership to a full acquisition. In 2022, PepsiCo held a 50% equity ownership in Sabra through a joint venture, as noted in the brands and intellectual property section. By 2024, PepsiCo fully acquired Sabra, as evidenced by the $122 million pre-tax gain ($92 million after-tax or $0.07 per share) recorded in the FLNA division from the remeasurement of its previously held 50% equity stake in Sabra at fair value. This change had significant financial implications, including the recognition of a gain on the transaction, which contributed positively to PepsiCo's financial results in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Owns]-> PRODUCT <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Sabra (PRODUCT)",
        "Sabra (PRODUCT) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7386,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2474,
        "completion_tokens": 169,
        "total_tokens": 2643
      }
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "Adobe's treatment of Adobe Scan evolved between 2023 and 2024 by integrating it more explicitly into the broader Adobe Document Cloud ecosystem. In 2023, Adobe Scan was listed among Adobe's key trademarks, indicating its recognition as a core product. By 2024, Adobe Scan was explicitly included as part of Adobe Document Cloud, which emphasizes digital document workflows and integrates with other tools like Adobe Acrobat and Adobe Acrobat Sign. This shift highlights Adobe's strategic positioning of Adobe Scan as a complementary tool within a unified cloud-based document management and productivity suite.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Adobe Scan (PRODUCT)",
        "Adobe Scan (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5997,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2132,
        "completion_tokens": 152,
        "total_tokens": 2285
      }
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "General Motors' (GM) financial exposure and nature of obligations to Stellantis, particularly regarding indemnifications and historical liabilities, have evolved from 2022 to 2024. Following the 2017 sale of the Opel/Vauxhall business to Stellantis, GM has ongoing indemnification obligations for certain losses, including emissions claims, product liabilities, and recalls related to pre-sale vehicles. In 2022, GM noted that it was responding to regulatory inquiries from the European Commission and UK CMA concerning Opel's past conduct, with an immaterial accrual at that time. By 2024, GM continued to face potential liabilities from consumer lawsuits and regulatory investigations related to Opel/Vauxhall, with an updated immaterial accrual and no material estimate for potential indemnification claims from Stellantis. Additionally, GM has indemnified Stellantis for an immaterial amount related to Takata inflator recalls in legacy Opel vehicles, with future indemnifications considered remote. These obligations reflect GM's ongoing exposure tied to its historical ownership of the Opel/Vauxhall business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Guarantees]- ORG",
      "triplets_used": [
        "GM (ORG) -> Stellantis (COMP)",
        "Stellantis (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6572,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2281,
        "completion_tokens": 278,
        "total_tokens": 2559
      }
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's relationship with co-packers has remained operationally significant, as the company continues to rely on a highly distributed network of plants, warehouses, and distribution centers owned or leased by co-packers, strategic alliances, and joint ventures in which PepsiCo holds an equity interest. While there is no explicit change in the level of operational dependency, the consistent mention of co-packers in both 2022 and 2024 filings highlights their ongoing strategic importance in supporting PepsiCo's production and distribution infrastructure. Additionally, the mutual dependency between PepsiCo and co-packers, as shown in the KG triplets, underscores a reciprocal relationship that remains integral to the company's operational model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Co-Packers (COMP)",
        "Co-Packers (COMP) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2971,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 194,
        "total_tokens": 1570
      }
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "Between 2023 and 2024, SPG's financial relationship with ABG evolved significantly in terms of gains and strategic investments. In 2023, SPG recognized non-cash pre-tax gains of $59.1 million from deemed disposals due to ABG's capital transactions and an additional $157.1 million from its share of the gain on the sale of a portion of its ABG interests. In 2024, SPG sold a portion of its interest in ABG, resulting in a pre-tax gain of $18.8 million. Additionally, in early 2022, SPG entered into a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., marking a key expansion of their collaborative relationship. These transactions and strategic moves reflect SPG's ongoing optimization of its stake in ABG and expansion of joint ventures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> ABG (COMP)",
        "ABG (COMP) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6645,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2288,
        "completion_tokens": 198,
        "total_tokens": 2487
      }
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "Lockheed Martin's (LMT) involvement in Sikorsky helicopter programs evolved from 2022 to 2024 with increased production volume and continued program scope. In 2022, higher production volume on Sikorsky helicopter programs contributed to a $560 million increase in product costs at RMS. By 2024, Sikorsky helicopter programs remained a key focus for RMS, which designs, manufactures, and supports military and commercial helicopters, including the Black Hawk, Seahawk, and CH-53K King Stallion. The continued emphasis on these programs reflects their strategic importance to LMT’s Rotary and Mission Systems segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Sikorsky Helicopter Programs (PRODUCT)",
        "Sikorsky Helicopter Programs (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10316,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3224,
        "completion_tokens": 153,
        "total_tokens": 3377
      }
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Walmart's ownership stake and financial investment in Alert Innovation evolved significantly. In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to 100%. By fiscal 2024, although no further acquisitions of Alert Innovation were made, the company had already consolidated full ownership. However, it is noted that Alert Innovation was subsequently sold and deconsolidated in fiscal 2025, indicating that Walmart's 100% ownership in fiscal 2023 marked the peak of its investment and control in the company.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Acquires]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Alert Innovation (COMP)",
        "Alert Innovation (COMP) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4905,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1854,
        "completion_tokens": 149,
        "total_tokens": 2003
      }
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "Between 2023 and 2024, SPG's utilization and management of the Supplemental Facility evolved significantly in terms of borrowing activity and repayment strategy. In 2023, SPG borrowed €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility, which was later repaid in full on November 17, 2023, using proceeds from the issuance of €750.0 million in senior unsecured bonds. Additionally, SPG entered into interest rate swaps in January 2023 to hedge the floating rate exposure on Euro-denominated borrowings under the Supplemental Facility, which were terminated following the repayment. In 2024, SPG did not draw on the Supplemental Facility, as evidenced by the absence of outstanding balances under the Commercial Paper program and the repayment of prior Supplemental Facility borrowings, reflecting a strategic shift toward repaying existing debt and issuing long-term fixed-rate notes to manage its capital structure and preserve credit ratings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Supplemental Facility (FIN_INST)",
        "Supplemental Facility (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9271,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2962,
        "completion_tokens": 244,
        "total_tokens": 3207
      }
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "Between 2023 and 2024, Linde has continued to position helium as a primary product within its industrial gases business, particularly in the merchant distribution segment, as highlighted in both the 2023 and 2024 10-K filings. In 2023, helium was explicitly listed among Linde’s primary process gases, and the company noted that merchant helium can be shipped over long distances, supporting its strategic value in meeting customer demand across geographies. By 2024, this positioning remained consistent, with the continued emphasis on helium as a key product in Linde’s portfolio, underscoring its importance in supply agreements and its integration into the company’s broader industrial gases operations. Linde’s supply strategy for helium remains centered on the merchant model, leveraging its production and distribution infrastructure to deliver helium to customers with flexible, multi-year supply contracts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> RAW_MATERIAL <-[Depends_On]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Helium (RAW_MATERIAL)",
        "Helium (RAW_MATERIAL) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2023.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5373,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1990,
        "completion_tokens": 228,
        "total_tokens": 2219
      }
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "Between 2022 and 2023, the allocation of assets in the U.S. Retiree Health Care Plan shifted, with fixed income securities and cash equivalents decreasing from $248 million to $210 million, and equity securities declining from $137 million to $54 million. This indicates a reduction in both asset categories, with a more pronounced decline in equity securities. The total assets of the U.S. Retiree Health Care Plan also decreased from $385 million in 2022 to $264 million in 2023, reflecting an overall reduction in the plan's holdings during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "TXN (ORG) -> U.S. Retiree Health Care Plan (FIN_INST)",
        "U.S. Retiree Health Care Plan (FIN_INST) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4202,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1700,
        "completion_tokens": 139,
        "total_tokens": 1839
      }
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "Between 2022 and 2023, Trodelvy, a product produced by Gilead (GILD), showed significant strategic and regulatory progress, although its revenue generation remained modest compared to Gilead’s larger product lines. In 2022, Trodelvy generated $380 million in total revenue, reflecting its early stage in the market. By 2023, while no updated revenue figures were provided, the product achieved key regulatory milestones, including FDA and EC approvals for the treatment of HR+/HER2- metastatic breast cancer, expanding its market access and therapeutic utility. Additionally, Gilead’s broader strategic positioning in oncology was reinforced through acquisitions and collaborations, such as Tmunity Therapeutics and Arcellx, which complemented Trodelvy’s development and commercialization efforts. These moves underscored Gilead’s commitment to strengthening its oncology portfolio, with Trodelvy playing an increasingly important role in its therapeutic and financial strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Trodelvy (PRODUCT)",
        "Trodelvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 36068,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 9656,
        "completion_tokens": 244,
        "total_tokens": 9900
      }
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "From 2022 to 2024, Chevron's downstream-related earnings from GS Caltex, its 50% joint venture in South Korea, were consistently highlighted as a contributor to income from equity affiliates, with 2022 noting \"higher downstream-related earnings from CPChem and GS Caltex.\" By 2024, GS Caltex remained a key equity affiliate, with significant intercompany transactions, including $6,547 million in purchases of crude oil and products in 2024, and $556 million in accounts payable to affiliated companies. These figures, along with the joint venture's role in importing, producing, and marketing petroleum products and petrochemicals, underscore the strategic importance of GS Caltex in Chevron's downstream operations, reflecting both financial performance and operational integration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> GS Caltex (COMP)",
        "GS Caltex (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3547,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 196,
        "total_tokens": 1726
      }
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "From 2022 to 2024, the CH-53K program showed improvements in both production volume and risk retirements, contributing to financial performance. In 2022, higher production volume and risk retirements for the CH-53K were key drivers of increased operating profit for Sikorsky helicopter programs under RMS. By 2024, while the broader MFC segment faced a significant decline in operating profit due to adjustments and losses on a classified program, the RMS segment continued to highlight the CH-53K as a major program, indicating ongoing production and operational focus. This suggests sustained progress in production and risk management for the CH-53K during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "LMT (ORG) -> CH-53K (PRODUCT)",
        "CH-53K (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3289,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 167,
        "total_tokens": 1626
      }
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "Between 2022 and 2023, PayPal has evolved its approach to seller protection programs by enhancing strategic emphasis on merchant and consumer trust, while managing risk exposure through its robust payments platform. In 2022, PayPal highlighted the risk exposure tied to its seller protection programs, noting that transaction loss rates ranged between 0.09% and 0.15% of TPV, with potential increases due to macroeconomic pressures and merchant insolvencies. By 2023, PayPal shifted to a more proactive stance, emphasizing the importance of these programs in fostering confidence among merchants and consumers, particularly in mitigating counterparty nonperformance. The company underscored its competitive differentiation through seller protection, alongside analytics and risk management, as key value propositions for merchants, reflecting a strategic emphasis on trust and platform security as central to sustainable growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Risk]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Seller Protection Programs (ACCOUNTING_POLICY)",
        "Seller Protection Programs (ACCOUNTING_POLICY) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10284,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3220,
        "completion_tokens": 232,
        "total_tokens": 3452
      }
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "Between 2023 and 2024, Starbucks' approach to its ready-to-drink beverages has evolved in terms of both revenue recognition and supplier dependency. In 2023, revenue from ready-to-drink beverages, along with other products, was generally recognized upon shipment to customers, depending on contract terms, and included in \"Other Revenues\" in the consolidated statements of earnings. By 2024, Starbucks continued to source ready-to-drink beverages from several specialty suppliers under long-term contracts, emphasizing its dependency on these suppliers for product availability in stores. The company expressed confidence in the reliability of its suppliers, noting that the risk of non-delivery was remote due to established relationships and historical performance. Thus, while the revenue recognition method remained consistent, Starbucks maintained a strategic and stable supplier relationship to support its ready-to-drink beverage offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Ready to Drink Beverages (PRODUCT)",
        "Ready to Drink Beverages (PRODUCT) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10814,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3347,
        "completion_tokens": 236,
        "total_tokens": 3584
      }
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "Between 2022 and 2023, Trodelvy’s geographic reach and regulatory approvals expanded significantly. In 2022, Trodelvy was primarily sold in the U.S. with $370 million in sales, while international markets showed minimal presence. By 2023, Gilead received FDA approval for Trodelvy to treat HR+/HER2- metastatic breast cancer, reinforcing its U.S. market position. Additionally, the European Commission approved Trodelvy as a monotherapy for similar indications, marking a key regulatory expansion into Europe. These approvals in 2023 reflect a strategic effort to broaden Trodelvy’s global availability and therapeutic applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Trodelvy (PRODUCT)",
        "Trodelvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8402,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2720,
        "completion_tokens": 158,
        "total_tokens": 2878
      }
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group (SPG) experienced a decline in its ownership stake in Authentic Brands Group (ABG) due to multiple capital transactions. As of December 31, 2023, SPG's ownership was diluted to approximately 9.6%, down from 11.7% in the third quarter of 2023 and 12.3% in the second quarter of 2023. SPG recognized cumulative non-cash pre-tax gains of $10.3 million, $12.4 million, and $36.4 million in these transactions during 2023, with corresponding deferred tax impacts of $2.6 million, $3.1 million, and $9.1 million, respectively. The ownership stake had previously increased through transactions in 2021 and 2022, including the exchange of licensing ventures for additional ABG interests. However, the 2023 dilutions reflect a strategic shift, as SPG's stake in ABG continued to decrease in 2024, consistent with the trend of deemed disposals and capital restructuring.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> ABG (COMP)",
        "ABG (COMP) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7303,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2449,
        "completion_tokens": 226,
        "total_tokens": 2675
      }
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "Between the 2023 and 2024 filings, the 2012 Equity Incentive Plan was amended with the addition of a **Fourth Amendment**, disclosed in the 2024 filing under Exhibit 10.2(C)+ and filed on August 1, 2024. In terms of award agreements, the 2023 filing included forms up to **10.2(D)+**, with additional forms dated as far back as July 31, 2012, and May 4, 2017. The 2024 filing expanded the disclosure significantly, adding **six new forms of award agreements** (10.2(E)+ through 10.2(K)+), with the most recent additional form dated April 25, 2024, indicating a broader and more detailed evolution in the structure and administration of the plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "META (ORG) -> 2012 Equity Incentive Plan (ACCOUNTING_POLICY)",
        "2012 Equity Incentive Plan (ACCOUNTING_POLICY) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_128",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11828,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3609,
        "completion_tokens": 161,
        "total_tokens": 3770
      }
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "Between 2022 and 2023, the capitalized software licenses increased from $152 million to $223 million, reflecting a $71 million rise in the company’s investment in software licensing. The treatment of these licenses remained consistent, as they are amortized on a straight-line basis over the term of the license, as disclosed in the 2022 filing. This increase suggests a strategic expansion in software-related capital expenditures, indicating a growing emphasis on software assets to support the company’s operations or growth initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Amortizes]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "TXN (ORG) -> Capitalized Software Licenses (FIN_INST)",
        "Capitalized Software Licenses (FIN_INST) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2022.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2023.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10243,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3212,
        "completion_tokens": 135,
        "total_tokens": 3347
      }
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "PayPal increased its utilization of European customer balances for credit activities from 37% in 2022 to 39% in 2023, with the approved amounts rising from $3.8 billion to $3.0 billion, respectively. This evolution reflects PayPal's strategic approach to leverage internal liquidity to fund credit products, while also seeking external funding sources, as evidenced by the $5.5 billion in loan and interest receivables sold in 2023 under a multi-year agreement with a global investment firm. The continued designation of customer balances indicates a balanced strategy to support credit growth while maintaining regulatory compliance and investment-grade credit ratings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Designates]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Credit Activities (FIN_INST)",
        "Credit Activities (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9220,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2955,
        "completion_tokens": 167,
        "total_tokens": 3123
      }
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "Between fiscal years 2023 and 2024, Starbucks' investment in Valor Siren Ventures I L.P. has shown a notable increase in carrying value, rising from an implied portion of the total $211.9 million (as of September 29, 2024) to a previously unspecified amount in fiscal 2023. While the exact prior carrying value for Valor Siren Ventures I L.P. is not explicitly stated for 2023, the total carrying value of Starbucks' private equity investments, including this fund, was $211.9 million as of fiscal 2024, compared to a prior year balance of $19.1 million in accounts receivable from equity investees, suggesting a modest overall financial impact. Starbucks' share of income or losses from these private equity interests is reported in \"interest income and other, net\" on its consolidated statements of earnings, though these activities were not material during the periods presented.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Valor Siren Ventures I L.P. (COMP)",
        "Valor Siren Ventures I L.P. (COMP) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4948,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1902,
        "completion_tokens": 220,
        "total_tokens": 2123
      }
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "Between 2022 and 2023, Analog Products remained a central pillar of TI's strategic positioning, leveraging its four sustainable competitive advantages—manufacturing and technology, product portfolio breadth, market channel reach, and product diversity—to drive financial performance and long-term free cash flow growth. In 2022, Analog contributed significantly to revenue growth and margin expansion, with TI reporting a 27% revenue increase and a gross margin of 67.5%, reflecting the efficiency of its manufacturing strategy and the quality of its analog product portfolio. By 2023, TI further emphasized Analog's role in its strategy, reiterating its focus on analog and embedded processing as the foundation for maximizing free cash flow per share, with the competitive advantages reinforcing TI's ability to generate and return significant cash to shareholders.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "TXN (ORG) -> Analog Products (PRODUCT)",
        "Analog Products (PRODUCT) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2022.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7614,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2540,
        "completion_tokens": 216,
        "total_tokens": 2757
      }
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "Chevron's capital allocation strategy in the Lower 48 region evolved significantly from 2022 to 2023, as reflected in the increase in depreciation, depletion, amortization, and impairments (DD&A) from $4,854 million in 2022 to $5,729 million in 2023, representing a 17.8% year-over-year increase. This rise suggests higher capital investment and asset utilization in the Lower 48, where Chevron operates and discloses its financial activities. The increase in DD&A aligns with Chevron's broader strategy to prioritize capital allocation in high-return regions, as evidenced by the consistent growth in DD&A in the Lower 48 compared to other regions like Europe, Middle East and North Africa, and Asia Pacific, which saw declines.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Lower 48 (GPE)",
        "Lower 48 (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5875,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2105,
        "completion_tokens": 182,
        "total_tokens": 2287
      }
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "Between 2023 and 2024, Verizon has increasingly positioned Fixed Wireless Access (FWA) Broadband as a core component of both its Consumer and Business product portfolios, emphasizing its role as an alternative to traditional landline internet access. In 2023, FWA was highlighted as a service available to both Consumer and Business customers through 5G and 4G LTE networks, with 3.1 million connections reported. By 2024, the company further integrated FWA into its strategic offerings, with the Consumer segment promoting it as a key wireline alternative and the Business segment explicitly listing FWA as a core service for enterprises and public sector clients. This evolution reflects a broader effort to leverage Verizon’s wireless infrastructure to serve both residential and commercial broadband needs more comprehensively.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "VZ (ORG) -> FWA Broadband (PRODUCT)",
        "FWA Broadband (PRODUCT) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8258,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2708,
        "completion_tokens": 207,
        "total_tokens": 2916
      }
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "Emerson's relationship with AspenTech evolved significantly from 2022 to 2024, transitioning from a partnership to Emerson acquiring a controlling stake in the newly formed \"New AspenTech\" in 2024, owning 55% of the outstanding shares. This acquisition positively impacted Emerson's gross margin, contributing to a 0.6 percentage point improvement in 2023 and further supporting a 1.8 percentage point increase in 2024, despite challenges like inventory step-up amortization. Financially, the equity structure was also affected, as Emerson's ownership stake in AspenTech became a significant component of its consolidated financial position, while the proceeds from the sale of its Copeland equity interest and note receivable in 2024 added to its equity through a $539 pretax gain in discontinued operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9781,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3082,
        "completion_tokens": 202,
        "total_tokens": 3285
      }
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "From 2022 to 2023, the financial relationship between NEE and FPL Group Capital Inc remained characterized by NEE's role as a guarantor for FPL Group Capital Inc's obligations, particularly in the form of junior subordinated debentures. In 2022, the 10-K filing highlighted NEE's guarantee of FPL Group Capital Inc's subordinated debt through historical agreements, including the 1998 Guarantee Agreement. By 2023, NEE continued to support FPL Group Capital Inc's capital structure by issuing new junior subordinated debentures (e.g., Series P in 2021 and additional amendments in 2022), with NEE acting as the guarantor. These obligations reflect NEE's ongoing involvement in FPL Group Capital Inc's capital structure, reinforcing the parent-subsidiary relationship and financial interdependence.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> FPL Group Capital Inc (COMP)",
        "FPL Group Capital Inc (COMP) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_120",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14676,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4317,
        "completion_tokens": 199,
        "total_tokens": 4516
      }
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "Between 2022 and 2024, the positioning and market acceptance of InterStim II evolved as part of Medtronic’s broader Pelvic Health therapies, with continued growth and integration within the company’s neurostimulator portfolio. In 2022, InterStim II was highlighted alongside the InterStim Micro and InterStim X neurostimulators for treating overactive bladder, urinary retention, and bowel incontinence, indicating its role in a diversified product line. By 2024, InterStim II was specifically noted as a recharge-free neurostimulator, positioned alongside the InterStim X (also recharge-free) and the InterStim Micro (rechargeable), reflecting a strategic emphasis on offering flexible treatment options. This evolution aligns with the broader growth of Pelvic Health therapies within Medtronic’s Specialty Therapies division, as the company continues to expand its neurostimulation solutions for chronic conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MDT (ORG) -> InterStim II (PRODUCT)",
        "InterStim II (PRODUCT) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8060,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2660,
        "completion_tokens": 229,
        "total_tokens": 2889
      }
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "Simon Property Group's utilization and management of the Supplemental Facility evolved significantly between 2022 and 2024. As of 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, with the potential to increase to $4.5 billion during its term, and an initial maturity date of January 31, 2026. By 2024, the Operating Partnership repaid €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023, using proceeds from the issuance of €750.0 million in senior unsecured bonds. Additionally, interest rate swap agreements were terminated in 2023 after the repayment of Euro-denominated borrowings, indicating a shift in interest rate strategy toward fixed-rate debt issuance, such as the 2023 and 2024 senior unsecured notes. These actions reflect a strategic focus on managing debt costs and maintaining covenant compliance, as the company remained in compliance with all covenants of its unsecured debt as of December 31, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Supplemental Facility (FIN_INST)",
        "Supplemental Facility (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11420,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3510,
        "completion_tokens": 251,
        "total_tokens": 3762
      }
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "From 2023 to 2024, Verizon shifted its device payment plans from fixed-term subsidized plans to more flexible, non-subsidized financing structures. In 2023, Verizon no longer offered fixed-term, subsidized service plans for devices to Consumer customers, though it continued to offer them to Business customers. By 2024, device payment plans were structured as non-interest-bearing installment notes, typically over 36 months, with no upfront device charge. Promotional incentives in 2024 included billing credits contingent on service retention, which were allocated to performance obligations based on relative selling price. Additionally, Verizon introduced trade-in rights under certain promotions, which were accounted for as guarantee obligations, reducing device revenue upon sale. These changes reflect a move toward more transparent, customer-centric financing and promotional structures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "VZ (ORG) -> Device Payment Plans (PRODUCT)",
        "Device Payment Plans (PRODUCT) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11589,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3537,
        "completion_tokens": 224,
        "total_tokens": 3761
      }
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company has maintained its legal position that it has no obligation for Aqua-Chem’s asbestos-related liabilities, as disclosed in both the 2023 and 2024 10-K filings. The Company continues to assert in litigation that it is not responsible for past, present, or future claims against Aqua-Chem, which it sold in 1981. Conversely, Aqua-Chem has previously claimed that Coca-Cola is liable for costs not covered by insurance related to asbestos claims arising before the 1981 sale. The litigation remains stayed pending resolution of insurance coverage disputes, and management of The Coca-Cola Company continues to believe that any liabilities from these proceedings will not have a material adverse effect on the company.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sold]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Aqua-Chem (COMP)",
        "Aqua-Chem (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8906,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2865,
        "completion_tokens": 189,
        "total_tokens": 3055
      }
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "Intel's utilization of non-US tax credits significantly reduced its long-term income tax liabilities, decreasing from $4.3 billion in 2022 to $1.6 billion in 2024, a reduction of $2.7 billion. This decline indicates that Intel's international tax strategy effectively leverages non-US tax credits to offset future tax obligations, thereby lowering its overall tax burden and improving cash flow. The consistent application of these credits, as disclosed in both 2022 and 2024 filings, reflects a deliberate and strategic approach to managing global tax liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Positively_Impacts]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Non-US Tax Credits (ACCOUNTING_POLICY)",
        "Non-US Tax Credits (ACCOUNTING_POLICY) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1177,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 953,
        "completion_tokens": 141,
        "total_tokens": 1095
      }
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "Between 2022 and 2024, the treatment and risk exposure of pension risk transfers have evolved in response to interest rate sensitivity and increasing regulatory influence. In 2022, MET's Retirement and Income Solutions segment, which includes pension risk transfers, was exposed to interest rate fluctuations, with hypothetical scenarios showing potential margin compression in both rising and declining rate environments. By 2024, regulatory changes and evolving supervisory policies have introduced additional constraints, particularly in the context of defined benefit pension plan funding, which may delay plan terminations or risk transfers, thereby affecting the composition of MET's pension risk transfer portfolio. Furthermore, regulatory actions could increase capital and reserve requirements, impacting MET's risk management and financial condition. These developments highlight a growing regulatory influence that, combined with interest rate sensitivity, has shaped the strategic and operational approach to pension risk transfers during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "MET (ORG) -> Pension Risk Transfers (PRODUCT)",
        "Pension Risk Transfers (PRODUCT) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7519,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2528,
        "completion_tokens": 265,
        "total_tokens": 2794
      }
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "Between 2022 and 2024, Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved to emphasize its role in Medtronic’s Pelvic Health therapies, particularly for treating overactive bladder, urinary retention, and chronic fecal incontinence. In 2022, the InterStim Micro was highlighted alongside the InterStim II and InterStim X neurostimulators as part of a broader growth strategy within the Specialty Therapies division. By 2024, the InterStim Micro was specifically positioned as a rechargeable option within a suite of neurostimulators, including the recharge-free InterStim X and II, reflecting a more nuanced product portfolio tailored to patient needs. This evolution underscores Medtronic's continued focus on expanding and differentiating its neuromodulation offerings to enhance treatment accessibility and outcomes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MDT (ORG) -> InterStim Micro (PRODUCT)",
        "InterStim Micro (PRODUCT) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8060,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2645,
        "completion_tokens": 216,
        "total_tokens": 2861
      }
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group's use of the Supplemental Facility evolved with notable changes in outstanding borrowings and repayment actions. As of December 31, 2021, the Supplemental Facility had a maximum aggregate outstanding balance of $2.1 billion under the Facilities, with $11.8 million in letters of credit. By December 31, 2024, the weighted average outstanding balance had decreased to $311.1 million, and letters of credit were reduced to $8.6 million. A significant repayment action occurred on November 17, 2023, when the Operating Partnership repaid €750.0 million ($815.4 million U.S. dollar equivalent) outstanding under the Supplemental Facility using proceeds from the issuance of €750.0 million in senior unsecured bonds. This repayment was accompanied by the termination of interest rate swaps that had been used to manage the Euro-denominated borrowings. Overall, the data indicates a reduction in reliance on the Supplemental Facility over the period, with active repayment actions contributing to the decline in outstanding borrowings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Extends]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Supplemental Facility (FIN_INST)",
        "Supplemental Facility (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10653,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3306,
        "completion_tokens": 268,
        "total_tokens": 3575
      }
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "COP's investment activity in the Lower 48 region increased significantly from 2022 to 2023, as reflected in the rise of depreciation, depletion, amortization, and impairments (DD&A) expenses from $4,854 million in 2022 to $5,729 million in 2023. This increase aligns with the substantial development activity in the Lower 48, as shown in the exploratory and development data, where 2022 saw 339 productive development wells compared to 127 in 2021, indicating a growing asset base and capital investment in the region. The higher DD&A expense in 2023 suggests continued expansion and operational scaling in the Lower 48, consistent with COP's strategic focus in the area.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Lower 48 (GPE)",
        "Lower 48 (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_172",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5002,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1886,
        "completion_tokens": 167,
        "total_tokens": 2054
      }
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "From 2023 to 2024, Verizon's approach to corporate networking solutions has evolved by emphasizing the integration of wireless and wireline services within its Business segment, as highlighted in both the 2023 and 2024 10-K filings. In 2023, the Business segment provided corporate networking solutions as part of a broader portfolio that included data, video, conferencing, and managed network services, with Enterprise and Public Sector contributing significantly to Business revenues. By 2024, the description of corporate networking solutions was more explicitly tied to advanced communication services and delivered alongside fixed wireless broadband, security, and IoT offerings, underscoring a strategic shift toward a more comprehensive and technology-driven service portfolio. This evolution reflects a stronger emphasis on converged connectivity solutions tailored to meet the evolving needs of businesses and public sector clients.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "VZ (ORG) -> Corporate Networking Solutions (PRODUCT)",
        "Corporate Networking Solutions (PRODUCT) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8258,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2710,
        "completion_tokens": 235,
        "total_tokens": 2946
      }
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "From 2022 to 2024, MetLife's valuation approach for FVO securities remained sensitive to fair value changes, particularly in response to U.S. dollar appreciation. In 2022, the estimated fair value of FVO securities was $1,602 million, with a sensitivity of -$54 million under a 10% U.S. dollar appreciation, indicating a moderate negative impact. By 2024, MetLife continued to apply similar valuation techniques for FVO securities, as outlined in its Level 3 fair value disclosures, which rely on significant unobservable inputs and are sensitive to changes in market conditions. The sensitivity to U.S. dollar appreciation remained a key factor, as noted in the 2024 filing, where changes in fair value are influenced by long U.S. dollar net asset positions. This suggests that while the valuation methodology for FVO securities remained consistent, the evolving U.S. dollar environment continued to impact their fair value estimates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> FVO Securities (FIN_INST)",
        "FVO Securities (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_151",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_250",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13158,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3935,
        "completion_tokens": 233,
        "total_tokens": 4169
      }
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "NextEra Energy’s engagement in power marketing activities evolved significantly between 2022 and 2023, as reflected in the financial performance of its NEER segment. In 2023, NEER reported a net income of $3,558 million, a substantial increase from $285 million in 2022, primarily driven by its energy trading and power marketing activities. This growth indicates a marked improvement in the financial performance of NextEra Energy’s energy trading services. The 2022 financial results were impacted by credit losses, including $146 million in bad debt expense, largely due to the operational and market disruptions from the February 2021 winter storm in Texas. By 2023, these challenges were mitigated, and the company capitalized on favorable commodity price movements and optimized the value of its generation and infrastructure assets through its power marketing and trading operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Engages]-> PRODUCT <-[Operates_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Power Marketing (PRODUCT)",
        "Power Marketing (PRODUCT) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7298,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2470,
        "completion_tokens": 222,
        "total_tokens": 2692
      }
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company (KO) maintained a strategic financial relationship with Coca-Cola FEMSA, as evidenced by its stake ownership and implications for equity income. As of December 31, 2023, KO’s stake in Coca-Cola FEMSA was implicitly referenced in the context of rating agencies considering the financial performance of key bottlers, including FEMSA, in assessing KO’s credit strength. This indicates that KO’s ownership in FEMSA had a material influence on its equity income, as a decline in FEMSA’s credit ratings could reduce KO’s equity income due to potential increases in FEMSA’s interest expenses. By December 31, 2024, KO explicitly reported owning 28% of Coca-Cola FEMSA’s outstanding shares, confirming its continued significant equity investment. This stake remains a key component of KO’s equity method investments, where its proportionate share of FEMSA’s net income or loss directly impacts KO’s consolidated financial results. Thus, the relationship evolved from an indirect influence on credit ratings and equity income in 2023 to a clearly defined 28% ownership stake with direct financial reporting implications in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Coca-Cola FEMSA (COMP)",
        "Coca-Cola FEMSA (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7599,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2543,
        "completion_tokens": 291,
        "total_tokens": 2834
      }
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "Between 2022 and 2023, COP significantly increased its operational focus and financial investment in the Lower 48 region, as evidenced by both production volumes and depreciation expenses. Production volumes in the Lower 48 rose from 447 thousand barrels of crude oil per day in 2022 to 829 thousand barrels per day in 2023, while natural gas production increased from 1,340 million cubic feet per day in 2022 to 3,162 million cubic feet per day in 2023. Depreciation expenses for the Lower 48 also increased from $4,854 million in 2022 to $5,729 million in 2023, reflecting higher capital investment and operational activity in the region. This growth underscores COP's strategic shift toward the Lower 48 as a core asset base.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Lower 48 (GPE)",
        "Lower 48 (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_169",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8436,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2742,
        "completion_tokens": 182,
        "total_tokens": 2924
      }
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "Between 2023 and 2024, Verizon's 4G LTE network has continued to play a foundational role in the company's network infrastructure and growth initiatives, particularly in supporting FWA broadband services as an alternative to traditional landline internet access, as noted in the 2023 10-K. In 2024, the 4G LTE network remains a critical component of Verizon's strategy, complementing its 5G capabilities and fiber infrastructure to drive innovative products and services, while also supporting the monetization of its networks and enhancing customer connectivity. The network's integration with both wireless and wireline services across Verizon's Consumer and Business segments underscores its ongoing strategic importance in delivering reliable connectivity and maintaining the company's competitive advantage.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "VZ (ORG) -> 4G LTE Network (PRODUCT)",
        "4G LTE Network (PRODUCT) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5108,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1920,
        "completion_tokens": 203,
        "total_tokens": 2123
      }
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "From 2022 to 2024, Emerson's (EMR) financial and strategic relationship with AspenTech evolved significantly. In 2022, Emerson acquired Heritage AspenTech, which contributed to a notable increase in the backlog for AspenTech, rising from $328 million in 2021 to $1,042 million in 2022, as reflected in the total backlog increase from $6,533 million to $8,053 million. This acquisition positively impacted Emerson's gross margin in 2023 by 0.6 percentage points. By 2024, Emerson owned 55% of the outstanding shares of AspenTech, and the integration of the Heritage AspenTech acquisition continued to influence financial metrics, with gross margin increasing to 50.8% in 2024, partly due to the Test & Measurement acquisition. Thus, Emerson's stake value and ownership structure solidified, and the strategic integration positively affected financial performance metrics like backlog and gross margin over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5368,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1992,
        "completion_tokens": 229,
        "total_tokens": 2221
      }
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "Between 2022 and 2023, NEE's financial commitment to the Mountain Valley Pipeline (MVP) remained consistent with its role as a 32.8% equity investor in the joint venture. In 2022, NEE's equity method investments totaled approximately $6,159 million, with MVP being one of the key entities in which NEE holds a stake. By 2023, NEE disclosed a 20-year natural gas transportation agreement with MVP, committing approximately $70 million per year, contingent on the completion of MVP's pipeline construction. This indicates that NEE's investment strategy continues to focus on long-term infrastructure development in natural gas, aligning with its broader strategy to support energy infrastructure through strategic equity investments and long-term contractual commitments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Mountain Valley Pipeline (COMP)",
        "Mountain Valley Pipeline (COMP) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6196,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2190,
        "completion_tokens": 192,
        "total_tokens": 2382
      }
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "Coca-Cola's relationship with Costa Limited in 2023 was characterized by direct retail operations, with Costa acting as a platform for Coca-Cola to sell beverages directly to consumers, and these operations were included in the Global Ventures segment. By 2024, Costa remained a key component of the Global Ventures segment, which also includes innocent and doğadan businesses, indicating a continued strategic focus on integrating and managing Costa as part of Coca-Cola's broader portfolio of ventures. This evolution reflects Coca-Cola's ongoing strategy to leverage Costa's retail presence to enhance its market reach and consumer engagement within the Global Ventures framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Costa Limited (COMP)",
        "Costa Limited (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10790,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3339,
        "completion_tokens": 170,
        "total_tokens": 3510
      }
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "Intel's investment in financial institution instruments, particularly in terms of the fair value of economically hedged marketable debt investments, has shown a decline between 2022 and 2024. As of December 30, 2022, the fair value was $17.1 billion, which decreased to $13.5 billion by December 28, 2024. This reduction was accompanied by net losses of $464 million in 2024, following net gains of $534 million in 2023 and net losses of $748 million in 2022. These investments are part of Intel's broader portfolio of marketable debt instruments, which includes corporate debt and government debt, and are classified as short-term investments, often used to hedge market risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Includes]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Financial Institution Instruments (FIN_INST)",
        "Financial Institution Instruments (FIN_INST) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8654,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2819,
        "completion_tokens": 169,
        "total_tokens": 2988
      }
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "From 2023 to 2024, AMT's financial focus on communications sites shifted toward strengthening recurring revenue generation and managing asset retirement liabilities. In 2023, AMT emphasized its role as a leading owner and operator of multitenant communications real estate, with 99% of total revenues derived from property operations, primarily through long-term leases on communications sites. By 2024, the company highlighted that a significant majority of its property operations revenue was recurring, with a strategic focus on maintaining and converting this recurring revenue into operating profit while minimizing costs. Additionally, AMT reported asset retirement obligations of $4.5 billion as of December 31, 2024, reflecting its ongoing liability to remediate sites upon asset removal, underscoring the financial responsibility tied to its long-term communications infrastructure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Communications Sites (PRODUCT)",
        "Communications Sites (PRODUCT) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6214,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2198,
        "completion_tokens": 222,
        "total_tokens": 2421
      }
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "XOM's strategic positioning in Guyana has evolved significantly between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis. In 2023, the Guyana Petroleum Activities Act 2023 provided a regulatory foundation, granting XOM a structured legal framework with exploration periods up to 10 years and production periods of 20 years for oil fields, each with a 10-year renewal option. By 2024, XOM had integrated Guyana into its \"Advantaged Volume Growth\" strategy, highlighting its importance as a key asset in driving earnings through high-value production and strategic projects. This shift reflects XOM's growing emphasis on Guyana as a core growth driver within its global portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Guyana (GPE)",
        "Guyana (GPE) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6531,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2265,
        "completion_tokens": 182,
        "total_tokens": 2447
      }
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "Caterpillar's involvement in the diesel-electric locomotives business remained a core part of its operations in both 2023 and 2024, with consistent strategic positioning under the Machinery, Energy & Transportation (ME&T) segment. In 2023, the business included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing remanufacturing services for other companies, and was integrated with inter-segment sales. By 2024, the business continued to focus on diesel-electric locomotives and components, along with rail-related products and services, including remanufacturing and leasing, with no significant changes in operational scope. The strategic positioning reflects Caterpillar's ongoing commitment to rail solutions, supported by its broader ME&T operations and aligned with its product development and service strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Diesel-Electric Locomotives (PRODUCT)",
        "Diesel-Electric Locomotives (PRODUCT) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10760,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3343,
        "completion_tokens": 220,
        "total_tokens": 3564
      }
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "The company's reliance on securitized debt obligations as a funding source has increased from 2022 to 2024, as disclosed in its 2024 10-K filing, where securitized debt obligations amounted to $14,264 million. While the 2022 filing mentioned securitized debt obligations as part of its funding strategy, it did not provide a specific figure, indicating a qualitative emphasis on their use. The inclusion of a precise amount in 2024 suggests a more prominent role for securitized debt in the company's funding strategy, reflecting a shift toward leveraging structured financing tools to diversify its funding sources beyond traditional deposits and notes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Raises]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "COF (ORG) -> Securitized Debt Obligations (FIN_INST)",
        "Securitized Debt Obligations (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_219",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5054,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1910,
        "completion_tokens": 163,
        "total_tokens": 2073
      }
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "Between 2023 and 2024, McDonald's treatment of developmental licensees remained consistent in terms of financial reporting, as it continued to recognize royalty income based on a percentage of sales and initial fees, similar to its historical approach. However, in 2024, the Company emphasized its ongoing evaluation of business relationships, including developmental licensees, to determine if any qualify as variable interest entities, though it concluded that consolidation was not appropriate. Additionally, the 2024 10-K introduced a change in rounding presentation to the nearest whole number in millions, which could affect the precision of financial figures related to developmental licensees but was noted as not significant. These updates reflect a continued focus on accurate financial reporting and relationship management without material changes in the structure or accounting of developmental licensee arrangements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Developmental Licensees (COMP)",
        "Developmental Licensees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4376,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1735,
        "completion_tokens": 232,
        "total_tokens": 1967
      }
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "Between 2023 and 2024, Southern Company’s Equity and Incentive Compensation Plan saw a notable shift in share availability and executive award disclosures. As of December 31, 2023, 26.9 million shares were available for awards under the plan. In 2024, the plan was formally disclosed as the \"Southern Company Equity and Incentive Compensation Plan, effective May 26, 2021,\" with specific executive awards under this plan detailed in filings, including terms for named executive officers. Additionally, the plan was amended further, as evidenced by the Ninth Amendment to the Southern Company Employee Savings Plan dated December 16, 2024, indicating ongoing adjustments to the compensation framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Equity and Incentive Compensation Plan (ACCOUNTING_POLICY)",
        "Equity and Incentive Compensation Plan (ACCOUNTING_POLICY) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_232",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_316",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 19606,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5566,
        "completion_tokens": 175,
        "total_tokens": 5741
      }
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "Inlyta's revenue increased from $1.003 billion in 2022 to $1.036 billion in 2023, representing a 3% growth globally and a 5% increase in the U.S., driven by the adoption of combination therapies involving Inlyta and immune checkpoint inhibitors for advanced renal cell carcinoma (RCC). However, this growth was partially offset by lower volumes and reduced net pricing in certain European markets. The overall growth trajectory was supported by continued expansion in emerging markets, as noted in the operational commentary.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Inlyta (PRODUCT)",
        "Inlyta (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 25424,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6985,
        "completion_tokens": 131,
        "total_tokens": 7116
      }
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "From 2023 to 2024, McDonald's relationship with its franchisees evolved in terms of financial structure and dependency, particularly in revenue recognition and cost-sharing for technology platforms. In 2023, franchisees contributed to McDonald's revenue primarily through rent and royalties based on a percentage of sales, along with initial fees, emphasizing a model where franchisee sales directly drive McDonald's revenue. By 2024, the Company clarified its revenue recognition practices, stating that it recognizes revenue from technology platforms on a gross basis, as it acts as the principal in these arrangements, with related expenses recognized as incurred. Additionally, McDonald's noted that it may share in the cost of restaurant improvements with franchisees, often managing and funding projects upfront before finalizing cost allocations with the franchisee upon project completion. This reflects a more integrated financial structure and increased operational involvement in technology and capital improvements, while still maintaining a revenue model heavily dependent on franchisee sales performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12526,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3780,
        "completion_tokens": 279,
        "total_tokens": 4060
      }
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "The fair value of energy-related derivatives held by Southern Company's subsidiaries increased from $59 million in 2022 to $110 million in 2023. This rise indicates a growing exposure to energy market fluctuations, as the higher fair value suggests increased sensitivity to changes in energy prices and market conditions. The increase reflects a broader shift in the energy derivatives portfolio, particularly with subsidiaries like Alabama Power and Georgia Power holding significant positions in 2023, underscoring the company's continued engagement in energy markets and the potential financial impact of price volatility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Energy-related derivatives (FIN_INST)",
        "Energy-related derivatives (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_285",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_277",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 21182,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5950,
        "completion_tokens": 156,
        "total_tokens": 6107
      }
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "The Procter & Gamble 2019 Stock and Incentive Compensation Plan was initially adopted by shareholders on October 8, 2019, and was disclosed in PG’s 2021 10-K with additional terms and conditions. By 2022, it remained a key compensatory plan referenced in the 10-K filing, indicating its ongoing relevance in the company’s executive compensation strategy. In 2024, the plan continued to be included in the disclosure of equity compensation plans under Item 12, showing its sustained significance as part of PG’s broader compensation framework alongside other historical plans. This consistent inclusion across filings from 2021 to 2024 reflects the plan’s enduring role in aligning executive incentives with shareholder interests.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PG (ORG) -> 2019 Stock and Incentive Compensation Plan (ACCOUNTING_POLICY)",
        "2019 Stock and Incentive Compensation Plan (ACCOUNTING_POLICY) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2863,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 182,
        "total_tokens": 1564
      }
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "From 2023 to 2024, Southern Company has maintained a consistent approach to managing the risk of large losses in its pension plan assets, emphasizing diversification, formal rebalancing programs, and prudent oversight of external investment managers. Both years highlight the use of a diversified mix of assets, monitoring of risk factors such as volatility and correlations, and adherence to long-term investment strategies aligned with the nature of pension liabilities. While no significant changes in risk management emphasis are explicitly stated between the two years, the 2024 filing reiterates the same risk mitigation strategies as 2023, indicating a stable and continuous focus on minimizing large losses through established diversification and governance practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Manages]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "SO (ORG) -> Risk of Large Losses (RISK_FACTOR)",
        "Risk of Large Losses (RISK_FACTOR) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_263",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_255",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3673,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 194,
        "total_tokens": 1767
      }
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "Between 2022 and 2023, NVIDIA's role in the development and supply of the CUDA platform has evolved from a foundational component of its accelerated computing ecosystem to a more integrated and strategic pillar across its full-stack solutions. In 2022, CUDA was highlighted as a core parallel programming model within the broader accelerated computing platform, supporting GPUs used in data centers and servers. By 2023, CUDA's role expanded as NVIDIA emphasized its integration with software libraries, APIs, and frameworks to optimize computing, networking, and storage across the entire data center stack, including new offerings like the NVIDIA DGX Cloud. This shift indicates a strategic focus on strengthening NVIDIA's position in AI and enterprise computing by providing comprehensive, end-to-end solutions that leverage CUDA as a central enabler of performance and scalability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Develops]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> CUDA Platform (PRODUCT)",
        "CUDA Platform (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5502,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2017,
        "completion_tokens": 221,
        "total_tokens": 2238
      }
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "Between 2022 and 2023, Pfizer's financial relationship with Viatris evolved through ongoing manufacturing and supply agreements established during the Upjohn separation and combination with Mylan to form Viatris. In 2022, Pfizer reported $780 million in revenues from manufacturing legacy Upjohn products for Viatris under these agreements. By 2023, while no new revenue figures specific to Viatris were highlighted, the outstanding balances showed a reduction, with net amounts due to Viatris decreasing to $33 million as of December 31, 2023, from $94 million as of December 31, 2022. Additionally, services under transition service agreements (TSAs) were largely completed by the end of 2023, indicating a continued shift toward finalizing post-separation obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Viatris (COMP)",
        "Viatris (COMP) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11756,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3569,
        "completion_tokens": 192,
        "total_tokens": 3762
      }
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "Between 2023 and 2024, the treatment and disclosure of communications sites in relation to debt obligations evolved in terms of securitization activity and covenant compliance. In 2023, American Tower repaid $1.3 billion in Series 2013-2A Notes using proceeds from the 2023 Securitization, which secured $1.3 billion of new Secured Tower Revenue Securities backed by communications sites and related cash flows, with a 5% risk retention requirement. By 2024, the focus shifted to maintaining compliance with loan covenants and managing liquidity, emphasizing the importance of recurring revenue from communications sites and the need to avoid losing sites through lease non-renewals. Additionally, asset retirement obligations were disclosed as $4.5 billion in 2024, reflecting a broader consideration of long-term liabilities tied to site operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Secures]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Communications Sites (PRODUCT)",
        "Communications Sites (PRODUCT) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8984,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2877,
        "completion_tokens": 212,
        "total_tokens": 3090
      }
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "Comcast's approach to retransmission consent agreements between 2022 and 2023 remained consistent in terms of revenue recognition and distribution models, with no significant changes disclosed. In 2022, revenue from retransmission consent agreements was recognized as part of distribution revenue, based on multiyear agreements tied to the number of subscribers, with monthly fees recognized as programming is provided. In 2023, the company continued to receive fees under these agreements, including those under NBC and Telemundo retransmission consent agreements, with revenue similarly based on subscriber counts and per-subscriber fees. Both years emphasized that these arrangements are accounted for as licenses of functional intellectual property, with revenue recognized on a monthly basis as services are delivered.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Retransmission Consent Agreements (ACCOUNTING_POLICY)",
        "Retransmission Consent Agreements (ACCOUNTING_POLICY) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7830,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2615,
        "completion_tokens": 205,
        "total_tokens": 2821
      }
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "From 2023 to 2024, Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives has evolved to reflect a broader integration within its Energy & Transportation segment. In 2023, Caterpillar's locomotive activities were part of a segment that included remanufacturing services and rail-related products, with inter-segment sales contributing to revenue. By 2024, the company explicitly positioned diesel-electric locomotives as a key component of its Energy & Transportation portfolio, emphasizing their role alongside other rail-related products and services. This shift highlights Caterpillar's strategic focus on expanding its rail offerings and aligning them with broader energy and transportation solutions, including electrified powertrains and zero-emission technologies, to meet evolving regulatory and market demands.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Diesel-Electric Locomotives (PRODUCT)",
        "Diesel-Electric Locomotives (PRODUCT) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10373,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3232,
        "completion_tokens": 216,
        "total_tokens": 3448
      }
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "Between 2023 and 2024, McDonald's relationship with its franchisees evolved in terms of **revenue recognition** and **cost-sharing arrangements**, reflecting both regulatory updates and operational practices. In 2024, the adoption of **ASU 2023-07** enhanced segment disclosures, providing more transparency on franchisee-related expenses, particularly those tied to franchise operations. Additionally, McDonald's continues to recognize **royalty and rental income** from franchisees based on a percentage of sales, with variable rent and royalties recognized at the time of the underlying sales. The Company also provides **technology platforms** to franchisees, recognizing related revenue on a gross basis as services are delivered, with expenses recognized as incurred, primarily under **Other restaurant expenses**. Furthermore, McDonald's shares in the cost of **restaurant improvements** with franchisees, with the Company typically managing and funding projects upfront, and allocating costs between **Property and Equipment** and **Accounts Receivable**, reflecting a collaborative cost-sharing model. These practices highlight a continued integration and financial interdependence between McDonald's and its franchisees.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7000,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2382,
        "completion_tokens": 307,
        "total_tokens": 2689
      }
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "Between 2023 and 2024, Southern Company's approach to executive equity compensation, under its 2021 Equity and Incentive Compensation Plan, evolved with increased documentation and formalization of award terms. In 2023, the company disclosed that stock-based compensation, including performance share units (PSUs) and restricted stock units (RSUs), was granted to employees, including executives, under the plan. By 2024, specific terms for named executive officer equity awards were further detailed and formally referenced in filings, including the 10-K, indicating a more structured and transparent approach to plan documentation and award specifications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Equity and Incentive Compensation Plan (ACCOUNTING_POLICY)",
        "Equity and Incentive Compensation Plan (ACCOUNTING_POLICY) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_276",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_316",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 18792,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5355,
        "completion_tokens": 164,
        "total_tokens": 5519
      }
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "Procter & Gamble's strategic reliance on membership club stores has remained a key component of its retail channel strategy from 2022 to 2024, as evidenced by the continued inclusion of membership club stores among its primary customer channels in both the 2022 and 2024 10-K filings. In 2022, membership club stores were listed as one of the key customer segments, alongside mass merchandisers, grocery stores, and e-commerce channels. By 2024, the company reiterated the importance of managing relationships with retail trade customers, including membership club stores, while emphasizing the need to adapt to evolving retail trends such as e-commerce and hard discounter channels. This continuity suggests that P&G views membership club stores as a stable and strategic distribution channel, even as it diversifies and evolves its broader retail strategy to address competitive pressures and shifting consumer preferences.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells_To]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "PG (ORG) -> Membership Club Stores (COMP)",
        "Membership Club Stores (COMP) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12998,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3895,
        "completion_tokens": 231,
        "total_tokens": 4126
      }
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "AMT's involvement with Nigeria Letters of Credit decreased between 2023 and 2024, as evidenced by the $3.4 million carrying value in 2023, which dropped to zero in 2024. This indicates that AMT either fulfilled or settled its financial obligations related to this instrument during 2024, reducing its exposure. The Nigeria Letters of Credit were previously disclosed as part of AMT's variable rate debt in 2023, highlighting their significance in the company's broader debt structure before their resolution in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Nigeria Letters of Credit (FIN_INST)",
        "Nigeria Letters of Credit (FIN_INST) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2111,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 129,
        "total_tokens": 1305
      }
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "Between 2022 and 2024, the valuation methodology and composition of GD's Retirement Annuity Contracts remained classified as Level 3 assets, but the 2024 filing provided more detailed clarification on the categorization of these assets within the fair value hierarchy. In 2022, Retirement Annuity Contracts were listed in a table alongside other Level 3 assets, with a value of $35 million as of December 31, 2021, showing minimal changes in value over the prior years. In contrast, the 2024 filing explicitly stated that Retirement Annuity Contracts are included in Level 3 assets, which are valued using unobservable inputs. This consistency in classification, combined with the additional detail in 2024, suggests that GD is maintaining transparency in its reporting while enhancing clarity about the nature and valuation challenges of these less liquid assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Consists_Of]- ORG",
      "triplets_used": [
        "GD (ORG) -> Retirement Annuity Contracts (FIN_INST)",
        "Retirement Annuity Contracts (FIN_INST) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4121,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1686,
        "completion_tokens": 216,
        "total_tokens": 1902
      }
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "Between 2022 and 2024, the restricted cash for securitization investors remained at a consistent value of $441 million. However, its fair value hierarchy classification changed significantly. In 2022, the fair value hierarchy classification details were not explicitly provided, but by 2024, the entire $441 million was classified under Level 1, indicating it is valued based on quoted prices in active markets for identical assets. This shift suggests an improvement in the transparency and reliability of the valuation method for this restricted cash.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Reports]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "COF (ORG) -> Restricted Cash for Securitization Investors (FIN_INST)",
        "Restricted Cash for Securitization Investors (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_179",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_219",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6372,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2251,
        "completion_tokens": 138,
        "total_tokens": 2389
      }
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "Between 2023 and 2024, McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management through changes in accounting standards and revenue recognition practices. In 2023, McDonald's recognized goodwill from acquiring restaurants from franchisees, using discounted cash flow methodologies based on expected profitability, and wrote off goodwill depending on the timing of restaurant sales. By 2024, the adoption of ASU 2023-07 improved segment disclosures, enhancing transparency around franchisee-related expenses and revenues. Additionally, McDonald's continued to recognize royalty and rental income from franchisees based on a percentage of sales, while also managing shared costs for restaurant improvements, allocating expenses between property and equipment and accounts receivable. These changes reflect a more transparent and structured approach to financial recognition and asset management in the franchise relationship.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8046,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2641,
        "completion_tokens": 243,
        "total_tokens": 2885
      }
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "Between 2022 and 2024, the 2019 Stock and Incentive Compensation Plan remained a key component of Procter & Gamble's equity compensation framework, as evidenced by its continued inclusion in the company's disclosures. In 2022, the plan was referenced alongside older compensation plans like the 2009 and 2014 plans, with regulations and terms outlined under the oversight of the Compensation and Leadership Development Committee. By 2024, the 2019 Plan was still actively part of the company's equity compensation structure, as it was explicitly listed among other active plans in the disclosure of security ownership and equity compensation matters. This indicates that the 2019 Plan maintained its role as a central vehicle for equity compensation, coexisting with earlier plans but continuing to be a primary mechanism for incentivizing executives and directors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PG (ORG) -> 2019 Stock and Incentive Compensation Plan (ACCOUNTING_POLICY)",
        "2019 Stock and Incentive Compensation Plan (ACCOUNTING_POLICY) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16526,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4812,
        "completion_tokens": 216,
        "total_tokens": 5028
      }
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "Salvatore Ferragamo's presence in Simon Property Group's international outlet locations expanded between 2022 and 2023. In 2022, Salvatore Ferragamo was listed as a tenant in several of Simon's Japanese Premium Outlets, including Gotemba, Kobe-Sanda, Rinku, Sano, and Toki Premium Outlets, but was absent from U.S. outlet locations. By 2023, Salvatore Ferragamo made a notable appearance as a tenant in the Las Vegas North Premium Outlets in the U.S., marking its entry into Simon's domestic outlet portfolio, while maintaining its presence in international Japanese locations. This reflects an expansion of the brand's retail footprint within Simon's global outlet portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Salvatore Ferragamo (COMP)",
        "Salvatore Ferragamo (COMP) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16364,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4721,
        "completion_tokens": 169,
        "total_tokens": 4890
      }
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "COP's natural gas position in the Asia Pacific/Middle East region declined from 312 billion cubic feet at the end of 2023 to 296 billion cubic feet at the end of 2024, reflecting a reduction of 16 billion cubic feet. This decline was driven by production and sales deductions, partially offset by minor revisions and discoveries. Additionally, the 2023 data from Chunk 1 shows that COP held 422,000 gross acres and 152,000 net acres in the region, with a significant portion (11,088,000 gross acres and 7,439,000 net acres) classified as undeveloped. The reduction in natural gas reserves and the large volume of undeveloped acreage suggest that COP may be shifting its operational focus away from active development in the Asia Pacific/Middle East region, potentially reallocating resources to more economically viable areas.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Asia Pacific/Middle East (GPE)",
        "Asia Pacific/Middle East (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_155",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11307,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3470,
        "completion_tokens": 206,
        "total_tokens": 3677
      }
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "Comcast's approach to wireless gateways has evolved from 2022 to 2024 with a growing strategic emphasis on integrating advanced connectivity solutions into its broadband offerings. In 2022, Comcast offered wireless gateways to enhance in-home Wi-Fi coverage and provide customers with tools for network management and security, highlighting their role in delivering reliable internet speeds. By 2024, the company explicitly included wireless gateways as a key focus area for capital expenditures, signaling a strategic shift toward scalable infrastructure and network upgrades to support multigigabit symmetrical speeds. This reflects an increased investment in wireless gateways as part of broader efforts to expand and modernize its connectivity platform.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Wireless Gateways (PRODUCT)",
        "Wireless Gateways (PRODUCT) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10659,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3298,
        "completion_tokens": 189,
        "total_tokens": 3488
      }
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "Between 2022 and 2024, the G600's market presence and production evolved significantly, with cumulative deliveries increasing from nearly 150 at year-end 2021 to over 300 by year-end 2024, reflecting strong adoption and performance. As part of Gulfstream's product lineup, the G600, introduced in 2019, replaced the G450 and G550 models and is part of a broader family that includes the G500, which together offer improved speed, fuel efficiency, and cabin volume. The G600 plays a key role in Gulfstream’s strategy of expanding commonality across its aircraft family, particularly with the G400, which was developed alongside it. Additionally, the G600 continues to support Gulfstream’s leadership in setting industry standards for performance and innovation, as seen in its contribution to the company's extensive global fleet and service network.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GD (ORG) -> G600 (PRODUCT)",
        "G600 (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8583,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2785,
        "completion_tokens": 212,
        "total_tokens": 2997
      }
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved as AIG continued to reduce its ownership stake in Corebridge, holding 52.2% of Corebridge's common stock as of December 31, 2023, with plans to further divest over time. In 2024, AIG recognized equity method income from Corebridge, which included both dividends received and changes in Corebridge's stock price from June 9, 2024, to December 31, 2024. This reflects AIG's ongoing exposure to Corebridge's performance through its remaining equity ownership, as well as its transition toward full divestiture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Impacts]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Corebridge (COMP)",
        "Corebridge (COMP) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6457,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2246,
        "completion_tokens": 145,
        "total_tokens": 2391
      }
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "Between 2022 and 2024, Tesla's production strategy for the Solar Roof has evolved to become more integrated with its broader manufacturing and supply chain operations, while facing increasing operational challenges. In 2022, Tesla produced the Solar Roof at Gigafactory New York, emphasizing its role in developing and manufacturing solar products alongside energy storage and Supercharger components. However, by 2024, Tesla acknowledged broader production risks and challenges, including potential delays in ramping Solar Roof production, which were linked to supply chain disruptions, single-source supplier dependencies, and the complexities of scaling localized procurement at new and existing manufacturing sites. These challenges underscored Tesla's growing reliance on a complex global supply chain and the need to manage production bottlenecks and supplier risks to maintain its production and cost-efficiency goals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Solar Roof (PRODUCT)",
        "Solar Roof (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10382,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3233,
        "completion_tokens": 231,
        "total_tokens": 3465
      }
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "From 2023 to 2024, Qualcomm has increasingly emphasized on-device artificial intelligence (AI) as a core component of its business strategy, reflecting its commitment to foundational technologies like high-performance computing and wireless connectivity. In 2023, Qualcomm highlighted its role in developing and commercializing on-device AI as part of its broader mission to bring intelligent computing to diverse industries beyond mobile handsets, such as automotive and IoT. By 2024, this focus intensified, with Qualcomm continuing to invest significantly in on-device AI, leveraging its existing technical and business expertise while also pursuing strategic transactions to expand into new product areas. The company’s investment approach underscores a long-term strategy to drive growth through innovation in AI and related technologies, positioning on-device AI as a key differentiator in an evolving technological landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> On-Device AI (PRODUCT)",
        "On-Device AI (PRODUCT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13850,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4105,
        "completion_tokens": 233,
        "total_tokens": 4338
      }
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "The presence of Dolce & Gabbana in SPG-operated properties expanded significantly between 2022 and 2023, as it was listed as a tenant in multiple Japanese premium outlets in 2022 but appeared in only one property—Las Vegas Outlets North—in 2023. This shift indicates a strategic repositioning by SPG to feature Dolce & Gabbana in high-traffic, high-end U.S. locations, emphasizing its focus on elevating brand prestige and aligning with luxury retail trends in its premium outlet portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Dolce & Gabbana (COMP)",
        "Dolce & Gabbana (COMP) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16364,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4737,
        "completion_tokens": 122,
        "total_tokens": 4860
      }
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "COP's investment in exploration activities in the Asia Pacific/Middle East region increased from $49 million in 2023 to $46 million in 2024, as shown in the respective 10-K filings. While the dollar amount slightly decreased, the consistent allocation of resources to exploration in this region, combined with the company's operational presence and disclosures in the region, indicates a sustained strategic focus on maintaining and potentially expanding its footprint in Asia Pacific/Middle East. This suggests COP views the region as a key area for long-term growth and resource development.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Asia Pacific/Middle East (GPE)",
        "Asia Pacific/Middle East (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_156",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 21358,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5990,
        "completion_tokens": 148,
        "total_tokens": 6138
      }
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "Comcast's financial stake in Universal Beijing Resort has remained consistent at a 30% interest from 2022 to 2024. Regarding debt involvement, as of December 31, 2024, Universal Beijing Resort had $3.4 billion in debt outstanding, including a $3.0 billion term loan, compared to $3.5 billion in debt outstanding, including a $3.1 billion term loan, as of December 31, 2023. This indicates a slight reduction in total debt by $100 million from 2023 to 2024. Comcast consolidates Universal Beijing Resort due to its ability to direct activities significantly impacting its economic performance, and its maximum risk of financial loss remains limited to its 30% equity stake.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Universal Beijing Resort (COMP)",
        "Universal Beijing Resort (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6665,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2296,
        "completion_tokens": 168,
        "total_tokens": 2464
      }
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "From 2022 to 2023, Duke Energy's net derivatives balance decreased from $29 million at the beginning of 2023 to $13 million at the end of 2023, primarily due to higher settlements of $68 million compared to purchases of $42 million. In contrast, in 2022, the net derivatives balance increased from $22 million to $29 million, driven by purchases of $74 million and lower settlements of $32 million. The significant reduction in 2023, along with a loss of $10 million included on the Consolidated Balance Sheet, indicates a more active unwinding or reduction of derivative positions, suggesting a potential strategy to lower exposure or hedge effectiveness during that period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Derivatives (net) (FIN_INST)",
        "Derivatives (net) (FIN_INST) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_199",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_192",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3856,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1616,
        "completion_tokens": 168,
        "total_tokens": 1784
      }
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "From 2022 to 2023, SPG's treatment and disclosure of LTIP Units evolved in terms of their dilutive effect and valuation modeling. In 2022, SPG disclosed that no securities, including LTIP Units, had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2023, SPG provided more detailed information on LTIP Units, explaining that they are a form of limited partnership interest issued by the Operating Partnership and are accounted for as participating securities under the two-class method of computing earnings per share. Additionally, the 2023 filing clarified that the grant-date fair values of market-based LTIP Units are estimated using a Monte Carlo model, with resulting fixed expenses recorded regardless of whether market conditions are met, indicating a more transparent and sophisticated valuation approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> LTIP Units (FIN_INST)",
        "LTIP Units (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5718,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2064,
        "completion_tokens": 212,
        "total_tokens": 2276
      }
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "Between 2022 and 2024, Comcast's financial commitment to Atairos Group, Inc. has remained structured under the terms of the November 2020 agreement. As of 2024, Comcast has committed to fund Atairos up to $4.5 billion in aggregate at any one time, with an annual capital call cap of $400 million plus previously distributed amounts. Additionally, Comcast has separately committed to fund a $40 million annual management fee for Atairos. In terms of cash distributions, Comcast received $217 million in 2023 and $297 million in 2024 from Atairos, reflecting the returns on its equity method investment. These figures illustrate the ongoing financial involvement and structured capital commitments from Comcast to Atairos during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Controls]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Atairos Group, Inc. (COMP)",
        "Atairos Group, Inc. (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5972,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2138,
        "completion_tokens": 184,
        "total_tokens": 2322
      }
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region decreased slightly from 312 billion cubic feet at the end of 2023 to 296 billion cubic feet at the end of 2024, according to the provided reserve data. This decline was primarily driven by production and minor revisions, partially offset by small additions from extensions and discoveries. Given that the Asia Pacific/Middle East region is where COP discloses its PSC-related reserves (which are sensitive to commodity price fluctuations), the modest change in reserves suggests a cautious operational approach in this area, likely influenced by economic conditions and regulatory frameworks. The region remains a key geographic reporting area for COP, but the data indicates a stable rather than expansionary focus in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Asia Pacific/Middle East (GPE)",
        "Asia Pacific/Middle East (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_137",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13572,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4041,
        "completion_tokens": 197,
        "total_tokens": 4239
      }
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "In 2022, Comcast (CMCSA) procured wireless gateways as part of its strategy to support residential and business customers, as noted in its 2022 10-K. By 2024, the company shifted its focus to deploying wireless gateways as part of broader network infrastructure investments, as outlined in its 2024 10-K, which emphasized upgrading the network to deliver multigigabit symmetrical speeds and expanding capacity. This evolution reflects a move from procurement to active deployment as part of a larger connectivity and platform investment strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Purchases]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Wireless Gateways (PRODUCT)",
        "Wireless Gateways (PRODUCT) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10841,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3340,
        "completion_tokens": 136,
        "total_tokens": 3477
      }
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Solar Roof product has shifted from being a part of broader energy growth to facing notable production challenges that underscore its strategic importance. In 2022, the Solar Roof contributed to the 40% increase in energy generation and storage revenue, indicating its role in expanding Tesla’s energy offerings. However, by 2024, Tesla acknowledged potential delays in ramping up Solar Roof production, alongside other products, due to complex manufacturing, supply chain constraints, and the need for efficient scaling at multiple global facilities. These challenges highlight the product's strategic value while also revealing the operational hurdles Tesla must overcome to realize its full potential.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Solar Roof (PRODUCT)",
        "Solar Roof (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6540,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2271,
        "completion_tokens": 187,
        "total_tokens": 2459
      }
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased significantly from $53 million at the end of 2022 to $14 million at the end of 2023. This reduction indicates a strategic shift or reduction in the company's exposure to this category, potentially reflecting a focus on liquidity, risk management, or reallocation of capital to other investment opportunities. The decline suggests Duke Energy is streamlining its investment portfolio, emphasizing more categorized and transparent asset classes over pending or other less-defined investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Net Pending Transactions and Other Investments (FIN_INST)",
        "Net Pending Transactions and Other Investments (FIN_INST) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_226",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_219",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4769,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1857,
        "completion_tokens": 143,
        "total_tokens": 2001
      }
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "Between 2023 and 2024, the company has maintained its liability-driven investment framework, with consistent equity/fixed income target allocations of 20%/80% for pension plans and 55%/45% for postretirement plans. However, defined contribution plan expenses increased, rising from $109 million in 2023 to $112 million in 2024, reflecting a $3 million year-over-year increase. Additionally, the 2024 filing provides more explicit disclosure of the actual composition of plan assets at December 31, 2024, indicating a broader characterization of the asset allocation, which suggests enhanced transparency in reporting plan asset composition compared to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Implements]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Liability-Driven Investment Framework (ACCOUNTING_POLICY)",
        "Liability-Driven Investment Framework (ACCOUNTING_POLICY) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3576,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 164,
        "total_tokens": 1730
      }
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Qualcomm has reinforced its strategic focus on On-Device AI by emphasizing its integration with 5G and high-performance, low-power computing to expand beyond mobile handsets into industries like automotive and IoT. In fiscal 2023, Qualcomm highlighted the importance of remaining a leader in 5G and AI technologies to sustain long-term growth, while in fiscal 2024, the company explicitly stated its continued investment in foundational technologies, including on-device AI, through research, development, and strategic transactions. These investments reflect a clear direction to leverage AI in new product areas and applications, aligning with Qualcomm’s broader goal to drive innovation and maintain leadership in emerging markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Positively_Impacts]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> On-Device AI (PRODUCT)",
        "On-Device AI (PRODUCT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11175,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3443,
        "completion_tokens": 192,
        "total_tokens": 3636
      }
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "The classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members remained consistent between the 2022 and 2023 10-K filings, as both filings disclose the \"Second Amended and Restated Voting Trust Agreement, Voting Agreement and Proxy dated as of March 1, 2004\" under Exhibit 9.1. This consistency indicates a stable governance structure, with no material changes to the agreement or its presentation, suggesting continuity in the control and voting rights arrangements among the Simon family and the corporate entity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Voting Trust Agreement (ACCOUNTING_POLICY)",
        "Voting Trust Agreement (ACCOUNTING_POLICY) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_144",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_140",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 20268,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5743,
        "completion_tokens": 146,
        "total_tokens": 5889
      }
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased slightly from 312 billion cubic feet at the end of 2023 to 296 billion cubic feet at the end of 2024, according to the reserve changes disclosed in the 10-K filings. Despite a small decline, the region remains a part of COP's global reserves portfolio, with its reserves being influenced by revisions, production, and limited extensions. However, compared to the significant growth in U.S. reserves (from 6,896 to 7,982 billion cubic feet), the Asia Pacific/Middle East region appears to hold a diminishing strategic importance in COP's global reserves portfolio, as its reserves have not kept pace with growth in other key regions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Asia Pacific/Middle East (GPE)",
        "Asia Pacific/Middle East (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_154",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12359,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3744,
        "completion_tokens": 177,
        "total_tokens": 3921
      }
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly in terms of debt structure and equity method income. In 2023, Corebridge had a total debt of $9,368 million, including $7,702 million in senior unsecured notes and $989 million in junior subordinated debt, none of which were guaranteed by AIG. By 2024, AIG began accounting for Corebridge under the equity method following its spin-off, with equity method income reflecting dividends received and changes in Corebridge's stock price post June 9, 2024. This shift from direct debt guarantees to equity method accounting illustrates a structural and strategic repositioning of AIG's financial stake in Corebridge.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Impacts]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Corebridge (COMP)",
        "Corebridge (COMP) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6399,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2231,
        "completion_tokens": 175,
        "total_tokens": 2406
      }
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "NextEra Energy's investment strategy in Special Use Funds has shifted significantly from 2022 to 2024, with a marked increase in equity securities allocation. In 2022, the Special Use Funds were entirely categorized under fixed income securities with a carrying amount of $2,505 million. By 2024, the Special Use Funds under NEE included $2,614 million in equity securities, alongside $722 million in U.S. government and municipal bonds and other debt securities. This shift suggests a higher risk appetite and a potential reallocation toward growth-oriented assets, while still maintaining a portion of fixed income for liquidity and stability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Special Use Funds (FIN_INST)",
        "Special Use Funds (FIN_INST) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6247,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2225,
        "completion_tokens": 161,
        "total_tokens": 2386
      }
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "The risk associated with site infrastructure sharing has increased in magnitude and complexity between 2022 and 2024, particularly as 5G technology adoption has accelerated. In 2022, AMT highlighted that infrastructure sharing, especially driven by 5G, could reduce new lease activity and lead to decommissioning of existing equipment due to network redundancy. By 2024, this risk has intensified, with AMT noting that extensive sharing through RAN sharing, roaming, or resale arrangements—again linked to 5G deployment—continues to pose a threat to new lease growth and could result in churn from customer consolidations or restructuring. Additionally, the 2024 filing emphasizes broader macroeconomic challenges, such as high interest rates and supply chain disruptions, which further strain customer financials and amplify the negative impact of infrastructure sharing on AMT’s lease activity and revenue stability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Site Infrastructure Sharing (RISK_FACTOR)",
        "Site Infrastructure Sharing (RISK_FACTOR) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10876,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3381,
        "completion_tokens": 229,
        "total_tokens": 3611
      }
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "Between 2022 and 2023, Chevron's financial relationship with Angola LNG Limited remained consistent in terms of its investment structure, as Chevron maintained a 36.4 percent equity interest in the company, with no significant changes in ownership or accounting treatment reported in either year. In both the 2022 and 2023 10-K filings, Chevron accounted for its investment in Angola LNG Limited using the equity method, indicating that it continues to consolidate its share of the affiliate's earnings and losses. There were no notable differences between the carrying value of Chevron's investment and its underlying equity in the net assets of Angola LNG Limited mentioned in either year, suggesting stability in the investment's valuation and performance during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Angola LNG Limited (COMP)",
        "Angola LNG Limited (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5049,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1904,
        "completion_tokens": 194,
        "total_tokens": 2099
      }
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "From 2022 to 2023, the G600 aircraft has solidified its role as a key performer in Gulfstream's product lineup, demonstrating strong performance metrics and continued production success. In 2022, the G600 was highlighted as part of Gulfstream's advanced aircraft lineup, offering improved speed, fuel efficiency, and cabin volume compared to the models it replaced. By 2023, the G600 had achieved over 250 cumulative deliveries and contributed to Gulfstream's leadership in city-pair speed records, with the entire product line holding more than 355 such records. The aircraft remains in active production and continues to support Gulfstream's strategy of technological innovation and customer-focused performance enhancements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GD (ORG) -> G600 (PRODUCT)",
        "G600 (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5792,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2081,
        "completion_tokens": 181,
        "total_tokens": 2263
      }
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with its franchisees has evolved to emphasize deeper strategic collaboration and shared financial investment. In 2022, the company outlined its franchise and developmental licensee arrangements, where franchisees operate under strict standards and contribute revenue through rent, royalties, and initial fees, while McDonald's maintains oversight to ensure consistency and quality. By 2024, the company expanded this model by co-investing with franchisees to fund restaurant and operating system improvements, reflecting a more active financial involvement aimed at modernizing locations and enhancing brand value. Additionally, McDonald's reinforced its commitment to inclusion and values-driven collaboration, integrating franchisees into initiatives that prioritize community impact, employee engagement, and safe, respectful workplaces, thereby strengthening the partnership beyond financial transactions to shared purpose and operational alignment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6613,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2285,
        "completion_tokens": 250,
        "total_tokens": 2535
      }
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, the financial performance of smokeable products showed a slight decline in net revenues, decreasing from $22,476 million to $21,756 million. However, operating income remained relatively stable, with a marginal decrease from $10,688 million to $10,670 million. This indicates that despite lower net revenues, the segment maintained strong operational efficiency. Additionally, the goodwill and intangible assets related to smokeable products remained consistent in 2021 and 2020, with goodwill at $99 million and net intangible assets at $3,017 million in 2021, reflecting a stable asset base over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Smokeable products (PRODUCT)",
        "Smokeable products (PRODUCT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3154,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 155,
        "total_tokens": 1580
      }
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "From 2022 to 2024, Opdivo has remained a central component of BMY's product development and commercialization strategy, particularly through its continued collaboration with Ono in key Asian markets. In 2022, BMY and Ono jointly developed and commercialized Opdivo in Japan, South Korea, and Taiwan, with shared profits, losses, and development costs, underscoring the strategic partnership. By 2024, Opdivo achieved a significant therapeutic expansion with FDA approval in March for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma in combination with cisplatin and gemcitabine, reflecting its evolving role in oncology. This approval highlights BMY's ongoing focus on leveraging Opdivo through both collaborative frameworks and new therapeutic indications to strengthen its commercial and developmental footprint.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Develops]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Opdivo (PRODUCT)",
        "Opdivo (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4537,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1779,
        "completion_tokens": 215,
        "total_tokens": 1994
      }
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "AMT's disclosure regarding interest rate benchmarks for debt instruments evolved from referencing LIBOR and EURIBOR in 2022 to referencing SOFR in 2024. In 2022, AMT disclosed that USD denominated borrowings were based on LIBOR, EUR denominated borrowings on EURIBOR, and that facilities allowed borrowing at a defined base rate, LIBOR, or EURIBOR. By 2024, AMT indicated that drawn amounts under letters of credit in Nigeria bore interest based on SOFR plus a spread. Additionally, in both years, AMT emphasized that its debt agreements included financial and operating covenants, with non-compliance potentially leading to default and acceleration of outstanding amounts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Operating Covenants (REGULATORY_REQUIREMENT)",
        "Operating Covenants (REGULATORY_REQUIREMENT) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3643,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1568,
        "completion_tokens": 168,
        "total_tokens": 1737
      }
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with franchisees evolved to emphasize real estate ownership and co-investment strategies, reinforcing the Company's role as a franchisor and its alignment with franchisees. In 2022, the Company highlighted the importance of ESG initiatives and the need for Systemwide coordination, which included working with franchisees on sustainability and operational standards. By 2024, McDonald's continued to maintain a model where it generally owns or secures long-term leases for restaurant land and buildings, while franchisees co-invest in equipment, signage, and décor under conventional franchise agreements. This strategy supports high performance and leverages the strengths of both McDonald's and franchisees, ensuring alignment in brand standards and operational excellence.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12260,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3695,
        "completion_tokens": 205,
        "total_tokens": 3901
      }
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "Between 2022 and 2023, the 2015 Stock Compensation Plan for Non-Employee Directors was amended and restated effective October 26, 2022, as disclosed in the 2022 10-Q filing referenced in the 2023 10-K. In 2022, the plan had 703,256 shares available for issuance, indicating ongoing use for director compensation. The continued documentation and amendment of the plan suggest that Altria maintains a structured and transparent governance approach to director compensation, ensuring alignment with long-term shareholder interests through formalized and periodically updated equity compensation mechanisms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "MO (ORG) -> 2015 Stock Compensation Plan for Non-Employee Directors (ACCOUNTING_POLICY)",
        "2015 Stock Compensation Plan for Non-Employee Directors (ACCOUNTING_POLICY) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8437,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2792,
        "completion_tokens": 150,
        "total_tokens": 2943
      }
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "From 2022 to 2024, the impact of roaming and resale arrangements among wireless service providers on American Tower Corporation’s (AMT) leasing activity has intensified, reflecting growing competitive pressures that are slowing new lease growth. In 2022, AMT noted that such arrangements, particularly with the adoption of advanced technologies like 5G, could reduce the need for carriers to lease new infrastructure, as shared equipment or network rationalization could render existing sites redundant. By 2024, this concern had evolved into a more pronounced risk, with AMT emphasizing that extensive infrastructure sharing—through RAN sharing, roaming, or resale—could significantly slow new lease activity and lead to decommissioning of equipment on existing sites. This trend indicates that competitive dynamics, including carrier consolidation and cost optimization strategies, are increasingly constraining AMT’s ability to grow its leasing portfolio, as carriers prioritize shared infrastructure over new deployments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Roaming Arrangements (RISK_FACTOR)",
        "Roaming Arrangements (RISK_FACTOR) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10876,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3383,
        "completion_tokens": 256,
        "total_tokens": 3639
      }
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with its franchisees has evolved to emphasize greater strategic investment and operational alignment. In 2022, the company highlighted the need to execute its \"Accelerating the Arches\" strategy to drive growth, which included adapting to changing consumer behavior and operational challenges, particularly in the wake of the pandemic. By 2024, McDonald's had increased its collaborative investment approach, co-investing with franchisees to fund restaurant and operating system improvements aimed at enhancing customer experience and brand value. The company also reinforced its expectations for franchisees to meet rigorous operational standards and actively reinvest in their businesses, reflecting a stronger emphasis on shared responsibility and performance. This shift underscores a more integrated and strategic partnership model, where McDonald's supports franchisees while ensuring consistency and quality across the system.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2022.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12450,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3747,
        "completion_tokens": 244,
        "total_tokens": 3992
      }
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "NextEra Energy's investment strategy in equity securities within its Special Use Funds evolved significantly from 2022 to 2024. In 2022, the Special Use Funds were reported at $8,922 million, primarily as part of \"Other assets\" in the balance sheet. By 2024, the equity securities held within the Special Use Funds had grown substantially, with NEE's equity securities in the Special Use Funds amounting to $2,614 million (Level 1) and $3,321 million (Level 2), totaling $6,164 million. This indicates a strategic shift toward a more diversified and substantial allocation of equity investments within the Special Use Funds, reflecting a more active and expanded investment approach compared to the 2022 balance sheet presentation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Special Use Funds (FIN_INST)",
        "Special Use Funds (FIN_INST) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12733,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3814,
        "completion_tokens": 182,
        "total_tokens": 3997
      }
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, the financial performance of smokeable products showed a decline in net revenues, decreasing from $22,476 million in 2022 to $21,756 million in 2023. However, operating income for smokeable products remained relatively stable, with a slight decrease from $10,688 million in 2022 to $10,670 million in 2023. This suggests that while revenue for the segment declined, cost management or pricing strategies helped maintain operating income. The data also indicates that the decline in smokeable products is a focus area for the company, as noted in the knowledge graph where MO is linked to smokeable products with a \"Decreases\" relationship.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Smokeable products (PRODUCT)",
        "Smokeable products (PRODUCT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4795,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1834,
        "completion_tokens": 164,
        "total_tokens": 1998
      }
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "Between 2022 and 2023, the utilization of Accenture plc Class A Ordinary Shares evolved through both open-market share purchase programs and their intended usage for employee-related purposes. In 2022, the Board had authorized $3,129,296 for open-market purchases and other share repurchase programs, including shares held by current and former leadership. By 2023, these shares were being held as treasury shares and were primarily utilized for select employee benefits, such as equity awards and share withholding to satisfy payroll tax obligations arising from equity grants under employee share plans. Notably, purchases made for employee share plans in 2023 did not impact the remaining authorization for open-market share purchases, indicating a strategic allocation of shares for both capital return and employee compensation purposes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Class A Ordinary Shares (FIN_INST)",
        "Class A Ordinary Shares (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5135,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1930,
        "completion_tokens": 210,
        "total_tokens": 2140
      }
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "Between 2022 and 2024, AMT's operating covenants have evolved in terms of the types of debt instruments and interest rate benchmarks used. In 2022, AMT's covenants applied to a range of USD and EUR denominated borrowings under credit facilities and term loans, with interest rates tied to LIBOR and EURIBOR benchmarks. By 2024, the debt structure had shifted to include USD-denominated subsidiary debt, with interest rates based on SOFR plus a spread, reflecting a transition from LIBOR to SOFR as the benchmark rate. Additionally, the 2024 covenants now cover other subsidiary debt instruments, emphasizing continued compliance with financial and operational restrictions to avoid default.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Operating Covenants (REGULATORY_REQUIREMENT)",
        "Operating Covenants (REGULATORY_REQUIREMENT) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4862,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1878,
        "completion_tokens": 172,
        "total_tokens": 2050
      }
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "Between the 2023 and 2024 SEC filings, Disney+ Hotstar maintained a paid subscriber base of approximately 36 million as of September 28, 2024, consistent with the 2023 report. Meanwhile, the consolidation of Star+ into Disney+ in Latin America at the end of June 2024 streamlined Disney’s international streaming strategy by unifying its offerings, enhancing user experience, and simplifying distribution. This move reflects a broader effort to optimize its global DTC footprint, as Disney+ is now available in over 150 countries, excluding the U.S. and Canada, and strengthens Disney’s position in key international markets by leveraging a single, integrated platform.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Disney+ Hotstar (PRODUCT)",
        "Disney+ Hotstar (PRODUCT) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9242,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2963,
        "completion_tokens": 167,
        "total_tokens": 3130
      }
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "From 2022 to 2023, the number of employees covered under collective labor agreements decreased from approximately 3,000 to 2,100, as the company moved from negotiating 21 agreements in 2022 to 20 agreements in 2024. Despite this reduction, the proportion of employees under collective agreements remained consistent at approximately one-fifth of the company’s subsidiary workforce in both years. This suggests a stable labor agreement strategy, with the company maintaining a similar level of unionized workforce while slightly reducing the number of agreements to manage, potentially streamlining negotiations without significant operational disruption.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Negotiates]- ORG",
      "triplets_used": [
        "GD (ORG) -> Collective Agreements (ACCOUNTING_POLICY)",
        "Collective Agreements (ACCOUNTING_POLICY) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8178,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2697,
        "completion_tokens": 163,
        "total_tokens": 2860
      }
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "NextEra Energy's investment in U.S. Government and municipal bonds increased from $137 million in 2022 to $722 million in 2024, representing a significant rise of $585 million over the two-year period. This growth is evident across different categories, including NEE, FPL, and other investments, with the largest portion held under NEE's equity securities. The change reflects a strategic shift or expansion in NextEra Energy's fixed-income portfolio during this time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> U.S. Government and Municipal Bonds (FIN_INST)",
        "U.S. Government and Municipal Bonds (FIN_INST) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7826,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2606,
        "completion_tokens": 117,
        "total_tokens": 2723
      }
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "Between 2022 and 2024, Opdivo's role in Bristol-Myers Squibb's (BMY) product portfolio has evolved both in terms of manufacturing strategy and therapeutic approvals. In 2022, BMY highlighted its flexible manufacturing network, which includes both internal and third-party manufacturing for Opdivo, emphasizing the company's capability to manage complex biologics production and maintain supply stability. By 2024, Opdivo received a significant therapeutic approval from the FDA in March for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma in combination with cisplatin and gemcitabine, expanding its clinical utility. This approval, along with continued reliance on a hybrid manufacturing approach involving internal and third-party resources, underscores Opdivo's ongoing strategic importance in BMY's oncology portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Opdivo (PRODUCT)",
        "Opdivo (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9676,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3058,
        "completion_tokens": 217,
        "total_tokens": 3276
      }
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "Between 2023 and 2024, Disney's relationship with National Geographic magazine has evolved in terms of business structure and strategic positioning by integrating it more closely with its digital and content distribution strategies. In 2023, National Geographic magazine was reported under the Entertainment segment, specifically within the Content Sales/Licensing line of business, and was noted as being 73% owned by Disney. By 2024, National Geographic magazine was still listed under Content Sales/Licensing but was also highlighted as a brand featured in the Disney+ interface, indicating a shift toward leveraging the National Geographic brand within Disney's direct-to-consumer (DTC) platforms to enhance content offerings and subscriber engagement. This integration reflects a strategic move to position National Geographic as a key component of Disney's broader content portfolio, aligning its magazine and online business with the Company's digital streaming ambitions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "DIS (ORG) -> National Geographic Magazine (PRODUCT)",
        "National Geographic Magazine (PRODUCT) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8645,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2813,
        "completion_tokens": 244,
        "total_tokens": 3058
      }
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "PayPal's description of its transaction management databases' capabilities in 2023 highlighted their role in enabling seamless global payment processing across approximately 150 currencies, with the ability to send payments in 200 markets and withdraw funds in 56 currencies. By 2024, the company maintained the importance of these databases but noted a slight reduction in supported currencies for sending payments to 140, while expanding withdrawal capabilities to 57 currencies. This evolution reflects PayPal's ongoing efforts to enhance its global payment infrastructure, particularly in terms of currency flexibility and operational efficiency, as part of its broader strategy to innovate and improve customer experiences in the digital payments ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Develops]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Transaction Management Databases (PRODUCT)",
        "Transaction Management Databases (PRODUCT) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9653,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3069,
        "completion_tokens": 190,
        "total_tokens": 3259
      }
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "The interest rate on the Series K Debentures increased from 4.60% in 2023 to 6.051% in 2024 following a remarketing in March 2023, reflecting NEE's strategy to adjust debt terms in response to market conditions and maintain access to capital. This adjustment, along with the full and unconditional guarantee by NEE, indicates a proactive approach to managing long-term financing obligations and optimizing cost structures amid shifting interest rate environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Series K Debentures (FIN_INST)",
        "Series K Debentures (FIN_INST) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_120",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13077,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3911,
        "completion_tokens": 115,
        "total_tokens": 4027
      }
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "ExxonMobil's application of the Unit-of-Production Depreciation method remained consistent between 2022 and 2023, as both years' 10-K filings describe the same methodology for calculating depreciation based on proved reserves. In both periods, depreciation is determined by dividing asset cost by total proved or proved developed reserves, applied to actual production. However, in 2023, there was a slight expansion in the description of lower-emission business opportunities, which may reflect evolving strategic priorities that could influence future reserve estimates and asset life assumptions. The 2023 filing also reiterated that if proved reserves are substantially de-booked and the depreciation charge becomes inequitable, the company adjusts the method using the most recent SEC prices to ensure a more meaningful allocation of costs. Thus, while the core method remained unchanged, the context of evolving reserves and strategic shifts may have influenced the practical application of the method in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Unit-of-Production Depreciation (ACCOUNTING_POLICY)",
        "Unit-of-Production Depreciation (ACCOUNTING_POLICY) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11775,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3607,
        "completion_tokens": 254,
        "total_tokens": 3861
      }
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "Between 2023 and 2024, Netflix has increasingly emphasized scaling its internal studio operations to produce original programming, as evidenced by its acquisitions of Scanline and Animal Logic in 2023 and continued studio expansion in 2024. This shift reflects a strategic move to reduce reliance on third-party production partners, although the company still contracts with external entities for development, production, and distribution. The 2023 filing highlights Netflix's investment in building internal capabilities to control production risks and costs, while the 2024 filing reaffirms this trend, emphasizing the importance of scaling internal expertise in creative, marketing, and other disciplines to support original content production. This evolution underscores Netflix's long-term strategy to strengthen its competitive position by enhancing control over its content pipeline and brand differentiation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Original Programming (PRODUCT)",
        "Original Programming (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13709,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4078,
        "completion_tokens": 229,
        "total_tokens": 4307
      }
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "Between 2022 and 2023, Mastercard's Cyber and Intelligence Solutions evolved from being a value-added product under Other Revenues (as described in the 2022 10-K) to a more strategically emphasized component of Mastercard's broader technology and security offerings. In 2022, these solutions were primarily positioned as fraud prevention and transaction safety services offered alongside Mastercard's payment products. By 2023, the strategic positioning shifted to highlight these solutions as integral to enabling secure, confident, and seamless transactions across all stakeholders in the global payments ecosystem, aligning with Mastercard’s broader mission to make payments \"safe, simple, smart, and accessible.\" This evolution reflects a stronger integration of Cyber and Intelligence Solutions into Mastercard’s core value proposition and technology-driven growth strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Provides]- ORG",
      "triplets_used": [
        "MA (ORG) -> Cyber and Intelligence Solutions (PRODUCT)",
        "Cyber and Intelligence Solutions (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8005,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2635,
        "completion_tokens": 219,
        "total_tokens": 2855
      }
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "From 2023 to 2024, Tesla's approach to energy storage products has evolved with a stronger focus on addressing production challenges and strategic dependencies. In 2023, Tesla emphasized leveraging vehicle component technologies and modular design to optimize manufacturing capacity and reduce field assembly for products like the Megapack. However, by 2024, the company acknowledged potential bottlenecks and delays in ramping production of energy storage products, similar to those experienced with vehicles. These challenges include supplier dependencies, component shortages, and the need for efficient supply chain management. Tesla also highlighted the risk of delays in design, construction, and regulatory approvals for new manufacturing facilities, which could impact the timely production and deployment of energy storage solutions. Thus, while Tesla has advanced its in-house engineering and modular design capabilities, it now faces heightened strategic dependencies on supplier performance and manufacturing scalability to meet its energy storage production goals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Energy Storage Products (PRODUCT)",
        "Energy Storage Products (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9861,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3107,
        "completion_tokens": 269,
        "total_tokens": 3376
      }
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "From 2023 to 2024, NextEra Energy Capital Holdings (NEECH) expanded its issuance strategy for floating rate debentures by increasing the principal amount and diversifying the maturity structure. In 2023, NEECH issued $600 million of floating rate debentures due in 2026, as disclosed in the 2023 10-K. By 2024, NEECH significantly increased the principal amount, issuing $3.8 billion in total debentures, including $600 million in floating rate debentures with a 2026 maturity, alongside a broader range of fixed-rate debentures with maturities extending from 2025 to 2062, as detailed in the 2024 10-K. This evolution reflects a strategic shift toward larger-scale financing with extended maturity horizons to manage interest rate exposure and optimize capital structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Floating Rate Debentures (FIN_INST)",
        "Floating Rate Debentures (FIN_INST) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6566,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2291,
        "completion_tokens": 193,
        "total_tokens": 2484
      }
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "From 2023 to 2024, Intel has expanded its focus on supply chain responsibility by significantly increasing the scope of supplier engagement and deepening collaboration on industry-wide initiatives. In 2023, Intel announced its goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050 and emphasized expanding the number of suppliers covered by its engagement activities, particularly in areas such as emissions reduction, responsible minerals sourcing, and labor practices. By 2024, the company maintained its leadership in industry initiatives, continuing to collaborate with other companies to set standards and improve transparency in the global electronics supply chain, while also reinforcing its commitment to supplier diversity and human rights across both direct and indirect suppliers. This evolution reflects a broader and more integrated approach to supply chain responsibility, aligning with Intel’s RISE strategy and long-term sustainability goals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> CONCEPT <-[Partners_With]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Industry Initiatives (CONCEPT)",
        "Industry Initiatives (CONCEPT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12196,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3699,
        "completion_tokens": 244,
        "total_tokens": 3944
      }
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "Between 2022 and 2023, XOM's characterization of the assumptions underlying the standardized measure of discounted future cash flows has remained consistent in both content and framing. In both disclosures, the company emphasizes that the standardized measure is prepared on the basis of prescribed assumptions, including the use of first-day-of-the-month average prices, which are described as discrete points in time that may cause significant year-to-year variability in cash flows. Notably, XOM continues to assert that the standardized measure does not provide a reliable estimate of its expected future cash flows or the value of its proved reserves. The 2023 disclosure mirrors the 2022 language, indicating no substantive evolution in how the company frames its dependency on these assumptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Prepared_On_Basis_Of]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Prescribed Assumptions (ACCOUNTING_POLICY)",
        "Prescribed Assumptions (ACCOUNTING_POLICY) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_141",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2120,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 200,
        "total_tokens": 1410
      }
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "Between 2022 and 2023, MA's digital identity solutions have evolved by enhancing their integration with open banking capabilities and expanding their reach across financial institutions. In 2022, MA emphasized the role of digital identity solutions in securing and streamlining digital payments, leveraging technologies like device intelligence, behavioral biometrics, and document proofing. By 2023, MA advanced this integration by partnering with leading financial institutions to launch an ACH payment solution using open banking, enabling seamless consumer bill payments. Additionally, MA's open banking capabilities reached over 95% of U.S. deposit accounts and connected with approximately 3,000 banks in Europe, demonstrating significant growth in both functionality and institutional adoption.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Provides]- ORG",
      "triplets_used": [
        "MA (ORG) -> Digital Identity Solutions (PRODUCT)",
        "Digital Identity Solutions (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6668,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2317,
        "completion_tokens": 200,
        "total_tokens": 2517
      }
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "Between 2023 and 2024, Tesla's approach to the Solar Roof product has evolved to emphasize production scalability and integration with broader energy systems, while also highlighting ongoing challenges. In 2023, Tesla described the Solar Roof as a product engineered for aesthetic appeal and durability, designed to integrate with Powerwall and leveraging in-house expertise in power electronics and modular design. However, by 2024, the 10-K filing revealed that Tesla faced and continues to face production delays and bottlenecks in ramping Solar Roof, alongside other products, due to complex manufacturing processes, supply chain dependencies, and the need for skilled labor. These challenges underscore Tesla's strategic dependency on efficient manufacturing capabilities and stable supplier relationships to meet production goals and maintain product quality.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Solar Roof (PRODUCT)",
        "Solar Roof (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9861,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3101,
        "completion_tokens": 216,
        "total_tokens": 3317
      }
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "NextEra Energy, Inc. entered into a Pledge Agreement on September 1, 2022, involving Deutsche Bank Trust Company Americas as Collateral Agent, Custodial Agent, and Securities Intermediary, and The Bank of New York Mellon as Purchase Contract Agent, as disclosed in its 2023 10-K filing. In 2024, as shown in its 2024 10-K filing, the company executed a new Pledge Agreement on June 1, 2024, with the same counterparties, indicating a continuation and reinforcement of its collateral arrangements with these institutions. This evolution reflects NextEra Energy’s ongoing use of Pledge Agreements with consistent counterparties to support its financial obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Pledge Agreement (FIN_INST)",
        "Pledge Agreement (FIN_INST) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_123",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 26829,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 7345,
        "completion_tokens": 165,
        "total_tokens": 7511
      }
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "From 2023 to 2024, Intel has significantly advanced its strategic positioning in Edge AI by expanding its software platform offerings and strengthening ecosystem partnerships. In 2023, Intel emphasized its edge-native software platform, which enabled developers to build, deploy, and secure distributed edge infrastructure and AI applications across multiple verticals, while also leveraging open software frameworks and AI-enabled solutions. By 2024, the company further solidified its commitment to transforming fixed-function hardware into general-purpose, cloud-native software platforms, enhancing agility and automation through AI. Intel also expanded its collaboration with over 500 network builders and ecosystem partners to deliver optimized compute and connectivity solutions, reinforcing its role in enabling intelligent edge solutions and driving digital transformation across industries.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enables]-> CONCEPT <-[Positively_Impacts]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Edge AI (CONCEPT)",
        "Edge AI (CONCEPT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11487,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3509,
        "completion_tokens": 225,
        "total_tokens": 3734
      }
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "The 1.75% senior notes due August 2030, with a face value of $1,250 million, remained unchanged in value between 2023 and 2024, as shown in both the 2023 and 2024 long-term debt schedules. This consistency indicates that there were no repayments, redemptions, or issuances related to this specific tranche during the period. The notes are part of CVS's broader long-term debt structure and are disclosed by the company as a component of its senior notes due in 2030, reflecting a stable composition for this particular debt instrument.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> 1.75% Senior Notes (FIN_INST)",
        "1.75% Senior Notes (FIN_INST) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_168",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_161",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5996,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2147,
        "completion_tokens": 133,
        "total_tokens": 2281
      }
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "Between 2023 and 2024, Netflix's ad-supported subscription plan evolved from being a newly introduced, lower-priced option to a more integrated part of its pricing strategy aimed at meeting diverse consumer needs and supporting membership growth. In 2023, the plan was introduced as a strategic move to attract price-sensitive members while managing content costs and mitigating macroeconomic pressures. By 2024, the plan was explicitly included in Netflix’s broader pricing strategy, reflecting its role in enhancing accessibility and driving growth, particularly in competitive and price-sensitive markets. The evolution underscores Netflix’s focus on balancing revenue per membership with broader membership expansion objectives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Ad-Supported Subscription Plan (PRODUCT)",
        "Ad-Supported Subscription Plan (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11189,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3446,
        "completion_tokens": 183,
        "total_tokens": 3629
      }
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "Between 2023 and 2024, Tesla's approach to the Tesla Semi has evolved from early production and deliveries in 2023 to entering pilot production in 2024, as noted in the 2024 10-K. In 2023, the Semi was described as part of Tesla’s broader strategy to expand into commercial electric vehicles, leveraging its proprietary technologies like Full Self-Driving and battery innovations. By 2024, the Semi was in pilot production at Tesla’s Nevada facility, indicating a shift toward scaling up production and preparing for broader market entry. This progression reflects Tesla’s strategic positioning to strengthen its presence in the commercial vehicle segment and advance its mission of sustainable energy adoption.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Tesla Semi (PRODUCT)",
        "Tesla Semi (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4674,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1798,
        "completion_tokens": 177,
        "total_tokens": 1976
      }
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "The expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024, as evidenced by the inclusion of new agreements with executives such as Nicole J. Daggs (2024) and Brian Bolster (2024) in the 2024 10-K filing, suggests a deliberate and ongoing commitment to leadership continuity and the strategic retention of key executive talent. The consistent filing of these agreements over the years, from 2009 through 2024, indicates a long-standing corporate policy to secure the services of critical leaders through structured employment agreements, reinforcing stability and continuity in executive leadership. This approach underscores the company's recognition of the value of experienced leadership in executing its strategic objectives, particularly in a dynamic and capital-intensive industry like energy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Executive Retention Employment Agreement (ACCOUNTING_POLICY)",
        "Executive Retention Employment Agreement (ACCOUNTING_POLICY) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_123",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_125",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14643,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4335,
        "completion_tokens": 208,
        "total_tokens": 4544
      }
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "From 2023 to 2024, Intel's approach to xPU products has evolved to emphasize strategic focus on product competitiveness and the expansion of the x86 ecosystem, while accelerating development of xPU technologies to meet diverse computing and AI workloads. In 2023, Intel highlighted the challenges of its foundry strategy and the risks associated with high R&D and capital investments, including delays in process technology and product development. By 2024, the company shifted toward a more structured strategy, announcing an x86 advisory group to enhance ecosystem compatibility and simplify software development, and emphasizing a broad xPU portfolio that includes GPUs, IPUs, FPGAs, and accelerators. Intel also underscored its commitment to AI across the entire continuum, from GenAI to edge computing, and highlighted the use of third-party foundries to enhance flexibility and performance in product development.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Focuses_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "INTC (ORG) -> xPU Products (PRODUCT)",
        "xPU Products (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12340,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3719,
        "completion_tokens": 229,
        "total_tokens": 3948
      }
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "Between 2023 and 2024, Netflix has significantly evolved its approach to advertising technology by focusing on organizational development and infrastructure investment. In 2023, the company emphasized the need to develop the technology and related infrastructure to support advertising, as well as the importance of building an advertising sales organization. By 2024, Netflix expanded on this, highlighting its efforts to develop and expand both an advertising sales and advertising technology organization team, indicating a more integrated and specialized approach. Additionally, the company continued to stress the importance of developing the technology and related infrastructure to support advertising and drive value to advertisers, showing a clear progression in its commitment to enhancing its advertising capabilities through both organizational and technological investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Develops]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Advertising Technology (PRODUCT)",
        "Advertising Technology (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11602,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3545,
        "completion_tokens": 221,
        "total_tokens": 3766
      }
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "Between 2023 and 2024, Tesla's approach to free Supercharging programs evolved in both revenue recognition and program structure. In 2023, free Supercharging was included as part of the upfront value of vehicle sales, bundled with features like FSD and over-the-air updates, and recognized as part of automotive sales revenue. By 2024, Tesla shifted to deferring revenue related to these programs, indicating a more structured and separate accounting treatment for the free Supercharging benefit. This change reflects a more granular approach to recognizing the value of long-term services over time, aligning with evolving accounting standards and program complexity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Free Supercharging Programs (PRODUCT)",
        "Free Supercharging Programs (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3733,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1577,
        "completion_tokens": 167,
        "total_tokens": 1744
      }
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "Between 2023 and 2024, NextEra Energy's approach to issuing Series O Junior Subordinated Debentures has shifted from fixed-rate long-term maturities to a more diversified structure with both shorter-term and longer-term maturities, as well as the introduction of a floating rate option. In 2023, the Series O Debentures had a maturity of May 1, 2079, with a fixed coupon rate of 5.55% for long-term issuance (Chunk 1). By 2024, NextEra Energy issued the Series O Debentures with a shorter maturity of November 1, 2029, and also introduced a floating rate debenture due in 2026 (Chunk 2). This evolution suggests a strategic shift toward greater flexibility in financing, potentially to better align with changing interest rate environments and optimize capital structure by balancing long-term stability with short-to-medium-term cost efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Creates]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Series O Debentures (FIN_INST)",
        "Series O Debentures (FIN_INST) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_120",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14207,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4214,
        "completion_tokens": 211,
        "total_tokens": 4425
      }
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "ExxonMobil's consideration of OPEC investment activities in its impairment assessment framework remained consistent from 2022 to 2023, with both years emphasizing the influence of OPEC's production policies and investment decisions on long-term global oil supply dynamics. In 2022, the company acknowledged that OPEC investment activities impact world oil supplies, particularly as a counterbalance to declining production from mature fields. By 2023, this understanding was integrated into the broader Global Outlook and Corporate Plan, where OPEC's role continued to be a key factor in shaping long-term commodity price and margin expectations used for impairment assessments. Both years underscored that while short-term price fluctuations are not indicative of impairment, long-term supply fundamentals—including OPEC's strategic actions—are critical in evaluating the recoverability of long-lived assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Considers]-> MACRO_CONDITION <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> OPEC Investment Activities (MACRO_CONDITION)",
        "OPEC Investment Activities (MACRO_CONDITION) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13118,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3937,
        "completion_tokens": 227,
        "total_tokens": 4164
      }
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "Netflix's approach to its ad-supported subscription plan evolved from a cautious, forward-looking acknowledgment in 2023 to a more strategic and explicit emphasis in 2024. In the 2023 10-K, the ad-supported plan was mentioned primarily in the context of uncertainties and risks, highlighting the difficulty in predicting consumer adoption and the lack of operating history with such offerings. By 2024, the 10-K explicitly included the ad-supported subscription plan as a key component of Netflix's core strategy, stating its intent to offer a range of pricing plans to meet diverse consumer needs. This shift reflects a move from uncertainty to a more defined strategic offering, signaling increased confidence and integration of the plan into Netflix's broader business approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Ad-Supported Subscription Plan (PRODUCT)",
        "Ad-Supported Subscription Plan (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11732,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3581,
        "completion_tokens": 195,
        "total_tokens": 3776
      }
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "Between 2022 and 2024, Amazon's approach to shipping offers has evolved to emphasize fulfillment efficiency as a key cost driver and strategic focus. In 2022, shipping costs were a significant portion of cost of sales, driven by increased carrier rates, labor costs, and supply chain inefficiencies, with Amazon projecting continued cost increases as customers used shipping offers more frequently and faster delivery options expanded. By 2024, Amazon had made progress in mitigating these costs through fulfillment network optimizations and productivity improvements, as reflected in the 2024 10-K, which highlights that fulfillment cost increases were partially offset by network efficiencies. Additionally, Amazon continued to view shipping offers as a strategic marketing tool, underlining their role in driving customer acquisition and retention while investing in infrastructure and technology to enhance delivery speed and operational efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Positively_Impacts]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Shipping Offers (PRODUCT)",
        "Shipping Offers (PRODUCT) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7897,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2616,
        "completion_tokens": 238,
        "total_tokens": 2854
      }
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "Between 2023 and 2024, Duke Energy's utilization of the Master Retirement Trust remained focused on managing post-retirement assets, including VEBA trusts and 401(h) accounts, with an investment objective centered on achieving sufficient returns while managing portfolio risk. In 2023, the asset allocations for the VEBA trusts were disclosed, and by 2024, Duke Energy provided a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically highlighting Level 3 fair value measurements. Additionally, in 2024, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiary registrants, such as Duke Energy Carolinas and Progress Energy, reflecting a more detailed breakdown of how the trust's assets were distributed across its operating entities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Master Retirement Trust (FIN_INST)",
        "Master Retirement Trust (FIN_INST) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_218",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_228",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1574,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1041,
        "completion_tokens": 217,
        "total_tokens": 1259
      }
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "Between 2022 and 2024, Google's financial relationship with Google Network Partners has primarily revolved around payment obligations for advertising displayed on their properties, as outlined in both the 2022 and 2024 10-K filings. In 2022, it was noted that the cost of revenues for ads on Google Network properties is significantly higher than for ads on Google Search due to higher TAC (traffic acquisition costs) paid to these partners. By 2024, these payments remained a major use of cash from operating activities, with increased cash outflows attributed to higher cost of revenues and operating expenses. The evolution indicates a sustained and substantial financial dependency on Google Network Partners, with TAC continuing to represent a key component of Google's cost structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Supplies]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Network Partners (COMP)",
        "Google Network Partners (COMP) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5874,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2112,
        "completion_tokens": 197,
        "total_tokens": 2309
      }
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "Between 2022 and 2023, UPS continued to manage its non-hedging swap and foreign currency positions by entering into offsetting contracts to economically offset fair value changes and settlement risks. In 2022, these contracts were used to hedge portions of debt and foreign currency exposures, with fair value changes and settlements reported in the consolidated income. By 2023, the treatment remained consistent, with derivative instruments not designated as hedges recorded at fair value and unrealized gains and losses impacting earnings each period. The financial impact of these activities was reflected in the consolidated income statements for both years, showing ongoing efforts to mitigate market valuation effects through offsetting positions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Offsetting Swap Positions (FIN_INST)",
        "Offsetting Swap Positions (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_159",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2427,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 188,
        "total_tokens": 1449
      }
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "The increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures, compared to 2023, indicates a shift in the company's director compensation strategy toward emphasizing nonqualified deferred compensation. In 2023, the Directors' Savings Plan was mentioned in the context of amendments and historical plans, such as the 2014 and 2021 amendments, suggesting it was already in place but not a focal point. However, in 2024, the plan is highlighted as a key component of Duke Energy’s broader compensation structure, with detailed descriptions of how outside directors can defer compensation and the phantom investment options available, including the Duke Energy Common Stock Fund. This shift suggests a strategic move to enhance director retention and align long-term interests with shareholders through deferred compensation mechanisms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Amends]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Directors' Savings Plan (ACCOUNTING_POLICY)",
        "Directors' Savings Plan (ACCOUNTING_POLICY) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_245",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_239",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 23080,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6424,
        "completion_tokens": 215,
        "total_tokens": 6639
      }
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "Between 2022 and 2024, American Express has evolved its approach to developing value propositions by increasingly focusing on innovation, digital integration, and tailored customer experiences in response to competitive pressures and shifting consumer behaviors. In 2022, the company emphasized the need to differentiate itself through compelling value propositions, particularly in mobile and online payments, while addressing the threat of alternative payment providers and evolving customer spending habits. By 2024, American Express expanded this strategy to include targeted efforts in premium consumer segments, such as Millennials and Gen-Z, through new benefits, rewards programs, and digital enhancements like the Amex app. Additionally, the company is investing in a multiproduct digital ecosystem and strategic partnerships to strengthen customer loyalty and expand merchant coverage, reflecting a more proactive and technology-driven approach to maintaining competitive advantage.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Depends_On]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Value Propositions (RISK_FACTOR)",
        "Value Propositions (RISK_FACTOR) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2022.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12464,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3767,
        "completion_tokens": 248,
        "total_tokens": 4015
      }
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "Between 2022 and 2024, Exxon Mobil's long-term debt financing composition remained stable, as both filings disclose the same long-term notes: 0.524% Notes due 2028, 0.835% Notes due 2032, and 1.408% Notes due 2039. However, the 2022 filing also lists 0.142% Notes due 2024, which are not mentioned in the 2024 filing, suggesting these notes may have matured or been retired by 2024. This indicates a slight shift in the maturity structure, with Exxon Mobil potentially reducing shorter-term obligations and maintaining a focus on longer-term fixed-rate debt.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> 1.408% Notes due 2039 (FIN_INST)",
        "1.408% Notes due 2039 (FIN_INST) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5212,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1944,
        "completion_tokens": 139,
        "total_tokens": 2084
      }
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "Between 2022 and 2024, American Express has maintained a consistent strategic emphasis on strengthening its position in commercial payments, particularly through evolving card value propositions and further differentiating its corporate card and accounts payable expense management solutions. In 2022, the company highlighted its focus on designing innovative products and features, including financing, banking, and payment solutions for business customers. By 2024, this emphasis remained, with a continued push to build on its strong position in commercial payments while enhancing its global, integrated network to provide merchants with fraud protection services, marketing insights, and connections to higher-spending card members. This evolution reflects a strategic shift toward not only product innovation but also broader integration and value-added services for business clients.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enhances]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Corporate Card (PRODUCT)",
        "Corporate Card (PRODUCT) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3916,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1619,
        "completion_tokens": 222,
        "total_tokens": 1841
      }
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "Between 2022 and 2024, Amazon's financial relationship with AWS Services has evolved with AWS continuing to be a critical driver of cash flow generation for Amazon as a whole. In 2024, Amazon reported operating cash flows of $115.9 billion, a significant increase from $84.9 billion in 2023, with AWS likely contributing substantially to this growth due to its role as a high-margin, scalable service. This cash flow is then used by Amazon (ORG) to support its broader operations, including investments in new products and services, as highlighted in the 2022 10-K. However, the relationship is not unidirectional; AWS Services (PRODUCT) also negatively impacts Amazon in terms of operational complexity and competitive pressures, as Amazon must continue to invest heavily in AWS to maintain its leadership in cloud computing. This strategic emphasis on AWS reflects Amazon's ongoing prioritization of high-growth, technology-driven segments to sustain its financial performance and competitive edge.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> PRODUCT <-[Pays_For]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> AWS Services (PRODUCT)",
        "AWS Services (PRODUCT) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7152,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2427,
        "completion_tokens": 250,
        "total_tokens": 2677
      }
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "Between 2023 and 2024, the scope of trend analyses used in evaluating the historical consistency of regulatory asset balances remained consistent in both years, as both DUK_10k_2023 and DUK_10k_2024 disclose that trend analyses were utilized for this purpose. However, in 2024, the focus expanded slightly to include a more detailed understanding of the composition of the balances and the regulatory environment, such as recently approved orders and asset retirement obligations specific to coal ash, indicating a broader contextual evaluation while maintaining the core analytical approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Trend Analyses (ACCOUNTING_POLICY)",
        "Trend Analyses (ACCOUNTING_POLICY) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2937,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 148,
        "total_tokens": 1526
      }
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "Between 2022 and 2023, Costco increased the penetration of private-label items as part of its strategy to manage cost and pricing pressures. In 2022, Costco noted that inflation and rising merchandise costs prompted adjustments in pricing and merchandise mix, including a deliberate focus on expanding private-label offerings to maintain competitive pricing and member value. By 2023, this strategy continued, with Costco emphasizing the role of private-label items in supporting its pricing authority and responding to ongoing cost pressures, while balancing gross margin impacts. The reciprocal relationship between Costco and private-label items reflects their mutual influence in driving sales and cost management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Increases]- ORG",
      "triplets_used": [
        "COST (ORG) -> Private Label Items (PRODUCT)",
        "Private Label Items (PRODUCT) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9940,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3123,
        "completion_tokens": 179,
        "total_tokens": 3302
      }
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "Based on Pfizer's 2023 and 2024 10-K filings, the financial outlook for Paxlovid has shifted significantly. As of December 31, 2024, remaining performance obligations for Paxlovid totaled approximately $1 billion, compared to no specific figure for 2023, though the 2023 filing noted the product's continued emergency use authorization and its role in Pfizer’s portfolio. The 2024 data indicates ongoing contracted revenue for Paxlovid through 2025 to 2028, though the timing may be subject to renegotiation. This suggests a more defined, though potentially flexible, revenue outlook for Paxlovid in 2024 compared to 2023, when the product's financial impact was more closely tied to government inventory returns and reversals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Paxlovid (PRODUCT)",
        "Paxlovid (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7769,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2569,
        "completion_tokens": 181,
        "total_tokens": 2751
      }
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "American Express's use of the Reasonable and Supportable (R&S) Period in estimating credit loss reserves has shown a consistent emphasis on incorporating both historical data and forward-looking economic conditions, as noted in both the 2022 and 2024 filings. In 2022, the R&S Period was used to model expected credit losses by integrating current and future economic conditions, with losses beyond this period estimated by reverting to long-term average loss rates. By 2024, the company maintained this approach, with the R&S Period remaining a key assumption in the estimation process, as highlighted in the audit procedures for credit loss reserves. This continuity suggests a deliberate and stable approach to financial risk management, where American Express balances short-term economic volatility with long-term historical trends to ensure robust credit loss provisioning.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "AXP (ORG) -> R&S Period (ACCOUNTING_POLICY)",
        "R&S Period (ACCOUNTING_POLICY) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2022.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9162,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2957,
        "completion_tokens": 219,
        "total_tokens": 3177
      }
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "Amazon's approach to debt financing between 2022 and 2024 reflects a continuation of its strategy to issue low-yield, long-term notes to manage its capital structure. In 2022, Amazon had previously issued a 5.200% Note due 2025 in December 2017 and a 0.800% Note due 2025 in June 2020, indicating a mix of higher and lower interest rates depending on market conditions. By 2024, Amazon maintained the 0.800% Note due 2025 as part of its outstanding debt, while also issuing new notes with higher coupon rates, such as the 4.600% Note due 2025 in December 2022, reflecting rising interest rates in the broader financial environment. This evolution shows Amazon's strategic balance between locking in historically low rates and adapting to market shifts by issuing higher-yield debt to extend maturities and manage liquidity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> 0.800% Note due 2025 (FIN_INST)",
        "0.800% Note due 2025 (FIN_INST) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12188,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3681,
        "completion_tokens": 205,
        "total_tokens": 3887
      }
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "The Twenty-third Supplemental Indenture, dated June 1, 1978, was disclosed in the 2022 filing as part of a long series of historical supplemental indentures under DUK's mortgage and deed of trust (Chunk 1). However, in the 2024 filing, the Twenty-third Supplemental Indenture is not listed among the more recent supplemental indentures, which include updates as recent as March 14, 2024 (Chunk 2). This indicates that the Twenty-third Supplemental Indenture is no longer being actively referenced or updated, suggesting it has become a historical document with no ongoing relevance to current debt structures or obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Twenty-third Supplemental Indenture (FIN_INST)",
        "Twenty-third Supplemental Indenture (FIN_INST) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_249",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_252",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16353,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4746,
        "completion_tokens": 156,
        "total_tokens": 4902
      }
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "The repurchase activity for Class C Capital Stock evolved as follows from 2022 to 2024: in 2022, $59.3 billion of Class A and Class C shares were repurchased, with $18.396 billion specifically attributed to Class C Capital Stock based on the 2022 10-K data; in 2023, the total repurchase value increased to $62.2 billion, though the exact allocation to Class C is not specified in the provided data; and in 2024, $62.0 billion of Class A and Class C shares were repurchased. The total value repurchased for Class C Capital Stock in 2022 was $18.396 billion, while the 2024 10-K indicates continued significant repurchase activity, though the specific breakdown for Class C in 2023 and 2024 is not detailed in the chunks provided.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Repurchases]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class C Capital Stock (FIN_INST)",
        "Class C Capital Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10399,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3241,
        "completion_tokens": 182,
        "total_tokens": 3423
      }
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "Between the 2022 and 2024 SEC filings, there is no new or updated documentation specifically for the American Express Company Salary/Bonus Deferral Plan in the 2024 filing. Both filings reference the same historical documents for the plan, including its original 1988 version (Exhibit 10.20) and a 1994 amendment (Exhibit 10.4). However, the 2022 filing includes a reference to a 1997 amendment affecting both the Salary/Bonus Deferral Plan and the Key Executive Life Insurance Plan (Exhibit 10.37), while the 2024 filing does not explicitly include this cross-reference. This suggests a potential omission or reorganization in the 2024 filing regarding the 1997 amendment, though the core plan documentation remains unchanged in both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Salary/Bonus Deferral Plan (ACCOUNTING_POLICY)",
        "Salary/Bonus Deferral Plan (ACCOUNTING_POLICY) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2022.pdf",
          "page_id": "page_165",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_171",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10577,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3295,
        "completion_tokens": 185,
        "total_tokens": 3480
      }
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "Starbucks' exposure to interest rate swaps evolved significantly between 2022 and 2024, with a notable shift in both balance sheet classification and liability magnitude. In 2022, Starbucks reported a derivative liability of $34.0 million for interest rate swaps, classified under \"Other long-term liabilities\" as of October 2, 2022. By 2024, this liability had decreased to $19.2 million and was still classified under \"Other long-term liabilities\" as of September 29, 2024, indicating a reduction in exposure while maintaining the same classification. This evolution reflects a strategic adjustment in Starbucks' hedging activities and financial risk management over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Interest rate swap (FIN_INST)",
        "Interest rate swap (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5598,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2044,
        "completion_tokens": 170,
        "total_tokens": 2214
      }
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "Between 2022 and 2024, the Directors' Savings Plan at Duke Energy has remained a key component of director compensation governance, allowing outside directors to defer all or a portion of their annual compensation, typically in the form of retainers. In 2022, the plan was disclosed as an amended and restated plan effective January 1, 2014, with a further amendment effective December 16, 2021, indicating ongoing adjustments to its structure. By 2024, the plan continued to function as a nonqualified deferred compensation plan, with deferred amounts credited to unfunded accounts and adjusted based on phantom investment options, including the Duke Energy Common Stock Fund. This evolution suggests that Duke Energy maintains a structured and flexible approach to director compensation governance, emphasizing deferral mechanisms to align director interests with long-term shareholder value while adhering to regulatory and tax constraints.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Directors' Savings Plan (ACCOUNTING_POLICY)",
        "Directors' Savings Plan (ACCOUNTING_POLICY) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_258",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_239",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14440,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4270,
        "completion_tokens": 235,
        "total_tokens": 4506
      }
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "Between 2022 and 2023, Costco's Kirkland Signature brand has evolved in positioning by increasing its sales penetration and emphasizing its role in differentiating Costco's merchandise offerings with high-quality, lower-cost private-label products that generally earn higher margins. However, the associated risk profile has also grown, as the brand's reputation and success are now more central to Costco's competitive advantage and profitability. This increased reliance on Kirkland Signature exposes Costco to greater risks, including potential damage to its reputation from product failures, which could lead to recalls, litigation, and adverse impacts on business performance. Additionally, Costco faces external risks such as foreign exchange fluctuations, natural disasters, and global health crises, all of which could negatively affect the brand's supply chain, product availability, and overall financial outcomes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "COST (ORG) -> Kirkland Signature (PRODUCT)",
        "Kirkland Signature (PRODUCT) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8052,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2645,
        "completion_tokens": 231,
        "total_tokens": 2876
      }
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "From 2022 to 2024, COP's natural gas reserves in the Asia Pacific/Middle East region declined from 326 billion cubic feet at the end of 2022 to 296 billion cubic feet at the end of 2024. Key changes in 2023 included negative revisions (-243 billion cubic feet in 2023), while in 2024, there were positive revisions (102 billion cubic feet) and significant purchases (47 billion cubic feet) that partially offset production declines. Additions in 2023 were primarily driven by purchases (47 billion cubic feet) and revisions, while in 2024, additions came from purchases (47 billion cubic feet) and revisions (102 billion cubic feet), though these were partially offset by production reductions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Asia Pacific/Middle East (GPE)",
        "Asia Pacific/Middle East (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_167",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 18705,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5320,
        "completion_tokens": 173,
        "total_tokens": 5494
      }
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "Between 2022 and 2024, FedEx has maintained ownership of its entire fleet of 114 Boeing 767F aircraft, as noted in the 2022 10-K. In 2024, FedEx emphasized the Boeing 767F as a key component of its modernization strategy, highlighting its role in achieving long-term fuel efficiency and operational savings by replacing older aircraft. This reflects a strategic focus on modernizing the fleet while maintaining full ownership of the 767F, underscoring its importance in FedEx’s broader fleet optimization efforts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Boeing 767F (PRODUCT)",
        "Boeing 767F (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2562,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 128,
        "total_tokens": 1405
      }
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "From 2022 to 2024, Starbucks' involvement with roasted coffee evolved both in terms of inventory value and production infrastructure. In 2022, the inventory value of roasted coffee was $310.3 million, an increase from $233.5 million in 2021, indicating a growing investment in roasted coffee stock. By 2024, Starbucks had significantly expanded its production infrastructure, with multiple large facilities dedicated to roasting, warehousing, and distribution, including sites in York, PA; Minden, NV; Kunshan, China; and Kent, WA. These developments reflect Starbucks' strategic focus on enhancing its roasted coffee production and supply chain capabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Roasted Coffee (PRODUCT)",
        "Roasted Coffee (PRODUCT) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1708,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1059,
        "completion_tokens": 164,
        "total_tokens": 1224
      }
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "Based on the provided filings, PepsiCo's utilization of the 2.750% Senior Notes due 2025 remained consistent between 2023 and 2024, as both the 2023 and 2024 10-K filings reference the issuance and authorization of these notes under PepsiCo's broader debt management strategy. In 2023 (Chunk 1), the 2.750% Senior Notes due 2025 are listed among several other senior notes authorized by the Board of Directors. Similarly, in 2024 (Chunk 2), the same 2.750% Senior Notes due 2025 are again included in the list of authorized debt instruments, indicating no material change in PepsiCo's use or structure of this specific debt instrument during the period. The notes are governed by indentures that remained unchanged between the two years, as referenced in both filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "PEP (ORG) -> 2.750% Senior Notes due 2025 (FIN_INST)",
        "2.750% Senior Notes due 2025 (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 22508,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6273,
        "completion_tokens": 192,
        "total_tokens": 6465
      }
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "FedEx's planned utilization of the B777F aircraft decreased from 2 units in 2023 to 4 units in 2024, as shown in the 2022 10-K, and further declined to just 2 units in 2025 according to the 2024 10-K. This reduction in B777F utilization over time indicates a diminishing strategic role for the aircraft in FedEx's fleet, suggesting a shift in focus toward other aircraft types like the Cessna SkyCourier 408 and ATR 72-600F, which show increased planned utilization. The decline aligns with the knowledge graph pattern showing a decrease in the relationship between FedEx and the B777F.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> B777F (PRODUCT)",
        "B777F (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1669,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1049,
        "completion_tokens": 146,
        "total_tokens": 1195
      }
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "From 2022 to 2024, Starbucks' \"Foreign currency - other\" derivative liabilities decreased from $0.3 million in 2022 to being included in net gains/(losses) in AOCI with a positive value of $11.5 million in 2024, indicating a shift from a liability position to a net gain position. This evolution suggests that the company's foreign currency hedges became more effective in offsetting currency fluctuations over time, reducing exposure and generating gains. The increasing positive AOCI values for \"Foreign currency - other\" from $55.3 million in 2022 to $11.5 million in 2024 reflect improved hedging outcomes and reduced volatility in foreign currency exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Foreign currency - other (FIN_INST)",
        "Foreign currency - other (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5265,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1981,
        "completion_tokens": 165,
        "total_tokens": 2146
      }
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "Between 2023 and 2024, PepsiCo's engagement with the 2.625% Senior Notes due 2026 remained consistent as part of its broader debt instrument disclosures. In 2023, the notes were included in the Board of Directors Resolutions authorizing officers to establish terms for multiple senior notes, as detailed in Exhibit 4.65 of the 10-K filing. By 2024, the 2.625% Senior Notes due 2026 were again listed among numerous other senior notes in the updated Board Resolutions (Exhibit 4.64), indicating no material change in PepsiCo's issuance or management of these notes. Additionally, the 2024 filing introduced a new Indenture dated February 12, 2024, with U.S. Bank Trust Company, suggesting an updated framework for future debt instruments, though no specific changes were noted for the 2026 notes themselves. Overall, the notes remained a standard component of PepsiCo’s debt structure during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "PEP (ORG) -> 2.625% Senior Notes due 2026 (FIN_INST)",
        "2.625% Senior Notes due 2026 (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 22508,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6273,
        "completion_tokens": 225,
        "total_tokens": 6499
      }
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "Cisco's exposure to and reliance on overcoming technical hurdles has increased from 2022 to 2024, particularly as the company continues to invest in strategic growth areas such as End-to-End Security, Internet for the Future, and Secure, Agile Networks. In 2022, Cisco acknowledged the risks associated with product planning, timing, and technical challenges, emphasizing that failure to overcome these hurdles could result in loss of market share and competitive disadvantage. By 2024, the company highlighted an even greater dependency on successfully navigating complex technological transitions, including AI, cloud, and observability, with the added complexity of delivering high-performance software subscription services. The 2024 filing underscores that not only are technical hurdles more critical due to the evolving market landscape, but also that the costs and operational demands of overcoming them have risen, with potential impacts on scalability, customer retention, and financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Depends_On]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Technical Hurdles (RISK_FACTOR)",
        "Technical Hurdles (RISK_FACTOR) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12430,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3757,
        "completion_tokens": 252,
        "total_tokens": 4009
      }
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "Between 2022 and 2023, Google Ad Manager continued to play a significant role in driving Google Network revenues, as highlighted in both the 2022 and 2023 filings. In 2022, Google Ad Manager was explicitly cited as a key contributor to the $8.6 billion increase in Google Network revenues, alongside AdMob and AdSense. By 2023, the product remained central to the advertising ecosystem, with the 10-K noting that Google Ad Manager is one of the primary platforms through which customers purchase advertising inventory, particularly for ads placed on Google Network properties. The continued emphasis on Google Ad Manager in 2023, combined with its positive impact on the broader organization as per the KG triplet, indicates that its role in driving Google Network revenues remained strong and strategically important in both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Positively_Impacts]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Ad Manager (PRODUCT)",
        "Google Ad Manager (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5579,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2044,
        "completion_tokens": 208,
        "total_tokens": 2252
      }
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "Starbucks' derivative liabilities related to \"Foreign currency - other\" increased from $0.3 million in 2022 to $4.7 million in 2024, representing a change of $4.4 million. This evolution is evident from the 2022 10-K, which reported a liability of $0.3 million under \"Accrued liabilities,\" to the 2024 10-K, which shows a liability of $4.7 million, also under \"Accrued liabilities.\" The knowledge graph confirms the connection between Starbucks and the \"Foreign currency - other\" financial instrument, highlighting the ongoing relationship and liability exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Foreign currency - other (FIN_INST)",
        "Foreign currency - other (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5598,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2040,
        "completion_tokens": 140,
        "total_tokens": 2181
      }
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "PepsiCo's issuance of the 4.600% Senior Notes due 2045 remained consistent between 2023 and 2024, as both the 2023 and 2024 10-K filings list the notes as part of the company's authorized senior notes. In 2023, the notes were included in the Board of Directors' resolutions authorizing various debt instruments, and in 2024, they were similarly listed, indicating no change in issuance status. This continuity suggests that PepsiCo is maintaining a long-term, fixed-rate debt component in its capital structure, which aligns with a strategy to manage interest costs and extend debt maturities to reduce refinancing risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "PEP (ORG) -> 4.600% Senior Notes due 2045 (FIN_INST)",
        "4.600% Senior Notes due 2045 (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 22508,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6274,
        "completion_tokens": 155,
        "total_tokens": 6429
      }
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "COP’s natural gas position in the Asia Pacific/Middle East region declined significantly between 2022 and 2024, from 764 billion cubic feet at the end of 2021 to 326 billion cubic feet by the end of 2022, and further to 296 billion cubic feet by the end of 2024. This reduction, despite some additions from purchases and discoveries, indicates a strategic shift or reduced emphasis on natural gas development in the region, potentially reflecting a reallocation of resources to other areas or a focus on optimizing higher-potential assets elsewhere.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Asia Pacific/Middle East (GPE)",
        "Asia Pacific/Middle East (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_173",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11307,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3471,
        "completion_tokens": 137,
        "total_tokens": 3608
      }
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "From 2022 to 2023, Google Play's role in Google's non-advertising revenue strategy has evolved from being one of several growing revenue streams to a more clearly defined and emphasized component of Google Services' broader non-advertising portfolio. In 2022, Google Play was mentioned as a long-term investment generating revenue from app and in-app purchases, alongside hardware and YouTube non-advertising. By 2023, Google Play is explicitly categorized under \"platforms,\" with a specific focus on app and in-app purchase sales, indicating a more structured and strategic integration into the company's non-advertising revenue framework. This shift highlights Google's increasing emphasis on monetizing its digital ecosystem beyond advertising, leveraging Google Play as a key platform for user engagement and revenue generation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Generates_Revenue]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Play (PRODUCT)",
        "Google Play (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9892,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3113,
        "completion_tokens": 208,
        "total_tokens": 3321
      }
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "The projected utilization of the Cessna SkyCourier 408 increased from 11 units in 2023 to 12 in 2024, as shown in the 2022 10-K filing, and further rose to 17 units in 2025 according to the 2024 10-K filing. This upward trend, combined with the continued emphasis on the Cessna SkyCourier 408 in subsequent years (reaching a total of 31 units in the 2024 filing), indicates a growing strategic reliance by FedEx on this aircraft model for its regional freight operations, as reflected in the ORG -[Increases]-> PRODUCT <-[Depends_On]- ORG relationship.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Cessna SkyCourier 408 (PRODUCT)",
        "Cessna SkyCourier 408 (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1669,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1063,
        "completion_tokens": 138,
        "total_tokens": 1201
      }
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "Between 2022 and 2023, AIG refined its use of expected loss ratio methods by enhancing segmentation and expanding the types of casualty lines analyzed. In 2022, AIG segmented its excess casualty analysis by automobile-related and non-automobile claims, with further segmentation for latent exposures like construction defects and mass torts, and by attachment point bands to account for delayed reporting. By 2023, AIG extended this approach to U.S. Workers' Compensation, applying expected loss ratio methods alongside loss development and frequency/severity techniques, and introducing more granular segmentation by deductible size, state, industry subset, and claim-handling methods (AIG vs. third-party administrators). This evolution reflects a broader application of expected loss ratio methods across casualty lines and a more nuanced approach to handling risk-sharing features and long-tail exposures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Expected Loss Ratio Methods (ACCOUNTING_POLICY)",
        "Expected Loss Ratio Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_263",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5294,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1977,
        "completion_tokens": 227,
        "total_tokens": 2204
      }
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "Between fiscal years 2022 and 2024, the classification of unallocated products within Nike's consumer construct remained consistent in structure but evolved in context due to the ongoing implementation of the Consumer Direct Acceleration strategy. In fiscal 2022, unallocated products were included in the \"Others\" category, which encompassed products not assigned to Men's, Women's, NIKE Kids', or Jordan Brand, as well as adjustments not tied to consumer-designated products. By fiscal 2024, the categorization retained this framework, with \"Others\" continuing to capture unallocated products and adjustments, reflecting a stable reporting approach under the revised consumer construct introduced in 2022. This consistency suggests that Nike maintained its method of classifying unallocated products within the broader organizational structure, even as it refined its consumer-focused segmentation strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Includes]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Unallocated Products (PRODUCT)",
        "Unallocated Products (PRODUCT) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2534,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 227,
        "total_tokens": 1509
      }
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "Between 2023 and 2024, PepsiCo maintained its engagement with the 3.500% Senior Notes due 2025, as evidenced by the continued inclusion of these notes in the company’s Board of Directors Resolutions in both the 2023 and 2024 10-K filings. In 2023, the 3.500% Senior Notes due 2025 were among several notes authorized for issuance, and in 2024, they were again listed in the updated resolutions, indicating no change in their status or terms. This consistency suggests that PepsiCo is managing its debt portfolio with a long-term strategy of maintaining a diversified mix of maturities and interest rates to optimize its capital structure and manage refinancing risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "PEP (ORG) -> 3.500% Senior Notes due 2025 (FIN_INST)",
        "3.500% Senior Notes due 2025 (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 22508,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6275,
        "completion_tokens": 166,
        "total_tokens": 6442
      }
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "Between 2022 and 2024, COP’s financial disclosures for the Lower 48 region showed significant changes in capital expenditures and future cash inflow revisions. In 2022, capital expenditures for the Lower 48 were $3,129 million, reflecting a notable increase compared to $1,881 million in 2020. By 2024, COP revised its Lower 48 disclosures to include additional future cash inflows and production costs, as noted in the 2024 10-K. These revisions suggest a strategic reassessment of the region's economic potential, aligning with COP’s broader focus on optimizing capital allocation and enhancing long-term value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Lower 48 (GPE)",
        "Lower 48 (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_149",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_158",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6745,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2323,
        "completion_tokens": 153,
        "total_tokens": 2476
      }
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "Between 2023 and 2024, Comcast's financial commitments and governance arrangements with Atairos Group evolved through amendments to their shareholders agreement and ongoing capital obligations. In 2022, the Fourth Amended and Restated Shareholders Agreement was established, and by June 2023, it was amended further, indicating a continued refinement of governance structures. Financially, Comcast committed to fund Atairos up to $4.5 billion in aggregate, with an annual capital call limit of $400 million, plus prior distributions, and a separate $40 million annual management fee commitment. Comcast holds 99% of the economic loss exposure and is entitled to 86% of residual returns, while governance is controlled by management companies led by Comcast’s former CFO, who also contributes at least $40 million annually. These arrangements reflect a long-term strategic partnership with significant financial and control implications for Comcast.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Atairos Group, Inc. (COMP)",
        "Atairos Group, Inc. (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10808,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3348,
        "completion_tokens": 237,
        "total_tokens": 3585
      }
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "FedEx's projected utilization of the Cessna SkyCourier 408 increased from a total of 49 units planned through 2027 in the 2022 filing to 31 units in the 2023 filing, despite a reduction in the planning horizon. This indicates a continued but slightly scaled-back strategic emphasis on the Cessna SkyCourier 408 compared to other aircraft like the ATR 72-600F and B767F, which also saw reduced total utilization projections. The shift suggests a potential realignment of FedEx's fleet strategy toward larger aircraft or alternative configurations for its regional freight operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Cessna SkyCourier 408 (PRODUCT)",
        "Cessna SkyCourier 408 (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1668,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1067,
        "completion_tokens": 145,
        "total_tokens": 1213
      }
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "From 2022 to 2024, Nike's approach to the Air Max product line has evolved in both revenue transparency and technological innovation emphasis. In 2022, Nike included Air Max as part of its major product line revenue disaggregation in its 10-K filing, indicating a level of revenue transparency for the product line. By 2024, while no single customer accounted for 10% or more of consolidated net revenues, Nike emphasized continued investment in research, design, and development, particularly in technical innovation. Air Max was specifically highlighted among other technologies like Nike Air, Zoom, and React, reflecting its ongoing role in Nike’s innovation strategy. This suggests that while Air Max remains a key product line, its innovation focus has expanded to incorporate broader consumer preferences and sustainability goals, even if explicit revenue figures for Air Max were not provided in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Air Max (PRODUCT)",
        "Air Max (PRODUCT) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3993,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1633,
        "completion_tokens": 227,
        "total_tokens": 1860
      }
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "Comcast's capital expenditure strategy regarding Epic Universe evolved from 2023 to 2024 by maintaining a focus on the theme park's development while aligning with broader infrastructure investments. In 2023, capital expenditures for Epic Universe increased as part of the Theme Parks segment, though specific investment amounts were not disclosed. By 2024, Comcast reiterated its commitment to continue investing in new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plans, which also emphasized Connectivity & Platforms infrastructure. While no exact 2024 investment figure for Epic Universe was provided, the company's financial flexibility—supported by debt issuances and share repurchase strategies—underscored its ongoing prioritization of theme park development alongside network expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Epic Universe (PRODUCT)",
        "Epic Universe (PRODUCT) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6798,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2346,
        "completion_tokens": 214,
        "total_tokens": 2560
      }
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "Between 2022 and 2023, FedEx significantly reduced its projected utilization of the ATR 72-600F aircraft, as reflected in their fleet projections. In 2022, the total projected ATR 72-600F aircraft was 24 across 2023–2027, but by 2023, this number dropped to 10 across 2025–2029. Additionally, the 2023 projections show a sharp decline in planned ATR 72-600F aircraft for 2026, from 1 unit in 2022 to 3 in 2023, indicating a strategic shift in fleet composition over the planning period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> ATR 72-600F (PRODUCT)",
        "ATR 72-600F (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1668,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1051,
        "completion_tokens": 121,
        "total_tokens": 1173
      }
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024, Nike's approach to estimating product return reserves evolved in terms of transparency and specificity in its accounting methodology. In fiscal 2022, the company reported a sales-related reserve balance of $1,015 million, with an estimated inventory cost for returns of $194 million. By fiscal 2024, Nike clarified its methodology, stating that it estimates the most likely amount of variable consideration and records an anticipated reduction against revenues at the time of recognition, with an offsetting increase to Accrued liabilities. This indicates a more refined and forward-looking revenue recognition approach, where returns and discounts are estimated and accounted for at the point of sale, reflecting a shift toward ASC 606 compliance and a more dynamic estimation process for variable consideration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Athletic Footwear (PRODUCT)",
        "Athletic Footwear (PRODUCT) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8136,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2681,
        "completion_tokens": 212,
        "total_tokens": 2894
      }
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "Between 2022 and 2023, the planned fleet composition of the Cessna SkyCourier 408 increased significantly for the year 2025 and beyond. In 2022's 10-K filing, FedEx planned for 12 Cessna SkyCourier 408 aircraft in 2025, but by 2023, this number rose to 17. Additionally, the total planned fleet of the Cessna SkyCourier 408 increased from 49 to 31 aircraft for all years beyond 2025, indicating a strategic shift toward greater reliance on this aircraft model for future operations. This increase suggests that FedEx is placing stronger emphasis on the Cessna SkyCourier 408 to support its fleet strategy, likely due to its performance and suitability for regional freight operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Cessna SkyCourier 408 (PRODUCT)",
        "Cessna SkyCourier 408 (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1669,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1073,
        "completion_tokens": 171,
        "total_tokens": 1244
      }
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "Mastercard expanded its real-time account-based payments infrastructure from 2023 to 2024 by enhancing operational scale and integrating advanced security capabilities. As of December 31, 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets, enabling instant, data-rich payments between bank accounts. By 2024, the company continued to leverage its globally integrated, distributed network architecture to support real-time clearing and settlement, emphasizing scalability for issuers and seamless cross-border and domestic transaction processing. In terms of security, Mastercard employs a multi-layered approach, incorporating fraud scoring, tokenization, and compliance with global standards like EMV, while also collaborating with stakeholders to strengthen the payments ecosystem. These enhancements reflect Mastercard’s ongoing commitment to secure, efficient, and scalable real-time payment solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Provides]- ORG",
      "triplets_used": [
        "MA (ORG) -> Real-Time Account-Based Payments (PRODUCT)",
        "Real-Time Account-Based Payments (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11676,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3569,
        "completion_tokens": 237,
        "total_tokens": 3806
      }
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "Between 2022 and 2024, Nike’s use of foreign exchange forwards and options had a notable impact on its financial liabilities and hedging strategy. In 2022, these instruments resulted in a net gain of $8 million after tax, primarily affecting revenues, cost of sales, and other income/expense categories, reflecting an active hedging strategy to mitigate foreign exchange risks. By 2024, the total derivative liabilities related to foreign exchange forwards and options decreased to $110 million from $93 million in 2023, while total derivative liabilities overall declined from $180 million to $151 million, indicating a slight reduction in exposure or a shift in hedging approach. This evolution suggests Nike adjusted its hedging strategy to better align with its financial risk management objectives during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Foreign Exchange Forwards and Options (FIN_INST)",
        "Foreign Exchange Forwards and Options (FIN_INST) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10805,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3355,
        "completion_tokens": 205,
        "total_tokens": 3561
      }
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "The product category classification of Puffs within the Baby, Feminine & Family Care segment changed between 2022 and 2023. In 2022, Puffs was listed under the \"Family Care\" sub-category, which included products like Paper Towels, Tissues, and Toilet Paper. However, in 2023, Puffs was reclassified and appeared only under the \"Feminine Care\" category, which now includes Adult Incontinence and Menstrual Care. This reclassification suggests a strategic shift or reorganization in how P&G categorizes its product lines within the segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG",
      "triplets_used": [
        "PG (ORG) -> Puffs (PRODUCT)",
        "Puffs (PRODUCT) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5039,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1885,
        "completion_tokens": 134,
        "total_tokens": 2020
      }
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "Between 2022 and 2023, Tampax's positioning within P&G's product portfolio remained under the \"Baby, Feminine & Family Care\" segment, but its categorization within this segment evolved. In 2022, Tampax was listed under the \"Feminine Care\" sub-category, which also included \"Adult Incontinence.\" By 2023, the sub-category was rebranded as \"Menstrual Care,\" reflecting a more specific and potentially market-focused classification. This shift highlights P&G's strategic emphasis on menstrual health, aligning with broader consumer and regulatory trends. Additionally, Tampax continued to be grouped with other major brands like Always and Always Discreet, underscoring its role as a key brand in P&G's feminine care offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG",
      "triplets_used": [
        "PG (ORG) -> Tampax (PRODUCT)",
        "Tampax (PRODUCT) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5039,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1895,
        "completion_tokens": 181,
        "total_tokens": 2076
      }
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "Between fiscal 2022 and fiscal 2023, Oracle's strategy for Oracle Engineered Systems has shifted toward maintaining a stable revenue contribution while emphasizing continued research and development (R&D) investment to enhance and expand its hardware offerings. In fiscal 2022, the hardware business, which includes Oracle Engineered Systems, was characterized by stable revenue performance, with the business contributing a significant portion of total revenues, though specific percentages were not provided. By fiscal 2023, Oracle reported that its hardware business represented 6% of total revenues in both fiscal 2024 and 2023, indicating a consistent contribution. Additionally, Oracle explicitly stated its expectation to continue making R&D investments to improve existing hardware products and develop new ones, signaling a strategic focus on innovation and competitiveness in the hardware segment. This evolution reflects Oracle’s ongoing commitment to its hardware business despite the challenges of lower operating margins compared to its cloud and license business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Engineered Systems (PRODUCT)",
        "Oracle Engineered Systems (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7444,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2514,
        "completion_tokens": 269,
        "total_tokens": 2784
      }
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "Between 2022 and 2023, Honeywell's investment in private funds for its Non-U.S. pension plans decreased significantly, from $1,105 in 2022 to $115 in 2023. In 2022, these private funds were entirely classified under Level 3 of the fair value hierarchy, indicating no observable market inputs. In contrast, by 2023, the $115 allocation was split across Levels 2 ($41) and 3 ($74), reflecting a shift in classification. Additionally, investments measured at NAV for private funds dropped from $1,105 in 2022 to just $8 in 2023, highlighting a substantial reduction in both the overall allocation and reliance on private fund investments in the Non-U.S. pension plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "HON (ORG) -> Private funds (FIN_INST)",
        "Private funds (FIN_INST) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7528,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2530,
        "completion_tokens": 166,
        "total_tokens": 2697
      }
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "Between 2023 and 2024, the 2014 USD Notes, which were due in April 2024, were classified as short-term debt on MA's consolidated balance sheet as of December 31, 2023. In 2024, the $1 billion principal amount of the 2014 USD Notes matured and was fully repaid in April 2024. This repayment was part of MA's broader financing activities, which also included the issuance of $4 billion in new debt through the 2024 USD Notes to support liquidity and general corporate purposes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "MA (ORG) -> 2014 USD Notes (FIN_INST)",
        "2014 USD Notes (FIN_INST) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4553,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1774,
        "completion_tokens": 118,
        "total_tokens": 1893
      }
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "Between 2022 and 2024, Lowe's continued to disclose its Officer Indemnification Agreements under similar exhibit numbering (10.31 in 2022 and 10.23 in 2024), indicating consistent documentation and regulatory reporting practices. In 2022, the agreement was referenced as part of the 2019 filings, while in 2024, it remained unchanged in form and reference, suggesting no material amendments to the indemnification terms during this period. This consistency reflects a stable approach to executive risk management and governance continuity, emphasizing the company's commitment to protecting its officers in line with established corporate governance practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Officer Indemnification Agreement (ACCOUNTING_POLICY)",
        "Officer Indemnification Agreement (ACCOUNTING_POLICY) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10034,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3178,
        "completion_tokens": 165,
        "total_tokens": 3343
      }
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "In the 2022 10-K filing, Always Discreet was noted to hold over 10% market share in key markets within the adult incontinence category. By 2023, as shown in the 2023 10-K filing, Always Discreet was explicitly listed under the \"Feminine Care\" segment, which now includes \"Adult Incontinence\" as a sub-category, indicating a strategic repositioning of the product within Procter & Gamble’s business structure. While specific market share figures for 2023 are not provided, the inclusion of Always Discreet as a major brand in the 2023 reportable segment suggests a continued or potentially strengthened market presence, aligning with P&G’s broader focus on this category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG",
      "triplets_used": [
        "PG (ORG) -> Always Discreet (PRODUCT)",
        "Always Discreet (PRODUCT) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6216,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2193,
        "completion_tokens": 167,
        "total_tokens": 2361
      }
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "Between 2022 and 2023, Oracle's strategic positioning of Engineered Systems has evolved to reinforce their role as a foundational component of Oracle's cloud transformation narrative. In 2022, Oracle Engineered Systems were described as core to both cloud-based and on-premise data center infrastructure, emphasizing their pre-integrated design combining Oracle's database, storage, operating system, and management software with hardware. These systems, such as the Oracle Exadata Database Machine, were highlighted for their ability to deliver performance, scalability, and operational efficiency, and were offered through on-premise, cloud (OCI), and hybrid deployment options. By 2023, Oracle further integrated Engineered Systems into its broader hardware business, which accounted for 6% of total revenues in both fiscal 2023 and 2024. The 2023 filing emphasized the interdependence of hardware and software components, as well as the importance of hardware support services, which align with Oracle's strategy to provide comprehensive, lifecycle solutions. This evolution reflects Oracle's continued investment in Engineered Systems to support both traditional on-premise environments and cloud infrastructure, thereby strengthening its position in the transition toward cloud-centric IT ecosystems.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Engineered Systems (PRODUCT)",
        "Oracle Engineered Systems (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9849,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3121,
        "completion_tokens": 326,
        "total_tokens": 3447
      }
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "Between the 2022 and 2023 10-K filings, the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolved by omitting specific details present in the 2022 filing. In the 2022 filing, it was explicitly stated that the 2020 Stock Plan is the successor to the 2011 Stock Plan and that 5,530,106 shares previously available under the 2011 Stock Plan were carried over for use under the 2020 Stock Plan. However, the 2023 filing no longer mentions this successor relationship or the carryover of shares from the 2011 Stock Plan, providing a more general description of the 2020 Stock Plan without referencing its predecessor.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> 2020 Stock Plan (ACCOUNTING_POLICY)",
        "2020 Stock Plan (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1960,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 161,
        "total_tokens": 1294
      }
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "Honeywell's allocation strategy toward private funds remained relatively stable between 2022 and 2023, with private fund investments increasing slightly from $1,244 million in 2022 to $1,265 million in 2023. This consistency, despite a broader decline in total investment assets—from $20,560 million in 2022 to $16,594 million in 2023—suggests that the company is maintaining a deliberate focus on private fund investments as part of its capital deployment strategy. This could indicate a continued preference for alternative investments to preserve capital or achieve long-term returns, especially in a shifting financial environment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "HON (ORG) -> Private funds (FIN_INST)",
        "Private funds (FIN_INST) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7192,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2439,
        "completion_tokens": 158,
        "total_tokens": 2598
      }
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "Between 2023 and 2024, the Class B-2 Common Stock remained non-outstanding, as no shares were issued or outstanding prior to the Class B-1 Common Stock exchange offer in both years. In 2023, the stock was subject to conversion calculations for dividend purposes and potential dilution due to the U.S. retrospective responsibility plan, which could reduce the conversion rate into Class A Common Stock. By 2024, the disclosure reiterated the non-outstanding status and continued to reference the impact of the retrospective responsibility plan on conversion rates, maintaining the relationship between Class B-2 and other stock classes through the Company's regulatory disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Class B-2 Common Stock (FIN_INST)",
        "Class B-2 Common Stock (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1861,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 170,
        "total_tokens": 1280
      }
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "The financial obligations related to the Target Circle program decreased significantly from $72 million in 2021, $89 million in 2022, to $117 million in 2024, and further to $19 million in 2025, as reflected in deferred revenue included in Accrued and Other Current Liabilities. This decline suggests a shift in the program's structure, likely due to the introduction of the Target Circle Card Reloadable Account and the evolution of the rewards model, which may have altered how obligations are accrued and recognized. The changes indicate a strategic evolution of the program toward a more flexible, card-based system with potentially different financial implications compared to the earlier RedCard-based model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Target Circle Program (PRODUCT)",
        "Target Circle Program (PRODUCT) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3499,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 178,
        "total_tokens": 1695
      }
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $1,111 million as of December 31, 2022, to $996 million as of December 31, 2023. This decline suggests that market conditions or investor perception may have shifted during the period, potentially reflecting higher interest rates or increased risk premiums for long-term debt, as the notes mature in November 2026. The reduction in fair value indicates that investors may have demanded higher yields, leading to a corresponding decrease in the market value of the notes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> 4.375% Senior Notes (FIN_INST)",
        "4.375% Senior Notes (FIN_INST) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6978,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2394,
        "completion_tokens": 133,
        "total_tokens": 2527
      }
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "Between 2023 and 2024, the equity structure related to Class C Common Stock evolved primarily through the May 2024 exchange offer, where Visa issued 48 million shares of Class C Common Stock in exchange for 241 million shares of Class B-1 Common Stock. This issuance increased the presence of Class C Common Stock in the equity structure, as evidenced by the 10 shares issued and outstanding as of September 30, 2024, compared to 2023. Additionally, the equity classification remained consistent, with Class C Common Stock listed under the common stock section of the balance sheet with a $0.0001 par value, while changes in equity were also reflected in the additional paid-in capital and accumulated comprehensive income accounts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Class C Common Stock (FIN_INST)",
        "Class C Common Stock (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 17677,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5059,
        "completion_tokens": 183,
        "total_tokens": 5242
      }
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "From 2022 to 2024, Lowe's engagement with Rough Plumbing has evolved from being a product category under its Building Products division to also becoming a key component of its installed services and extended protection plans. In 2022, Rough Plumbing was classified under the Building Products division, which included categories like Building Materials, Electrical, and Lumber. By 2024, Rough Plumbing was integrated into Lowe's installed sales model, where it accounted for a significant portion of installed sales, alongside categories like Kitchens & Bath and Flooring. Additionally, Rough Plumbing became eligible for Lowe's extended protection plans, which offer enhanced coverage and repair services beyond manufacturer warranties. This evolution reflects Lowe's strategic shift toward offering more value-added services and solutions to customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Operates_In]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Rough Plumbing (PRODUCT)",
        "Rough Plumbing (PRODUCT) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5371,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1978,
        "completion_tokens": 213,
        "total_tokens": 2192
      }
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "The Class B-2 common stock was introduced in 2024 with $77 million in value, as it did not exist in 2023, as noted in the 2024 10-K. This introduction coincided with a class B-1 common stock exchange offer, as disclosed in the 2024 filing. The emergence of Class B-2 common stock in 2024 suggests a structural change in the company's capital structure, potentially to create distinct classes with varying voting or economic rights, thereby allowing for more nuanced equity management or control.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Class B-2 Common Stock (FIN_INST)",
        "Class B-2 Common Stock (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1512,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1025,
        "completion_tokens": 123,
        "total_tokens": 1149
      }
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "The financial liability associated with the Target Circle program significantly decreased from $117 million in 2024 to $19 million by February 1, 2025, as disclosed in the accrued liabilities. This reduction suggests that the program may have seen improved redemption rates or adjustments in deferred revenue recognition, potentially indicating a more mature or optimized loyalty program. Additionally, the program's integration with credit card offerings, managed by TD Bank Group, highlights its role in driving customer engagement and generating ancillary revenue for Target through profit-sharing arrangements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Target Circle Program (PRODUCT)",
        "Target Circle Program (PRODUCT) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4977,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1888,
        "completion_tokens": 153,
        "total_tokens": 2042
      }
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "NVDA's exposure to and concern about pollution limits between 2023 and 2024 has grown, reflecting increasing regulatory and operational pressures. In 2023, NVDA highlighted that pollution limits and other climate-related regulations could lead to higher compliance costs, changes in manufacturing processes, and increased capital expenditures, which could affect both its operations and financial performance. By 2024, the company expanded on these concerns, emphasizing that regulations limiting energy or water availability could impair customers' ability to expand data centers, directly affecting NVDA’s product demand. Additionally, NVDA reiterated that such regulations could result in higher compliance and energy costs, further impacting its operations and results. The evolving regulatory landscape and its potential to restrict data center expansion underscore a growing concern for NVDA’s business model and long-term growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Pollution Limits (REGULATORY_REQUIREMENT)",
        "Pollution Limits (REGULATORY_REQUIREMENT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13304,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3984,
        "completion_tokens": 234,
        "total_tokens": 4218
      }
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "Between 2023 and 2024, the composition and valuation of the company's Guaranteed Senior Notes evolved as follows: In November 2023, the Japanese subsidiary issued $500 in Guaranteed Senior Notes with fixed interest rates ranging from 1.400% to 2.120%, and these were valued using Level 3 inputs. By July 2024, $77 of these Guaranteed Senior Notes were repaid, reducing the outstanding balance. The valuation of these notes remained based on Level 3 inputs, while the broader long-term debt fair value decreased from approximately $5,738 at the end of 2023 to $5,412 at the end of 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "COST (ORG) -> Guaranteed Senior Notes (FIN_INST)",
        "Guaranteed Senior Notes (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5311,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1977,
        "completion_tokens": 146,
        "total_tokens": 2123
      }
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "From 2022 to 2024, Netflix (NFLX) increased its investment in streaming service improvements, as reflected in higher personnel-related costs in 2022 to support headcount growth for technology and development, particularly for enhancing its streaming service. By 2024, the company had significantly expanded its cybersecurity risk management framework, introducing a robust enterprise-wide information security program led by an experienced Vice President of Security and Privacy Engineering. This evolution indicates a shift from operational investment in 2022 to a more strategic and risk-focused approach in 2024, with enhanced oversight by the Audit Committee and proactive measures to mitigate cybersecurity threats that could negatively impact the streaming service and, consequently, Netflix’s operations and financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Streaming Service (PRODUCT)",
        "Streaming Service (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5976,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2149,
        "completion_tokens": 209,
        "total_tokens": 2358
      }
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "Between 2023 and 2024, The Bank of New York Mellon Corporation introduced the 2024 Form of Restricted Stock Unit Agreement in its 2023 10-K filing (Chunk 1), indicating a forward-looking update to its equity compensation structure. By 2024, the 2024 Form of Restricted Stock Unit Agreement was referenced again in the 2024 10-K filing (Chunk 2), now disclosed as previously filed and incorporated by reference, suggesting it had become an established part of the company's executive compensation framework. Additionally, the 2025 Form of Restricted Stock Unit Agreement was introduced in the 2024 filing, signaling a continued evolution in lifecycle management of these instruments. This progression reflects a strategic shift toward standardizing and updating equity terms to align with evolving executive compensation goals and regulatory expectations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "BK (ORG) -> 2024 Form of Restricted Stock Unit Agreement (ACCOUNTING_POLICY)",
        "2024 Form of Restricted Stock Unit Agreement (ACCOUNTING_POLICY) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12002,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3689,
        "completion_tokens": 213,
        "total_tokens": 3903
      }
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "The 4.90% Senior Notes, issued in November 2023 with a principal amount of $750 million and a maturity date of April 15, 2029, had a carrying amount of $743 million as of January 28, 2024, and $744 million as of February 2, 2025, indicating a slight increase in their carrying value over the year. These notes, introduced by HD, are structured with semi-annual interest payments due on April 15 and October 15, beginning April 15, 2024, and remain subject to potential redemption by HD under the terms outlined in the indenture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "HD (ORG) -> 4.90% Senior Notes (FIN_INST)",
        "4.90% Senior Notes (FIN_INST) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12604,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3791,
        "completion_tokens": 132,
        "total_tokens": 3923
      }
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "Between 2023 and 2024, Costco's Japanese subsidiary issued Guaranteed Senior Notes totaling approximately $500 in November 2023, with fixed interest rates ranging from 1.400% to 2.120% and maturities extending to 2043. In July 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes, indicating a partial reduction in the debt. These notes were valued using Level 3 inputs, reflecting their complexity and lack of observable market data. The issuance and repayment are part of Costco’s broader financing activities, which in 2024 included significant debt repayments, such as the $1,000 payment on the 2.750% Senior Notes in May 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "COST (ORG) -> Guaranteed Senior Notes (FIN_INST)",
        "Guaranteed Senior Notes (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6332,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2218,
        "completion_tokens": 160,
        "total_tokens": 2379
      }
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "From 2022 to 2023, the risk associated with competitors developing after-market parts for DHR's products has remained a consistent concern, with no significant escalation in its direct mention in 2023, but the broader competitive and cost-containment pressures in the healthcare industry have intensified, indirectly amplifying the risk. In 2022, DHR highlighted that competitors developing after-market parts could detract from its sales, emphasizing the potential for reduced revenue and market share. By 2023, while the specific risk of after-market parts was not expanded upon, the company noted increased cost-containment efforts by governments and payors, including price controls and reimbursement limitations, which heighten competitive pressures and the likelihood of commoditization—factors that could make after-market parts more attractive to cost-sensitive customers. These evolving dynamics suggest that the risk, while not explicitly heightened, has a greater potential financial impact on DHR’s business and financial statements due to the broader industry cost environment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "DHR (ORG) -> After-Market Parts (RISK_FACTOR)",
        "After-Market Parts (RISK_FACTOR) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10588,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3305,
        "completion_tokens": 272,
        "total_tokens": 3577
      }
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "From 2022 to 2024, Netflix evolved its membership plans by adjusting pricing and introducing new features to address business challenges such as slowing membership growth and competition. In 2022, Netflix increased average monthly revenue per paying membership through price changes and foreign exchange benefits, despite a 50% decline in paid net membership additions. By 2024, the company introduced a lower-priced ad-supported subscription plan and enforced terms to limit shared viewing, aiming to retain existing members and attract cost-conscious users. These changes were intended to counter declining growth rates, manage fixed content costs, and compete with other entertainment providers offering diverse content and pricing models.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Membership Plans (PRODUCT)",
        "Membership Plans (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8941,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2886,
        "completion_tokens": 185,
        "total_tokens": 3071
      }
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "Between 2022 and 2023, Boeing's approach to in-orbit incentive payments has evolved with increased financial recognition and heightened risk exposure. In 2022, the company highlighted that its development programs, including those with in-orbit incentive payments, carried the risk of reduced fees, program cancellation, or the loss of incentive payments due to technical or schedule issues. This was particularly relevant for satellite programs, where failure to meet performance criteria could result in the loss of future in-orbit payments and potential refund obligations. By 2023, Boeing explicitly outlined the financial risks tied to in-orbit incentive payments in its 10-K, noting that the net present value of these fees is recognized as revenue during the construction period. However, if satellites fail to meet contractual performance standards, the company may face significant charges and the loss of future payments, underscoring a more pronounced recognition of the financial exposure associated with these incentives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Invests_In]- ORG",
      "triplets_used": [
        "BA (ORG) -> In-Orbit Incentive Payments (REGULATORY_REQUIREMENT)",
        "In-Orbit Incentive Payments (REGULATORY_REQUIREMENT) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8366,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2746,
        "completion_tokens": 258,
        "total_tokens": 3004
      }
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "Between 2023 and 2024, the disclosure and accessibility of BNY Mellon’s Directors' Code of Conduct remained consistent in terms of availability on the company’s website, but there was a slight evolution in the context and emphasis of its presentation. In 2023, the Directors' Code of Conduct was disclosed as part of the broader corporate governance section in the 10-K and referenced on the company’s website, with a commitment to disclose amendments or waivers. In 2024, the Directors' Code of Conduct was explicitly listed among other key governance documents made available on the company’s website, indicating a more structured and centralized approach to governance disclosure. This reflects an ongoing commitment to transparency and accessibility under the same accounting policy framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "BK (ORG) -> Directors' Code of Conduct (ACCOUNTING_POLICY)",
        "Directors' Code of Conduct (ACCOUNTING_POLICY) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6962,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2378,
        "completion_tokens": 199,
        "total_tokens": 2577
      }
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "Between 2022 and 2023, Mobileye Drive™ evolved from a newly launched SAE L4 self-driving system with initial commercial collaborations to a more strategically positioned solution for fleet deployment and AMaaS (Autonomous Mobility as a Service). In 2022, Mobileye launched Mobileye Drive™ and secured partnerships for autonomous cargo delivery with Udelv and self-driving mobility services with Transdev, along with a consumer L4 design win with Geely. By 2023, the deployment strategy shifted to focus on supplying Mobileye Drive™ to transportation network companies, public transit operators, and AV-ready vehicle platform suppliers, with plans to bundle it with Moovit’s mobility intelligence platform. This reflects a broader, more scalable approach aligned with the anticipated growth of shared-vehicle mobility and the maturation of the Robotaxi market as a precursor to consumer AV adoption.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Launches]-> PRODUCT <-[Supplies]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Mobileye Drive™ (PRODUCT)",
        "Mobileye Drive™ (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8751,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2809,
        "completion_tokens": 224,
        "total_tokens": 3033
      }
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "From 2022 to 2024, the structure and distribution rate of the Tower Preferred Interests evolved significantly. In 2022, the Tower Preferred Interests consisted of two series—Class A-1 ($1,500) with a 5.0% distribution rate and Class A-2 ($4,500) with a 4.75% distribution rate, both resetting every five years. By 2024, in August 2024, AT&T amended the 2019 Tower Preferred Interests, restructuring them into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) with a 5.90% distribution rate and introducing Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which pay SOFR plus 250 basis points. The Floating Rate Interests could reach $525 by 2028 if not called earlier. The restructuring, effective November 2024, reflects a shift toward a hybrid fixed and floating rate structure, with the call option for the Floating Rate Interests available at any time and the Fixed Rate Interests callable in November 2029.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Can_Call]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> Tower Preferred Interests (FIN_INST)",
        "Tower Preferred Interests (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10625,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3286,
        "completion_tokens": 243,
        "total_tokens": 3529
      }
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "From 2022 to 2023, the Balanced Index Fund, in which BA's OPB plan assets are primarily invested (approximately 60% equities and 40% debt securities), showed a significant shift in unrealized gains/(losses) for Level 3 assets. In 2022, the changes in unrealized losses were ($16) for corporate fixed income, ($11) for mortgage-backed and asset-backed fixed income, and ($14) for municipal fixed income, reflecting a challenging market environment. In contrast, 2023 saw unrealized gains of $2 for corporate fixed income, $6 for mortgage-backed and asset-backed fixed income, and $3 for other fixed income, indicating a marked improvement in the valuation of these assets. The investment approach for the Balanced Index Fund remained focused on a balanced equity-debt allocation, with valuations primarily based on market approaches, though the Level 3 components experienced a notable turnaround in performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "BA (ORG) -> Balanced Index Fund (FIN_INST)",
        "Balanced Index Fund (FIN_INST) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1851,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1099,
        "completion_tokens": 227,
        "total_tokens": 1327
      }
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "BNY Mellon's emphasis on accounting developments in its forward-looking statements has shifted from a general mention in 2023 to a more integrated and strategic focus in 2024. In 2023, accounting developments were listed among various factors affecting the company’s business, without specific prioritization. By 2024, however, the company explicitly included the impacts of accounting developments as a key consideration within its broader strategic priorities, such as capital management, risk processes, and financial outlook. This evolution reveals a growing influence of accounting standards on BNY Mellon’s strategic planning, reflecting increased alignment with regulatory expectations and the need to proactively manage financial reporting implications in a dynamic regulatory environment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Guides_On]- ORG",
      "triplets_used": [
        "BK (ORG) -> Accounting Developments (ACCOUNTING_POLICY)",
        "Accounting Developments (ACCOUNTING_POLICY) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9318,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2996,
        "completion_tokens": 199,
        "total_tokens": 3196
      }
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "In 2022, Home Depot (HD) focused on positively impacting the associate experience through engagement initiatives such as digital platforms, recognition programs, and diversity, equity, and inclusion efforts, which historically showed strong associate engagement. However, in 2023, the evolution of risks related to store safety and cybersecurity began to negatively impact the associate experience. Increased shrink due to organized retail crime and the need for operational changes to address safety concerns may have raised costs and reduced margins, while also affecting associate morale and retention. Additionally, the growing threat of cybersecurity risks, including data breaches and cyberattacks, introduced vulnerabilities that could compromise associate and customer data, further straining the associate experience. These 2023 risks contrast with the engagement-focused initiatives of 2022, highlighting a shift from positive to negative impacts on the same concept—associate experience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Positively_Impacts]-> CONCEPT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "HD (ORG) -> Associate Experience (CONCEPT)",
        "Associate Experience (CONCEPT) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7558,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2544,
        "completion_tokens": 249,
        "total_tokens": 2793
      }
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "Between 2022 and 2023, the role of the 'learning curve' in influencing cost and production estimates has become increasingly critical to program profitability and risk management for Boeing. In 2022, the learning curve was highlighted as a factor contributing to production delays, rework, and higher abnormal production costs, particularly in the 787 program, where uncertainties in production stability and regulatory coordination with the FAA negatively impacted delivery timelines and profitability. By 2023, the learning curve remained a key factor in estimating production costs, with its influence embedded in the rigorous quarterly reassessment of accounting quantities, cost trends, and supplier performance. The increased global regulatory scrutiny and complexity of new programs like the 777X and 737 MAX derivatives further amplified the risks associated with achieving anticipated cost reductions and production efficiencies, thereby heightening the importance of accurate learning curve assumptions in managing program risks and gross margins.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Depends_On]- ORG",
      "triplets_used": [
        "BA (ORG) -> Learning Curve (RISK_FACTOR)",
        "Learning Curve (RISK_FACTOR) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8433,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2758,
        "completion_tokens": 264,
        "total_tokens": 3022
      }
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "The treatment and disclosure of the Dividend Reinvestment Plan between BK's 2023 and 2024 SEC filings remained consistent in acknowledging that certain officers or directors participated in the plan and related equity programs, with trading arrangements potentially falling under Rule 10b5-1 or non-Rule 10b5-1 frameworks. However, the 2023 filing included additional context in ITEM 9B(a) regarding amendments to the Executive Severance Plan, which indirectly relates to broader executive compensation and equity management practices that may influence participation in such plans. No substantive changes were disclosed in the Dividend Reinvestment Plan itself or its regulatory treatment in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "BK (ORG) -> Dividend Reinvestment Plan (FIN_INST)",
        "Dividend Reinvestment Plan (FIN_INST) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2023.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4030,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1666,
        "completion_tokens": 174,
        "total_tokens": 1841
      }
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "The Home Depot's investment in creating an interconnected shopping experience evolved significantly from fiscal 2021 to fiscal 2023, with a shift from foundational investments to more advanced, data-driven personalization. In fiscal 2021, the company invested $2.6 billion in capital expenditures to build a seamless, frictionless shopping experience that integrated digital and physical elements. By fiscal 2023, the focus expanded to leveraging enhanced merchandising technology tools to tailor the experience to customers' shopping intent and location, while also optimizing product assortments and introducing innovative products. Additionally, the company continued to invest in services such as tool rentals and installation offerings, enhancing convenience and personalization for both DIY and professional customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> CONCEPT <-[Builds]- ORG",
      "triplets_used": [
        "HD (ORG) -> Interconnected Shopping Experience (CONCEPT)",
        "Interconnected Shopping Experience (CONCEPT) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10276,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3230,
        "completion_tokens": 206,
        "total_tokens": 3436
      }
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "Between 2022 and 2023, the financial relationship between DHR and Aldevron evolved significantly, particularly in terms of capital investment and acquisition-related expenditures. In 2022, DHR's capital expenditures were estimated at $1.5 billion, driven by the need to expand manufacturing capacity, including for products related to the Aldevron acquisition. The 2021 Aldevron acquisition itself was partially funded through commercial paper and debt issuance, contributing to a year-over-year increase in cash provided by financing activities. By 2023, the financial impact of the acquisition is further reflected in Aldevron's integration into DHR’s consolidated financials, with significant net assets acquired totaling $10,976 million, including $6,149 million in goodwill and $3,483 million in other intangible assets. This underscores the substantial capital investment and long-term strategic value DHR placed on Aldevron following the acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Aldevron (COMP)",
        "Aldevron (COMP) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7960,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2627,
        "completion_tokens": 239,
        "total_tokens": 2866
      }
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "From 2022 to 2024, the total value of Telco LLC's preferred interests increased from $2,000 (Class A-1) to $7,250, following the issuance of an additional $5,250 in April 2023 (Class A-2 and A-3). The initial distribution rate for the original Telco Class A-1 was 4.25%, resetting every seven years, while the newly issued Telco Class A-2 and A-3 had a higher initial distribution rate of 6.85%, with the first reset scheduled for November 1, 2027, and every seven years thereafter. Thus, the structure evolved from a single series with a lower rate to a multi-tiered structure with higher-yielding preferred interests and a staggered reset schedule.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Can_Call]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> Telco Preferred Interests (FIN_INST)",
        "Telco Preferred Interests (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10625,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3308,
        "completion_tokens": 162,
        "total_tokens": 3471
      }
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "Between 2022 and 2024, AIG has continued to apply Expected Loss Ratio (ELR) Methods primarily for the latest accident year across various insurance lines, including aviation and U.S. Property, where they are used in combination with loss development methods. In 2022, AIG noted that ELR methods are used to determine loss reserves for the latest accident year, supported by ground-up claim projections, particularly in short-tail and high-severity lines such as aviation. By 2024, AIG expanded the application of ELR methods to U.S. Workers' Compensation, where they are used alongside loss development and frequency/severity methods, especially as the proportion of large deductible business has increased, altering claim reporting patterns. The rationale for using ELR methods remains consistent: they are well-suited for lines with low frequency/high severity losses and where earned premium can be reliably projected to estimate ultimate expected losses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Expected Loss Ratio Methods (ACCOUNTING_POLICY)",
        "Expected Loss Ratio Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_273",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_151",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6964,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2397,
        "completion_tokens": 239,
        "total_tokens": 2636
      }
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "From 2023 to 2024, Target has evolved its approach to owned brands by increasing strategic emphasis on expanding and strengthening its owned brands portfolio as a core element of its growth strategy. In 2023, Target highlighted its focus on \"strengthening our owned brands portfolio\" to deliver newness, style, and value to customers. By 2024, this emphasis translated into a broader and more diverse portfolio of owned and exclusive brands, with approximately one-third of merchandise sales attributed to these brands, including well-known names like Project 62™, Hearth & Hand™, and Threshold™. Additionally, Target expanded its global sourcing operations to support the development and quality of these owned brands, reinforcing their role in differentiating Target’s offerings and enhancing customer value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Expands]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Owned Brands (PRODUCT)",
        "Owned Brands (PRODUCT) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6271,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2202,
        "completion_tokens": 202,
        "total_tokens": 2404
      }
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "IBM's continued listing of the 0.875% Notes due 2030 in 2024, alongside the new issuance of 2.900% Notes due 2030, suggests a strategic move to refinance or supplement existing low-yield debt with higher-yield instruments, likely to access more favorable market conditions for long-term borrowing. The persistence of the lower-rate 0.875% Notes indicates that IBM may still find value in retaining some of its historically lower-cost debt, while the issuance of the 2.900% Notes reflects current market rates and IBM’s ongoing need for capital, signaling a balanced approach to managing its debt portfolio amid evolving interest rate environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Financial_Instrument]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 0.875% Notes due 2030 (FIN_INST)",
        "0.875% Notes due 2030 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6172,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2201,
        "completion_tokens": 161,
        "total_tokens": 2363
      }
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "Between 2022 and 2024, AT&T's long-term debt composition remained largely consistent, with the 4.000% Global Notes due June 1, 2049 continuing to be a part of its registered debt instruments in both years. However, in 2024, AT&T introduced a new long-term note, the 4.300% Global Notes due November 18, 2034, which was not listed in 2022. This addition reflects a shift in AT&T's capital structure, indicating a strategic move to diversify its long-term debt offerings while maintaining existing instruments like the 2049 notes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> 4.000% Global Notes due June 1,2049 (FIN_INST)",
        "4.000% Global Notes due June 1,2049 (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_2",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_2",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5851,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2121,
        "completion_tokens": 132,
        "total_tokens": 2253
      }
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "The financial impact of the Heritage AspenTech acquisition evolved between 2023 and 2024, with intangibles amortization increasing from $258 in 2023 to $560 in 2024, although the latter was attributed to the NI acquisition rather than Heritage AspenTech. In 2023, the acquisition also contributed to a $24 mark-to-market gain from foreign currency forward contracts, which were terminated by June 21, 2023. Meanwhile, restructuring costs rose significantly from $72 in 2023 to $228 in 2024, reflecting broader cost-restructuring initiatives across the company, though these costs were not specifically tied to the Heritage AspenTech acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "EMR (ORG) -> Heritage AspenTech (COMP)",
        "Heritage AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2246,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 161,
        "total_tokens": 1364
      }
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "Between 2022 and 2024, AIG has continued to apply expected loss ratio methods for workers' compensation, particularly for the most recent accident years and for excess of deductible business. In 2022, expected loss ratio methods were given significant weight in the most recent five accident years for excess of deductible business and only in the most recent year for guaranteed cost business. AIG emphasized segmentation by state (notably excluding California and New York due to distinct development patterns), industry subsets, and deductible size, reflecting the increasing proportion of large deductible accounts, which have slowed claim reporting. By 2024, AIG maintained a similar reserving approach, continuing to use expected loss ratio methods in combination with loss development and frequency/severity methods. The 2024 disclosure reiterates the importance of segmentation by deductible size, state, and third-party administration, as well as the impact of large deductible accounts on claim emergence and settlement timing. These methods and segmentation strategies have evolved to address changing risk profiles, including the shift toward insured risk retention structures and the ongoing impact of medical and legal cost trends.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Expected Loss Ratio Methods (ACCOUNTING_POLICY)",
        "Expected Loss Ratio Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_260",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_151",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7603,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2566,
        "completion_tokens": 311,
        "total_tokens": 2878
      }
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "From 2023 to 2024, Target has enhanced its cybersecurity threat investigation and response, particularly through its Cyber Fusion Center, by maintaining a proactive threat intelligence program and strengthening collaboration with external organizations. In 2023, the Cyber Fusion Center was already operational as part of Target’s systems and processes to investigate and respond to threats, supported by industry-leading tools and internal technologies. By 2024, the Cyber Fusion Center continued to play a central role, with additional emphasis on regular training, compliance activities, and expanded use of third-party vendors to assess and test cybersecurity capabilities. Target also deepened its cross-industry collaboration in 2024, sharing threat intelligence and best practices to combat cybercrime and adapt to evolving regulatory environments, reflecting a more integrated and externally engaged approach to cybersecurity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Cyber Fusion Center (PRODUCT)",
        "Cyber Fusion Center (PRODUCT) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8508,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2780,
        "completion_tokens": 233,
        "total_tokens": 3014
      }
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "Eli Lilly's financial relationship with Baqsimi evolved between 2023 and 2024 through the recognition of revenue from the sale of rights for Baqsimi in 2023, which contributed $579.0 million in U.S. revenue. In 2024, this transaction was categorized under collaboration and other revenue, reflecting the contractual arrangement and ongoing recognition of revenue from the sale of rights, as disclosed in Note 4 of the 10-K filing. This indicates a shift from a one-time revenue recognition in 2023 to a broader categorization of the arrangement in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Baqsimi (PRODUCT)",
        "Baqsimi (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2451,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 138,
        "total_tokens": 1385
      }
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "From 2023 to 2024, AT&T evolved its capital structure management by repurchasing the remaining 213 million Mobility Preferred Interests in April 2023 for $5,414, funded primarily by the issuance of additional Telco LLC preferred interests. In 2023, AT&T expanded its Telco LLC preferred interests by issuing $5,250 of nonconvertible cumulative preferred interests with an initial distribution rate of 6.85%, which were included in its capital structure as of December 31, 2023. By 2024, AT&T further restructured its Tower Holdings preferred interests, resetting the rates and transitioning a portion to floating rate instruments, with fixed rate distributions at 5.90% and floating rate distributions tied to SOFR plus 250 basis points. These actions reflect AT&T's strategy to optimize its capital structure through repurchases and refinancing of preferred interests while managing distribution obligations and credit flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Repurchases]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> Mobility Preferred Interests (FIN_INST)",
        "Mobility Preferred Interests (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8938,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2904,
        "completion_tokens": 233,
        "total_tokens": 3137
      }
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "From 2023 to 2024, Emerson's relationship with AspenTech evolved from being a partner and partial owner to consolidating its ownership and rebranding the combined entity as \"New AspenTech.\" In 2023, Emerson acquired Heritage AspenTech, which positively impacted its gross margin by 0.6 percentage points due to favorable mix and pricing. By 2024, Emerson completed the transaction to own 55% of AspenTech and rebranded it under its previous name, Aspen Technology, Inc., with stock traded under the ticker 'AZPN.' This transformation led to a 1.8 percentage point increase in Emerson’s gross margin in 2024 to 50.8%, driven by the Test & Measurement acquisition and higher pricing, though partially offset by $231 in acquisition-related inventory step-up amortization. The ownership structure shifted significantly, with Emerson now holding a controlling stake in the combined entity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5491,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2012,
        "completion_tokens": 221,
        "total_tokens": 2233
      }
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "AIG's Japan pension plans' contribution to non-U.S. pension obligations decreased from 54% in 2023 to 50% in 2024, while the weighted average discount rate applied to these plans increased from 1.48% at December 31, 2023, to 1.81% at December 31, 2024, as determined by reference to the Mercer Yield Curve for Japan. This change in the discount rate reflects updated market conditions and assumptions in the local economic environment, consistent with the methodology applied to non-U.S. pension plans using country-specific yield curves.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Japan Pension Plans (FIN_INST)",
        "Japan Pension Plans (FIN_INST) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_311",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_183",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3802,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1606,
        "completion_tokens": 134,
        "total_tokens": 1741
      }
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "Between 2022 and 2023, Amazon's framing of the impact of competitive stores on its business remained consistent in acknowledging their influence but became slightly more concise in its 10-K filings. In 2022, the company explicitly listed \"the introduction of competitive stores, websites, products, services, price decreases, or improvements\" as a factor affecting its sales and operating results, emphasizing the broad range of competitive pressures. In 2023, the same factor was mentioned but without elaboration, reflecting a streamlined presentation. Both filings framed competitive conditions as part of a broader set of external market risks, including economic and geopolitical factors, indicating that Amazon continued to view competition as a dynamic and ongoing challenge within the larger context of market volatility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Competes_With]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Competitive Stores (COMP)",
        "Competitive Stores (COMP) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9549,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3036,
        "completion_tokens": 207,
        "total_tokens": 3243
      }
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "Target's exposure to port security risks between 2023 and 2024 has remained a significant concern, with continued geographic focus on major U.S. ports, particularly in California, where a substantial portion of imported merchandise is received. In 2023, disruptions such as periodic closings, labor disputes, and congestion at these ports were highlighted as operational risks, with potential impacts on inventory flow and costs. By 2024, the company reiterated these risks, noting that geopolitical conflicts, labor unrest, and other disruptions at ports globally—and specifically at U.S. ports—could increase costs and affect merchandise availability. Additionally, in 2024, the mention of recent U.S. tariffs and potential retaliatory actions from trading partners added a new layer of complexity, potentially compounding the operational impact of port security issues through increased procurement costs and supply chain volatility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Port Security (RISK_FACTOR)",
        "Port Security (RISK_FACTOR) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10550,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3277,
        "completion_tokens": 234,
        "total_tokens": 3511
      }
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "Between 2023 and 2024, Emerson's financial relationship with Heritage AspenTech evolved through acquisition-related amortization and restructuring costs. In 2023, Emerson contributed approximately $6.0 billion to acquire Heritage AspenTech, with intangible assets recognized from the transaction. That year, amortization related to the Heritage AspenTech acquisition was $258 million, compared to $560 million in 2024, which primarily related to the NI acquisition rather than Heritage AspenTech. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, reflecting broader cost-reduction and operational efficiency initiatives across Emerson's businesses, including those inherited from AspenTech.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "EMR (ORG) -> Heritage AspenTech (COMP)",
        "Heritage AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2646,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 187,
        "total_tokens": 1491
      }
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "AIG's use of Expected Loss Ratio (ELR) methods has evolved between 2022 and 2024, with a continued emphasis on applying these methods to more recent accident years across various lines of business, particularly in D&O, E&O, EPLI, and professional liability, where low frequency and high severity losses are typical. In 2022, AIG noted that ELR methods were given more weight in recent accident years, while loss development methods were prioritized for more mature years, with IBNR factors used for low-frequency/high-severity exposures. By 2024, this approach persisted, with AIG continuing to apply ELR methods in recent accident years, especially in lines like U.S. Workers’ Compensation, where risk-sharing features and long-tail characteristics necessitate a blend of methods. The evolution reflects AIG’s ongoing adaptation to emerging claim patterns, underwriting changes, and the need to refine loss estimates in response to factors such as inflation, reinsurance adjustments, and market dynamics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Expected Loss Ratio Methods (ACCOUNTING_POLICY)",
        "Expected Loss Ratio Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_270",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_151",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7446,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2522,
        "completion_tokens": 251,
        "total_tokens": 2773
      }
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "Between 2022 and 2023, Amazon's monetization strategy for its film groups evolved with a significant increase in capitalized video and music content costs, rising from $16.7 billion in 2022 to $17.4 billion in 2023. This growth was accompanied by a corresponding rise in total video and music expenses, from $16.6 billion in 2022 to $18.9 billion in 2023, reflecting higher licensing and production costs. The weighted average remaining life of capitalized video content also increased from 2.6 years in 2022 to 3.5 years in 2023, indicating a shift toward longer-term content planning and amortization strategies. These changes suggest a more aggressive investment in content to drive Prime membership value and customer engagement, with film groups continuing to be evaluated for impairment and monetized as a unit across major geographies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Positively_Impacts]-> PRODUCT <-[Monetizes]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Film Groups (PRODUCT)",
        "Film Groups (PRODUCT) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10897,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3368,
        "completion_tokens": 210,
        "total_tokens": 3578
      }
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "Between 2022 and 2024, Philip Morris International (PM) maintained a financial relationship with Rothmans, Benson & Hedges (RBH) through an equity investment, as evidenced by the stake PM held in RBH. In 2022, PM continued to report the volume of brands sold by RBH for which PM subsidiaries were the trademark owners, indicating an ongoing commercial and brand relationship. By 2024, developments in the Canadian tobacco litigation led to significant financial implications for PM. Specifically, PM recorded a non-cash impairment charge of $2,316 million ($1.49 per diluted share) due to uncertainty surrounding the allocation of a CAD 32.5 billion settlement among RBH and its partners. This impairment reflects a decline in the estimated fair value of PM’s investment in RBH below its carrying value, marking a material change in the financial relationship between the two entities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "PM (ORG) -> RBH (COMP)",
        "RBH (COMP) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4596,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1780,
        "completion_tokens": 221,
        "total_tokens": 2002
      }
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "Based on the disclosures in the 2023 and 2024 10-K filings, LLY’s net product revenue is sensitive to changes in sales return, rebate, and discount liabilities, which are accounted for under its critical accounting estimates related to revenue recognition. In 2023, a 5% change in the consolidated sales return, rebate, and discount liability would have resulted in a $615 million change in revenue, with approximately 90% of this liability stemming from U.S. sales programs such as managed care, Medicare, Medicaid, and patient assistance. The 2024 filing reaffirms the continued use of similar accounting policies and estimation methodologies, though it does not explicitly update the sensitivity figure. Therefore, while the 2024 filing does not provide a revised sensitivity amount, it confirms that the same critical accounting estimates and U.S.-centric liability structure remain in place, suggesting that the sensitivity framework likely remained consistent between 2023 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Current Contracts (ACCOUNTING_POLICY)",
        "Current Contracts (ACCOUNTING_POLICY) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9527,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3039,
        "completion_tokens": 247,
        "total_tokens": 3286
      }
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "From 2022 to 2024, the role and revenue contribution of Union Pacific's (UNP) Bulk shipments evolved significantly. In 2022, the average revenue per car for Bulk was $3,305, showing a 6% increase compared to 2020 and a 1% decrease compared to 2019. By 2024, Bulk shipments accounted for 32% of Union Pacific's total freight revenues, underscoring their continued importance in the company’s operations. This group includes grain and grain products, fertilizer, food and refrigerated products, and coal and renewables, with the railroad playing a key role in connecting major production areas to export and domestic markets. The increase in revenue contribution highlights the strategic value of Bulk shipments in Union Pacific’s diversified freight portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Bulk (PRODUCT)",
        "Bulk (PRODUCT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7557,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2514,
        "completion_tokens": 189,
        "total_tokens": 2704
      }
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "The interest rate of IBM's 1.750% Notes due 2028 remained unchanged at 1.750% between 2023 and 2024, as both the 2023 and 2024 10-K filings list the same rate for these notes. This consistency in the interest rate suggests that IBM has maintained a stable debt structure for this particular instrument, indicating a strategy of preserving low-cost, fixed-rate debt to manage interest expenses predictably over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Financial_Instrument]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 1.750% Notes due 2028 (FIN_INST)",
        "1.750% Notes due 2028 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6172,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2184,
        "completion_tokens": 103,
        "total_tokens": 2287
      }
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "From 2023 to 2024, AT&T’s capital structure strategy regarding preferred interests evolved significantly. In 2023, AT&T repurchased all of its Mobility preferred interests for $5,414, effectively removing this liability from its capital structure (Chunk 1). In 2024, AT&T introduced new preferred instruments through its Tower Holdings and Telco LLC subsidiaries. The Tower Holdings preferred interests were restructured in August 2024, resetting their rates and transitioning a portion to floating rate instruments, with fixed rate instruments paying 5.90% and floating rate instruments tied to SOFR plus 250 basis points (Chunk 2). Additionally, AT&T expanded its Telco LLC preferred interests, issuing $7,250 in cumulative preferred interests with initial distributions of 4.25% and 6.85%, subject to reset every seven years. These new preferred instruments were included in noncontrolling interest on the consolidated balance sheets and provided flexibility in terms of callability and redemption features.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> Mobility Preferred Interests (FIN_INST)",
        "Mobility Preferred Interests (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6612,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2311,
        "completion_tokens": 252,
        "total_tokens": 2563
      }
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "Between 2022 and 2023, Amazon's characterization of the competitive threat from websites remained consistent in acknowledging the introduction of competitive stores and websites as a risk factor, as seen in both the 2022 and 2023 10-K filings. However, the 2023 filing introduced a more nuanced and expansive context by explicitly linking competitive threats to broader geopolitical and economic conditions, as well as the increasing sophistication of competitors through the use of artificial intelligence. This shift in language suggests a recognition that competition is no longer just about traditional e-commerce platforms but also involves advanced technological capabilities and global macroeconomic dynamics that could influence customer behavior and market demand.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Competes_With]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Competitive Websites (COMP)",
        "Competitive Websites (COMP) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9549,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3036,
        "completion_tokens": 193,
        "total_tokens": 3230
      }
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "From 2022 to 2024, PMI's relationship with KT&G has evolved from a global collaboration agreement to a more integrated strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free portfolio. In 2022, PMI announced a global collaboration with KT&G to commercialize KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. By 2024, PMI explicitly included KT&G's heat-not-burn products in its smoke-free revenue reporting, indicating a formal integration of these products into PMI's broader smoke-free strategy. This progression reflects PMI's increasing dependence on KT&G's innovations to expand its heat-not-burn offerings in select international markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "PM (ORG) -> KT&G (COMP)",
        "KT&G (COMP) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6657,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2302,
        "completion_tokens": 182,
        "total_tokens": 2484
      }
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "Between 2022 and 2024, IBM's use of the PWCC Plan remained consistent in its administration and scope, as both the 2022 and 2024 disclosures indicate that the plan was adopted in 2002 to fund awards for employees of PricewaterhouseCoopers Consulting who became IBM employees due to the acquisition. The plan is administered under terms substantively identical to the 2001 Plan, with no changes noted in its exclusivity to non-senior executives or its continued use for this specific employee group. The administration remains under the oversight of the Executive Compensation and Management Resources Committee, with no new developments or modifications to its structure or purpose identified in the provided disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Adopts]-> ACCOUNTING_POLICY <-[Announces]- ORG",
      "triplets_used": [
        "IBM (ORG) -> PWCC Plan (ACCOUNTING_POLICY)",
        "PWCC Plan (ACCOUNTING_POLICY) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2022.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8781,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2834,
        "completion_tokens": 180,
        "total_tokens": 3015
      }
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "Between 2023 and 2024, AT&T significantly reduced its financial obligations related to Mobility Preferred Interests by repurchasing the remaining 213 million interests in April 2023 for $5,414, including accrued distributions, effectively decreasing its noncontrolling interest liabilities. This action reflects a strategic shift to simplify and strengthen its capital structure by eliminating a source of recurring cash distributions and reducing complexity in its ownership structure. In contrast, AT&T continued to manage other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, by restructuring their terms (e.g., resetting rates and introducing floating rate components) to align with long-term capital management goals and interest rate dynamics. These moves collectively indicate a broader focus on optimizing leverage, reducing fixed obligations, and enhancing financial flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> Mobility Preferred Interests (FIN_INST)",
        "Mobility Preferred Interests (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8682,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2827,
        "completion_tokens": 230,
        "total_tokens": 3058
      }
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "Between 2022 and 2024, IBM's exposure to stock exchange regulations affecting its debt securities has remained consistent, as both filings highlight that the value of its debt securities is subject to factors including governmental and stock exchange regulations, which IBM has little or no control over. In 2022, the 10-K emphasized that these regulations could impact the fluctuation of debt security values, while the 2024 filing reiterated the same regulatory exposure, underscoring continued vulnerability to external regulatory environments. The regulatory relationship is bidirectional, with IBM depending on and being subject to these regulations, as reflected in the knowledge graph triplets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "IBM (ORG) -> Stock Exchange Regulations (REGULATORY_REQUIREMENT)",
        "Stock Exchange Regulations (REGULATORY_REQUIREMENT) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2022.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9328,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2984,
        "completion_tokens": 175,
        "total_tokens": 3159
      }
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "From 2022 to 2024, Disney's financial relationship with A&E, as an equity investee, saw a decline in equity income contribution. In 2022, A+E was a significant equity investment for Disney, with the company holding a 50% stake alongside Hearst, and its financial results contributing to Disney's \"Equity in the income (loss) of investees, net.\" However, by 2024, Disney's equity income from A+E had decreased, contributing to an overall $207 million decline in equity income from investees, with lower A+E performance being a key driver. This reflects a weakening financial contribution from A&E to Disney's consolidated results over the two-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "DIS (ORG) -> A&E (COMP)",
        "A&E (COMP) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1966,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 163,
        "total_tokens": 1278
      }
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "The carrying value of securitized debt obligations decreased from $42.3 billion in 2021 (as disclosed in the 2022 filing) to $18.043 billion by December 31, 2023, as shown in the 2023 financial data. This significant reduction suggests a strategic shift in the company’s long-term funding approach, likely reflecting a move away from securitization programs and toward alternative financing sources such as senior and subordinated notes, which totaled $31.248 billion in 2023. The change indicates a potential effort to diversify funding sources and manage maturity profiles to enhance financial stability and reduce reliance on complex securitization structures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "COF (ORG) -> Securitized Debt Obligations (FIN_INST)",
        "Securitized Debt Obligations (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_210",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5788,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2092,
        "completion_tokens": 165,
        "total_tokens": 2258
      }
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "Between 2022 and 2024, Disney has shifted its approach to scripted programming by increasingly prioritizing DTC platforms over its international general entertainment channels. In 2022, the Company highlighted that its international channels, including Fox, National Geographic, and Star, relied heavily on scripted content and operated in over 180 countries, but acknowledged that the focus on DTC distribution would negatively impact these channels by shifting monetization from linear licensing to streaming. By 2024, Disney had advanced this strategy, exemplified by the planned launch of a new DTC offering for ESPN in 2025 and the development of Venu Sports, a joint venture aiming to consolidate DTC sports content. This evolution reflects Disney's broader strategic realignment toward direct-to-consumer engagement, reducing reliance on traditional international linear channels for scripted programming distribution.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Scripted Programming (PRODUCT)",
        "Scripted Programming (PRODUCT) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7182,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2447,
        "completion_tokens": 231,
        "total_tokens": 2678
      }
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "From 2022 to 2023, Tesla faced evolving financial and operational challenges related to its energy storage products, particularly in accounts receivable and production scaling. In 2022, Tesla's accounts receivable were impacted by delays in collecting government rebates, which can take up to a year, and by the timing of payments from financial partners and regulatory credit sales, leading to significant period-to-period fluctuations. By 2023, Tesla highlighted ongoing production scaling dependencies, noting that ramping energy storage products required efficient manufacturing processes, supply chain management, and skilled labor, with risks of bottlenecks and supplier-related disruptions that could delay production and affect financial outcomes. These challenges underscored the interconnectedness of Tesla's financial performance and its ability to scale energy storage production effectively.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Energy Storage Products (PRODUCT)",
        "Energy Storage Products (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9028,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2909,
        "completion_tokens": 226,
        "total_tokens": 3135
      }
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "Between 2022 and 2023, the role of syrups in Coca-Cola's business model remained central to its concentrate operations, with continued emphasis on their sale to bottling partners and fountain retailers. In 2022, Coca-Cola (KO) highlighted that syrups are a key product sold to both consolidated and unconsolidated bottling partners, with revenue recognition differing based on the ownership structure of these partners. By 2023, the company reiterated that syrups, including fountain syrups, are a core offering of its concentrate operations, sold to bottling partners who then produce finished beverages or to fountain retailers for immediate consumption. This reflects a stable and integral role for syrups in supporting Coca-Cola’s broader beverage distribution model, particularly through its bottling partners and fountain channels globally.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "KO (ORG) -> Syrups (PRODUCT)",
        "Syrups (PRODUCT) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10461,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3248,
        "completion_tokens": 211,
        "total_tokens": 3460
      }
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) increased from $96 million in fiscal year 2022 to $120 million in fiscal year 2024. Despite this absolute increase, the proportion of Other MBS & ABS relative to the total fair value hierarchy slightly decreased, from 1% in 2022 to 1% in 2024, as the overall investment base shrank from $9,819 million to $8,073 million within the fair value hierarchy. This indicates a relatively stable but modest growth in the investment category compared to the broader portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Other MBS & ABS (FIN_INST)",
        "Other MBS & ABS (FIN_INST) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4273,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1724,
        "completion_tokens": 136,
        "total_tokens": 1860
      }
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "Between 2022 and 2023, the focus areas of Skunk Works' advanced development programs evolved to emphasize next-generation military aircraft capabilities such as air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. In 2022, Skunk Works was highlighted as part of Lockheed Martin's Aeronautics division, focusing on future systems and technology insertion into existing aircraft. By 2023, the emphasis expanded to include more explicit mentions of air dominance and hypersonics, aligning with broader U.S. military priorities. These developments reflect Lockheed Martin's ongoing investment in Skunk Works to maintain competitiveness in military aircraft design and production.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Partners_With]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Skunk Works (PRODUCT)",
        "Skunk Works (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11385,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3484,
        "completion_tokens": 183,
        "total_tokens": 3668
      }
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "From 2022 to 2023, Tesla's approach to the Powerwall evolved significantly in terms of integration strategy and production emphasis. In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products and highlighted growing customer interest driven by better availability and grid stability concerns. The company also focused on expanding production capacity for energy storage products, including the construction of the Lathrop Megafactory. By 2023, Tesla had further integrated Powerwall into its broader energy ecosystem, designing it to work seamlessly with Solar Roof and leveraging modular battery system designs to optimize manufacturing and interconnect with electricity grids. This shift reflects a stronger emphasis on system-level integration and scalability, aligning Powerwall more closely with Tesla’s vehicle and energy storage technologies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Powerwall (PRODUCT)",
        "Powerwall (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10032,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3141,
        "completion_tokens": 219,
        "total_tokens": 3361
      }
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024 by maintaining its role as a key product within the company's HIV portfolio, as highlighted in both the 2022 and 2024 filings. In 2022, Biktarvy was positioned as a leading once-a-day single-tablet regimen for the treatment of HIV-1, emphasizing its convenience and efficacy. By 2024, the product remained central to Gilead's HIV business, which generates a substantial portion of the company's revenue. However, the 2024 filing underscored heightened commercial risks, particularly the threat of market share erosion due to competition and the potential impact of shifts in treatment paradigms, such as the reduced role of nucleoside-based therapies like TAF, which is a core component of Biktarvy. This evolution reflects both the continued strategic importance of Biktarvy and the growing challenges in sustaining its market position amid competitive and therapeutic uncertainties.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Biktarvy (PRODUCT)",
        "Biktarvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9457,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3007,
        "completion_tokens": 240,
        "total_tokens": 3247
      }
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "Between 2022 and 2023, the U.S. Retrospective Responsibility Plan remained largely consistent in its core mechanisms, including the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, interchange judgment and loss sharing agreements, and the omnibus agreement. However, in 2023, the plan added a new mechanism: the makewhole agreements relating to the Class B-1 common stock exchange offer. This addition reflects a refinement in the structure of the plan to address potential liability under U.S. covered litigation, which includes the ongoing Interchange Multidistrict Litigation (MDL 1720) and related claims. The U.S. Litigation Escrow Agreement continues to serve as a key component of the plan, as disclosed by V in both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> U.S. Litigation Escrow Agreement (ACCOUNTING_POLICY)",
        "U.S. Litigation Escrow Agreement (ACCOUNTING_POLICY) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3830,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1622,
        "completion_tokens": 203,
        "total_tokens": 1825
      }
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "From 2022 to 2024, the strategic importance of Biktarvy for GILD has increased due to its robust patent protection, which extends to 2033 in both the U.S. and E.U., offering long-term exclusivity and positioning it as a key revenue driver in GILD's HIV portfolio. This is particularly significant as GILD disclosed in its 2024 10-K that a substantial portion of its revenue depends on HIV products, with risks tied to competition and potential shifts in treatment paradigms. The extended patent timeline for Biktarvy, compared to other HIV products with earlier expirations, enhances its role in sustaining GILD’s revenue and mitigating the risks associated with product dependency in the HIV space.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Biktarvy (PRODUCT)",
        "Biktarvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6956,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2381,
        "completion_tokens": 174,
        "total_tokens": 2556
      }
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "Between 2022 and 2023, there have been no modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company in terms of guarantee structure or referenced documentation. Both the 2022 and 2023 10-K filings list the same guarantees under 4-c, referencing the 2011 Exhibit 4-d, which includes Illinois Bell Telephone Company among other subsidiaries. The referenced documentation remains consistent, and no new or amended guarantees for Illinois Bell Telephone Company are indicated in the 2023 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> Illinois Bell Telephone Company (COMP)",
        "Illinois Bell Telephone Company (COMP) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_141",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 17574,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5051,
        "completion_tokens": 132,
        "total_tokens": 5183
      }
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "The consistent Class C common stock conversion rate of 4.0000 into Class A common stock between 2022 and 2023, as shown in both chunks, suggests that the voting power of Class A common stockholders in significant corporate transactions could be diluted if Class C shares are converted. This is because holders of Class B and C common stock, as noted in Chunk 1, have voting rights on major transactions such as mergers or consolidations, and their interests may diverge from those of Class A stockholders. The unchanged conversion rate implies that the potential increase in Class A shares from conversions would further dilute the voting influence of existing Class A stockholders, potentially complicating decisions on significant corporate actions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Class C Common Stock (FIN_INST)",
        "Class C Common Stock (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9685,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3076,
        "completion_tokens": 187,
        "total_tokens": 3264
      }
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "From 2022 to 2023, Tesla's relationship with the Solar Roof evolved in terms of production focus and strategic dependencies as the company continued to integrate the Solar Roof into its broader energy product suite while facing production and supply chain challenges. In 2022, Tesla produced the Solar Roof at Gigafactory New York and offered it through financing options to residential and commercial customers, positioning it as part of its energy generation and storage ecosystem. By 2023, the Solar Roof became more strategically dependent on Tesla’s manufacturing and supply chain capabilities, as production ramps and new product launches faced potential delays due to bottlenecks, supplier dependencies, and global supply chain disruptions. This highlighted the Solar Roof’s increasing integration with Tesla’s overall production strategy and its vulnerability to the same operational and logistical challenges affecting vehicle and energy storage production.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Solar Roof (PRODUCT)",
        "Solar Roof (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10291,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3202,
        "completion_tokens": 241,
        "total_tokens": 3443
      }
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "Between 2022 and 2023, the role of syrups in Coca-Cola's business model remained integral to both its concentrate and finished product operations. In 2022, syrups were defined as intermediate products in the beverage manufacturing process, produced by combining concentrates with water and sweeteners, and were primarily sold to bottling partners or fountain retailers for further processing into finished beverages. By 2023, the Company continued to emphasize that syrups, including fountain syrups, are a key output of its concentrate operations, which are sold to bottling partners and fountain retailers who mix them with water to create finished beverages for retail or immediate consumption. The distribution channels for syrups remained largely unchanged, with bottling partners and authorized wholesalers playing a central role in delivering these products to market, underscoring the continued dependency of finished beverage production on syrups as a foundational input.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "KO (ORG) -> Syrups (PRODUCT)",
        "Syrups (PRODUCT) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8489,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2763,
        "completion_tokens": 245,
        "total_tokens": 3008
      }
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "The company's operational focus on Africa/Eurasia between 2022 and 2024 remained relatively stable in terms of financial contribution, with operating profits of $203 million in 2022 and continuing to be part of the five reportable geographic segments under the Oral, Personal and Home Care product segment. In 2024, while there were no direct changes to Africa/Eurasia's operating profit figures, the company realigned its reporting structure for the skin health business, shifting it from the Europe segment to the North America segment effective July 1, 2024. This realignment, however, did not impact the geographic reporting structure or financial contribution of Africa/Eurasia, which continued to be disclosed as a distinct geographic segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "CL (ORG) -> Africa/Eurasia (GPE)",
        "Africa/Eurasia (GPE) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4617,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1793,
        "completion_tokens": 187,
        "total_tokens": 1981
      }
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson's Orthopaedics business demonstrated a 4.1% year-over-year increase in worldwide sales, reaching $8,942 million in 2023 from $8,587 million in 2022. The U.S. market saw a 3.8% growth, while international sales rose by 4.6%, indicating a balanced global performance. In 2024, JNJ emphasized the role of enabling technologies within its Orthopaedics portfolio, highlighting products that support hips, knees, trauma, spine, and sports applications. This strategic focus on advanced technologies aligns with the broader MedTech segment's expansion into innovative solutions, reinforcing JNJ's commitment to enhancing clinical outcomes and patient care globally.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Operates_In]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> Orthopaedics (PRODUCT)",
        "Orthopaedics (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11115,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3426,
        "completion_tokens": 174,
        "total_tokens": 3601
      }
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "Between 2022 and 2023, Visa expanded the scope of U.S. covered litigation under its loss sharing agreements to include actions brought by opt-outs from the MDL 1720 class, provided they are based on substantially similar facts. In 2022, Visa amended the loss sharing agreement to include such opt-out cases, and the omnibus agreement maintained a liability allocation of 66.6667% to Visa and 33.3333% to Mastercard for settlements or judgments. By 2023, the U.S. retrospective responsibility plan continued to incorporate the loss sharing agreement and omnibus agreement, with U.S. covered litigation explicitly including the Interchange Multidistrict Litigation and any related transferred or consolidated cases. This evolution reflects a broader allocation framework and continued reliance on pre-established liability-sharing mechanisms to manage litigation risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Loss Sharing Agreement (ACCOUNTING_POLICY)",
        "Loss Sharing Agreement (ACCOUNTING_POLICY) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7865,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2627,
        "completion_tokens": 216,
        "total_tokens": 2844
      }
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "Between 2022 and 2024, CL's investment in Guaranteed Investment Contracts (GICs) under its pension plans shifted significantly. In 2022, CL reported $1 in U.S. pension plan investments and $55 in international pension plan investments in GICs (Level 2 valuation). By 2024, the U.S. pension plan no longer held GICs, while the international pension plan's investment in GICs increased to $34. This shift suggests a strategic reallocation of pension plan assets, potentially to optimize risk-return profiles or align with changing investment priorities, with a reduced reliance on GICs in the U.S. plan and a modest increase in international holdings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "CL (ORG) -> Guaranteed investment contracts (FIN_INST)",
        "Guaranteed investment contracts (FIN_INST) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5184,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1946,
        "completion_tokens": 162,
        "total_tokens": 2108
      }
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "Between 2022 and 2024, the Mastercard Developer Platform evolved from a tool for simplifying access to and integration of Mastercard's digital assets into a more strategic enabler of blockchain-based business models and new technologies. In 2022, it was described as providing a single access point with tools and capabilities to integrate Mastercard services into new and existing solutions. By 2024, the platform continued to support this role but was also positioned within a broader context of enabling programmable payments and integration with blockchain ecosystems through the Mastercard Multi-Token Network™, allowing for secure and scalable transactions within digital asset environments. This evolution reflects Mastercard’s strategic shift toward supporting emerging technologies and digital currencies while maintaining its core focus on secure, seamless integration for partners and customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "MA (ORG) -> Mastercard Developer Platform (PRODUCT)",
        "Mastercard Developer Platform (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9205,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2961,
        "completion_tokens": 226,
        "total_tokens": 3187
      }
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "The company's investment in U.S. common stocks within its pension plans remained at $0 (Level 1) for both 2022 and 2024, indicating no direct allocation to U.S. common stocks during this period. However, the broader strategic asset allocation has shifted, with a decrease in fixed income securities and an increase in investments valued using NAV per share, such as equity and multi-asset funds. This suggests a potential reallocation toward more diversified and liquid fund-based strategies, rather than direct equity holdings, reflecting a shift in risk management and investment approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "CL (ORG) -> U.S. common stocks (FIN_INST)",
        "U.S. common stocks (FIN_INST) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5183,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1940,
        "completion_tokens": 147,
        "total_tokens": 2088
      }
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "Between 2022 and 2023, Disney's strategic focus on cruise ships evolved with continued capital investment in the Disney Cruise Line as part of broader Parks & Experiences initiatives, as outlined in the 2022 10-K. However, the 2023 10-K highlighted increased operational risk considerations, particularly due to unpredictable consumer preferences and external disruptions such as hurricanes and macroeconomic challenges. These risks underscored the vulnerability of cruise operations to adverse weather and shifting demand for out-of-home entertainment, which impacted Disney’s ability to fully realize returns on its cruise-related investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Operates_In]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Cruise Ships (PRODUCT)",
        "Cruise Ships (PRODUCT) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10941,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3374,
        "completion_tokens": 161,
        "total_tokens": 3536
      }
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "Between 2022 and 2024, Mastercard has continued to use short duration foreign exchange derivative contracts as part of its strategy to manage foreign exchange risk arising from daily settlement activities. These contracts are employed to offset potential fluctuations in the value of monetary assets and liabilities due to foreign exchange movements, particularly during the short period between payment transactions and subsequent settlements with customers. In 2021 (as detailed in the 2022 10-K), Mastercard described the objective of these contracts as reducing exposure to volatility from foreign currency gains and losses against its functional currencies. By 2024, this approach remained consistent, with the company entering into such contracts based on anticipated receipts and disbursements for respective currency positions. The evolution is evident in the increased net foreign currency gains reported in accumulated other comprehensive income, rising from a $34 million net gain in 2021 to $295 million in 2024, reflecting both the scale and effectiveness of these hedging activities over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Uses]- ORG",
      "triplets_used": [
        "MA (ORG) -> Short Duration Foreign Exchange Derivative Contracts (FIN_INST)",
        "Short Duration Foreign Exchange Derivative Contracts (FIN_INST) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_106",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7805,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2622,
        "completion_tokens": 276,
        "total_tokens": 2898
      }
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "From 2023 to 2024, Salesforce has evolved its strategic relationship with enterprise cloud companies by deepening its investment focus and enhancing ecosystem integration. In 2023, Salesforce emphasized managing a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, aiming to expand its solution ecosystem and drive innovation. However, it acknowledged the risks of market volatility, regulatory scrutiny, and potential reputational harm associated with these investments. By 2024, Salesforce continued to prioritize these investments, explicitly stating its intent to grow its strategic investment portfolio and reinvest proceeds from sales into new opportunities. Additionally, the company strengthened ecosystem integration by leveraging its partner ecosystem, including independent software vendors and system integrators, to expand market reach and deliver cloud-based applications through platforms like AppExchange. This evolution reflects a more proactive and integrated approach to building and supporting a robust enterprise cloud ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CRM (ORG) -> Enterprise Cloud Companies (COMP)",
        "Enterprise Cloud Companies (COMP) -> CRM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12605,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3796,
        "completion_tokens": 277,
        "total_tokens": 4074
      }
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, the company maintained a consistent methodology for recognizing vendor funds, with no material changes in the approach to accrual rates. In both years, accrual rates were developed based on the provisions of vendor agreements, historical purchase trends, and volumes, and were adjusted as necessary throughout the year. The company emphasized that amounts accrued could be impacted if actual purchase volumes deviated from projections, particularly for programs with graduated funding thresholds tied to purchase volume milestones. In fiscal 2023, a 10% change in projected purchase volumes could have significantly affected gross margin and inventory, though no specific sensitivity figures were provided for fiscal 2024. The company continued to confirm accruals with select vendors to ensure accuracy, reflecting ongoing sensitivity to projected purchase volumes in its accounting for vendor funding programs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Changes]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Accrual Rates (ACCOUNTING_POLICY)",
        "Accrual Rates (ACCOUNTING_POLICY) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10326,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3233,
        "completion_tokens": 237,
        "total_tokens": 3470
      }
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "From 2022 to 2024, the strategic relationship between LLY and Boehringer Ingelheim has evolved primarily through legal and regulatory developments surrounding the Jardiance product. In 2022, Boehringer Ingelheim was actively involved in U.S. patent litigation related to Jardiance, challenging generic drug applications, while LLY was not a party to the case. By 2024, the collaboration faced a new regulatory challenge as the U.S. government, under the Inflation Reduction Act, selected Jardiance for government-set pricing, effective in 2026, with a 66% discount from the 2023 list price. This decision by HHS highlights an increased regulatory pressure and a shift in pricing control, significantly impacting the financial outlook for the product. The dependency on Jardiance remains strong, as it is a key part of their joint collaboration, and the legal and pricing uncertainties underscore the growing influence of external regulatory forces on their strategic partnership.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Boehringer Ingelheim (COMP)",
        "Boehringer Ingelheim (COMP) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8577,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2793,
        "completion_tokens": 244,
        "total_tokens": 3038
      }
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "From 2022 to 2023, Disney's capital investment strategy toward cruise ships remained a key component of its broader Parks & Experiences business, reflecting continued prioritization of this segment. In 2022, Disney acknowledged the importance of cruise ships as part of its theme park and resort expansion efforts, noting that economic conditions could impact such investments. By 2023, Disney explicitly highlighted cruise ships as a significant area of capital spend, alongside theme park expansions and new attractions, emphasizing their role in enhancing guest experiences and driving revenue through resorts, vacations, and onboard offerings. This evolution underscores Disney’s ongoing commitment to strengthening its Parks & Experiences segment through strategic investments in cruise ships and related infrastructure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Cruise Ships (PRODUCT)",
        "Cruise Ships (PRODUCT) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11460,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3503,
        "completion_tokens": 206,
        "total_tokens": 3709
      }
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "Between 2022 and 2024, Mastercard Foundry has evolved from being a facilitator of innovation and fintech engagement to a more active enabler of scalable, secure, and future-ready payment solutions. In 2022, it supported innovation through programs like Digital First Card, Digital Doors, and Click to Pay, while experimenting with future technologies and early-stage fintechs. By 2024, Mastercard Foundry continued this role but with a stronger emphasis on blockchain integration, tokenization (30% of transactions tokenized), and expanding contactless solutions like Tap on Phone, which lowered barriers for small businesses. Additionally, Foundry’s work now includes supporting blockchain ecosystems and enabling programmable payments through the Multi-Token Network, reflecting a more mature and impactful engagement with emerging technologies and fintech partnerships.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "MA (ORG) -> Mastercard Foundry (PRODUCT)",
        "Mastercard Foundry (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9205,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2947,
        "completion_tokens": 218,
        "total_tokens": 3165
      }
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "The collaboration between LLY and Boehringer Ingelheim has evolved significantly between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures. In 2022, the partnership benefited from regulatory designations such as Breakthrough Therapy and Fast Track, which expedited the development and review of their therapies, including the FDA's Emergency Use Authorization for a treatment related to hospitalized COVID-19 patients. However, by 2024, the collaboration faced increasing pricing pressures due to the Inflation Reduction Act of 2022 (IRA), which led to government-set price reductions. Specifically, the U.S. Department of Health and Human Services selected Jardiance, a key product in the collaboration, for a 66% price discount effective in 2026, reflecting broader industry cost containment efforts and regulatory shifts that impact long-term revenue and investment strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Boehringer Ingelheim (COMP)",
        "Boehringer Ingelheim (COMP) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6474,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2267,
        "completion_tokens": 229,
        "total_tokens": 2496
      }
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "From 2023 to 2024, the strategic positioning of the CH-53K King Stallion heavy lift helicopter within Lockheed Martin’s Rotary and Mission Systems (RMS) segment has evolved as part of the company’s broader 21st Century Security vision, emphasizing advanced networking and multi-domain integration. In 2023, the CH-53K was highlighted as a key growth program within RMS, alongside radar surveillance systems, reflecting its importance in meeting current and future defense needs. By 2024, the CH-53K continued to be positioned as a core component of RMS’s portfolio, with a stronger emphasis on digital transformation, AI/ML, and all-domain mission solutions, underscoring its role in enhancing agility and interoperability for U.S. and international defense operations. This evolution reflects Lockheed Martin’s ongoing commitment to leveraging the CH-53K as a strategic asset within its defense ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> PRODUCT <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "LMT (ORG) -> CH-53K King Stallion Heavy Lift Helicopter (PRODUCT)",
        "CH-53K King Stallion Heavy Lift Helicopter (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11215,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3459,
        "completion_tokens": 226,
        "total_tokens": 3686
      }
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "The change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024—specifically the removal of Trajenta, Jentadueto, and Basaglar from the 2024 list—indicates a strategic shift in focus toward a more streamlined and competitive set of diabetes therapies. This suggests that LLY and Boehringer Ingelheim are prioritizing products with stronger market performance, regulatory approval advantages, and demonstrated cost-effectiveness, such as Jardiance, Glyxambi, Synjardy, and Trijardy XR. Given the competitive pressures highlighted in both years, including the threat of generics and the need for early market entry and payer coverage, the companies are likely aligning their commercialization efforts to emphasize therapies with broader therapeutic benefits and stronger market positioning.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Develops]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Diabetes Products (PRODUCT)",
        "Diabetes Products (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8483,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2770,
        "completion_tokens": 209,
        "total_tokens": 2979
      }
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "Between 2023 and 2024, the JASSM program saw a significant increase in production activity, contributing to both higher net sales and backlog growth. In 2023, JASSM was part of the Missiles and Fire Control (MFC) segment, which saw backlog growth due to classified and C-130 programs, though JASSM-specific production details were not highlighted. In 2024, JASSM production ramped up significantly, contributing to a $1.2 billion increase in MFC net sales, driven by production growth on JASSM, GMLRS, and LRASM. This production increase also led to higher orders, directly contributing to the 2024 backlog growth, particularly on the JASSM program. Despite MFC’s overall operating profit decline in 2024 due to lower profit booking adjustments, the strategic importance of JASSM grew, as reflected in its production ramp and impact on backlog.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "LMT (ORG) -> JASSM (PRODUCT)",
        "JASSM (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3662,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 211,
        "total_tokens": 1767
      }
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "JPM's focus in evaluating credit risk for Business Banking Loans evolved from a general emphasis on product composition and borrower segments in 2023 to a more detailed, data-driven approach in 2024 that prioritizes early warning signals such as delinquency rates and geographic distribution. In 2023, the focus was on the types of loans offered, including prime market business banking loans. By 2024, JPM explicitly highlighted delinquency rates—particularly those over 30 days—as a key early indicator of borrower distress, alongside geographic distribution as a proxy for regional economic impacts. This shift enhances the ability to proactively identify and respond to early signs of financial distress among borrowers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Impacts]- ORG",
      "triplets_used": [
        "JPM (ORG) -> Business Banking Loans (PRODUCT)",
        "Business Banking Loans (PRODUCT) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_242",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_250",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2917,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 181,
        "total_tokens": 1561
      }
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "Between 2022 and 2023, Target Corporation’s SPP II plan was amended and restated, with the 2022 filing referencing the plan as amended effective April 3, 2016, and the 2023 filing showing it was further amended and restated effective May 1, 2022. This evolution suggests a continued refinement of the company’s executive compensation framework, aligning it with updated corporate strategies and regulatory standards, as evidenced by the systematic updates to related incentive and deferred compensation plans during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "TGT (ORG) -> SPP II (FIN_INST)",
        "SPP II (FIN_INST) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16474,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4756,
        "completion_tokens": 132,
        "total_tokens": 4888
      }
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "From 2022 to 2024, LLY's financial obligations under the Olumiant collaboration with Incyte included potential future milestone payments. As of December 31, 2021, Incyte was eligible to receive up to $100.0 million for success-based regulatory milestones and up to $100.0 million for sales-based milestones. By 2024, while the collaboration remained in place with Incyte retaining rights to tiered royalties (up to 20% on worldwide net sales and additional low teens for COVID-19 sales exceeding a threshold), no new milestone payments were explicitly capitalized or disclosed, suggesting that the potential future payments from 2021 had either not been triggered or were not further updated in the 2024 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Incyte (COMP)",
        "Incyte (COMP) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3391,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 177,
        "total_tokens": 1661
      }
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "Cisco's financial exposure in the APJC region, as reflected in asset balances, increased slightly between fiscal 2022 and fiscal 2023. As of July 30, 2022, APJC assets were reported at $5,360 million, and by July 29, 2023, they rose to $5,382 million, representing a $22 million increase, primarily driven by acquisitions and foreign currency translation effects. Additionally, based on Cisco's segment reporting structure, where financial decisions are made on a geographic basis and sales are attributed to segments by customer location, the APJC region remains a key operational and financial segment for the company.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> APJC (GPE)",
        "APJC (GPE) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2324,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 155,
        "total_tokens": 1365
      }
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "The strategic collaboration between LLY and Boehringer Ingelheim regarding Jardiance has evolved significantly from 2022 to 2024 in response to regulatory changes, particularly under the U.S. Inflation Reduction Act of 2022 (IRA). In 2022, Jardiance revenue increased 30% in the U.S. and 28% outside the U.S., driven by strong demand and volume growth. By 2024, the collaboration faced new regulatory pressures as HHS selected Jardiance in August 2023 as one of the first ten drugs subject to government-set prices under the IRA, with a 66% discount from the 2023 list price effective in 2026. This regulatory development signals a long-term shift in pricing dynamics, potentially accelerating revenue erosion for Jardiance and influencing the strategic value of the collaboration as LLY and Boehringer Ingelheim adapt to the IRA's impact on pricing, reimbursement, and investment in innovation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Boehringer Ingelheim (COMP)",
        "Boehringer Ingelheim (COMP) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9048,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2904,
        "completion_tokens": 223,
        "total_tokens": 3128
      }
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "Between 2022 and 2023, GM's emphasis on the financial and reputational risks of product safety recalls, particularly for global platforms like the Chevrolet Bolt EV, remained consistent in its acknowledgment of the significant impact such recalls can have on costs and brand equity. In both years, GM highlighted that recalls involving global platforms can be especially costly due to their wide scope and the labor-intensive nature of repairs. Additionally, in 2023, the company expanded its focus to explicitly tie these risks to its positioning in emerging technologies like EVs and AVs, emphasizing how safety concerns—whether based on data or not—can damage consumer trust and impede GM’s leadership in these disruptive technologies. This evolution reflects a strategic alignment of product safety risks with GM’s broader EV/AV innovation goals, underscoring the reputational and competitive stakes involved.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "GM (ORG) -> Product Safety Recalls (RISK_FACTOR)",
        "Product Safety Recalls (RISK_FACTOR) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12825,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3873,
        "completion_tokens": 228,
        "total_tokens": 4101
      }
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "Between 2022 and 2024, Costco’s Japanese subsidiary issued Guaranteed Senior Notes as part of its long-term debt structure, with notable developments in 2023 and 2024. In November 2023, the subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates between 1.400% and 2.120%, with maturities extending to 2043. However, in July 2024, $77 of these Guaranteed Senior Notes were repaid, indicating active management of the debt. These notes are valued using Level 3 inputs, suggesting they are less liquid or more complex in valuation. This evolution reflects Costco’s strategy to maintain long-term financing flexibility through its subsidiary, while also selectively repaying debt to manage obligations, aligning with broader corporate financial discipline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "COST (ORG) -> Guaranteed Senior Notes (FIN_INST)",
        "Guaranteed Senior Notes (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5193,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1949,
        "completion_tokens": 199,
        "total_tokens": 2148
      }
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "The value of Cisco's available-for-sale debt investments decreased by $5,727 million between 2023 and 2024, as shown in Chunk 2, and the gains from these investments dropped significantly from $53 million in 2021 to $9 million in 2022, according to Chunk 1. This decline in both the value and gains from these investments suggests a potential reduction in Cisco's focus on holding such debt instruments, possibly reflecting a strategic shift toward more liquid assets or a reallocation of capital to other investment opportunities, as indicated by the broader reduction in total investments over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Reduces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Available-for-sale debt investments (FIN_INST)",
        "Available-for-sale debt investments (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1844,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 151,
        "total_tokens": 1263
      }
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "JPMorgan Chase's exposure to system damage risks, particularly from third-party vendor attacks and data recovery challenges, has evolved from 2023 to 2024 with increased emphasis on proactive oversight and response. In 2023, the company highlighted risks related to vulnerabilities in third-party open-source software and the potential for delayed detection and remediation of cyber incidents. By 2024, JPMorgan Chase explicitly added a new focus on the **oversight of third-party vendors and early detection of attacks against them**, including ransomware, reflecting a more structured approach to vendor risk management. Additionally, the 2024 filing emphasized **data recovery challenges**, noting the risk of extended delays in restoring stolen, manipulated, or destroyed data, as well as potential losses exceeding cyber insurance coverage—highlighting a more acute awareness of the operational and financial consequences of system damage.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "JPM (ORG) -> System Damage (RISK_FACTOR)",
        "System Damage (RISK_FACTOR) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10332,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3228,
        "completion_tokens": 236,
        "total_tokens": 3464
      }
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "By 2024, Costco had made operational investments in processing, packaging, and manufacturing facilities to support the private-label growth strategy mentioned in its 2022 filing. In its 2022 filing, Costco emphasized increasing the penetration of private-label items as part of its merchandising strategy to enhance value for members. To align with this strategy, Costco expanded its logistics and operational infrastructure, including facilities dedicated to the production of certain private-label items, as noted in the 2024 filing. These investments reflect Costco's commitment to strengthening its private-label offerings and supporting its long-term growth objectives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "COST (ORG) -> Private Label Items (PRODUCT)",
        "Private Label Items (PRODUCT) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5775,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2077,
        "completion_tokens": 168,
        "total_tokens": 2245
      }
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group's approach to Medicaid managed care contract bidding remained centered on assumptions regarding enrollment, utilization, medical costs, and other factors, as highlighted in both the 2022 and 2023 10-K filings. However, in 2023, the company emphasized the increased risk of chronic failure to meet government benchmarks potentially leading to termination of contracts, suggesting a heightened awareness of bid accuracy risks. The 2023 filing also noted the impact of Medicaid eligibility redeterminations in certain states, adding complexity to bid assumptions. Both years underscored the potential adverse effects of incorrect assumptions or competitive bidding pressures on UnitedHealth Group’s financial performance, reflecting a consistent but increasingly cautious approach to Medicaid managed care contract bidding.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_For]-> REGULATORY_REQUIREMENT <-[Bids_On]- ORG",
      "triplets_used": [
        "UNH (ORG) -> State Medicaid Managed Care Contracts (REGULATORY_REQUIREMENT)",
        "State Medicaid Managed Care Contracts (REGULATORY_REQUIREMENT) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12751,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3855,
        "completion_tokens": 215,
        "total_tokens": 4071
      }
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "MET's investment in Municipals evolved from 2022 to 2023 in terms of valuation hierarchy classification as follows: In 2022, the total estimated fair value of Municipals was $159 million, entirely classified under Level 2 of the fair value hierarchy, with no Level 1 or Level 3 allocations. By 2023, the investment in Municipals remained at $159 million, continuing to be classified entirely under Level 2, showing no change in its valuation hierarchy classification. This consistency suggests that the inputs and valuation techniques used for these securities remained unchanged during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MET (ORG) -> Municipals (FIN_INST)",
        "Municipals (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_308",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 18967,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5371,
        "completion_tokens": 149,
        "total_tokens": 5521
      }
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "From fiscal year 2022 to 2024, Microsoft has enhanced the licensing flexibility and customer agreement models for Office 365 subscriptions by introducing more tailored and simplified options. In 2022, Microsoft focused on estimating standalone selling prices (SSP) for performance obligations, particularly for on-premises licenses with Software Assurance (SA) and cloud services, emphasizing stratification by customer size and geographic region. By 2024, Microsoft expanded its approach with agreements like the Microsoft Customer Agreement and Microsoft Online Subscription Agreement, offering non-expiring, digital agreements that provide small and medium organizations with monthly or annual subscription flexibility. Additionally, the Microsoft Products and Services Agreement allowed medium and large organizations to license cloud and on-premises software without organization-wide commitments, with optional SA for perpetual licenses. These changes reflect a shift toward more adaptable and customer-centric licensing models, supporting diverse organizational needs and usage patterns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Includes]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Office 365 Subscriptions (PRODUCT)",
        "Office 365 Subscriptions (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8096,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2667,
        "completion_tokens": 273,
        "total_tokens": 2941
      }
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "Between 2022 and 2023, the composition of MET's Level 3 Fixed Maturity Securities AFS shifted significantly, with the 2023 Level 3 balance at $64 million compared to $11 million in 2022, indicating a substantial increase. This rise is primarily driven by an increase in corporate fixed maturity securities, which rose to $54 million from negligible levels in 2022. Additionally, foreign bonds increased slightly from $1 million to $2 million. These changes suggest a more active investment strategy by MET, with a focus on higher-risk, less liquid corporate bonds, which are typically classified under Level 3 due to their reliance on unobservable inputs. The shift reflects a potential reallocation toward assets with higher yield potential, albeit with increased valuation complexity and risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MET (ORG) -> Fixed Maturity Securities AFS (FIN_INST)",
        "Fixed Maturity Securities AFS (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_307",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_308",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11012,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3402,
        "completion_tokens": 198,
        "total_tokens": 3600
      }
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "Between 2022 and 2024, Microsoft has evolved Office 365's strategic positioning from a core cloud-based productivity service to a central component of its broader AI-integrated cloud portfolio. In 2022, Office 365 was highlighted as a key cloud-based solution under Microsoft’s service and other revenue category, emphasizing its role alongside Azure and Dynamics 365 in delivering software and platforms. By 2024, Microsoft explicitly underscored its investment in AI, embedding generative AI capabilities into both consumer and commercial offerings, with Office 365 likely serving as a primary vehicle for these enhancements. This shift reflects Microsoft’s response to competitive pressures from AI-driven services, as it seeks to maintain leadership in cloud and AI markets by enhancing the utility and platform-agnostic availability of its services, including Office 365, across diverse ecosystems.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Includes]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Office 365 (PRODUCT)",
        "Office 365 (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8411,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2757,
        "completion_tokens": 225,
        "total_tokens": 2983
      }
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group (UNH) maintained a consistent methodology for evaluating credit-related impairments on available-for-sale debt securities, focusing on the present value of expected cash flows relative to amortized cost, the financial condition of issuers, and the extent of fair value losses. In 2022, the Company noted that unrealized losses were primarily due to interest rate increases rather than credit quality deterioration, and it did not record significant impairments, as the losses were deemed temporary with no intent to sell. By 2023, the evaluation process remained similar, with credit-related impairments recorded as an allowance and non-credit impairments impacting other comprehensive income. The Company continued to emphasize investment-grade securities and portfolio diversification to limit exposure, and it excluded unrealized gains and losses from net earnings, reporting them in comprehensive income. These practices reflect a stable and conservative approach to managing credit risk across both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Records]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Credit-Related Impairment (RISK_FACTOR)",
        "Credit-Related Impairment (RISK_FACTOR) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7738,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2588,
        "completion_tokens": 263,
        "total_tokens": 2851
      }
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "From 2022 to 2023, the allocation of Fixed Maturity Securities AFS in MET's U.S. Pension Benefits remained consistent at 85%, aligning with the target. In 2023, the total fair value of Fixed Maturity Securities AFS for U.S. Pension Benefits was $6.714 billion, primarily valued at Level 2 ($4.924 billion) with smaller portions at Level 1 ($1.726 billion) and Level 3 ($64 million). For U.S. Other Postretirement Benefits, the allocation was 95% in 2022, and the total fair value in 2023 was $1.274 billion, with $663 million at Level 2 and $611 million at Level 1. This reflects a stable allocation strategy and a significant portion of these securities being classified under Level 2 fair value hierarchy in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MET (ORG) -> Fixed Maturity Securities AFS (FIN_INST)",
        "Fixed Maturity Securities AFS (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_305",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_308",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7540,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2530,
        "completion_tokens": 178,
        "total_tokens": 2709
      }
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "Between 2022 and 2023, Lowe's strategic positioning of the Kitchens & Bath product category evolved from being grouped under the Home Décor segment in 2022 to being explicitly listed as a standalone product category in 2023, alongside other core offerings like Appliances, Seasonal & Outdoor Living, and Lumber. This shift in categorization suggests a growing emphasis on Kitchens & Bath as a distinct and strategically important segment within Lowe's product portfolio. The 2023 report also highlights the company's focus on expanding product offerings, including the return of Klein Tools, which aligns with efforts to enhance customer offerings in key areas like Kitchens & Bath, further underscoring its importance in supporting Lowe's Total Home strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Kitchens & Bath (PRODUCT)",
        "Kitchens & Bath (PRODUCT) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5531,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2030,
        "completion_tokens": 190,
        "total_tokens": 2220
      }
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "Mondelez International's strategic focus on Cheese & Grocery has remained a part of its business portfolio between 2022 and 2024, as evidenced by its inclusion in the 2022 revenue breakdown and its continued mention in the 2024 10-K under the company's core adjacent categories. However, the 2022 data shows relatively modest global net revenues of $1.99 billion for Cheese & Grocery, with the majority of its contribution coming from Europe. In 2024, while Cheese & Grocery is still highlighted in the strategic overview, the company's emphasis has shifted toward driving growth in its core snacking categories—chocolate, biscuits, and baked snacks—indicating a prioritization of these higher-revenue, more globally scalable snack categories for long-term growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Cheese & Grocery (PRODUCT)",
        "Cheese & Grocery (PRODUCT) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_136",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6866,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2365,
        "completion_tokens": 191,
        "total_tokens": 2556
      }
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "Between the 2022 and 2023 10-K filings, Abbott maintained Jevity as a key product in its enteral feeding lineup under the Nutritional Products segment, but the 2023 filing introduced the Freego™ enteral pump and sets as a distinct product offering within the same category. In 2022, Jevity was listed alongside other enteral feeding products like Glucerna, Osmolite, and Oxepa, without any specific mention of pump systems. In 2023, Freego™ was explicitly introduced as part of Abbott’s enteral feeding solutions, indicating a strategic expansion into enteral pump technology. This shift suggests Abbott positioned Freego™ as a complementary product to Jevity, potentially enhancing Jevity’s utility in clinical settings by offering a dedicated delivery system.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Jevity (PRODUCT)",
        "Jevity (PRODUCT) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2022.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10645,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3301,
        "completion_tokens": 190,
        "total_tokens": 3492
      }
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "From 2022 to 2023, MET’s investment in municipals evolved in both fair value and classification. In 2022, the fair value of municipals was $14,212 million, classified under fixed maturity securities AFS, with no allowance for credit loss. By 2023, the fair value of municipals dropped to $159 million, classified under Level 2 of the fair value hierarchy within pension benefits. This significant decline suggests a strategic shift toward lower-risk, more liquid municipal investments, reflecting MET’s focus on credit risk management by prioritizing stable, government-backed securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MET (ORG) -> Municipals (FIN_INST)",
        "Municipals (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_219",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_308",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9299,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2969,
        "completion_tokens": 147,
        "total_tokens": 3116
      }
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "Between 2022 and 2023, Abbott’s use of interest rate hedge contracts evolved in terms of notional value and their role in fixed-rate debt management. In 2022, the interest rate hedge contracts had a receivable position of $87 million with no payable position, as shown in the 2022 10-K. By 2023, the notional value of these contracts increased significantly to approximately $2.2 billion, as disclosed in the 2023 10-K. These contracts are used to hedge the fair value of fixed-rate debt by converting a portion of fixed-rate obligations to variable rates, thereby managing interest rate risk. This increase in notional value indicates a more extensive use of hedging instruments in 2023 to mitigate the impact of interest rate fluctuations on Abbott’s fixed-rate debt portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Interest Rate Hedge Contracts (FIN_INST)",
        "Interest Rate Hedge Contracts (FIN_INST) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2022.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5436,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2010,
        "completion_tokens": 194,
        "total_tokens": 2204
      }
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "Between 2022 and 2024, 3M's issuance and management of fixed rate registered notes evolved through strategic repayments and interest rate hedging. In 2022, 3M repaid $600 million in fixed-rate medium-term notes and 500 million euros in fixed-rate medium-term notes, demonstrating active debt management. In 2023, the company repaid $500 million in fixed-rate registered notes, $650 million in fixed-rate medium-term notes, and 600 million euros in fixed-rate medium-term notes, continuing its repayment activity. In 2024, 3M repaid $1.1 billion in medium-term notes that matured. Additionally, in 2021, 3M converted $800 million of fixed-rate notes (comprising $500 million from 2049 and $300 million from 2050) into floating rate debt via interest rate swaps, initially based on LIBOR and later amended to SOFR, reflecting a shift in interest rate strategy to manage exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Fixed Rate Registered Notes (FIN_INST)",
        "Fixed Rate Registered Notes (FIN_INST) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8588,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2794,
        "completion_tokens": 219,
        "total_tokens": 3014
      }
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "Between 2023 and 2024, securities issuances by CSC remained a key component of Schwab's capital structure, particularly as a source of capital in the capital markets, as highlighted in both the 2023 and 2024 10-K filings. In 2023, Schwab emphasized that its primary sources of capital included funds from subsidiary operations and securities issuances by CSC, supporting its capital management strategy focused on maintaining well-capitalized subsidiaries, absorbing potential losses, and returning excess capital to shareholders. By 2024, Schwab continued to rely on securities issuances as part of a broader set of funding sources, which now also included client-generated funds such as bank deposits and brokerage cash balances, as well as maturities of investment securities and external debt facilities. The 2024 filing further underscored Schwab’s emphasis on liquidity and diverse funding sources to meet obligations and manage capital needs across its subsidiaries, indicating a strategic evolution toward balancing market-based capital issuance with operational and client-driven liquidity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sources_Capital_From]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> Securities Issuances (FIN_INST)",
        "Securities Issuances (FIN_INST) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11070,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3420,
        "completion_tokens": 274,
        "total_tokens": 3695
      }
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "Coca-Cola's contingent payment obligations related to fairlife decreased from $270 million in 2020 to the remaining milestone payment as of 2024, which is contingent on fairlife achieving certain financial targets through 2024 and payable in 2025. This evolution, along with the $100 million milestone payment made in 2021 based on fairlife meeting its 2020 targets, indicates that fairlife has generally performed well against its financial targets, as it has triggered at least one milestone payment and the remaining obligation reflects ongoing performance expectations through 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> fairlife (COMP)",
        "fairlife (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7557,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2529,
        "completion_tokens": 146,
        "total_tokens": 2675
      }
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) has evolved significantly between 2022 and 2024, with a stronger focus on global market positioning and deeper integration with enterprise IT solutions. In 2022, OCI contributed to Oracle's Cloud and License segment, which accounted for 85% of total revenues, reflecting a 6% year-over-year growth in this area. By 2024, Oracle explicitly positioned OCI as a core component of its Oracle Cloud Services, emphasizing its role in providing integrated applications and infrastructure services that support flexible deployment models—on-premise, cloud-based, and hybrid. This evolution highlights Oracle's commitment to enabling enterprises to tailor their IT environments to specific business needs, reinforcing OCI's role as a strategic pillar in Oracle’s global enterprise IT solutions portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Cloud Infrastructure (PRODUCT)",
        "Oracle Cloud Infrastructure (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9000,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2906,
        "completion_tokens": 215,
        "total_tokens": 3121
      }
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "Between 2023 and 2024, the treatment and risk profile of PALs (Portfolio of Assets Loans) evolved significantly in terms of credit loss allowance and collateralization. In 2023, there was a slight decrease in PALs, and the allowance for credit losses decreased due to improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding the borrowings, and no allowance for credit losses was required as of December 31, 2024, reflecting a reduced credit risk profile. Additionally, the Company enforces strict collateral maintenance and charges off unsecured PAL balances no later than 90 days past due, further mitigating credit risk exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> PALs (FIN_INST)",
        "PALs (FIN_INST) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_146",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1519,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1011,
        "completion_tokens": 181,
        "total_tokens": 1192
      }
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "Between fiscal years 2023 and 2024, Nike's relationship with the Asia Pacific & Latin America (APLA) region has evolved in terms of both operational structure and strategic emphasis. Operationally, APLA remains a key geographic segment for Nike, as highlighted in the 2024 10-K, where it is explicitly listed as one of the reportable operating segments, alongside North America, EMEA, and Greater China. This reflects Nike's continued integration of APLA into its global operational framework, with the region operating predominantly in the design, development, and marketing of athletic footwear, apparel, and equipment. Strategically, Nike has emphasized labor and union dynamics in APLA, as noted in the 2023 10-K, where it acknowledges that certain employees in the region are represented by trade unions or works councils in accordance with local laws. This underscores a growing emphasis on labor relations and inclusive workplace practices in APLA, aligning with Nike's broader global DE&I initiatives aimed at fostering diverse and engaged workforces across all regions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NKE (ORG) -> APLA (GPE)",
        "APLA (GPE) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9286,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2961,
        "completion_tokens": 269,
        "total_tokens": 3231
      }
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "Between 2022 and 2023, Abbott continued to emphasize its U.S. Pediatric Nutritional business, with Pedialyte playing a key role in driving growth. In 2021, U.S. Pediatric Nutritional sales increased by 10.3 percent, with Pedialyte contributing to this growth alongside Similac and PediaSure. By 2023, Abbott’s broader Nutritional Products segment included Pedialyte as a core product, reflecting its ongoing strategic importance within the company’s pediatric portfolio. The 2023 10-K further highlighted Abbott’s continued investment in a diverse range of pediatric nutritional products, including Pedialyte, underscoring its positioning as a key offering in both consumer and institutional markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Pedialyte (PRODUCT)",
        "Pedialyte (PRODUCT) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7632,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2552,
        "completion_tokens": 175,
        "total_tokens": 2727
      }
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "From 2022 to 2023, RTX's financial position regarding its 7.100% notes due 2027 remained stable, with the aggregate principal balance remaining at $135 million in both years. This consistency suggests that RTX did not refinance or retire these specific notes during the period and maintained them as part of its long-term debt structure. The unchanged balance indicates a strategy of preserving existing debt obligations rather than altering them, reflecting a conservative approach to debt management and potentially aligning with broader refinancing or maturity management plans for other debt instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "RTX (ORG) -> 7.100% notes due 2027 (FIN_INST)",
        "7.100% notes due 2027 (FIN_INST) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3585,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 152,
        "total_tokens": 1691
      }
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Nike's relationship with Converse has shown a decline in revenue performance, with Converse revenues decreasing by 15% on a currency-neutral basis, primarily due to declines in North America and Western Europe. Unit sales decreased by 12% in combined wholesale and direct-to-consumer channels, with wholesale revenues declining by 16% across all geographies and direct-to-consumer revenues dropping by 14%, mainly due to reduced traffic in North America and Western Europe. This decline in revenue performance was reflected in a 30% decrease in reported EBIT for Converse, driven by lower revenues, gross margin contraction, and increased promotional activity. Strategically, Converse remains a wholly-owned subsidiary of Nike, with its operating results reported separately, indicating continued integration within Nike's broader portfolio of brands focused on casual sneakers and apparel.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Converse (COMP)",
        "Converse (COMP) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6206,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2181,
        "completion_tokens": 231,
        "total_tokens": 2413
      }
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "Coca-Cola's financial risk assessment regarding digital evolution has shifted from a general acknowledgment of its impact on consumer shopping behavior in 2022 to a more strategic and urgent focus on digital transformation as a core driver of sales growth and margin improvement by 2024. In 2022, the risk centered on the potential negative impact of failing to adapt to evolving digital shopping trends and consumer preferences, which could reduce revenue growth. By 2024, the Company explicitly states that its ability to digitalize operations—through data, AI, automation, and personalized consumer experiences—is critical to achieving both sales growth and margin expansion, with failure to do so directly threatening financial performance. This evolution reflects a more proactive stance, where digital transformation is now viewed not just as a risk but as a strategic imperative for competitive advantage and operational efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> MACRO_CONDITION <-[Depends_On]- ORG",
      "triplets_used": [
        "KO (ORG) -> Digital Evolution (MACRO_CONDITION)",
        "Digital Evolution (MACRO_CONDITION) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13142,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3937,
        "completion_tokens": 234,
        "total_tokens": 4172
      }
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "Oracle's strategic emphasis on Oracle Cloud Services has intensified from fiscal year 2022 to 2024, with a growing focus on cloud-based deployment models and increased investment in research and development (R&D). In fiscal 2022, Oracle invested $7.2 billion in R&D to enhance and expand its cloud offerings, emphasizing the integration of Oracle Cloud Infrastructure (OCI) with Oracle Fusion SaaS Applications to improve performance, security, and cost-effectiveness. By 2024, Oracle continued to position Oracle Cloud Services—comprising SaaS and OCI—as a central part of its enterprise IT strategy, offering customers flexible deployment options including on-premise, cloud-based, and hybrid models. The company reinforced its commitment to cloud innovation while maintaining support for on-premise solutions, ensuring interoperability and transition flexibility for customers. This strategic evolution reflects Oracle's broader goal of delivering comprehensive, secure, and scalable cloud solutions to meet evolving customer needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Cloud Services (PRODUCT)",
        "Oracle Cloud Services (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9682,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3080,
        "completion_tokens": 258,
        "total_tokens": 3339
      }
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "Between 2023 and 2024, the Norwest Corporation Directors' Formula Stock Award Plan has remained inactive with respect to future stock awards or deferrals, as stated in both chunks. In 2023, it was noted that no future stock awards or deferrals may be made under the plan. In 2024, this status was reaffirmed, with additional clarification that no future awards or deferrals will be made and that column (a) in the relevant table reflects all shares issuable under the plan upon distribution of outstanding deferred stock awards. Thus, the availability of shares under the plan has not changed—only existing deferred awards remain eligible for future distribution, with no new awards being issued.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "WFC (ORG) -> Norwest Corporation Directors' Formula Stock Award Plan (ACCOUNTING_POLICY)",
        "Norwest Corporation Directors' Formula Stock Award Plan (ACCOUNTING_POLICY) -> WFC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WFC_10k_2023.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WFC_10k_2024.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7007,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2414,
        "completion_tokens": 174,
        "total_tokens": 2588
      }
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "Between 2022 and 2023, McDonald's expanded its disclosure on food safety concerns, particularly in the context of supply chain risks and cost volatility. In 2022, the company highlighted that food safety is a top priority, with substantial resources dedicated to ensuring safe food products, and acknowledged that food safety events—whether actual or perceived—could harm its brand and financial results. It also noted that food safety issues could arise in the supply chain, restaurants, or delivery. By 2023, the discussion evolved to include how food safety concerns are now explicitly tied to commodity cost volatility, with factors such as product recalls, government regulation, and macroeconomic conditions impacting the supply chain. Additionally, the 2023 filing emphasized the broader context of environmental and social impact matters, noting that failure to address these issues could heighten existing risks, including those related to supply chain disruptions and commodity costs. This reflects a more integrated and forward-looking approach to managing food safety within a complex and volatile supply chain environment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Food Safety Concerns (RISK_FACTOR)",
        "Food Safety Concerns (RISK_FACTOR) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13898,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4120,
        "completion_tokens": 283,
        "total_tokens": 4404
      }
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "The carrying value of TMO's 1.750% 7-Year Senior Notes remained unchanged at $700 million between 2023 and 2024, as shown in both the 2023 and 2024 disclosures. The effective interest rate also remained stable at 1.89% during this period, indicating no material change in the cost of borrowing for this specific debt instrument.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG",
      "triplets_used": [
        "TMO (ORG) -> 1.750% 7-Year Senior Notes (FIN_INST)",
        "1.750% 7-Year Senior Notes (FIN_INST) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2023.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TMO_10k_2024.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14990,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4380,
        "completion_tokens": 82,
        "total_tokens": 4462
      }
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "RTX's exposure to its 7.000% notes due 2038 remained unchanged at $148 million between 2022 and 2023, as shown in both the 2022 and 2023 disclosures. However, the broader context of RTX's long-term debt management is evident from the significant increase in total long-term debt from $31,249 million in 2022 to $43,697 million in 2023, with a notable addition of new long-term notes maturing in 2033 through 2054. This suggests that RTX is extending its debt maturity profile to manage liquidity and reduce near-term refinancing risks, while maintaining existing long-term obligations like the 7.000% notes due 2038.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "RTX (ORG) -> 7.000% notes due 2038 (FIN_INST)",
        "7.000% notes due 2038 (FIN_INST) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5116,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1924,
        "completion_tokens": 154,
        "total_tokens": 2078
      }
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "Between 2022 and 2023, McDonald's financial relationship with its franchisees remained largely dependent on the collection of rent and royalties, which are based on a percentage of franchisee sales. In 2022, the Company had already collected substantially all of the approximately $1 billion in deferred rent and royalties from 2020, indicating a return to more normal collection patterns. By 2023, McDonald's continued to operate under its conventional franchise model, where franchisees pay rent and royalties, reinforcing the ongoing financial interdependence between McDonald's and its franchisees.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1118,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 913,
        "completion_tokens": 150,
        "total_tokens": 1064
      }
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "The Coca-Cola Company's financial stake in Embotelladora Andina S.A. (Andina) has significantly diminished from 2022 to 2024. In 2019, as noted in the 2022 10-K, Coca-Cola sold a portion of its ownership interest in Andina and continued to account for the remaining stake as an equity method investment. By 2024, as shown in the 2024 10-K, the fair value of Coca-Cola's stake in Andina had dropped to $168 million, with a carrying value of only $90 million, indicating a substantial reduction in value and ownership. This decline reflects a strategic shift by Coca-Cola to divest or reduce stakes in certain bottling operations, focusing instead on core markets and partnerships that offer stronger financial returns. The evolution of this investment underscores Coca-Cola's broader strategy of refranchising and optimizing its bottling investment portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Divests]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Embotelladora Andina S.A. (COMP)",
        "Embotelladora Andina S.A. (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5466,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2021,
        "completion_tokens": 214,
        "total_tokens": 2235
      }
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "Oracle's strategic investment in cloud infrastructure from 2022 to 2024 has shown a clear emphasis on internal development, as highlighted in the 2022 10-K, where Oracle stated its commitment to developing the majority of its products and services internally, including cloud offerings. This internal focus has been reinforced by Oracle's continued dedication to research and development to maintain and enhance its product portfolio. By 2024, Oracle Cloud Infrastructure (OCI) has been firmly positioned as a core component of Oracle's product offerings, integrated with Oracle Cloud Software-as-a-Service (SaaS) to provide comprehensive cloud solutions. The 2024 10-K emphasizes that OCI is a key part of Oracle Cloud Services, enabling customers to choose deployment models that best suit their needs, reflecting its strategic importance in Oracle’s broader enterprise IT offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Cloud Infrastructure (PRODUCT)",
        "Oracle Cloud Infrastructure (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6398,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2259,
        "completion_tokens": 221,
        "total_tokens": 2480
      }
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "TMO acquired The Binding Site Group in January 2023 as part of its strategy to expand its Specialty Diagnostics segment, adding innovative diagnostic solutions for blood cancers and immune disorders. By 2024, TMO's integration of The Binding Site Group is reflected in the weighted-average amortization periods of intangible assets, indicating a long-term strategic focus on sustaining and leveraging the acquired capabilities. This evolution suggests successful integration and alignment with TMO’s broader goals of enhancing diagnostic offerings and strengthening its market position in specialty diagnostics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Involved_In]- ORG",
      "triplets_used": [
        "TMO (ORG) -> The Binding Site Group (COMP)",
        "The Binding Site Group (COMP) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TMO_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6525,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2277,
        "completion_tokens": 152,
        "total_tokens": 2430
      }
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "Between 2022 and 2024, the disclosure and accessibility of BNY Mellon's Directors' Code of Conduct have remained consistent in scope, as it continues to apply to all directors of the company. However, the website links have been updated, reflecting a rebranding or restructuring of the company's web domain from \"bnymellon.com\" to \"bny.com\" in 2024. In 2022, the Directors' Code of Conduct was accessible at *https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf*, while in 2024, it was posted at *https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf*. This evolution indicates improved digital accessibility and alignment with the company's updated online presence, while maintaining the same governance scope for directors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "BK (ORG) -> Directors' Code of Conduct (ACCOUNTING_POLICY)",
        "Directors' Code of Conduct (ACCOUNTING_POLICY) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5015,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1908,
        "completion_tokens": 206,
        "total_tokens": 2114
      }
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "Between 2022 and 2023, McDonald's relationship with franchisees remained financially and strategically significant, with continued emphasis on franchise operations as a core component of its business model. In 2022, McDonald's clarified that the financial impact of restaurant businesses purchased or sold with franchisees was not material to its consolidated financial statements, and it maintained that most franchisee-related entities qualified for scope exceptions under variable interest entity consolidation guidance, indicating minimal direct consolidation of franchisee operations. By 2023, the Company reaffirmed that all restaurants are operated either by the Company or by franchisees, including conventional franchisees and developmental licensees, underscoring the continued strategic reliance on franchisees for global expansion and operations. Financially, the Company continued to apply accounting standards that did not materially impact its reporting related to franchisee relationships, maintaining consistent treatment of these entities in its disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4296,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1703,
        "completion_tokens": 269,
        "total_tokens": 1972
      }
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "Between 2023 and 2024, the contingent consideration liabilities related to the Clif Bar acquisition were measured at fair value using a Monte Carlo simulation based on Level 3 inputs, including financial projections and discount and volatility rates. As of December 31, 2023, $548 million was classified as long-term liabilities, with $132 million as other current liabilities, compared to $452 million and $102 million in 2022, respectively. In 2023, these liabilities were also subject to purchase price allocation adjustments, and in 2024, further purchase price allocation adjustments were made for Ricolino and Clif Bar, indicating ongoing refinements to the initial allocation of the acquisition cost. Fair value adjustments were recorded in selling, general, and administrative expenses in both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Owns]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Clif Bar (COMP)",
        "Clif Bar (COMP) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2409,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 202,
        "total_tokens": 1457
      }
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "AMD's strategic emphasis on Vulkan API support has evolved from a foundational inclusion in 2022 to a more prominent feature in 2024, reflecting its commitment to maintaining competitiveness in the discrete GPU market. In 2022, AMD explicitly stated that its Radeon discrete GPUs supported current generation APIs like DirectX 12 Ultimate and Vulkan, emphasizing their role in enabling immersive gaming experiences and VR capabilities. By 2024, the mention of Vulkan support remained, but was paired with a broader focus on high-performance AI/ML computing and immersive gaming, indicating an expanded use case for the API. This evolution suggests that AMD is leveraging Vulkan’s cross-platform and efficiency advantages to ensure its GPUs remain competitive in both gaming and professional markets, particularly as developers increasingly adopt Vulkan for performance optimization and cross-platform compatibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Features]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Vulkan (PRODUCT)",
        "Vulkan (PRODUCT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10422,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3246,
        "completion_tokens": 228,
        "total_tokens": 3475
      }
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "RTX's integration-related charges significantly impacted its operating profit trends between 2022 and 2023. In 2022, operating profit increased by $0.4 billion compared to 2021, partly due to a decrease in acquisition accounting adjustments, which had totaled $2,203 million in 2021. However, in 2023, operating profit decreased by $1.9 billion compared to 2022, primarily driven by a $2.9 billion charge associated with the Powder Metal Matter. This substantial charge in 2023, combined with the prior year's reduction in acquisition-related adjustments, highlights how integration-related accounting policies, such as Acquisition Accounting Adjustments, directly decreased operating profit, as reflected in the knowledge graph relationship.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Decreases]- ORG",
      "triplets_used": [
        "RTX (ORG) -> Acquisition Accounting Adjustments (ACCOUNTING_POLICY)",
        "Acquisition Accounting Adjustments (ACCOUNTING_POLICY) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1932,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 185,
        "total_tokens": 1328
      }
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "Between 2023 and 2024, MDLZ's relationship with Clif Bar evolved primarily through acquisition-related financial activities. In 2023, MDLZ completed the acquisition of Clif Bar on August 1, as noted in the 2023 10-K, and subsequent purchase price allocation adjustments for Clif Bar were made during the year. By 2024, these adjustments continued to be reflected in MDLZ's financial reporting, as indicated in the 2024 10-K, which specifically references purchase price allocation adjustments for Clif Bar during 2023. This progression highlights ongoing integration and valuation activities related to the Clif Bar acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Clif Bar (COMP)",
        "Clif Bar (COMP) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4963,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1870,
        "completion_tokens": 157,
        "total_tokens": 2027
      }
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "From 2023 to 2024, Gulfstream has advanced its commitment to energy-efficient engines by integrating them into newly developed aircraft that emphasize performance and sustainability. In 2023, Gulfstream highlighted its leadership in energy-efficient engines and sustainable aviation fuel (SAF), with the G500 and G600 models representing recent additions that replaced older models with more advanced technologies. By 2024, this evolution is reflected in the introduction of the G700, which entered service in March 2024 and features all-new engines that deliver superior high-speed performance, along with the ultra-large-cabin G800 and G400 introduced in 2021. These developments underscore Gulfstream’s ongoing investment in R&D to produce technologically advanced aircraft that align with its sustainability goals and industry leadership.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GD (ORG) -> Energy Efficient Engines (PRODUCT)",
        "Energy Efficient Engines (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4121,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1669,
        "completion_tokens": 210,
        "total_tokens": 1879
      }
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "From 2022 to 2024, AMD's relationship with semi-custom SoC products has evolved in terms of both revenue structure and strategic positioning. In 2022, AMD highlighted that revenue from semi-custom SoC products is contingent on their inclusion in customer products and the success of those products in the market, with revenue derived from non-recurring engineering fees and product sales to third parties. By 2024, AMD continued to include semi-custom SoC products in its product portfolio, indicating ongoing strategic importance, though no new revenue figures or specific developments were disclosed. This suggests that while semi-custom SoCs remain a part of AMD’s offerings, their contribution to revenue appears to be project-based and tied to customer demand, with no significant structural shift in their role within AMD’s broader business strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Semi-Custom SoC Products (PRODUCT)",
        "Semi-Custom SoC Products (PRODUCT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10000,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3141,
        "completion_tokens": 214,
        "total_tokens": 3355
      }
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "Between fiscal years 2023 and 2024, Medtronic (MDT) maintained the same authorized structure for its preferred shares, including 127.5 million Preferred Shares ($0.20 par value) and 500 thousand A Preferred Shares ($1.00 par value), with no changes in authorization levels. However, the company did not issue or have any of these preferred shares outstanding as of April 26, 2024, in both years. This consistency in preferred share authorization, combined with the absence of actual issuance, suggests that MDT’s capital strategy has prioritized ordinary share repurchases and stock-based compensation programs over leveraging preferred equity. The company’s focus on repurchasing shares—repurchasing 25 million in 2024 versus 6 million in 2023—further underscores its strategy to return capital to shareholders and support employee compensation plans, rather than utilizing preferred shares as a capital-raising tool.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> A Preferred Shares (FIN_INST)",
        "A Preferred Shares (FIN_INST) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6020,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2148,
        "completion_tokens": 229,
        "total_tokens": 2377
      }
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "Between 2022 and 2024, BK's framing of reputational risk related to adverse publicity has remained consistent in its recognition that such risks can negatively affect its business, financial condition, and operations. However, in 2024, the disclosure expands the context by linking reputational harm more explicitly to broader concerns such as sustainability, including climate change and diversity, which are noted as potential drivers of reputational risk. This evolution reflects an increased emphasis on how external factors and stakeholder expectations around ESG issues may impact BK's reputation and, by extension, its business performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "BK (ORG) -> Publicity (RISK_FACTOR)",
        "Publicity (RISK_FACTOR) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2022.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6618,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2302,
        "completion_tokens": 161,
        "total_tokens": 2464
      }
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "Amazon's financial investment and valuation approach toward Anthropic, PBC evolved from 2023 to 2024 by transitioning from a $1.25 billion convertible note classified as available-for-sale to a broader $22.1 billion portfolio of equity, equity warrant, and convertible debt investments, with Anthropic's convertible debt remaining a key component. In 2023, the note was reported at fair value with unrealized gains and losses in Accumulated Other Comprehensive Income (AOCI) and classified as Level 3, while Amazon retained an option to invest an additional $2.75 billion by Q1 2024. By 2024, the valuation approach for private company investments, including Anthropic, became more complex due to the lack of market data and global economic uncertainty, with valuations now subject to qualitative assessments and adjustments for impairments or observable price changes. This shift reflects Amazon's ongoing commitment to Anthropic, as well as a broader strategy to manage and report the fair value of its private equity and convertible debt investments with increased scrutiny and sensitivity to market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Anthropic, PBC (COMP)",
        "Anthropic, PBC (COMP) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9148,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2935,
        "completion_tokens": 278,
        "total_tokens": 3213
      }
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "Between 2023 and 2024, the nature of risks related to the protection of MDLZ's intellectual property, including know-how, has evolved to include heightened concerns about the impact of emerging technologies, particularly artificial intelligence, on the legal and regulatory landscape for intellectual property (Chunk 1). In 2024, MDLZ explicitly expanded its disclosure to emphasize the importance of trademarks, patents, copyrights, trade secrets, recipes, technology, and licensing agreements, and reiterated its proactive measures to protect these assets through legal frameworks, licensing agreements, and third-party agreements (Chunk 2). The evolution reflects both a growing awareness of external threats to IP protection and a commitment to adapting strategies in response to these evolving risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Protects]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Know-How (RISK_FACTOR)",
        "Know-How (RISK_FACTOR) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11318,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3463,
        "completion_tokens": 201,
        "total_tokens": 3664
      }
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between 2023 and 2024, as reflected in the referenced agreements and their timelines. In the 2023 filing, the company disclosed \"Amendments to Certain Non-Employee Director Equity Award Agreements\" incorporated by reference to its 2008 filing, indicating prior modifications to these agreements. By 2024, the referenced agreements included a \"Form of Non-Employee Director RSU Award Agreement (pre-2015)\" from 2014, suggesting continued use of pre-2015 award structures. Notably, no new amendments or updated agreements specific to 2024 were disclosed, implying that the treatment of these agreements remained largely unchanged from prior years, with existing pre-2015 forms still in use.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "GS (ORG) -> Non-Employee Director Equity Award Agreements (ACCOUNTING_POLICY)",
        "Non-Employee Director Equity Award Agreements (ACCOUNTING_POLICY) -> GS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_246",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9417,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3024,
        "completion_tokens": 192,
        "total_tokens": 3217
      }
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "Between 2022 and 2023, BKNG's relationship with travel service providers evolved in terms of **revenue recognition** and **contractual responsibilities**, reflecting the company's role as a facilitator rather than a principal in most transactions. In 2022, BKNG emphasized its mission of connecting consumers with travel service providers and highlighted the interdependency between its platforms and these providers, with the majority of revenue stemming from facilitating travel reservations. By 2023, BKNG clarified that its **revenue is presented on a net basis**, with contracts granting travel service providers the ability to market their availability without transferring responsibility for delivering the travel services to BKNG. This means BKNG earns either **commissions or margins** on travel transactions, with revenue recognition occurring at the point when travelers begin using the arranged services. Additionally, BKNG outlined **merchant and agency revenue categories**, showing how it handles payments and commissions depending on whether it facilitates the payment process. These developments underscore a continued focus on maintaining a **collaborative, yet financially transparent, relationship** with travel service providers, where BKNG's contractual obligations remain limited to its platform facilitation role.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "BKNG (ORG) -> Travel Service Providers (COMP)",
        "Travel Service Providers (COMP) -> BKNG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BKNG_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BKNG_10k_2023.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8611,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2794,
        "completion_tokens": 334,
        "total_tokens": 3128
      }
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "In the 2023 10-K filing, Goldman Sachs disclosed its Executive Life Insurance Policies under exhibits 10.11 and 10.12, referencing policies with Metropolitan Life Insurance Company and Pacific Life & Annuity Company for Participating Managing Directors, both dated August 25, 2006. In the 2024 10-K filing, these same policies were also disclosed under exhibits 10.12 and 10.13, respectively, with no apparent changes to the policy terms or insurers. However, the 2024 filing included an additional exhibit, 10.1, which introduced a new Amended and Restated Clawback Policy effective December 1, 2023, not present in the 2023 filing. This indicates that while the structure and content of the executive life insurance policy disclosures remained unchanged between the two years, a new clawback policy was added in 2024, reflecting a broader update to executive compensation-related disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GS (ORG) -> Executive Life Insurance Policy (FIN_INST)",
        "Executive Life Insurance Policy (FIN_INST) -> GS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_246",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10010,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3146,
        "completion_tokens": 223,
        "total_tokens": 3370
      }
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "Between 2022 and 2024, the strategic importance of FBAR filters has grown, with Broadcom (AVGO) continuing to fabricate these proprietary components internally to protect its intellectual property and accelerate time-to-market, as highlighted in both 2022 and 2024 filings. In 2022, internal fabrication was emphasized for products like FBAR filters due to their innovative and proprietary nature, while in 2024, this approach remained consistent, underscoring their continued technological and competitive significance. The manufacturing approach has remained stable, with internal III-V semiconductor wafer fabrication in the U.S. and Singapore, and outsourcing commodity processes. Competitively, FBAR filters position AVGO against major players in the semiconductor space, including Qorvo, Skyworks, and Murata, where technical performance and IP protection are key differentiators. The strategic emphasis on internal fabrication and IP protection reflects AVGO’s ongoing efforts to maintain a strong competitive edge in the wireless communications market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Supplies]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> FBAR Filters (PRODUCT)",
        "FBAR Filters (PRODUCT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2022.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11894,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3616,
        "completion_tokens": 265,
        "total_tokens": 3881
      }
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "Between 2023 and 2024, BMY's strategic positioning of Krazati evolved significantly, both in clinical development and financial valuation. In 2023, Krazati was focused on multiple oncology indications, including first-line NSCLC with TPS<50%, second-line CRC, and second-line plus mutated NSCLC, with trials such as KRYSTAL-17, KRYSTAL-10, and KRYSTAL-12. By 2024, BMY acquired Mirati for $4.8 billion, gaining full commercial rights to Krazati, which is FDA and EMA approved for second-line NSCLC and advanced CRC, and is being developed in combination with a PD-1 inhibitor for first-line NSCLC. This acquisition not only expanded Krazati’s clinical and commercial footprint but also added significant financial valuation, with the transaction including a contingent value right potentially worth up to $1.0 billion tied to future regulatory milestones.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Krazati (PRODUCT)",
        "Krazati (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2520,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 213,
        "total_tokens": 1477
      }
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "Between 2022 and 2023, BKNG's relationship with travel service providers evolved in terms of financial obligations and incentives, reflecting increased business volumes and a more structured approach to managing performance obligations. In 2022, BKNG emphasized brand and performance marketing to maintain its competitive edge against entities like Google and traditional travel agencies, which also compete with or depend on travel service providers. By 2023, BKNG expanded its financial management practices, including the use of \"Deferred Merchant Bookings\" to track obligations to travel service providers, with these amounts largely representing future payments to them. Additionally, BKNG continued to offer incentive programs such as rebates and loyalty points, which are recognized as a reduction in revenue, further shaping its financial dynamics with travel service providers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "BKNG (ORG) -> Travel Service Providers (COMP)",
        "Travel Service Providers (COMP) -> BKNG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BKNG_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BKNG_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9834,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3112,
        "completion_tokens": 221,
        "total_tokens": 3334
      }
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "From 2022 to 2024, Broadcom's (AVGO) involvement in the development of Custom Touch Controllers has evolved from being a supplier of such products to explicitly listing them as a key product offering in the Wireless market segment. In 2022, Broadcom's 10-K filing indicated that it supplies custom touch controllers as part of its broader portfolio of wireless connectivity solutions. By 2024, Custom Touch Controllers are highlighted in the \"Key Product Offerings\" table under the Wireless category, signaling a more defined and strategic role in the product lifecycle, likely reflecting increased focus, innovation, or market demand for these components in mobile device connectivity applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> Custom Touch Controllers (PRODUCT)",
        "Custom Touch Controllers (PRODUCT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9689,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3067,
        "completion_tokens": 174,
        "total_tokens": 3242
      }
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "From 2023 to 2024, Union Pacific's approach to freight cars has shifted from primarily leasing to a more strategic focus on asset acquisition and modernization. In 2023, the company leased freight cars as part of its operational needs, as noted in its 10-K filing. By 2024, Union Pacific made lease buyouts totaling $143 million, signaling a move toward owning more of its freight car fleet. Looking ahead, the 2025 capital plan emphasizes continued investment in acquiring freight cars to support both replacement and growth opportunities, aligning with broader goals to enhance operational efficiency and network resilience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Acquires]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Freight Cars (PRODUCT)",
        "Freight Cars (PRODUCT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2124,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 156,
        "total_tokens": 1317
      }
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "Nike's structural changes in APLA between FY2022 and FY2023, particularly the transition of certain NIKE Brand businesses to third-party distributors, had notable financial and operational impacts. In FY2022, the transition resulted in a non-recurring impairment charge, primarily reflecting the anticipated release of non-cash cumulative foreign currency translation losses. This charge was recorded in the Corporate segment. By FY2023, the restructuring was referenced in the operating segments disclosure, with the transition affecting the APLA region and being detailed in Note 18 – Divestitures. Operationally, these changes reflect a strategic shift in how Nike manages its geographic operations, impacting both the financial reporting structure and the management of foreign exchange risk across its global segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NKE (ORG) -> APLA (GPE)",
        "APLA (GPE) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6549,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2279,
        "completion_tokens": 205,
        "total_tokens": 2484
      }
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "From 2022 to 2024, Broadcom's involvement with InP lasers has remained central to its internal fabrication strategy, as both entities are mutually connected in a reciprocal supply and product relationship (AVGO ↔ InP Lasers). In 2022, Broadcom highlighted its use of internal fabrication for products like InP lasers, which are critical for fiber optic communications, emphasizing the protection of IP and acceleration of time-to-market. By 2024, this strategy remained consistent, with Broadcom continuing to leverage its internal III-V semiconductor wafer fabrication in the U.S. and Singapore for InP laser production, while outsourcing commodity processes. This focus on internal fabrication for proprietary processes has strengthened Broadcom’s competitive positioning, enabling it to maintain a technological edge in high-performance optical communications and defend against a consolidating and increasingly competitive semiconductor market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Supplies]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> InP Lasers (PRODUCT)",
        "InP Lasers (PRODUCT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2022.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11894,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3611,
        "completion_tokens": 237,
        "total_tokens": 3848
      }
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "Between 2022 and 2023, Swoosh, LLC maintained a significant controlling stake in NIKE, Inc., beneficially owning approximately 77% of Class A Common Stock in both years. However, the ownership structure remained unchanged in terms of percentages, as Swoosh, LLC's ownership in Class A Common Stock would convert to approximately 16% of Class B Common Stock in both 2022 and 2023, assuming full conversion. This structure grants Swoosh, LLC substantial influence over corporate governance due to the enhanced voting rights of Class A shares, despite its smaller proportional ownership in Class B shares. The continued concentration of ownership in Swoosh, LLC, managed indirectly by Travis Knight, reinforces the potential for significant shareholder influence over strategic decisions, voting rights, and corporate direction, with implications for market stability and potential stock price volatility if shares were to be sold in large quantities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Affects_Stock]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Swoosh,LLC (COMP)",
        "Swoosh,LLC (COMP) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11803,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3595,
        "completion_tokens": 237,
        "total_tokens": 3832
      }
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "From 2022 to 2023, PMI advanced its strategic positioning of Reduced-Risk Products (RRPs) by integrating Swedish Match, a leader in oral nicotine delivery, into its portfolio, creating a global smoke-free combination led by IQOS and ZYN. This acquisition, completed in November 2022, expanded PMI's RRP offerings and contributed to the availability of smoke-free products in 84 markets by December 31, 2023. Additionally, PMI streamlined its business into four geographical segments and planned to integrate Swedish Match results into these segments starting in Q1 2024, enhancing portfolio integration and market alignment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "PM (ORG) -> Reduced-Risk Products (PRODUCT)",
        "Reduced-Risk Products (PRODUCT) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5657,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2055,
        "completion_tokens": 156,
        "total_tokens": 2211
      }
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "Caterpillar's strategic role in the reciprocating engines business has evolved from 2022 to 2024, with a shift toward integrated systems and solutions for marine, oil and gas, and industrial applications, as well as a focus on electrified powertrain and zero-emission technologies. In 2022, Caterpillar sold reciprocating engines primarily through its global dealer network and to other manufacturers, with Perkins Engines and FG Wilson contributing through their distributor networks. By 2024, the company expanded its offerings to include remanufacturing services for Caterpillar and third-party engines, signaling a move toward lifecycle solutions. This evolution has likely enhanced Caterpillar’s revenue composition by diversifying into higher-margin service and technology-based solutions, potentially improving gross margin potential through value-added services and reduced reliance on commodity-driven pricing pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Reciprocating Engines (PRODUCT)",
        "Reciprocating Engines (PRODUCT) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10739,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3331,
        "completion_tokens": 232,
        "total_tokens": 3564
      }
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon maintained a consistent mechanism for disclosing amendments to the Directors' Code of Conduct by committing to post such changes on its official website, specifically at the provided URLs. However, the 2023 filing included a slightly updated URL path for the Code of Conduct document, indicating a potential reorganization or update in the website's structure. In both years, the company emphasized transparency by explicitly stating its intent to disclose amendments and waivers related to the Directors' Code of Conduct, ensuring stakeholders were informed through its publicly accessible corporate governance section.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Announces]- ORG",
      "triplets_used": [
        "BK (ORG) -> Amendments to Directors' Code of Conduct (ACCOUNTING_POLICY)",
        "Amendments to Directors' Code of Conduct (ACCOUNTING_POLICY) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4517,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1806,
        "completion_tokens": 163,
        "total_tokens": 1970
      }
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "Between FY22 and FY23, Nike's strategic approach to the APLA market evolved through a stronger focus on its Consumer Direct Acceleration strategy, which emphasized direct-to-consumer operations and digital transformation. In FY22, Nike reported strong growth in its NIKE Direct business in APLA, driven by North America, APLA, and EMEA, despite supply chain disruptions and a resurgence of COVID-19 in Greater China. By FY23, the APLA segment remained a key operational focus, with its results now managed within the broader geographic operating segments, including both NIKE and Jordan brands. Nike also transitioned certain APLA businesses to third-party distributors, as noted in Note 18 of the FY23 10-K, reflecting a more streamlined and localized operational structure. These changes highlight Nike’s shift toward optimizing market participation through a mix of direct and selective wholesale channels while aligning with its long-term digital and consumer-centric strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NKE (ORG) -> APLA (GPE)",
        "APLA (GPE) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9928,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3112,
        "completion_tokens": 245,
        "total_tokens": 3358
      }
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "From 2022 to 2024, Favorable Price Realization has consistently positively impacted Caterpillar’s sales and profitability. In 2021 (as detailed in the 2022 10-K), sales increased by 22% to $50.971 billion, with favorable price realization contributing alongside higher demand and inventory changes. By 2024 (as shown in the 2024 10-K), despite a 3% decline in total sales to $64.809 billion due to lower sales volume, favorable price realization partially offset this decline and helped maintain profitability, with profit increasing to $10.792 billion from $10.335 billion in 2023. Thus, while sales volume declined, favorable price realization remained a key driver in sustaining and even improving Caterpillar’s profitability over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> MACRO_CONDITION <-[Positively_Impacts]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Favorable Price Realization (MACRO_CONDITION)",
        "Favorable Price Realization (MACRO_CONDITION) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4628,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1800,
        "completion_tokens": 186,
        "total_tokens": 1986
      }
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "Between 2023 and 2024, General Motors has evolved its approach to EV manufacturing capacity by increasing strategic investments and focusing on supply chain development to support long-term EV demand. In 2023, GM emphasized its commitment to expanding EV manufacturing capacity, acknowledging the risks and uncertainties tied to demand expectations. By 2024, the company further solidified its strategy by planning to develop a more resilient, scalable, and sustainable North American EV supply chain, including strategic sourcing initiatives and multi-year supply agreements with raw material suppliers. This shift reflects a broader focus on securing supply chain stability and reducing reliance on external constraints, as GM aims to align its manufacturing capacity with regulatory and market demands for EVs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GM (ORG) -> EV Manufacturing Capacity (PRODUCT)",
        "EV Manufacturing Capacity (PRODUCT) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12940,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3879,
        "completion_tokens": 203,
        "total_tokens": 4083
      }
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "Based on the disclosed remaining performance obligations in the 10-K filings, Pfizer's financial commitment to Paxlovid has significantly declined from 2022 to 2024. In 2022, while Paxlovid was a key focus as an emergency use authorized treatment, no specific remaining performance obligation amount for Paxlovid was disclosed. However, by 2024, the remaining performance obligations for Paxlovid were approximately $1 billion as of December 31, 2024, compared to $4 billion for Comirnaty (the vaccine). This indicates a notable reduction in contracted future revenue for Paxlovid, reflecting shifting demand and evolving public health needs over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Paxlovid (PRODUCT)",
        "Paxlovid (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9245,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2944,
        "completion_tokens": 164,
        "total_tokens": 3108
      }
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "Between 2022 and 2023, Caterpillar has enhanced its approach to monitoring supplier financial viability by maintaining and reinforcing its global strategic sourcing models, which aim to build long-term supplier relationships and leverage enterprise spend. In both years, Caterpillar utilized contractual agreements with suppliers to protect its intellectual property and processes, while monitoring key risks such as supplier financial viability, production flexibility, business continuity, quality, and delivery. In 2023, Caterpillar continued to emphasize the importance of supplier financial stability amid ongoing supply chain disruptions, reflecting a consistent but increasingly vigilant risk mitigation strategy compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> RISK_FACTOR <-[Monitors]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Supplier Financial Viability (RISK_FACTOR)",
        "Supplier Financial Viability (RISK_FACTOR) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9716,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3083,
        "completion_tokens": 184,
        "total_tokens": 3267
      }
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "Between 2022 and 2024, Visa has evolved its **Risk and Identity Solutions** by positioning it more prominently within its **value-added services**, reflecting a strategic shift toward diversifying revenue and enhancing client offerings. In 2022, Visa described its Risk and Identity Solutions as part of its broader suite of value-added services, which included issuing, acceptance, and advisory services, emphasizing secure and efficient money movement. By 2024, Visa explicitly categorized **Risk and Identity Solutions** as one of five core categories of value-added services, alongside Issuing and Acceptance Solutions, and highlighted its role in helping clients optimize performance and mitigate fraud. This evolution underscores Visa’s broader strategy to provide **network-agnostic services** and expand beyond traditional payment processing, leveraging its global network to deliver integrated, modular solutions that support both Visa and non-Visa transactions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "V (ORG) -> Risk and Identity Solutions (PRODUCT)",
        "Risk and Identity Solutions (PRODUCT) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9003,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2901,
        "completion_tokens": 242,
        "total_tokens": 3143
      }
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "The company's exposure to shelf space limitations as a risk factor has intensified between 2022 and 2023, as retail trade customers have increasingly imposed limitations on access to shelf space, often leveraging their bargaining power to demand higher trade discounts and investments. In 2022, the risk was tied to the growing concentration of retail trade and the rise of large-format and eCommerce retailers, which limited shelf access and could lead to delisting or reduced visibility for the company's products. By 2023, this risk had worsened due to evolving retail landscapes, including the continued growth of eCommerce and the emergence of alternative retail channels like subscription services and direct-to-consumer models, which have created pricing pressures and strained relationships with key retailers. These changes have further exposed the company to potential declines in sales and profitability, underscoring the negative impact of retail customer policies and channel shifts on its business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "CL (ORG) -> Shelf Space Limitations (RISK_FACTOR)",
        "Shelf Space Limitations (RISK_FACTOR) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10893,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3386,
        "completion_tokens": 253,
        "total_tokens": 3639
      }
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "Between fiscal years 2023 and 2024, Oracle has reinforced its strategic emphasis on hybrid deployments by expanding and refining its product offerings to provide greater flexibility and interoperability. In 2023, Oracle highlighted its hybrid deployment models, such as Oracle Exadata Cloud@Customer and Dedicated Region offerings, emphasizing the integration of on-premise and cloud-based environments to meet diverse customer needs. By 2024, Oracle continued to position hybrid deployments as a core component of its IT strategy, maintaining and enhancing its comprehensive suite of Oracle Cloud Services (SaaS and OCI), which enable customers to seamlessly transition between deployment models. Additionally, Oracle's ongoing investment in research and development—reaching $8.9 billion in fiscal 2024—supports the innovation and enhancement of these hybrid solutions, reinforcing Oracle's commitment to delivering flexible, secure, and interoperable technologies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Hybrid Deployments (PRODUCT)",
        "Hybrid Deployments (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9437,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2999,
        "completion_tokens": 241,
        "total_tokens": 3241
      }
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "Based on the provided information, Pfizer's financial commitment to Paxlovid has significantly decreased between 2022 and 2024. In 2022, while the company acknowledged Paxlovid's potential for ongoing revenue, it also noted uncertainty about post-pandemic revenue levels. By 2024, the remaining performance obligations for Paxlovid were approximately $1 billion, compared to $4 billion for Comirnaty, indicating a much smaller contractual revenue commitment for Paxlovid. This reflects a shift in focus and financial exposure, with Paxlovid's role diminishing relative to Comirnaty in Pfizer's long-term revenue outlook.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Paxlovid (PRODUCT)",
        "Paxlovid (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11385,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3481,
        "completion_tokens": 155,
        "total_tokens": 3636
      }
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "Between 2022 and 2023, Caterpillar's relationship with its independent dealers has remained centered on contractual obligations under standard sales and service agreements, which grant dealers the right to sell and service Caterpillar products within specified geographic territories. In 2023, these agreements emphasized the dealer's obligations to promote Caterpillar products, maintain adequate personnel and inventory, and provide feedback on product safety, while Caterpillar continued to support dealers with pricing guidance, warranty, and technical support. The strategic emphasis has remained on leveraging this global dealer network to build long-term customer relationships, as highlighted in 2022, with no significant changes to the contractual framework or strategic focus observed in the provided information.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Partners_With]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Independent Dealers (COMP)",
        "Independent Dealers (COMP) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2022.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9233,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2949,
        "completion_tokens": 205,
        "total_tokens": 3155
      }
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "From 2022 to 2023, the company's financial allocation and operational focus related to Africa/Eurasia evolved with increased capital expenditures and restructuring charges. In 2022, capital expenditures in Africa/Eurasia were $33 million, up from $13 million in 2021, indicating a growing operational focus in the region. In 2023, the 2022 Global Productivity Initiative included restructuring charges for Africa/Eurasia estimated at 10% of the total $200–$240 million range, reflecting strategic reallocation and operational streamlining efforts in the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "CL (ORG) -> Africa/Eurasia (GPE)",
        "Africa/Eurasia (GPE) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2873,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 140,
        "total_tokens": 1497
      }
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "From 2022 to 2024, Qualcomm has maintained and deepened its strategic focus on 5G technologies, emphasizing both investment and commercialization. In 2022, Qualcomm highlighted its ongoing significant investments in 5G-based technologies and new product areas such as automotive and IoT, aiming to extend its technologies beyond mobile handsets. It acknowledged the challenges of entering new industries with long design cycles and high regulatory standards, while stressing the importance of 5G development and commercialization for future growth. By 2024, Qualcomm continued to invest in the development of 5G and its foundational intellectual property, maintaining a leading patent portfolio for LTE and 5G NR. Commercialization outcomes were evident in QTL licensing revenues, primarily driven by sales of OFDMA-based 5G products, including multimode 3G/4G/5G devices. The company also expanded its strategic investments through Qualcomm Ventures, supporting early-stage opportunities in 5G and related fields, further reinforcing its commitment to 5G leadership and ecosystem growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> 5G Technologies (PRODUCT)",
        "5G Technologies (PRODUCT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2022.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12940,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3873,
        "completion_tokens": 272,
        "total_tokens": 4145
      }
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "Between 2022 and 2024, Pfizer's financial and strategic positioning of Paxlovid evolved significantly. In 2022, Paxlovid contributed $76 million in revenue, primarily due to its role in addressing high-risk COVID-19 infections. By 2024, contractual commitments for Paxlovid were reflected in remaining performance obligations of approximately $1 billion, indicating ongoing supply obligations to customers, with expected deliveries from 2025 through 2028. Additionally, 2024 saw a $771 million favorable adjustment in revenue related to returned EUA-labeled treatment courses, demonstrating the financial impact of revised expectations around U.S. government inventory returns. This highlights both the initial revenue contribution and the evolving contractual and financial dynamics surrounding Paxlovid.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Paxlovid (PRODUCT)",
        "Paxlovid (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13140,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3922,
        "completion_tokens": 201,
        "total_tokens": 4124
      }
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "Between 2022 and 2023, Colgate-Palmolive (CL) has maintained its exposure to credit market tightness as a supply chain risk, with the risk explicitly listed in both years as a factor that could negatively impact its operations through its suppliers’ access to credit or capital. In 2022, the company highlighted the potential impact of tighter credit or capital markets on suppliers as part of a broader list of supply chain risks, emphasizing the vulnerability of its supply chain to external financial conditions. In 2023, the company reiterated this risk, maintaining it in the same context, suggesting that the company’s vulnerability to credit market tightness has remained consistent. This continuity indicates that while CL has not reduced its exposure to this risk, it continues to manage it through business continuity and contingency planning, reflecting ongoing caution about its vulnerability to external financial conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "CL (ORG) -> Credit Market Tightness (RISK_FACTOR)",
        "Credit Market Tightness (RISK_FACTOR) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2023.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7294,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2483,
        "completion_tokens": 234,
        "total_tokens": 2717
      }
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "From 2022 to 2024, Pfizer's financial commitment and contractual obligations related to Paxlovid evolved significantly. In 2022, Paxlovid received Emergency Use Authorization (EUA) in the U.S. in December 2021 and Conditional Marketing Authorization (CMA) in the EU in January 2022, indicating its rapid deployment to combat the pandemic. By 2024, Pfizer disclosed remaining performance obligations for Paxlovid totaling approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. Additionally, 2024 included a $771 million favorable adjustment related to the return of EUA-labeled treatment courses by the U.S. government, reflecting changes in government inventory management and revenue recognition. These figures highlight a shift from initial high-volume government procurement in 2022 to a more stabilized contractual commitment and financial adjustment phase by 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Paxlovid (PRODUCT)",
        "Paxlovid (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7487,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2505,
        "completion_tokens": 234,
        "total_tokens": 2740
      }
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "From 2023 to 2024, the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved as follows: In 2023, the parent company (MMM) had an accrual of $574 million for respirator mask/asbestos liabilities (excluding Aearo accruals) and paid $88 million in legal defense costs and settlements, with an additional $57 million increase in accruals for these liabilities. By 2024, through its Aearo subsidiary, the company had established a more specific accrual of $51 million for Aearo-related asbestos, silica-related, and coal mine dust claims. This reduction reflects the impact of an agreement with Cabot, which limits Aearo's liability to exposures alleged to have occurred on or after January 1, 1997, and an informal cost-sharing arrangement among the Payor Group. However, the risk exposure remains significant due to uncertainties in future claim volumes, legal costs, and potential disruptions in the Payor Group’s financial viability or contractual obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Involved_In]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Aearo Holding Corp. (COMP)",
        "Aearo Holding Corp. (COMP) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12609,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3787,
        "completion_tokens": 254,
        "total_tokens": 4041
      }
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "The retail share of Skoal, a product of MO, decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in its market presence. Comparing this to its shipment volume trend, Skoal's shipment volume also declined between 2020 and 2021, dropping from 208.5 million to 197.4 million units, indicating a consistent downward trend in both retail share and shipment volume over these periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Skoal (PRODUCT)",
        "Skoal (PRODUCT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2145,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 97,
        "total_tokens": 1267
      }
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "From 2022 to 2024, Qualcomm's approach to multimedia technologies has evolved by expanding its engineering focus areas to include more advanced capabilities such as computer vision, sensor perception, and AI integration, particularly through the development of specialized engines like NPU for low-power computing. In 2022, the company emphasized enhancing existing products and supporting new applications like automotive and IoT through strategic investments and R&D in multimedia technologies such as camera, video, and display. By 2024, Qualcomm further integrated these advancements into broader product offerings, including automotive systems for connectivity and digital cockpit, and extended its AI research to generative AI with a focus on on-device execution and power efficiency. This evolution reflects Qualcomm's strategy to diversify its multimedia technologies across multiple industries and device categories, enhancing the performance and value of its integrated chipsets and platforms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Develops]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> Multimedia Technologies (PRODUCT)",
        "Multimedia Technologies (PRODUCT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12269,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3712,
        "completion_tokens": 250,
        "total_tokens": 3963
      }
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "Between 2023 and 2024, 3M's financial relationship with the Aearo Entities evolved significantly due to reconsolidation and related financial adjustments. In the second quarter of 2023, 3M reconsolidated the Aearo Entities after their bankruptcy proceedings were dismissed, reversing a prior deconsolidation in 2022. At the end of 2022, 3M had a $0.7 billion equity investment in the Aearo Entities and a $0.6 billion net liability for intercompany balances. By December 31, 2023, these balances were eliminated from 3M's consolidated balance sheet due to reconsolidation. Additionally, in January 2024, 3M amended the CAE Settlement to pay cash instead of stock for the $1 billion equity portion, further solidifying the financial interconnection between 3M and the Aearo Entities during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Reconsolidates]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Aearo Entities (COMP)",
        "Aearo Entities (COMP) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11027,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3394,
        "completion_tokens": 200,
        "total_tokens": 3595
      }
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "Between 2022 and 2024, Visa's Risk and Identity Solutions have evolved to become a more strategically central component of the company's broader value-added services portfolio. In 2022, the solutions were primarily highlighted for their role in transforming data into insights for fraud prevention and account authentication, supporting the security of digital and omnichannel commerce. By 2024, the strategic positioning of Risk and Identity Solutions had expanded to align with Visa’s three-part value-added services strategy, which includes providing services for Visa transactions, delivering network-agnostic solutions for non-Visa transactions, and offering services that go beyond payments. This evolution reflects Visa's broader focus on enhancing security, trust, and innovation across the payment ecosystem, with Risk and Identity Solutions now playing a key role in enabling secure, real-time, and integrated payment experiences for clients and partners.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "V (ORG) -> Risk and Identity Solutions (PRODUCT)",
        "Risk and Identity Solutions (PRODUCT) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8815,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2854,
        "completion_tokens": 241,
        "total_tokens": 3095
      }
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "RTX's Acquisition Accounting Adjustments had a negative impact of $1,998 million on operating profit in 2023, compared to $1,893 million in 2022, indicating an increase in the negative impact by $105 million. While the 2024 text chunk does not explicitly quantify the 2024 Acquisition Accounting Adjustments, it provides context on related FAS/CAS adjustments, which were influenced by changes to Raytheon’s domestic pension plans effective December 31, 2022. These changes also affected the 2023 adjustments, suggesting a continued impact from acquisition-related accounting in 2024, though the exact figure for 2024 is not disclosed in the provided data.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "RTX (ORG) -> Acquisition Accounting Adjustments (ACCOUNTING_POLICY)",
        "Acquisition Accounting Adjustments (ACCOUNTING_POLICY) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2024.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5139,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1936,
        "completion_tokens": 164,
        "total_tokens": 2100
      }
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "Between fiscal years 2022 and 2023, Microsoft's Office 365 Commercial revenue contributed to the growth of the Microsoft Cloud, which increased from $91.4 billion in 2022 to $111.6 billion in 2023. While specific Office 365 Commercial figures are not provided, its inclusion in the broader Microsoft Cloud revenue and the disclosed growth in Productivity and Business Processes revenue in 2022 (driven by Office 365 Commercial) indicate a positive growth trajectory. This suggests that Office 365 Commercial remains a key driver within the Microsoft Cloud ecosystem, supporting its continued expansion alongside Azure and other cloud services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Office 365 Commercial (PRODUCT)",
        "Office 365 Commercial (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3128,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 160,
        "total_tokens": 1600
      }
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "Merck's alliance revenue related to Lynparza grew by 9% in 2024 compared to the prior year, primarily driven by higher demand in most international markets. This growth was further supported by the January 2025 approval of Lynparza in China for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, which expanded its market reach. Additionally, the collaboration structure for Lynparza involves Merck's share of profits from product sales, net of costs, as outlined in the 2023 10-K, which provides the foundational context for how alliance revenue is calculated and reported.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Lynparza (PRODUCT)",
        "Lynparza (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5336,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1961,
        "completion_tokens": 160,
        "total_tokens": 2121
      }
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "The treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024 in terms of its inclusion in equity compensation reporting and regulatory context. In 2023, the plan was referenced in the context of related regulations and additional terms and conditions, as seen in the exhibit listings. By 2024, the 2014 Plan was explicitly included in the equity compensation reporting under Item 12 of the 10-K, alongside other active plans such as the 2009 and 2019 Stock and Incentive Compensation Plans, indicating its ongoing relevance in the company’s equity compensation framework and compliance with SEC reporting requirements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PG (ORG) -> 2014 Stock and Incentive Compensation Plan (ACCOUNTING_POLICY)",
        "2014 Stock and Incentive Compensation Plan (ACCOUNTING_POLICY) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2023.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15608,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4579,
        "completion_tokens": 170,
        "total_tokens": 4750
      }
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "In the 2023 10-K filing, the 1992 Stock Plan is referenced as one of the historical equity compensation plans adopted by Procter & Gamble, specifically under Exhibit (10-3), indicating its role as an earlier framework for equity compensation. By the 2024 10-K filing, the 1992 Stock Plan is still listed among the active equity compensation plans under Item 12, but it is now grouped with more recent plans such as the 2001, 2009, 2014, and 2019 Stock and Incentive Compensation Plans, suggesting a diminished role within the company's broader and more updated equity compensation structure. This evolution reflects the company's shift toward newer, more flexible compensation frameworks while retaining the 1992 Plan as part of its legacy structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Adopts]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PG (ORG) -> 1992 Stock Plan (ACCOUNTING_POLICY)",
        "1992 Stock Plan (ACCOUNTING_POLICY) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8522,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2781,
        "completion_tokens": 187,
        "total_tokens": 2968
      }
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "Between 2023 and 2024, the company (ACN) has maintained a strong emphasis on large-scale transformations, as highlighted in both the 2023 and 2024 10-K filings. Despite economic and geopolitical uncertainties affecting client spending—particularly on smaller, shorter-duration contracts and consulting services—clients have continued to prioritize large-scale transformation initiatives. These projects convert to revenue over a longer period, indicating a shift in spending patterns toward more strategic, long-term investments. This trend reflects a growing client preference for sustained, high-impact engagements, which aligns with ACN’s focus on and investment in large-scale transformation offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Large-Scale Transformations (PRODUCT)",
        "Large-Scale Transformations (PRODUCT) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9958,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3139,
        "completion_tokens": 176,
        "total_tokens": 3315
      }
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "Accenture issued 7,970 Class A Ordinary Shares for employee share programs in fiscal 2024, as shown in Chunk 2. This issuance, as part of employee compensation, increased additional paid-in capital by $1,943,912 and impacted retained earnings by reducing it by $103,889, while treasury shares increased by $841,720 and 3,292 shares. Comparing this to fiscal 2023, as described in Chunk 1, shares were primarily acquired via share withholding for payroll tax obligations related to employee equity awards, with no impact on the overall share purchase authorization. Thus, the 2024 issuance reflects a continuation of employee compensation through share programs, affecting the equity structure by increasing paid-in capital and adjusting retained earnings and treasury shares.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Class A Ordinary Shares (FIN_INST)",
        "Class A Ordinary Shares (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6373,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2240,
        "completion_tokens": 193,
        "total_tokens": 2434
      }
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "MDLZ's exposure to Canadian-denominated debt instruments increased from a net outflow of $3 million in 2022 to $8 million in 2023, reflecting a growing liability position in Canadian notes. This contrasts with the company's overall trend in managing foreign currency-denominated debt during the period, where it reduced exposure to other currencies such as the Euro, British pound, and Swiss franc, as seen in the net outflows for these instruments in 2023 compared to 2022. The shift highlights a strategic reallocation of debt obligations, with MDLZ decreasing its reliance on some foreign currencies while increasing its exposure to Canadian-denominated debt.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Canadian notes (FIN_INST)",
        "Canadian notes (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2398,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 165,
        "total_tokens": 1420
      }
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "From 2023 to 2024, Accenture has evolved its approach to engaging with growth-stage companies by deepening its strategic involvement and maintaining active investment activity through Accenture Ventures. In both years, Accenture Ventures partners with and invests in growth-stage companies that develop innovative enterprise technologies, reflecting a consistent commitment to fostering emerging innovation. Additionally, the firm has reinforced its innovation ecosystem by leveraging its global network of over 100 innovation hubs, as well as its R&D investments—$1.3 billion in 2023 and $1.2 billion in 2024—to support the development and scaling of cutting-edge solutions. This evolution underscores Accenture’s strategic focus on aligning with and accelerating the growth of innovative enterprises while enhancing its own technological capabilities and client offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Growth-Stage Companies (COMP)",
        "Growth-Stage Companies (COMP) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7716,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2572,
        "completion_tokens": 218,
        "total_tokens": 2790
      }
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "From 2022 to 2024, Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca has shown growth in alliance revenue and continued amortization of the associated intangible asset. In 2022, Merck reported an intangible asset balance of $1.1 billion related to Lynparza, which includes capitalized milestone payments and is being amortized through 2028. By 2024, alliance revenue from Lynparza grew by 9%, driven by higher demand in international markets, including a significant approval in China in January 2025 for adjuvant treatment of early breast cancer. This growth reflects both the ongoing commercial success of Lynparza and the strategic expansion into new geographies, supported by the shared development and commercialization framework with AstraZeneca.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Amortizes_Asset]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Lynparza (PRODUCT)",
        "Lynparza (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6379,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2241,
        "completion_tokens": 198,
        "total_tokens": 2439
      }
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "AVGO's strategic emphasis on ValueOps has evolved from being a key offering within the Distributed Software portfolio in 2023 to a more central role in 2024, as it is now explicitly positioned alongside DevOps and AIOps as a domain that delivers end-to-end visibility across the digital lifecycle. This shift indicates that ValueOps is playing an increasingly critical role in aligning business, development, and operational teams to optimize the planning, development, and delivery of business-critical services, reflecting AVGO's broader focus on enhancing digital transformation and operational efficiency for its customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> ValueOps (PRODUCT)",
        "ValueOps (PRODUCT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14029,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4145,
        "completion_tokens": 156,
        "total_tokens": 4301
      }
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "Between 2023 and 2024, FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolved from emphasizing the potential operational efficiencies and network flexibility to a more cautious outlook, acknowledging heightened implementation risks and uncertainties in achieving expected cost savings. In 2023, the focus was on the importance of Network 2.0 as part of the DRIVE strategy, with recognition that failure to execute could adversely affect financial results and operational alignment with demand. By 2024, FedEx outlined specific integration challenges, such as legal challenges, cultural differences, and unforeseen expenses, which could delay or increase the cost of implementation. The 2024 filing also highlighted the risk of not achieving the anticipated cost savings and permanent cost structure reductions, emphasizing that actual outcomes may differ from initial expectations, thus underscoring a more risk-conscious and realistic assessment of the transformation's trajectory.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Network 2.0 (PRODUCT)",
        "Network 2.0 (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11418,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3498,
        "completion_tokens": 252,
        "total_tokens": 3750
      }
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "Between 2022 and 2023, the financial impact from MDLZ's equity method investment contracts shifted from no reported impact in 2022 to a gain of $7 million in 2023, as disclosed in the respective 10-K filings. This change suggests an improvement in the performance or valuation of these investments during 2023. Additionally, the inclusion of equity method investment contracts in MDLZ's derivative instruments in 2022, with a net asset value of $(3) million, indicates that MDLZ maintains a strategic engagement with these investments, actively managing their financial exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Equity Method Investment Contracts (FIN_INST)",
        "Equity Method Investment Contracts (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5061,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1918,
        "completion_tokens": 144,
        "total_tokens": 2063
      }
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained consistent at $38 million from fiscal year 2023 to fiscal year 2024, as reported in both the 2023 and 2024 10-K filings. This stability in the estimated cost to complete, combined with a 67% completion rate, suggests that the development progress for this product aligns with initial expectations, with no significant cost overruns or delays observed during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Announces]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> VMware Cloud Foundation July 2024 Releases (PRODUCT)",
        "VMware Cloud Foundation July 2024 Releases (PRODUCT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3934,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1656,
        "completion_tokens": 118,
        "total_tokens": 1774
      }
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "Between 2023 and 2024, the strategic positioning of FedEx Office's Ship and Go kiosk has evolved by reinforcing its integration with broader e-commerce logistics and returns management solutions, as highlighted in both chunks. In 2023, the Ship and Go kiosk was described as a self-serve shipping solution in approximately 1,300 locations, enabling customers to generate shipping labels via mobile or QR code and drop off packages securely. By 2024, the kiosk's role was further contextualized within a more comprehensive ecosystem, including FedEx Returns Technology and FedEx Consolidated Returns, which streamline in-store return label printing and no-box/no-label return drop-offs. This evolution indicates that FedEx is enhancing the Ship and Go kiosk as a central touchpoint for both outbound shipping and returns, reflecting a strategic focus on providing seamless, customer-centric logistics solutions tailored to the growing e-commerce market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Ship and Go Kiosk (PRODUCT)",
        "Ship and Go Kiosk (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11897,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3625,
        "completion_tokens": 238,
        "total_tokens": 3863
      }
    }
  ]
}